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Abstract 
 
 Mammalian cell cultures are nowadays adopted as industrial platforms for monoclonal 
antibody (mAb) manufacture. Although improving product quality and expression stability 
becomes predominant these days, enhancement in mAb production still remains one of the 
greatest challenges facing the industrial biotechnology community. One of reasons behind this 
is the synthesis of mAb is restricted by the decline phase occurring in the mammalian cell 
cultures as a result of cell death. Prolongation of culture viability via suppression of cell death 
appears as a potential strategy to improve mAb production and productivity. Understanding of 
cell death in the mammalian cell cultures is, therefore, crucial to the improvement of the 
strategy toward mAb production and productivity enhancement. 
 Apoptosis, or programmed cell death, is found to be the major cause of culture viability 
loss in the mammalian cell cultures. It is a highly-organised physiological process of cell death 
that can be triggered through activation of the genetic programme underlying a signal cascade 
that governs particular morphological and physiological changes in response to extracellular 
and intracellular stimuli. In order to devise strategies to optimise degrees of apoptosis in the 
mammalian cell cultures, understanding of apoptosis is inevitable. However, to establish the 
understanding of apoptosis is an extremely challenging task given the complexity arising from 
the dynamic nature of apoptosis and its association with internal and external milieu, including 
other cellular processes and environmental conditions.   
 This thesis presents a combined experimental and modelling approach for a study of 
apoptosis in GS-NS0 cell cultures, aiming to identify relevant metabolic stresses, evaluate their 
impact on apoptosis induction, and investigate kinetics of apoptosis in response to the identified 
stresses. The novelty of this study is a systemic view of apoptosis where apoptosis is studied 
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in accordance with dynamic changes in culturing conditions, as well as cell proliferation and 
metabolic activities. Batch culture experiments of GS-NS0 cell line demonstrate interplay 
between apoptosis and other cellular processes, including cell cycle progression and 
metabolism. In addition, the batch cultures allow evaluating impact of metabolic stresses and 
culture conditions on induction of apoptosis. Fed-batch culture experiments help validate links 
between apoptosis and metabolic stresses as suggested based on the batch cultures, and also 
shed some light on feeding strategies for a delay in apoptosis induction. The first-principles 
mathematical model for apoptosis in the GS-NS0 cell cultures demonstrates a good 
reproduction of the experimental data. Model analysis reveals model characteristics through 
global parameter sensitivities and helps guide further model modification toward development 
of a predictive apoptosis mathematical model. 
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Nomenclature  
 
V    The total volume of the system (L) 
Fin    The total flowrate of feeding streams (L/hr)  
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   than apoptosis (hr-1) 
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Glcin    The concentration of fed glucose (mM) 
Qglc    The specific glucose utilisation rate (mmol.cells
-1.hr-1) 
Yx, glc    The yield of cells over glucose (cells/mmol) 
mglc    The glucose-associated maintenance energy constant  
   (mmol.cells-1.hr-1) 
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Qlac, pro, Qlac, con  The specific lactate production and consumption rates,   
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Qala, con, Qgln, con glutamine utilisation rates, respectively (mmol.cells
-1.hr-1) 
Qala, pro, Qgln, pro  The specific alanine and glutamine production rates,   
   respectively (mmol.cells-1.hr-1) 
fglu, asp, fglu, arg, fglu, ala The yield of glutamate over aspartate, arginine, alanine and   
fglu, gln   glutamine, respectively (mmol/mmol) 
Yx, glu    The yield of cells over glutamate (cells/mmol) 
mglu    The glutamate-associated maintenance energy constant   
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   effect (mM) 
Asp    The extracellular concentration of aspartate (mM) 
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fasp, asn    The yield of aspartate over asparagine (mmol/mmol) 
Yx, asp    The yield of cells over aspartate (cells/mmol) 
masp    The aspartate-associated maintenance energy constant   
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Arg    The extracellular concentration of arginine (mM) 
Argin    The concentration of fed arginine (mM) 
Qarg    The specific arginine utilisation rates (mmol.cells
-1.hr-1) 
Yx, arg    The yield of cells over arginine (cells/mmol) 
marg    The arginine-associated maintenance energy constant  
   (mmol.cells-1.hr-1) 
Kmarg, arg   The Monod constant for arginine-associated arginine limiting effect 
   (mM)  
Ala   The extracellular concentration of alanine (mM) 
Yala, glu   The yield of alanine over glutamate (mmol/mmol) 
Yx, ala    The yield of cells over alanine (cells/mmol) 
mala    The alanine-associated maintenance energy constant  
   (mmol.cells-1.hr-1) 
Kmala, glu   Monod constant for alanine-associated glutamate limiting effect  
   (mM) 
Gln    The extracellular concentration of glutamine (mM) 
Ygln, glu   The yield of glutamine over glutamate (mmol/mmol) 
Yx, gln    The yield of cells over alanine (cells/mmol) 
mala    The alanine-associated maintenance energy constant  
   (mmol.cells-1.hr-1) 
Kmala, glu   The Monod constant for alanine-associated glutamate limiting effect  
   (mM) 
Leu   The extracellular concentration of leucine (mM) 
Qleu    The specific leucine utilisation rates (mmol.cells
-1.hr-1) 
Yx, leu    The yield of cells over leucine (cells/mmol) 
mleu    The leucine associated maintenance energy constant  
   (mmol.cells-1.hr-1) 
Kmarg, arg   The Monod constant for leucine -associated leucine limiting effect  
   (mM) 
Ab    The extracellular concentration of mAb (mg/L) 
Qab    The specific mAb prediction rate (mg.cells
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 ~ XIV ~ 
mRNAatf5   The relative fold change of atf5 expression (-) 
βmRNAatf5  The maximal fold change of atf5 expression (hr-1) 
Kmasp, atf5, Kmab, atf5  The Monod constants for atf5 associated-aspartate (mM) and mAb  
   (mg/L) limiting effect, respectively 
αmRNAatf5   The mRNA degradation rate of atf5 (hr-1)  
mRNA trp53bp2   The relative fold change of trp53bp2 expression (-) 
βmRNAtrp53bp2   The maximal fold change of trp53bp2 expression (hr-1) 
Kmglu, trp53bp2,   The Monod constants for trp53bp2 associated-glutamate and lactate 
Kmlac, trp53bp2  limiting effect, respectively (mM) 
αmRNAtrp53bp2   The mRNA degradation rate of trp53bp2 (hr-1)  
mRNAcasp8   The relative fold change of casp8 expression (-) 
βmRNAcasp8   The maximal fold change of casp8 expression (hr-1) 
Kmglu, casp8   The Monod constant for casp8 associated-glutamate limiting effect 
   (mM) 
αmRNAcasp8   The mRNA degradation rate of casp8 (hr-1)  
mRNAbcl2   The relative fold change of bcl-2 expression (-) 
βmRNAbcl2   The maximal fold change of bcl-2 expression (hr-1) 
Kmtrp53bp2, bcl-2,  The Monod constants for trp53bp2 and atf5 limiting effects,  
Kmatf5, bcl-2  respectively, on bcl-2 expression (-) 
αmRNAbcl2   The mRNA degradation rate of bcl-2 (hr-1) 
mRNAbax   The relative fold change of bax expression (-) 
βmRNAbax   The maximal fold change of bax expression (hr-1) 
Kmbcl-2, bax   The Monod constants for bcl-2 and trp53bp2 limiting effects, 
Kmtrp53bp2, bax  respectively, on bax expression (-) 
αmRNAbax   The mRNA degradation rate of bax (hr-1) 
mRNAcasp3   The relative fold change of casp3 expression (-) 
βmRNAcasp3   The maximal fold change of casp3 expression (hr-1) 
Kmcasp3, iC3   The Monod constant for caspase 3 limiting effect, respectively, on 
casp3    expression (mM) 
αmRNAcasp3   The mRNA degradation rate of casp3 (hr-1)  
iCasp3   The concentration of procaspases-3 (mM) 
Casp3,   The concentration of Caspases-3 (mM)  
Bax4    The concentration of active bax (mM)  
Casp8    The concentration of caspase-8 (mM)  
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βiC3   The maximal procaspase-3 translation rate based on the expression of 
   casp3 (mmol.hr-1) 
kC3, kC8   The rate constants for active bax and caspase-8, respectively,  
   associated-caspase-3 activation (L.mmol-1.hr-1) 
KbiC3    The Monod constant for mRNAcasp3 limiting effect on the translation of 
   procaspase-3 (-) 
iBax, Bcl2   The concentration of inactive Bax and Bcl-2, respectively (mM) 
βibax    The maximal inactive Bax translation rate based on the expression of 
   bax (mmol.hr-1) 
kbax, k_bax   The rate constants for the Bax tetramerization (L
3.mmol-3.hr-1) and the 
   inhibitive binding of Bcl-2 to active Bax (L.mmol-1.hr-1), respectively 
Kbibax    The Monod constant for mRNAbax limiting effect on the translation of 
   inactive Bax (-) 
βbcl2    The maximal Bcl-2 translation rate based on the expression of bcl2 
   (mmol.hr-1) 
Kbbcl2    The Monod constant for mRNAbcl2 limiting effect on Bcl-2 translation  
βcasp8    The maximal caspase-8 translation rate based on the expression of  
   casp8 (mmol.hr-1) 
KbC8    The Monod constant for mRNAcasp8 limiting effect on the translation of 
   caspase-8 (-) 
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1.1 Motivation 
 
 Mammalian cell culture systems are the reliable platforms for the manufacture of 
monoclonal antibodies (mAbs), one of the most important bio-therapeutics. Given the 
continuously increasing global demand for mAbs (Buss et al., 2012, Elvin et al., 2013), 
attention is drawn to optimisation of the mammalian cell culture systems toward improved 
mAb productivity as well as product quality (Torkashvand et al., 2015). Currently, 
improvement of mAb production becomes relatively mature; as high as 10 g/L of mAbs can be 
achieved from fed-batch cultures of mammalian cells, and research on mAb-producing cell 
culture systems has started to focus on shortening times spent for process development and 
improving product quality as well as expression stability (Li et al., 2010, Ho et al., 2013). 
However, given the steady increase in global demand for mAbs, further enhancing the mAb 
production/productivity in order to reduce the manufacturing cost remains one of greatest 
challenges facing the biotechnology community (Xing et al., 2012, Nasseri et al., 2014, Kang 
et al., 2014).    
The cellular mAb synthesis is subject to a number of factors, nevertheless, its strong 
association with metabolic stresses is predominant in batch and fed-batch cultures, which are 
widely utilised for large-scale mAb production (Whitford, 2006). These metabolic stresses, 
which include nutrient exhaustion as well as toxic metabolite accumulation, affect the cell cycle 
at the centre of growth, productivity and cell death - lowering the culture lifespan and the final 
mAb titre. An insight into the interrelationship between the metabolic stresses, and cell 
proliferation as well as death is therefore required in order to develop strategies for the 
improvement of the mAb-production platforms toward the optimisation of mAb 
production/productivity. 
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 Apoptosis, or programmed cell death, is believed to be the main cause of viability loss 
in mammalian cell cultures (Goswami et al., 1999, DiStefano et al., 1996, Browne and Al-
Rubeai, 2011a, Singh et al., 1994). The induction of apoptosis is strongly subject to the 
metabolic stresses, including deprivation of nutrients (Simpson et al., 1998, Moley and 
Mueckler, 2000, Browne and Al-Rubeai, 2011b) and accumulation of toxic metabolites 
(Mastrangelo et al., 2000b, Figueroa et al., 2001). Moreover, there is strong interplay between 
the onset of apoptosis and cell cycle progression (Simpson et al., 1999b, Tey and Al-Rubeai, 
2005, Mazel et al., 1996), and its impact on mAb production/productivity (Ibarra et al., 2003, 
Tey and Al-Rubeai, 2005). The onset of apoptosis was also found to be affected by culture 
conditions, such as culture temperature (Moore et al., 1997, Shi et al., 2005, Swiderek and Al-
Rubeai, 2007) and the addition of nutrients during the culture period (DiStefano et al., 1996, 
Zhou et al., 1997a). These established facts attest the major involvement of apoptosis in the 
mammalian cell cultures, representing a mechanism of cell death as well as its links to 
environmental as well as physiological conditions. Given that prolonged culture viability is 
preferable due to the detrimental effects of cell death on mAb production and product quality 
(Yoon et al., 2003b, Majid et al., 2007, Tey et al., 2000a), understanding of apoptosis kinetics 
in association with the metabolic stresses is potentially the key to develop strategies to achieve 
longer culture viability, and thus higher mAb production/productivity as well as better product 
quality.     
 Apoptosis is however a highly complex cellular processes, which can be triggered 
through several pathways involving a number of apoptotic factors formed into regulatory 
networks governing apoptosis in response to both intracellular and extracellular apoptotic 
signals (Majors et al., 2007, Hengartner, 2000). Adding to its complexity, apoptosis has strong 
links to other cellular processes, as discussed above. Therefore, it is difficult to gain clear 
understanding of apoptosis kinetics by solely relying on in-vitro investigation. Using 
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mathematical modelling; mathematical equations relate culturing conditions including 
temperature, nutrient feeding strategies as well as medium composition, to cellular activities 
including growth, death (apoptosis), metabolism and product (mAb) synthesis, complements 
the understanding of apoptosis obtained from the experimental study. The systematic and 
quantitative nature of mathematical modelling enables us to simulate changes in variables of 
interest over time, and thus quantitatively explore and/or predict effects of the changes in these 
variables on cellular activities (Augusto et al., 2008). In addition, given its capability to 
simulate and predict dynamics of cell behaviour under different culturing conditions, 
mathematical modelling can be exploited for experimental planning (i.e. design of experiment), 
and thus reduce a number of possible trial and error experiments. It can also be used to guide 
process design, scaling up, optimisation as well as control of bioreactors when it comes to the 
development of large-scale mAb production platforms (Augusto et al., 2008). Therefore, it is 
essential to conduct in-silico study together with experimental investigation to establish 
insights into apoptosis kinetics. This approach is potentially one of the most effective 
approaches to study apoptosis. 
 The constructed mathematical model can be valid only for the system as well as the 
experimental conditions that the mathematical model is constructed based on. For example, 
different culture performances (growth, metabolism and death) are commonly seen among 
cultures of different lines of a mammalian cell host (i.e. NS0 cell lines), and thus the model 
constructed based on a line of the host might not be valid for other lines of the same cell host. 
Given that mathematical models are constructed based on existing general and relevant 
molecular biology together with experimental observation, they can be therefore refined, which 
might involve re-estimating parameter values and modifying model equations based on the 
experimental data from other culture systems and experimental conditions different from ones 
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used for the model construction. In this way, the model validity can be extended for the 
different culture systems and different culturing conditions.  
1.2 Thesis structure 
 
 The outline of this thesis is as follow:  
 Chapter 1 describes the brief background and motivation behind the thesis. The 
structure of the thesis is also included in this chapter. 
 Chapter 2 presents a literature review. The review includes relevant molecular biology 
as well as apoptosis. An overview of mammalian cell cultures for the production of mAbs as 
well as factors that affect culture performance are also included. The effects of culture 
conditions, including culture temperature, medium contents and addition of nutrients, are 
discussed here. This chapter also provides a detailed review of apoptosis inhibition and cell 
cycle regulation–associated strategies for the improvement of mammalian cell cultures toward 
a higher production of bio-therapeutics. Finally, the frameworks for model development as 
well as model analysis are also summarised here. Additionally, existing mathematical models 
for the mammalian cell cultures as well as apoptosis are presented.  
 Chapter 3 lists research gaps identified from the literature review in Chapter 2. Given 
the identified research gaps, the research goal of the thesis is also introduced in this chapter. 
 Chapter 4 describes materials and methods applied in this study. The procedures for 
the cultures of GS-NS0 cell line, including medium preparation, cryopreservation and cell 
expansion, are described. The experimental conditions, including batch and fed-batch modes 
of cultures, are also elucidated. The procedures for analytical techniques, which include cell 
analysis and extracellular metabolite measurements, are also briefly summarised. The summary 
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of experimental data analysis as well as the method for statistical analysis are also included in 
this chapter. Appendix A includes the supplementary details of the analytical technique 
procedures as well as the calculation examples for the data analysis. 
 Chapter 5 presents the study of apoptosis in the batch culture of GS-NS0 cell line. This 
chapter reveals the effect of identified metabolic stresses - inherently occurring in the batch 
culture - upon the induction of apoptosis. In addition, metabolic shifts in response to the 
metabolic stresses are also elucidated. A map of cell cycle, apoptosis and metabolism for the 
batch culture of GS-NS0 cell line is herein presented.   
 Chapter 6 focuses on the study of culture condition effects on the induction of 
apoptosis. This chapter presents the effect of temperature shifts on the onset of apoptosis, cell 
proliferation, and mAb productivity. In addition, the effects of different medium blends on 
transcriptional control of apoptosis as well as the regulation of cell cycle progression are 
discussed. In this chapter, metabolic shifts and apoptosis induction as a result of the addition 
of nutrients are explored. Supplementary results are included in Appendix B.        
 Chapter 7 presents the mathematical model for apoptosis in the culture of GS-NS0 
cells. This chapter illustrates mathematical model expressions constructed based on the 
observed phenomena discussed in Chapter 5 & 6. The model reproducibility with the 
preliminary set of parameter estimates is discussed here. In addition, model characteristics and 
further improvements suggested by model analysis are also described in this chapter.    
 Chapter 8 provides the main conclusion and the possible future research direction 
based on what was achieved in this study.      
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2.1 Cell biology 
 
2.1.1 An overview of mAb synthesis-associated cellular processes  
 Synthesis of mAb involves cellular metabolism. There are two cellular processes 
involved: catabolism and anabolism (Alberts et al., 2002), as shown in Figure 2.2.1. The former 
is where basic building blocks, including amino acids and nucleotides, as well as cellular 
energy, such as adenosine triphosphate (ATP) nutrients, are produced through the breakdown 
of macro-molecules, such as glucose. The latter involves synthesising macromolecules 
including proteins, by utilising the cellular energy and the basic building blocks obtained from 
the catabolism. 
 
Figure 2.1.1 An overview of cell metabolism; catabolism and anabolism. Adapted from 
(O'Connor and Adams, 2010). 
 Controlling these metabolic activities is the central dogma, which involves cellular 
processes at transcriptional and translational levels. These processes are whereby regulatory 
molecules, including proteins and enzymes, are synthesised in response to external and internal 
stimuli and in turn translocated throughout the entire cellular system to manipulate cellular 
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biochemical activities (Shuler and Kargi, 2002). The stimuli are basically connected to changes 
in intracellular and extracellular conditions, such as the presence/absence of nutrients and heat 
shock (O'Connor and Adams, 2010).  
Transcription and translation processes 
The type of protein present in a cell and its amount are basically controlled by 
transcription and translation processes whereby proteins are synthesised. It begins from 
deoxyribonucleic acids (DNAs) where genetic information is stably stored as a sequence of 
three-letter long codes forming from four types of nucleobases: A (Adenine), G (Guanine), C 
(Cytosine) and T (Thymine) or U (Urasil) in ribonucleic acids (RNAs). Then the genetic 
information is transcribed into RNA molecules, which in turn serve as templates for protein 
synthesis. The process where information flows from DNA to RNA is called “transcription” 
and the process where information flows from RNA to protein is called “translation” (O'Connor 
and Adams, 2010).  
 
 
 
 
 
 
 
 
Figure 2.1.2 An overview of transcription 
and translation in eukaryotic cells. Adapted 
from (O'Connor and Adams, 2010). 
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Figure 2.1.3 Alternative splicing. Adapted from (Clancy, 2008b). 
DNA molecules have two strands bound with each other forming double helix chains. 
One strand is used at a time as a template for transcription. The template strand is called "the 
noncoding strand" while the coding strand refers to the strand not serving as a template for 
transcription but having the same sequence as the single-stranded RNA produced from 
transcription. However, there are times that both strands serve as templates given that they are 
at the same time transcripted in a different direction. The process of transcription starts once 
RNA polymerase, an enzyme that catalyses the synthesis of RNA, binds to a region on the 
DNA template strand, called promoter. The activity of RNA polymerase; whether it proceeds 
to transcription, is basically controlled by regulatory proteins acting in accordance with 
intracellular and extracellular stimuli. These proteins can be "activators" or "repressors". When 
these proteins bind to regions on the template strand, the former helps facilitate the activity of 
RNA polymerase while the latter inhibits the transcription. When transcription is initiated, the 
DNA double helix unwinds as the RNA polymerase adds nucleobases onto the RNA chain 
according to the nucleobases it reads on the template strand. The transcription terminates 
differently depending the type of RNA polymerase used in the process. The termination of 
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transcription can rely on either factors that helps unwind the bond between DNA and RNA or 
a termination sequence on the template strand, i.e. a stop codon (Clancy, 2008a, O'Connor and 
Adams, 2010). 
The single-stranded RNA obtained from the transcription process is called the 
“precursor messenger RNA” (pre-mRNA) which is premature and contains sequences that will 
not be used for protein synthesis. “Introns” are the sequences that are removed from the pre-
mRNA while “exons” are the sequences that remain in the pre-mRNA (Figure 2.1.2). The 
process of removing introns and chaining exons is called "splicing". Splicing occurs in many 
steps involving cleavage of the pre-mRNA at splice sites (conserved sequences at the two ends 
of introns), the attachment onto a complementary sequence within introns of small nuclear 
ribonucleoproteins (snRNPs) that catalyse the process, and introns looping out as well as 
covalently bonding between adjacent exons. Given that there are a large number of introns and 
exons in a single pre-mRNA molecule, different forms of mature messenger RNAs (mRNAs) 
arising from various combinations of exons can be achieved through splicing. This is so-called 
"alternative splicing" as can be seen in Figure 2.1.3 (Clancy, 2008b). Two forms of IgM 
immunoglobulin molecules, for example, are encoded by two different forms of mRNA 
molecules obtained through splicing though only a gene underlies the synthesis of these two 
mRNA molecules (Early et al., 1980). 
It is worth noting here that not all RNA molecules after transcription become mRNA 
molecules which are later used for protein synthesis. Those RNA molecules not converted into 
mRNA molecules are called non-coding RNAs (ncRNAs). The ncRNA molecules include key 
RNA molecules, such as transfer RNAs (tRNAs) and ribosomal RNAs (rRNAs) used in 
translation, and microRNAs which play a role in regulating splicing and post-transcriptional 
regulation. It was suggested that there are thousands of ncRNAs existing, most of which have 
functionality while some of which might be non-functional (van Bakel et al., 2010). 
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mRNA molecules after splicing and before being transported to cytoplasm are  
modified through adding the 5-prime end cap and the polyA tail (4 adenosine molecules) as 
can be seen in Figure 2.1.2. The mature mRNA then undergoes the translation process, which 
involves complex molecules arising from ribosomes or rRNAs, initiation factors and decoders 
or tRNAs. These tRNA molecules have genetic codes corresponding to the codes on mRNA 
molecules, which are so-called anticodons. The tRNA molecules also carry amino acids 
corresponding to the codons. These amino acids are basically building blocks of protein 
molecules. The protein synthesis happens when amino acids are linearly bonded to yield a long-
chain polypeptide. This process can selectively take place in either cytoplasm or rough 
endoplasmic reticulum (RER) where a larger number of ribosomal units are attached on its 
surface (Alberts et al., 2002).  
The synthesised polypeptides chains or proteins need to be folded and modified before 
they become functional. There are a number of types of post-translational modification (PTM) 
which have difference characteristics and occur at different places inside cells. Protein folding 
and assembly normally take place at Endoplasmic Reticulum (ER). Only properly folded and 
assembled proteins are transported to Golgi Apparatus while unfolded or misfolded ones are 
detained in the ER (Lodish H, 2000). Therefore, overexpression of protein synthesis (Kober et 
al., 2012) as well as misfolding of synthesised proteins can potentially lead to the ER stress, in 
turn activating cellular responses in order to alleviate the stress including cell death (Sano and 
Reed, 2013, Reynaud, 2010).  
Catabolism 
There is a series of three main pathways underlying how sugar molecules, such as 
glucose, are broken down into smaller molecules. As illustrated in Figure 2.1.4, the cytoplasmic 
glucose is passed through the first pathway, glycolysis, in which the glucose is split into two 
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molecules of pyruvates. With a sufficient supply of oxygen, the pyruvate is transferred to the 
mitochondrion and is converted into a molecule of Acetyl CoA, containing two carbon atoms, 
before entering into the eight-stage citric acid cycle or TCA cycle (O'Connor and Adams, 
2010). 
 
Figure 2.1.4 The breakdown of glucose into CO2 and H2O via three pathways of catabolism 
in eukaryotic cells: Glycolysis, Citric acid cycle (TCA cycle), and Oxidative phosphorylation. 
Adapted from (O'Connor and Adams, 2010). 
Glycolysis and TCA cycle generate energy-containing molecules: ATPs, as well as 
electron carriers: NADH, FADH2 and GTP. The electron carriers are then entered into the inner 
mitochondrial membrane where the final catabolic pathway, called the electron transport chain, 
takes place. Here, with the aid of transmembrane protein complexes, electrons are transferred 
from the electron carriers, across the membrane, to oxygen molecules (O2) which in turn form 
molecules of water (H2O). The difference of hydrogen ion concentration across the membrane 
causes the gradient of electrostatic potential inducing electron transferring. Every single 
electron transferred across the membrane, three molecules of ATP are achieved. It is worth 
noting that lack of O2 availability can result in incomplete oxidation of pyruvate molecules. 
This generates several products other than CO2. Lactate, for example, could be obtained via 
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glycolysis when there is need for cellular energy without sufficient supply of O2 (O'Connor and 
Adams, 2010).    
The structure of an antibody  
 Antibodies are protein molecules secreted from B lymphocyte cells to recognise 
antigenic determinants before disabling them via binding interactions. There are five classes, 
or isotypes, of antibodies: IgA, IgG, IgM, IgE and IgD. IgG is the most common one found in 
blood and extracellular fluid. 
 Figure 2.1.5 illustrates the general structure of an 
antibody. The Y-shape structure is structured from two 
identical long-chain polypeptides (or called heavy chains) 
and two identical short-chain polypeptides (or called light 
chains). The two identical top ends of the antibody are where 
antigens bind to antibodies, or antigen-binding sites. These 
sites are so variable that a number of different binding sites 
exist to specifically capture various types of antigens. An 
antigen binding site contains a variable region and a constant 
region. It is relatively stable compared to the variable region (Alberts et al., 2002).      
 B lymphocyte cells can produce a number of molecules of antibodies which have an 
identical antigen binding site. These cells are therefore utilised to produce antibodies which 
have a single specificity to an antigen, called monoclonal antibodies (mAbs). By fusing a B 
lymphocyte cell (extracted from a mammal immune system) with a cancer cell (i.e. a myeloma 
cell), a resulting cell, so-called “hybridoma”, which inherits characteristics of unlimited 
lifetime and antibody secretion from the B lymphocyte cell and cancer cells, can be achieved 
(Kohler and Milstein, 1975). This cell becomes a basis for the mAb production platform.    
Figure 2.1.5 The structure of 
IgG antibody. Adapted from 
(http://www.jenabioscience.com). 
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Glycosylation 
 After the translational process, proteins or antibodies are required to be structurally 
modified to generate their bioactivities, or so-called “the post-translational process”. N-linked 
glycosylation is one of the post-translational modification processes, where an oligosaccharide 
side chain (N-acetyl-glucosamine, or NAG) is covalently linked to a polypeptide chain at 
asparagine building block before further modifications.  
 The process initially takes place at the ER. Here, a branch of oligosaccharide chains 
with 14 sugar molecules is covalently attached to asparagine building blocks in polypeptide 
chains. Then, the attached oligosaccharide chains are trimmed by several specific enzymes to 
gradually eliminate the 14 sugar molecules. This process ends at Golgi apparatus. Finally, 
additional sugars or amino-sugar molecules are added to enable the polypeptide chains to have 
bioactive structures (Shuler and Kargi, 2002).    
 It is worth discussing that eukaryotic cell-based antibody producing platforms do not 
always produce humanlike, N-linked glycosylation antibodies. The secreted antibodies with 
non-human like N-linked glycosylation patterns may lack desired bioactivity. Consequently, 
they could not reach antigenic targets and they may initiate unwanted responses from immune 
systems (Shuler and Kargi, 2002). The type of antibody producing platforms or cell hosts can 
indicate how human like N-linked glycosylation pattern is. Moreover, a number of culture 
conditions can affect glycosylation profiles (Rodrigues et al., 2010).  
Cell cycle 
Cell cycle is a basic physiological process that represents how cells divide and are 
increased in numbers through cell division. There are five phases in cell cycle progression as 
can be seen from Figure 2.1.6. The phase where cells perform normal physiological activities 
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and grow, called G1 phase. However, in this phase cells can enter a state where the progress of 
cell growth as well as their physiological activities are halted. This is called G0 phase. In this 
phase, cells can either resume their proliferation states as well as normal physiological 
activities, or undergo programmed cell death, subject to signals, such as nutrient availability. 
It can takes about 9 hours in G1 phase for cells with a high growth rate (Alberts et al., 2002).  
 
 
Figure 2.1.6 Cell cycle and DNA content according to each phase in the cycle. Adapted from 
(O'Connor, 2008). 
 Cells later undergo the synthesis phase, or S phase, where cells prepare to undergo cell 
division, or G2 phase, and mitosis, or M phase, when receiving mitogenic signals. DNA 
molecules in the nucleus begin to duplicate in S phase (Figure 2.1.6). In typical animal cells, it 
takes around 10-12 hours in S phase, and much shorter (4.5 hours) for G2 phase. G1, S and G2 
phases can be all termed “interphase”. Cells perform complete cell division and end the cell 
cycle at M phase where cells break down nucleuses and form two identical daughter cells, 
having identical genetic information (Alberts et al., 2002). 
 
G0 
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Cell death 
 Generally, cell death can be classified into two types according to causes and 
physiological processes underlying cell death: necrosis and apoptosis. Through signal 
transduction cascades, apoptosis allows cells to programme themselves to die in response to 
lethal signals. In contrast, cells die via necrosis as a result of severe culture conditions. Necrotic 
cells typically become swollen and are finally broken down to release intracellular contents 
(Arden and Betenbaugh, 2004).    
  It was established that more than four-fifths of cell deaths in a serum-free culture of 
Chinese Hamster Ovary (CHO) cells are caused by apoptosis (Goswami et al., 1999). This 
directly affects the number of viable cells as well as production of bio-therapeutics, such as 
mAb. In the next section, apoptosis is reviewed given its significant influence on the 
mammalian cell cultures for the production of bio-therapeutic proteins. 
2.2 Apoptosis 
  
2.2.1 Apoptosis pathways 
 There are two main apoptotic pathways: the death-receptor pathway or the extrinsic 
pathway, and the mitochondrial pathway or the intrinsic pathway (Hengartner, 2000). As 
shown in Figure 2.2.1, apoptosis can be initiated through the two pathways in response to 
intracellular and extracellular lethal signals. Caspase-3, an aspartate-specific cysteine protease, 
is the final executor of apoptosis. As a result of activation of caspase-3, apoptosis can ultimately 
happen. The activation of caspase-3 is also where the two pathways execute apoptosis. The 
inactive form of caspase molecules is called “procaspases”, which requires proteolytic cleavage 
to become active (Arden and Betenbaugh, 2004). In addition to caspase-3, caspase-6 and 
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caspase-7 are believed to be among final executioners of apoptosis in the apoptotic pathways 
(Majors et al., 2007).   
 
Figure 2.2.1 Apoptotic pathways: the death-receptor pathway and the mitochondrial 
pathway. Adapted from (Hengartner, 2000). 
The death-receptor pathway is triggered by extracellular lethal signals. The signals are 
transduced through interactions between death receptors and death ligands, as can be seen in 
Figure 2.2.1. CD95 is for example one of the death receptors belonging to the tumour necrosis 
factor super-family (Arden and Betenbaugh, 2004). The death receptors lie across the cell 
membrane and become activated when binding to ligands. The recruitment of a protein FADD 
(Fas-associated death domain) is triggered by the activation of the death receptor. Procaspase-
8 molecules, an initiator of apoptosis, are bound to FADD, forming a complex where (active) 
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caspase-8 molecules are then released. However, the activation of caspase-8 can be inhibited 
by the recruitment of c-FLIP molecules, an anti-apoptotic protein (Sprick and Walczak, 2004). 
 As illustrated in Figure 2.2.1, mitochondria are central to signal transduction in the 
intrinsic pathway. Pro-apoptotic proteins in this pathway can be divided into two groups: one 
residing in cytoplasm, such as Bax and Bad, and the other residing in the space between outer 
and inner mitochondrial membranes, such as cytochrome c and Smac/DIABLO. Under 
exposure to internal and/or external apoptotic signals, there is a morphological change in the 
structure of the outer mitochondrial membrane, which is associated with Bax molecules, as can 
be seen in Figure 2.2.1. This change affects integrity of the mitochondrial membrane and 
formation of transport channels; including the mitochondrial permeability transition pore (PTP) 
and voltage-dependent anion channels (VDAC), whereby release of pro-apoptotic proteins 
residing inside the mitochondria, especially cytochrome c, is triggered (Majors et al., 2007). 
Release of cytochrome c is a necessary event for activation of caspase-9. Apoptosome is a 
complex molecule that is composed of cytochrome c, procaspase-9 and apoptosis protein 
activation factor-1 (Apaf-1). It activates caspase-9, which in turn triggers activation of caspase-
3 (Hengartner, 2000).   
 In the mitochondria-meditated apoptotic pathway, proteins in the Bcl-2 family play 
important roles in controlling the progression of apoptosis. These proteins can be categorised 
into three specific groups: anti-apoptotic members, such as Bcl-2 and Bcl-xL; pro-apoptotic 
members; Bax and Bak; and pro-apoptotic BH3-only members, such as Bid, Bad and Bim 
(Arden and Betenbaugh, 2004, Krampe and Al-Rubeai, 2010). Bcl-2 and Bcl-xL are essential 
survival factors that hinder pro-apoptotic effects of active Bax molecules on release of pro-
apoptotic factors from mitochondria, as shown in Figure 2.2.1. They were found to suppress 
Bax and Bid translocation to the outer mitochondrial membrane, and thus limit the 
morphological change in mitochondrial membrane, which is required for the activation of 
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caspase-9 (Majors et al., 2007). Bid is essentially a link between the extrinsic and intrinsic 
pathways, where death signals from the ligand-receptors interactions can be transduced to the 
mitochondria-meditated apoptotic pathway. Activation of caspase-8 can induce Bid to become 
activated (truncated Bid). The truncated Bids then activate Bax molecules (Figure 2.2.1), which 
in turn induce the mitochondria-associated apoptosis (Hengartner, 2000). 
It is worth discussing about the role of the pro-apoptotic BH3 proteins, including Bad, 
Bim, Noxa and Puma, which can be activated in accordance with cellular stresses, including 
DNA damage, shear stress and toxins, through several pathways (Majors et al., 2007). The role 
of Bad is to promote apoptosis via binding with Bcl-xL on the mitochondrial membrane. 
However, when Bad is phosphorylated, it loses its ability to bind the anti-apoptotic proteins. 
Phosphorylation of Bad was found to be associated with Protein kinase B (Akt), which plays 
key roles in many pathways underlying cellular processes including cellular survival, cell cycle 
and metabolism. Despite under exposure of cellular stresses due to nutrient deprivation, UV-
radiation, serum/growth factor withdrawal, and DNA damage, activation of Akt can 
phosphorylate Bad molecules, and ultimately inhibit apoptosis induction (Peso et al., 1997, 
Brognard et al., 2001, Hirai and Wang, 2001, Hwang and Lee, 2009). Jun N-terminal kinases 
(JNK) family, a group of cellular stress (UV radiation, heat and osmotic shock)-activated 
protein kinase enzymes, was also found to regulate apoptosis through interactions with the 
BH3-only proteins. In addition to caspase-8 activation, the tBid can be achieved through the 
activation of JNK, in turn promoting release of Smac/DIABLO and ultimately apoptosis via 
activation of caspase-9. JNK can also phosphorylate Bad, but at a different site to that by Akt. 
The phosphorylated Bad by JNK binds to Bcl-2, resulting in the inhibition of Bcl-2 activities 
(Dhanasekaran and Reddy, 2008).   
As can be seen from Figure 2.2.1, p53; a tumour suppressor as well as a sequence-
specific transcription factor, plays a role in the apoptotic pathway. It has been reported to play 
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important roles in growth arrest, cellular repair, and especially apoptosis through activation of 
the pro-apoptotic proteins. In general, p53 activities were reported to be controlled by a number 
of kinases underlying p53 phosphorylation required for its activation, and MDM2, the key 
antagonist of p53 found to normally mono-ubiquitinates p53 in order to stabilise its activities 
and to facilitate the degradation of p53 (Moll and Petrenko, 2003, Amaral et al., 2010). The 
cellular stresses (i.e. DNA damage) activate p53 (through stress kinases) and, at the same time, 
suppresses MDM2 activities, making p53 more vulnerable to be activated through kinase-
associated phosphorylation. The activated p53 has been reported to induce apoptosis in several 
ways. One of them is to directly induce homo-oligomerisation of Bax as well as Bak molecules 
required for the activation of these molecules. These active molecules in turn translocate onto 
the mitochondrial membrane and induce the release of cytochrome c, and ultimately the 
intrinsic pathway. In addition, the activated 53 can also directly bind to Bcl-2 and Bcl-xL to 
neutralise their anti-apoptotic effects (Speidel, 2010, Hengartner, 2000, Amaral et al., 2010). 
Table 2.2.1 Target genes of p53 transcription factor. 
p53 transcriptional targets Roles references 
Bcl-2 family 
    bax 
    puma 
    noxa 
    bid 
    bcl-2 
    bcl-xL 
Death Receptor 
    DR5 
    CD95, Fas or APO-1 
Adapters 
    apaf-1 
    surviving 
 
+ 
+ 
+ 
+ 
- 
- 
 
- 
- 
 
+ 
- 
 
[1], [2] 
[1] 
[1] 
[1], [2] 
[2] 
[2] 
 
[1], [2] 
[1], [2] 
 
[1] 
[2] 
Caspases 
casp8 
 
+ 
 
[3] 
  +; up-regulation, -; down-regulation, [1] ;(Schuler and Green, 2005), [2] ;(Speidel, 2010) and [3] (Liedtke et al., 
2003). 
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Figure 2.2.2 The association of atf5 and trp53bp2 genes with the apoptotic pathways. 
In addition to the transcription-independent pro-apoptotic function, the activated p53 
can basically regulate apoptosis predominately through transcriptional activities (Amaral et al., 
2010). There are a number of transcriptional targets of p53 as can be seen from Table 2.2.1. 
Among those are genes representing the BH3 pro-apoptotic proteins including bax, noxa and 
puma. In addition, p53 can also up-regulate the death receptor pathway associated genes 
including CD95, Fas and casp8. In addition to the transcriptional targets of p53 as shown in 
Table 2.2.1, there are a number of genes that were found to be relevant to the transcription-
independent pro-apoptotic function of p53. The genes of activating transcription factor 5 (atf5) 
and transformation related protein 53 binding protein 2 (trp53bp2) were among those, which 
were reported to be significantly up-regulated during the culture of a mammalian cell line and 
their unregulated levels were suggested to be linked with cellular stresses (Browne and Al-
Rubeai, 2011b). As can be seen from Figure 2.2.2, the level of atf5 expression was believed to 
be dependent on the ER stress as well as amino acid deprivation (Watatani et al., 2007, Zhou 
et al., 2008) while trp53bp2 expression was suggested to be associated with cellular stresses 
(Browne and Al-Rubeai, 2011b). The up-regulation of atf5 activates bcl-2 (gene) expression 
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(Dluzen et al., 2011), providing a link to the apoptotic pathway via down-regulation of bax 
(gene) and Bcl-2 and Bax expression (Paul-Samojedny et al., 2005). 53BP2, the p53 binging 
protein 2 encoded by trp53bp2, was found to induce apoptosis through binding to p53 as well 
as Bcl-2 (Naumovski and Cleary, 1996, Samuels-Lev et al., 2001, Kobayashi et al., 2005). 
Given the targets of p53 (Table 2.2.1) and 53BP2, a link between trp53bp2 and the apoptosis 
pathway could be drawn (Figure 2.2.2). 
In addition to the apoptosis-associated role, p53 can also play regulatory roles in many 
cellular processes. Among those is control of cell cycle progression, where p53 was found to 
target one of important cell cycle regulator genes; CDKN1A (p21) encoding p21 protein 
(cyclin-dependent kinase inhibitor 1) (Li et al., 1994). This protein underlies cell growth arrest 
through directly interactions with cyclin-CDK complexes, in turn inhibiting the activity of 
these complexes required for the cell cycle phase transition (Goubin and Ducommun, 1995, 
Cazzalini et al., 2010). It was reported that p53 activation in response to DNA damage 
meditates the activity of p21, which then inhibits the activity of cyclin E/CDK2 complex, 
required for the G1 to S cell cycle phase transition, and ultimately causing cell cycle arrest at 
G1 phase (El-Deiry et al., 1994). In addition, p21 activation in response to cellular stresses was 
also found to regulate the G2 cell cycle phase checkpoint through suppressing the activation of 
cyclin A/CDK1/2 complexes as well as cyclin B1-CDK1 complex, leading to cell cycle arrest 
at this phase (Charrier-Savournin et al., 2004). Both p53 and p21 expression levels were found 
to be up-regulated by the exposure to hypothermia (Kaija et al., 2015) and hyperthermia 
(Ohtsubo et al., 2000, Abe, 2001), suggesting the regulatory role of p53/p21 pathway in 
apoptosis and cell cycle progression in response to the temperature-associated stress. Given its 
impact on cell cycle regulation, it was suggested that p53 could also provide the anti-apoptotic 
effect through the p21-associated pathway in response to cellular stresses, despite p21 being 
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also found to be associated with a number of pathways underlying cellular processes other than 
cell cycle arrest (Cazzalini et al., 2010). 
2.2.2 The ER stress-associated apoptotic pathway 
 
Figure 2.2.3 The upstream signalling of ER-stress associated pathways. Adapted from 
(Logue et al., 2013). 
In addition to the two apoptotic pathways as discussed above, apoptosis can be induced 
by the ER-associated stress. This typically arises from increased protein synthesis as well as 
misfolding of proteins to the extent that protein chaperones (the protein folding assistants) 
cannot manage, though it can be developed from other factors (Tabas and Ron, 2011). In 
response to the ER stress, cells develop the unfolded protein response (UPR) in order to manage 
the accumulation of unfolded proteins within the ER lumen to relieve the stress (Logue et al., 
2013). The UPR basically relies on activation of three upstream factors, including protein 
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kinase RNA (PKR)-like ER kinase (PERK), activating transcription factor 6 (ATF6), and 
inositol-requiring enzyme 1 (IRE1). These three proteins sense the ER stress (due to 
unfolded/misfolded protein accumulation), and later become active (via detaching the GRP78 
(or BIP) chaperone protein) and proceed the UPR via their own pathways. The pathways are 
illustrated in Figure 2.2.3. 
 
Figure 2.2.4 Caspase activation through the ER-stress associated pathway. Adapted from 
(Szegezdi et al., 2006). 
As can be seen from Figure 2.2.3, the active IRE1 promotes splicing of the transcription 
factor called XBP-1 in response to unfolded protein accumulation. This form of XBP-1 
(spliced) can activate transcription of various proteins underlying cellular activities required to 
restore ER homeostasis (i.e. ER chaperone, ER associated degradation, secretory pathway-
associated species as well as transcription factors: pro-apoptotic CHOP and XBP-1 itself) 
(Logue et al., 2013). Due to the dissociation of GRP78, PERK undergoes dimerization and 
autophosphorylation to become active. The active PERK then phosphorylates eIF2α which can 
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in turn inhibit translation. The active eIF2α also activates ATF4 which later translocates to the 
nuclease and triggers transcription of various proteins underlying amino acid biosynthesis, 
chaperones, secretory pathways and pro-apoptotic CHOP. It is worth noting here that eIF2 was 
reported to also affect the ATF5 mRNA level (Zhou et al., 2008). ATF6 becomes active in 
response to the ER stress through translocation to Golgi apparatus and cleavage by two 
proteases: S1P and S2P. The active ATF6 then translocates to the nuclease and drives 
transcription of proteins; including chaperones, ER degradation (EDEM1), CHOP and XBP1, 
providing pro-survival impact in response to the ER stress (Szegezdi et al., 2006, Logue et al., 
2013). It is worth noting that these three pathways take place selectively and in different timing; 
for example the simultaneous activation of the three pathways is not necessary to always take 
place in response to the severe ER stress (Tabas and Ron, 2011). 
The UPR appears to be a pro-survival mechanism in response to the ER stress given its 
activation targets, however, UPR can change from pro-survival to pro-apoptotic under 
exposure to a persistent and severe ER stress (Logue et al., 2013). Central to the ER-stress 
associated apoptotic pathway is release of calcium ions (Ca2+) from the ER, causing change in 
cytoplasmic Ca2+ levels, which in turn triggers apoptosis via activation of caspase-12, the 
mitochondrial apoptotic species, and ultimately activation of caspase-3 (Majors et al., 2007). 
The link between the upstream signalling of UPR-associated pathway and the release of Ca2+ 
is the activity of the Bcl-2 protein family, which can be controlled in accordance with the 
activation of UPR-associated pathways. CHOP (known as a growth arrest and DNA damage 
associated gene) and TRAF2 (TNF receptor associated factor 2) were reported to activate 
apoptosis in response to the ER stress. CHOP, activated by the UPR-associated pathways, was 
found to down-regulate Bcl-2, making its concentration reduced (Szegezdi et al., 2006). As can 
be seen in Figure 2.2.4, activation of IRE1 recruits TRAF2, triggers phosphorylation involving 
ASK1, and in turn activates JNK that can phosphorylate Bcl-2 as well as Bcl-xL. The 
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phosphorylated Bcl-2 by JNK loses the anti-apoptotic ability (McCullough et al., 2001). Pro-
apoptotic effects can also be achieved through the phosphorylated Bid and Bim by JNK 
(Szegezdi et al., 2006). As can be seen from Figure 2.2.4, without exposure to the ER stress, 
Bax and Bak are bound to Bcl-2, which is their inactive state; while the activation of Bim 
(BH3) is suppressed by attaching to cytoskeletal dynein. Once Bcl-2 and Bim are 
phosphorylated by JNK (as well as Bcl-2 is down-regulated by CHOP), Bcl-2 is unable to 
inhibit the Bax and Bak activity. In the meantime, Bim translocates to Bax and Bak and helps 
promote their pro-apoptotic activities. This pro-apoptotic activities of Bax and Bak enable the 
ER Ca2+ flux to be uncontrolled, ultimately causing the induction of apoptosis (Szegezdi et al., 
2006).   
2.3 Mammalian Cell Cultures for production of mAbs 
 
 Mammalian cell culture systems are widely utilised for manufacture of bio-
therapeutics, including production of mAb, given the fact that mammalian cell hosts have 
potential to synthesise therapeutic proteins possessing the pattern of post-translational 
modifications compatible with the human immune system (Werner et al., 1998). Over the last 
decade, there has been a steadily constant increase in global demand for mAb; almost 30 types 
of mAbs were commercialised with the total sale value of 18.5 billion dollars in 2010 and the 
sale is also expected to be continuously increasing within the next few years (Buss et al., 2012, 
Elvin et al., 2013). This is greatly contributed to therapeutic capability of mAbs to efficiently 
treat chronic diseases, such as cancers (Buss et al., 2012). The increase in demand for mAbs 
draws attention to improve performance of mammalian cell culture systems toward a higher 
quantity as well as a better quality of mAb produced.   
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2.3.1 Mammalian cell lines 
 Emergence of hybrid cells (i.e. hybridoma cells) paves the way for production of mAbs. 
The production of mAbs was initially achieved by in vivo cultures of the hybridoma cell line, 
which is derived from fusion of a mouse myeloma cell and spleen cells from an immunised 
BALB/c mouse (Kohler and Milstein, 1975). Later, in vitro cultures of hybridoma cell lines 
were developed, where cell growth as well as mAb titre were improved. However, the relatively 
low affinity of mAbs was often obtained in the in vitro cultures (Moroney and Plückthun, 
2005). Humanised mAbs can be also achieved from a hybridoma cell line that is derived from 
transgenic mouse spleen cells or primary human B cells (Davis et al., 1999). NS0 and Sp2/0 
cell lines are also the results of the hybridoma technology. These cell lines basically share the 
same origin, which is a BALB/c mouse plasmacytoma cell and spleen cells. 
 In addition to the hybridoma technology, there are other technologies for the 
development of cell hosts for mAb production. Chinese hamster’s ovary cells or CHO cells are 
derived from a Chinese hamster’s ovary biopsy. These cells have become a common platform 
for production of mAbs since its biological characteristics are well understood. In addition, 
human cell lines were utilised in order to obtain mAbs with human-like glycosylation as well 
as other posttranslational modification patterns. For example, HEK-293 is derived from a 
human embryonic kidney while PER.C6 originates from a human retinal cell. 
  The mammalian cell lines share similar characteristics, which show that they are 
suitable for bio-therapeutic production applications. These include capability to grow in a non-
aggregated condition (i.e. in a suspension culture), capability to generate desired 
posttranslational modifications, capability to robustly grow and achieve a high level of final 
mAb titre, and capability to adapt themselves to various culture conditions (Whitford, 2006, 
Chu and Robinson, 2001). It is worth mentioning that there is difference in metabolic activities 
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as well as characteristics among these cell lines, although these cell lines are derived from a 
similar origin (i.e. between NS0 and Sp2/0 cell lines).   
2.3.2 Glutamine synthetase (GS) expression systems  
 Glucose and glutamine are generally limiting substrates providing carbon as well as 
nitrogen sources for cell growth and bio-synthesis. Glutamine, in addition to providing a 
nitrogen source, is essentially required for anaplerotic activities in order to support the cellular 
energy production (i.e. in TCA cycle). Glutamine is a non-essential amino acid; therefore, it 
can be synthesised by cells. The enzyme that catalyses the reversible synthesis of glutamine is 
GS. The mechanism of this reaction involves hydrolysis of ATP and phosphorylation of 
glutamate by the enzyme-associated intermediate before being combined with ammonia to 
form glutamine (Barnes et al., 2000b).  
The development of the GS expression system is based on the fact that cells with a very 
low expression level of endogenous GS need 1) an external source of glutamine or 2) an 
enhanced GS reaction activity by exogenous GS in order to survive and perform normal cellular 
activities. The selection of cells can be achieved through incorporating the GS gene in a plasmid 
vector containing heterologous protein expression, and then culturing the cells with 
transfection of the plasmid vector in glutamine-free media. Surviving cells in glutamine-free 
media represent ones that successfully take up the plasmid, which can be also inferred that they 
are capable to express the heterologous protein (Cockett et al., 1990, Bebbington et al., 1992, 
Barnes et al., 2000b). Methionine sulfoximine (MSX) can be used for the further selection of 
cells that express a high level of GS, given that MSX specifically and irreversibly inhibits GS 
(Brown et al., 1992, Bebbington et al., 1992). The low concentration of MSX was used; 10-
100 µM for GS-NS0 cells and 250-500 µM for GS-CHO cells, in order to insert a reasonable 
level of GS inhibition, allowing to select cells with a relatively higher expression of GS gene. 
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Given that the GS gene is incorporated within the same plasmid vector as the heterologous 
protein gene, the high-expression GS cells achieved through the selection by the addition of 
MSX should simultaneously express a high level of the heterologous protein, allowing us to 
achieve the increase in production/productivity of the heterologous protein (Barnes et al., 
2000b).  
It is worth noting here that the presence of MSX can also affect cellular processes apart 
from the activities of GS. It was reported that cell growth and nitrogen assimilation, and thus 
cellular protein and nitrogen contents, were reduced in marine microalga Chlorella 
autotrophica due to the presence of MSX at 5 mM (Ahmad and Hellebust, 1985). In addition, 
MSX was found to increase the activities of ornithine decarboxylase (ODC), which is the key 
enzyme catalysing the rate-limiting reaction required for polyamine synthesis (Di Giacomo et 
al., 1997). The polyamines play essential roles in fundamental cellular processes; including 
DNA stabilisation, transcription, translation and semiconservative DNA replication. Moreover, 
the cell fate was found to be subject to the polyamine levels; apoptosis can be induced by a 
prolonged decrease in the polyamine levels under an exposure to oxidative stresses while 
increased polyamine levels due to ODC overexpression can trigger apoptosis (Pendeville et al., 
2001). Therefore, these effects of MSX have to be taken into account when MSX is added into 
the cultures to achieve the GS inhibition.   
The GS system is commonly used in CHO cells and NS0 cells. NS0 cells typically have 
as low endogenous GS level as phenotypical GS minus; therefore, they are favoured over CHO 
cells though the GS system has been extensively applied in CHO cells. As above discussed, 
the level of MSX used in the selection process of NS0 cells is much less than that of CHO cells. 
Compared to other systems (i.e. DHFR system), the GS system typically requires fewer copies 
of the plasmid vector (4-10 copies) in order to achieve stable and high production of the 
heterologous protein. In the GS system, glutamine can be intracellularly synthesised. Ammonia 
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is depleted in the synthesis process, providing a significant side benefit to the culture system 
where deleterious effects of toxic metabolite, especially due to ammonia accumulation can be 
avoided.    
2.3.3 Modes of mammalian cell cultures 
 Given that microbial fermentation has long been established, modes of operation 
applied in cultures of a variety of mammalian cell lines basically originate from those used for 
microbial fermentation. This section reviews the most common modes of mammalian cell 
cultures that are industrially utilised for manufacture of bio-therapeutic proteins. 
Batch culture 
  It is a basic and discontinuous mode of cell cultures. This mode allows cells to grow 
without an addition of nutrients as well as removal of metabolic by-products during cultivation. 
Cell growth as well as metabolism, thus, are limited to the level of nutrients at the beginning 
of cultures. Given that cell proliferation can suffer from osmotic impacts as well as toxic by-
product accumulation, the initial concentration of substrates is typically set at a relatively low 
level. Consequently, batch cultures usually achieve a relatively low cell concentration, and thus 
limited final titre of secreted proteins (in the range of 1-50 mg/L). However, this mode is widely 
utilised for the production of therapeutic proteins because of its simple configuration and 
operation (Ve´liz et al., 2008).    
Fed-batch culture  
 It is basically the batch culture with feeding stream(s) of nutrient(s). Therefore, a 
relatively higher cell concentration as well as final secreted protein titre can be achieved (more 
than 10 g/L of secreted proteins can be achieved (Robinson et al., 1994, Whitford, 2006, Pybus 
et al., 2014)). In addition, given that operation and configuration of fed-batch cultures are 
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relative moderate, this mode becomes the most common platform for manufacture of 
therapeutic proteins (Chu and Robinson, 2001). Prolonged culture viability achieved in the fed-
batch cultures leads to a longer culture lifetime. This causes secreted proteins to stay in the 
culture for a longer time,  and these proteins can be negatively affected by proteases and 
glycosidases released from lysed cells or dead cells (Goochee and Monica, 1990). In addition, 
a higher level of metabolic by-products, such as ammonia and lactate, is obtained in the fed-
batch culture. This can negatively affect both the quality and quantity of secreted proteins. 
Continuous culture 
 It is cell cultures with continuous feeding stream(s) of nutrient(s) and continuous 
removal stream(s) of cell suspension. The flowrate of inlet and outlet streams has to be equal 
to each other so that culture volume remains constant and the cultivation is allowed to reach a 
steady state, where cellular and metabolic activities are measured. However, given that cells 
are continuously removed, a relatively lower cell concentration, and thus a lower secretion of 
therapeutic proteins, are achieved in this mode of cultures. Given its relatively more 
complicated configuration and relatively lower production of heterologous proteins, this mode 
is still not mature as compared to batch and fed-batch modes of culture.  
Perfusion culture  
 It is an improved version of the continuous model of cell cultures. Cells are separated 
from the outlet stream(s) and returned to the culture, allowing maintaining a high level of cell 
concentration, and thus a high level of protein secretion. To date, this mode of cell cultures 
achieves the highest production and productivity of secreted proteins and is becoming more 
popular, both experimental and industrial scales. However, despite its advantages over other 
modes of cultures, its configuration as well as operation are highly complicated, making it 
Chapter 2 : Literature Review 
~ 33 ~ 
difficult to be practically applied for large scale production of therapeutic proteins (Ve´liz et 
al., 2008).  
2.3.4 Limitations of mammalian cell cultures 
 Compared to cultures of prokaryotic cells; such as algae as well as bacterial systems, 
as well as some eukaryotic systems; including yeast and fungi, to handle cultivation of 
mammalian cells is far more challenging, given that mammalian cells contain more complex 
intracellular structures as well as more intricate biochemical reactions involved. Hauser and 
Wagner (1997) pinpointed key characteristics of mammalian cell cultures for production of 
biopharmaceuticals as compared to those of prokaryotic cells as well as yeast and fungi as 
follows:       
 Lower cell growth rates. 
 Lower rates of production of desired products. 
 More sensitive to chemical milieus; such as levels of nutrient supply, metabolites, 
growth factors, etc.  
 More fragile to physical milieus due to having no cell wall. 
Given the above list, behaviour of mammalian cells, and thus culture performance, 
highly depend on cultivation conditions. The following is the most important parameters that 
significantly affect culture performance; 
 Initial concentrations of compositions in culture medium, including sugar(s), amino 
acids, inorganic ions and other growth factors. 
 Dissolved oxygen, both its concentration and how it is supplied in the culture. 
 Levels of toxic metabolite accumulation, especially lactate and ammonia. 
 Sheer stress, temperature, pH as well as osmotic pressure. 
 Feeding strategy for the fed-batch system. 
 The number of viable cells and the secreted protein concentration. 
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 The effect of these culture parameters on cellular activities as well as culture 
performance can also differ among cultures of different lines of mammalian cells.  Given the 
cell line specific manner, to establish a generalisation for optimal culture parameters and 
operating conditions is one of the greatest challenges facing biotechnology community.       
2.4 Temperature effects on culture performance 
 
 
Figure 2.4.1 Literature review for the temperature effect on cellular activities in the 
mammalian cell cultures. 
Culture temperature is one of the most important operating culture parameters. Given 
that culture temperature can be promptly measured and real-time manipulated during the 
cultivation, it draws attention to investigation of its impact on culture performance and 
identification of an optimal culture temperature profile for production of therapeutic proteins. 
The literature survey in this section focuses on impact of culture temperature on cellular 
activities. As illustrated in Figure 2.4.1, the effect of hypothermia (<35ºC), hyperthermia 
(>37ºC) and biphasic temperature profiles where temperature is shifted to hypothermia or 
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hyperthermia on especially cell metabolism (synthesis of desired biologics), cell cycle 
progression and apoptosis induction is reviewed. 
2.4.1 Hypothermic conditions 
37ºC is the physiological temperature level where cellular systems perform their normal 
activities. However, growing cells at temperature levels lower than the physiological one, or 
hypothermia (<35ºC), appears to influence cell proliferation and viability, and thus final titre 
and productivity of secreted proteins. It was reported that culture viability was prolonged when 
growing hybridoma cell lines under hypothermic conditions, despite achieving lower final 
mAb titre as well as productivity as compared to the cultures at 37ºC  (Reuveny et al., 1986, 
Sureshkumar and Mutharasan, 1991, Barnabé and Butler, 1994). The similar effects of 
hypothermia were also observed in the cultures of other mammalian cell lines under sub-
physiological temperatures. A lower maximum cell density, prolonged culture viability as well 
as no significant improvement in productivity were achieved in the cultures of BHK cell 
(Weidemann et al., 1994), CHO cell (Yoon et al., 2003a, Yoon et al., 2006), GS-NS0 cell 
(Swiderek and Al-Rubeai, 2007) and the human host cell F2N78 (Seo et al., 2013). However, 
in the culture of GS-NS0 cells, hypothermia (33ºC) did not affect the maximum cell density as 
well as the specific productivity, compared to the control culture (37ºC).   
On the contrary, increases in specific productivity of secreted proteins were observed 
in mammalian cell cultures under hypothermic conditions, although inhibition of cell growth 
and culture viability prolongation were still observed. The culture of CHO cell lines under 
hypothermia conditions (< 35ºC) demonstrated a higher level of specific productivity while cell 
proliferation was arrested (Fogolı́n et al., 2004, Fox et al., 2005, Furukawa and Ohsuye, 1998, 
Shi et al., 2005, Rodriguez et al., 2005, Vergara et al., 2014). By adapting CHO cells for 
hypothermic conditions (30ºC, 33ºC and 35ºC) before experiments at the corresponding 
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hypothermic temperatures, increases in specific productivity were achieved, however, 
volumetric productivity was lower than the culture at 37ºC due to lower maximum cell 
concentrations (Trummer et al., 2006). 
It was suggested that production of desired proteins and their mRNA levels could be 
correlated. Furukawa and Ohsuye (1998) observed an increase in both the secreted protein-
associated mRNA level and production of the secreted protein in the hypothermic culture. 
Yoon et al. (2003) and Fox et al. (2005) also agreed on the correlation between the mRNA 
level and the level of desired protein production, given that they observed an increase in 
erythropoietin (EPO) and interferon–γ, respectively, productivity with an increase in its 
protein-associated mRNA levels (Fox et al., 2005, Yoon et al., 2003b). However, later 
Marchant et al. (2008) proved that the correlation does not hold true for the cultures of GS-
NS0 and GS-CHO cell lines, given that cB72.3 mAb productivity did not increase as its 
corresponding mRNA level was found increased by temperature shifts to 32ºC (Marchant et 
al., 2008).  
The effect of hypothermia on control of cell cycle progression was also investigated so 
that detailed mechanistic explanations behind observed changes in cell proliferation as well as 
synthesis of desired proteins could be revealed. Yoon et al. (2003) and Trummer et al. (2006) 
suggested that CHO cells were arrested at G1/G0 phase in response to hypothermia, causing a 
lower specific growth rate as well as prolonged culture viability. This is in good agreement 
with the observation made by Bloemkolk et al. (1992), showing that the hybridoma cell line 
S4B6 spent longer time in G1 cell cycle phase due to the hypothermic condition (34
ºC). Given 
that there was no significant difference in productivity as compared to the culture at 37ºC, they 
suggested that arrested cells at G1 phase may not benefit mAb secretion (Bloemkolk et al., 
1992). Later, Shi et al. (2005) demonstrated that circa 50% of CHO cells were arrested at G2/M 
phase rather than G1/G0 phase in the culture at 30
ºC (Shi et al., 2005). The culture of GS-NS0 
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cell line under a strong hypothermic condition (22ºC) showed a sudden increase in cell fraction 
at G2 phase as well as an elevated level of Cdc2 (G2/M regulator) gene expression, suggesting 
cell cycle arrest at G2 phase (Swiderek and Al-Rubeai, 2007). However, Fox et al. (2005) 
observed an increase in cell fraction at S phase with an increase in specific productivity, 
suggesting that the productivity might not be associated with cell proliferation arrest, but 
actively proliferating states. This was later supported by further analysis of experimental data 
performed by Chong et al. (2008), showing that there was a correlation between cell fraction 
at S phase and specific productivity (Chong et al., 2008). 
Relationships between apoptosis and hypothermia were established. A significant lower 
degree of apoptosis was achieved when growing the CHO cell line producing antibody-IL-2 
fusion protein at 30ºC. In addition, this hypothermic culture showed a delay in the onset of 
apoptosis for 48 hours (Shi et al., 2005). It also reported that hypothermic conditions (at 22ºC 
and 34ºC) enabled GS-NS0 cells to suppress apoptosis, as indicated by the fraction of apoptotic 
cells in the culture at 22ºC after 120 hours of the culture being equal to that of the culture at 
34ºC after 72 hours and that of 37ºC after 48 hours of the cultures (Swiderek and Al-Rubeai, 
2007). However, this might be because the cultures under hypothermic conditions experienced 
nutrient deprivation at a later time than the culture at 37ºC as a result of decreases in specific 
nutrient consumption. The culture of the human host cell line demonstrated that culture 
viability was preserved in the culture at 33ºC while the culture at 37ºC rather allowed cells to 
die faster (Seo et al., 2013). 
Hypothermia was found to affect cell metabolism, as indicated by changes in the 
specific rates of consumption/production of metabolites and nutrients, including glucose, 
lactate, ammonia and key amino acids. Generally, there was a reduction in glucose 
consumption rates, and thus lactate production rates, in cultures under hypothermic 
temperatures of hybridoma cell lines (Reuveny et al., 1986, Sureshkumar and Mutharasan, 
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1991, Barnabé and Butler, 1994), BHK cell line (Weidemann et al., 1994), CHO cell line 
(Trummer et al., 2006), GS-NS0 cell line (Swiderek and Al-Rubeai, 2007) and human cell line, 
F2N78 (Seo et al., 2013).  Sureshkumar and Mutharasan (1991) reported that there was also a 
decrease in the yield of lactate over glucose in the hybridoma cell culture at hypothermic 
temperatures. However, Barnabé and Butler (1994) demonstrated that the yield of lactate over 
glucose in the culture of another hybridoma cell line did not significantly change with decreases 
in culture temperature, suggesting that glucose metabolic pathway could not be influenced by 
hypothermic conditions. The effect of hypothermia on glutamine consumption rates, and thus 
production of ammonia was found to be variable. Barnabé and Butler (1994) showed that 
specific rates of glutamine consumption as well as ammonia production rates decreased in the 
culture of hybridoma cell line at hypothermic temperatures. However, the specific rate of 
glutamine consumption was found to be increased as the temperature decreased in the CHO 
cell culture, although the specific rate of ammonia was reduced. It was suggested that glutamine 
consumption might be substituted for a decrease in glucose utilisation in hypothermic 
conditions (Trummer et al., 2006). Seo et al. (2013) reported that there was no significant 
difference of the specific utilisation rate of glutamine (and so the specific generation rate of 
ammonia) between the cultures at 37ºC and at 33ºC. Recently, it was suggested that 
hypothermia affects cell metabolism at the transcriptional processes, given that there was a 
significant change in expression of metabolic pathway-associated genes (i.e. glycolysis and 
pentose phosphate pathway-associated genes) in the cultures of CHO and GS-NS0 cell lines 
(Baik et al., 2006, Swiderek and Al-Rubeai, 2007).   
 Hypothermia was generally found to preserve the quality of secreted bio-therapeutic 
proteins in mammalian cell cultures. The quality of secreted proteins was found to benefit from 
hypothermic conditions indicated by the preserved degrees of sialylation in the cultures of CHO 
cell lines (Yoon et al., 2003b, Kaufmann et al., 2001), and the reduced degree of secreted 
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protein aggregation in the culture of the CHO cell line producing β-interferon (Rodriguez et 
al., 2005). However, in the culture of the human host cell line F2N78 at a hypothermic 
condition did not significantly affect the glycosylation pattern of produced mAb, compared to 
the control (Seo et al., 2013). Contrary to results from other studies, Epo-Fc sialylation in the 
cultures of CHO cell line at 30ºC and 33ºC was found to be worse compared to the control 
culture (Trummer et al., 2006). 
2.4.2 Hyperthermic conditions 
Given that hyperthermia (> 37ºC) is basically the opposite condition to hypothermia, it 
can be hypothesised that hyperthermia has the opposite impact on culture performance to that 
of hypothermia. The specific consumption rate of glucose, and thus the production rate of 
lactate, were found to be enhanced in the mild hyperthermic cultures of hybridoma cell lines 
(Sureshkumar and Mutharasan, 1991, Barnabé and Butler, 1994) and CHO cell line (Trummer 
et al., 2006). The specific glutamine consumption rates, and thus the production rates of 
ammonia, were also increased in the culture under hyperthermic conditions (Barnabé and 
Butler, 1994, Trummer et al., 2006). Compared to the cultures at 37ºC, the hyperthermic 
cultures resulted in a lower maximum cell density, causing increases in specific productivity 
with a lower final titre of secreted proteins (Sureshkumar and Mutharasan, 1991, Barnabé and 
Butler, 1994). However, the cultures of another hybridoma cell line and a CHO cell line at a 
hyperthermic temperature showed reductions in productivity, despite a lower maximum cell 
concentration. It was also suggested that hyperthermia has no significant effect on cell cycle 
progression, given that there was no significant change in cell cycle population distribution 
profiles, compared to the control cultures (at 37ºC) (Bloemkolk et al., 1992, Trummer et al., 
2006). In addition, it appeared that hyperthermia had no significant effect on sialylation in the 
culture of CHO cell line (Trummer et al., 2006).  
Chapter 2 : Literature Review 
~ 40 ~ 
The impact of hyperthermia on cellular activities at a transcriptional level was studied. 
The level of DNA synthesis was increased in the hyperthermic culture of human bone marrow-
derived stromal cells (BMSCs), suggesting a faster progression of cell proliferation. However, 
under the same condition, growth of human osblast-like osteosarcoma-derived MG-63 cells 
was arrested (Shui and Scutt, 2001). In addition, the level of cyclin D1, which plays a regulatory 
role in progression of cell cycle through controlling G1 checkpoint, was elevated as the culture 
temperature increased, suggesting that the hyperthermia-associated acceleration of cell 
proliferation involves induction of cyclin D1 synthesis (Han et al., 2002). Anti-apoptotic 
pathways were suggested to be a cellular mechanism in response to hyperthermia (Park et al., 
2005). It was later suggested that anti-apoptotic pathways could be initiated but it might not be 
the reason why a lower maximum cell density was achieved as a result of hyperthermia, given 
that apoptotic markers, including the activation of caspase-3 as well as DNA fragmentation, 
were not clearly detected in the culture at 39ºC (Sugimoto et al., 2012). 
It is worth noting that the concentration of Ca2+ in cytosol can be affected by either 
hypothermia or hyperthermia, and this could underlie the effect of these conditions on 
apoptosis induction. It was reported that elevated cytosolic Ca2+ levels could be achieved by 
the heat stress (Li et al., 2014, Gu et al., 2015). This could be because the heat stress activates 
STIM1, which acts as a ER Ca2+ sensor, and this protein then forms a plasma membrane and 
ER-associated pore (together with a plasma membrane pore-forming protein, Orai) facilitating 
ion transport, leading to Ca2+ influx (Xiao et al., 2011). The unbalanced level of cytosolic Ca2+ 
due to the Ca2+ influx could ultimately induce apoptosis through the ER-stress associated 
pathway (Li et al., 2014) as well as the mitochondrial apoptotic pathways (Gu et al., 2015), as 
previously discussed in Section 2.2.2. Given that STIM1 was found to be temperature-
sensitive, hypothermia could also affect the activity of STIM1, resulting in disturbed cytosolic 
Ca2+ levels. It was reported that hypothermia decreased the store-operated Ca2+ entry, which 
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can be inferred that the activity of STIM1 could be slowed down by reduced temperature 
(Thompson et al., 2009). The change in cytosolic Ca2+ level due to hypothermia could trigger 
apoptosis, depending on the degree of hypothermia and cellular systems since there are studies 
showing an inhibitive effect of mild hypothermia on apoptosis while there are studies reporting 
that severe hypothermia could induce the cold stress and lead to apoptosis induction 
(Neutelings et al., 2013, Alva et al., 2013). In addition to alteration in the Ca2+ level, 
hyperthermia is reported to promote the production of reactive oxygen species (ROS), which 
also underlies apoptosis induction. In contrast, hypothermia decreases the production of ROS, 
which might explain its anti-apoptotic effect (Hsu et al., 2011, Neutelings et al., 2013). 
 
 
 
 
 
 
 
 
 
Figure 2.4.2 The role of HSPs in the apoptotic pathways, Adapted from (Lanneau et al., 
2008). 
Hypothermia and hyperthermia were also reported to activate proteins that act in 
response to cellular stress as a result of temperature change; cold shock proteins (CSPs) and 
    Survival signals      Death signals 
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heat shock proteins (HSPs). CIRP and RBM3 are among CSPs that have been extensively 
studied. Their roles mainly involve regulation of transcription and translation in response to 
cold stress. CIRP was reported to be one of the components underlying growth arrest due to 
hypothermia. In addition, the binding of CIRP to RNA molecules under exposure to cellular 
stresses appeared to improve translation efficiency and the stability of RNA (Kumar et al., 
2007). RBM3 was reported to regulate protein synthesis in response to the cold stress through 
interactions with ribosomal subunits as well as microRNAs (Dresios et al., 2005, Kumar et al., 
2007). Both CIRP and RBM3 were reported to inhibit apoptosis (Kita et al., 2002, Sakurai et 
al., 2006) and this could contribute to the observed apoptosis inhibition due to hypothermia. 
There are various members of HSPs. They can be divided into two main groups 
according to the molecule size: high molecular weight (i.e. HSP90, HSP70 and HSP60) and 
small molecular weight (i.e. HSP27) (Lanneau et al., 2008). Given a large number of HSPs, 
HSPs involve in a number of cellular functions through taking part in many signalling 
pathways. The basic role of HSPs involves protein folding where HSPs serve as chaperones. 
They help prevent aggregation arising from denatured proteins due to heat shock, guide the 
protein folding process, and prevent misfolding (Sonna et al., 2002). They were reported to 
have direct interactions with components in several signalling pathways, including apoptosis 
(Lanneau et al., 2008). Some of HSPs are anti-apoptotic factors while some might also act as 
pro-apoptotic species (Garrido et al., 2001). Their relevance to apoptosis occurs at upstream, 
downstream, and mitochondrial levels (Lanneau et al., 2008).  
HSP70 is among those HSPs reported to act as an anti-apoptotic factor in response to 
cellular stresses. As can be seen from Figure 2.4.2, HSP70 plays the anti-apoptotic role in 
upstream signalling of apoptosis through regulating activities of JNK, Akt, p53, ERK and Bid 
(Lanneau et al., 2008). However, it was also found to inhibit nuclear factor-kappaB (NF-κB, a 
pro-survival factor) and in turn favour the death receptor apoptosis pathway (Ran et al., 2004). 
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At the downstream of apoptosis pathways, HSP70 was found to prevent bax translocation to 
the mitochondrial, which in turn inhibits activation of mitochondrial apoptosis pathway 
(Stankiewicz et al., 2005). In addition, activation of Apaf-1, and later recruitment of pro-
caspase-9, can be blocked by HSP70 (Beere et al., 2000). CAD (a DNA fragmentation 
regulator) and GATA1 (a survival factor) were also inhibited by HSP70. As can be seen from 
Figure 2.4.2, HSP90 was also found to regulate activation of Akt, Apaf-1, NF-κB, p53, Bcl-2 
and JNK, resulting in apoptosis inhibition (Lanneau et al., 2008). The anti-apoptotic effect of 
HSP27 involves its interaction with Akt. HSP27 was also reported to inhibit the mitochondrial 
pathway by interacting with cytochrome c and in turn preventing activation of caspase-9 and 
caspase-3 (Bruey et al., 2000, Pandey et al., 2000). In addition, reactive oxygen species can be 
inhibited by HSP27. HSP60 is normally bound by two molecules of HSP10 and serves as a 
chaperone. However, it was reported that HSP60 and HSP10 help activation of caspase-3 
(Xanthoudakis et al., 1999) in apoptosis as can be seen from Figure 2.4.2. They were also found 
to play anti-apoptotic role given the recent studies showing that overexpression of HSP60 
and/or HSP10 resulted in apoptosis inhibition (Lin et al., 2001b) and HSP60 can bind to Bax 
and inhibit its translocation to mitochondrial to induce apoptosis (Lanneau et al., 2008). The 
role of HSP60 in apoptosis remains inconclusive given evidence that HSP60 can help either 
promote or inhibit apoptosis. 
2.4.3 Temperature shift effects on culture performance 
Shifts to hypothermic temperatures  
As discussed earlier, the maximum cell concentration was decreased in the hypothermic 
cultures, and therefore volumetric productivity of secreted proteins was not enhanced despite 
increased specific productivity. It was hypothesised that lowering culture temperature (to < 
35ºC) during the mid-exponential phase of the cultures (temperature shift), where cells are in a 
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proliferative state, could derive benefits from a high level of cell density, and thus could 
improve volumetric productivity. Generally, temperature shifts to hypothermic levels 
improved specific productivity as a result of prolonged culture viability and a lower maximum 
cell concentration as compared to the control culture (at 37ºC). These effects was seen mainly 
in the cultures of CHO cell lines with temperature shifts to hypothermic levels (Furukawa and 
Ohsuye, 1999, Kaufmann et al., 1999, Fox et al., 2004, Hendrick et al., 2001, Rodriguez et al., 
2005, Oguchi et al., 2006, Bollati-Fogolín et al., 2005). Furukawa and Ohsuye (1999) and 
Rodriguez et al. (2005) pointed out that, compared to the monophasic hypothermic cultures, 
final secreted protein titre as well as the maximum cell density were higher, though culture 
viability was not prolonged. Only analysis performed by Fox et al. (2004) showed that the 
biphasic CHO cell culture with a temperature shift to 32ºC at an optimal culture time point 
achieved 90% and 40% higher volumetric productivity of interferon–γ as compared to the 
monophasic culture at 37ºC and 32ºC, respectively.  
In some cases, lowering temperature during the exponential phase of cell growth did 
not result in higher productivity of secreted proteins, despite achieving growth arrest as well as 
prolonged culture viability. This phenomenon was observed in the biphasic cultures of 
hybridoma cell line (Barnabé and Butler, 1994), BHK cell line (Weidemann et al., 1994) as 
well as GS expression systems (Marchant et al., 2008). There was no significant difference of 
cell density, viability as well as final mAb titre between the culture at 33ºC and the culture of 
hybridoma cell line with a temperature shift to 33ºC (Barnabé and Butler, 1994). Marchant et 
al. (2008) showed that in addition to final mAb titre, there was no improvement in volumetric 
productivity of mAb, compared to the culture at 37ºC.  
Most of cultures with a temperature shift to hypothermic levels showed the same effects 
on metabolic activities. Generally, the temperature shift to hypothermic levels resulted in 
reductions in specific consumption rates of glucose, as well as production rates of lactate, as 
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compared to the culture at 37ºC  (Weidemann et al., 1994, Barnabé and Butler, 1994, Moore et 
al., 1997, Furukawa and Ohsuye, 1999, Marchant et al., 2008). Furukawa and Ohsuye (1999) 
showed that more glucose was consumed in the culture with a temperature shift to 32ºC, as 
compared to the culture at 32ºC. However, given that a higher level of cell density was 
achieved, the specific glucose consumption rate might be equal to that of the culture at 32ºC. 
In addition, Marchant et al. (2008) showed that lactate generation was not affected by the 
decrease in specific glucose consumption rates as a result of a temperature shift to 32ºC. This 
might suggest that the effect of temperature shift to hypothermic levels is cell-line dependent.  
Effects of temperature shift to hypothermic levels on cell cycle, cell death and product 
quality were also studied. An increase in cell fraction at G1/G0 phase was observed in the 
biphasic cultures with temperature shifts to hypothermic levels of CHO cell lines (Moore et al., 
1997, Kaufmann et al., 1999, Hendrick et al., 2001) and GS expression systems (Marchant et 
al., 2008), suggesting growth arrest at G1/G0 phase given a lower level of cell density as 
compared to the culture at 37ºC. It was suggested that cell cycle arrest at G1/G0 could be a 
mechanism to delay apoptosis, given that apoptosis was delayed for 4 days after the 
temperature shift in the CHO cell culture. This could be because less toxic metabolites were 
produced due to the temperature shift (Moore et al., 1997). Like the monophasic hypothermic 
cultures, the biphasic cultures with a temperature shift to hypothermic levels did not negatively 
affect product quality. There was no deleterious effect on secreted protein bioactivity 
(Furukawa and Ohsuye, 1999); the pattern of glycosylation as well as the degree of sialylation 
(Bollati-Fogolín et al., 2005); the quality of N-glycosylation structures (Hendrick et al., 2001); 
and the degree of aggregation (Rodriguez et al., 2005).  
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The shift to hyperthermic temperatures 
 The concept of the temperature shifts to hypothermic levels was applied to 
hyperthermic cultures in an attempt to improve the yield of secreted protein while maintaining 
a high cell density/viability. Given that the highest level of cell density and the highest specific 
mAb productivity was obtained in the hybridoma cell culture at 33ºC and 39ºC, respectively, 
the temperature shift from 33ºC to 39ºC effect was studied. However, no significant increase in 
final mAb titre was observed. This might be because temperature difference of 6ºC inserted 
excessive stresses to the extent that cells could not manage to adapt themselves for the new 
temperature condition (Sureshkumar and Mutharasan, 1991). Contrary to this result, a 
temperature shift to 39ºC in the hybridoma cell culture increased final mAb titre (by 53%, 
compared to that of 37ºC), although volumetric productivity was not significantly improved 
due to a lower cell concentration (compared to that of 37ºC). In addition, the temperature shift 
to 39ºC improved the specific rates of nutrient utilisation as well as the lactate specific 
production rate. It is worth mentioning that the glutamine degradation rate was higher when 
shifting temperature to a higher level (Barnabé and Butler, 1994).  
2.5 Cellular responses to nutrient content shifts 
 
 One of the most influential parameters in cultures of mammalian cell lines is initial 
concentrations of nutrients (glucose and glutamine) as well as metabolic by-products (lactate 
and ammonia). This is because cell growth and metabolism are highly dependent on initial 
supply of nutrients as well as presence of metabolites at the beginning of the cultures. This 
section aims to discuss possible effects of nutrient and metabolite initial concentrations on 
culture performance as well as cellular activities. As described in Figure 2.5.1, the effect of 
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initial glucose, glutamine, lactate and ammonia on cell growth, metabolism and apoptosis is 
reviewed. 
 
Figure 2.5.1 Literature review for the effect of initial concentration of nutrients and 
metabolites on cellular activities in the mammalian cell cultures.  
2.5.1 Glucose and glutamine initial concentrations 
 It was established that the maximum cell density depends on initial glucose 
concentrations given that elevated levels (in the observed range) of glucose enhanced the 
specific growth rate in the culture of  CHO cell line (Takagi et al., 2001). The maximum cell 
density also increased as the glucose concentration increased in the culture of hybridoma cell 
line (Miller et al., 1988a). In addition, both maintaining glucose concentration as low as 0.2 
g/L in the culture of hybridoma cell line, and growing a CHO cell line with a low concentration 
of glucose (1 g/L) did not improve the maximum cell density (Sugiura, 1992, Kurokawa et al., 
1994). Effects of initial glutamine concentration on cell growth were found to be similar to 
those of glucose. Higher levels of initial glutamine increased cell growth in the culture of 
hybridoma cell lines (Schneider and Lavoix, 1990, Dalili et al., 1990, Jeong and Wang, 1995), 
CHO cell lines (Takagi et al., 2001, Rajendra et al., 2011) and a HEK-293E cell line (Rajendra 
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et al., 2011). However, Miller et al. (1988) reported that there was a slight change in the 
maximum cell density when initial glutamine concentration was varied from 3.0 mM to 7.6 
mM. In addition, Dalili et al. (1990) showed that the maximum cell density increased with 
increased initial glutamine concentrations, however, when the glutamine concentrations were 
above 2mM, the maximum cell concentration started to be unchanged. 
 Elevated levels of initial glucose supply were found to decrease productivity of secreted 
proteins in the culture of CHO cell lines (Sugiura, 1992, Takagi et al., 2001). In contrast, the 
cultures with lower initial glucose concentrations demonstrated improvement in productivity 
of secreted protein (Kurokawa et al., 1994). However, the perfusion culture of CHO cell line 
with a controlled level of glucose at <0.1 mM showed a slight decrease (15%) in 
immunoglobulin G productivity as compared to the high glucose culture (Takuma et al., 2007). 
It was found that specific productivity of secreted proteins increased with increased initial 
glutamine concentrations in the culture of hybridoma cell lines (Dalili et al., 1990, Schneider 
and Lavoix, 1990). However, in the culture of CHO cell line, an elevated initial glutamine 
concentration (at 5 mM) resulted in lower specific productivity, as compared to the control 
(Takagi et al., 2001), suggesting that the effect of initial glutamine concentration on 
productivity might be cell-line specific. Rajendra et al. (2011) showed that a controlled-
concentration of glutamine at a low level achieved higher production of an IgG mAb in CHO 
and HEK-293E cell cultures (Rajendra et al., 2011). Kurokawa et al. (1994) also showed that 
maintaining glucose and glutamine concentrations at a low level (0.2 and 0.1 g/L, respectively) 
enhanced productivity of mAbs in the hybridoma cell cultures. In addition, by implementing a 
feeding strategy to control glucose and glutamine at a low level, productivity was increased 
(Khattak et al., 2010). 
 Generally, the initial concentration of glucose affects the specific consumption rate of 
glucose, and thus the specific production rate of lactate. It was also suggested that a Michaelis-
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Menten correlation between the glucose consumption rate as well as the lactate production rate 
and the initial glucose concentration could be drawn (Cruz et al., 1999). Lowering glucose 
initial concentrations reduced glucose consumption rates (Takuma et al., 2007), and thus lactate 
production rates (Sugiura, 1992). Given that a significant increase in the specific oxygen 
consumption rate as well as a sharp decrease in the yield of lactate over glucose were observed 
at low initial glucose levels, a metabolic shift toward less lactate production could be induced 
(Miller et al., 1988a). However, Takagi et al. (2001) showed that there was no significant effect 
of initial glucose concentrations on glucose (and thus lactate) and glutamine (and thus 
ammonia) metabolism. Elevated initial glutamine concentrations were found to increase the 
glutamine consumption rate, and thus the production rate of ammonia (Takagi et al., 2001) as 
well as the consumption rate of glucose, and thus the production rate of lactate (Schneider and 
Lavoix, 1990). These metabolic activities were found to be reduced when lowering initial 
glutamine concentrations (Rajendra et al., 2011). However, there was a limit level of glutamine 
concentration where there was no significant increase in the rate of glutamine-associated 
metabolic activities with increased initial glutamine concentrations, as suggested by Cruz et al. 
(1999).  
 Glucose and glutamine initial concentrations were also found to affect product quality. 
Sugiura et al. (1992) showed that a high initial glucose concentration (at 3 g/L) reduced the 
bioactivity of the produced protein in the mono layer culture of CHO-B3 cell line. With the 
controlled glucose at a low level (<0.1 mM) in the continues culture of CHO cell line producing 
an IgG mAb, a slight increase in terminal galactosylation was observed, suggesting that glucose 
limitation could change galactosylation patterns (Takuma et al., 2007). Lowering initial 
glutamine concentrations was also found to enhance the galactosylation index (GI) and  the 
sialylation index (SI), which are indicators for quality of the secreted product in the culture of 
CHO cell line (Aghamohseni et al., 2014). 
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2.5.2 Lactate and ammonia initial concentrations 
 In general, the impact of lactate on cell growth depends on its concentration, modes of 
culture and cell lines. The presence of 25 mM lactate at the beginning of the hybridoma cell 
culture increased cell density (Reuveny et al., 1986), and 44 mM of the lactate initial 
concentration did not affect cell growth in the continuous hybridoma cell culture (Miller et al., 
1988b). However, lactate was found to negatively affect cell growth of other hybridoma cell 
lines (Kromenaker and Srienc, 1994), given that only half of cell density that was achieved in 
the control culture was achieved in the culture with 20 mM of lactate initial concentration 
(Duval et al., 1992). The inhibitory effect of lactate concentration was also seen in the culture 
of BHK cell line (Cruz et al., 2000) and CHO cell lines (Lao and Toth, 1997, Yang and Butler, 
2000, Choi et al., 2007). Lao et al. (1997) also excluded possible effects of change in osmolarity 
due to sodium lactate additions in order to elevate initial lactate concentrations, and they 
suggested that cell growth reduction was caused by the presence of lactate, not by osmolarity, 
which is in agreement with a later study (Chen et al., 2009). Ammonia, in general, was found 
to have stronger inhibitory impact on cell growth than lactate, given that cell growth inhibition 
was seen at a lower concentration of ammonia compared to that of lactate. The inhibitory effect 
on cell growth was observed in the culture of hybridoma cell lines with ammonia 
concentrations at above 2 mM (Reuveny et al., 1986, Miller et al., 1988b, Newland et al., 1994). 
Cell growth inhibition was also observed in the culture of BHK cell line with an ammonia 
concentration at 3.5 mM (Cruz et al., 2000) while there was no significant effect of ammonia 
on cell growth in the culture of CHO cell line (Lao and Toth, 1997).  
 Given that lactate and ammonia are metabolic by-products, they have effects on 
metabolic activities, especially ones involving production of them. The presence of lactate 
appears to inhibit the production rate of lactate. Both the specific rate of glucose utilisation and 
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the production rate of lactate were found to be decreased by elevated initial lactate 
concentrations in the culture of hybridoma cell line (Kromenaker and Srienc, 1994), and CHO 
cell lines (Cruz et al., 2000, Choi et al., 2007). In addition to glucose consumption and lactate 
production, elevated initial concentrations of lactate also have inhibitory effects on glutamine 
consumption as well as ammonia production, and alanine production indicating the effect of 
lactate on glutaminolysis (Cruz et al., 2000). However, Miller et al. (1988) suggested that an 
inhibitory level of lactate could be higher than 44 mM for the continuous culture of hybridoma 
cell line, given no significant effect on nutrient consumption rates (glucose and glutamine) and 
the lactate production rate observed (Miller et al., 1988b). The effect of ammonia on metabolic 
activities is similar to that of lactate. The specific production rate of ammonia was reduced by 
elevated ammonia initial concentrations in the culture of hybridoma and CHO cell lines (Miller 
et al., 1988b, Lao and Toth, 1997, Yang and Butler, 2000). Miller et al (1988) also suggested 
that there was a shift in the glutaminolysis pathway in response to elevated initial 
concentrations of ammonia, given that glutamine and oxygen consumption were reduced while 
there was an increase in alanine production. Lao and Toth (1997) also suggested a shift in the 
glutaminolysis pathway given that glutamate and aspartate consumption rates were increased.  
 Lactate and ammonia initial concentrations also have effect on production and quality 
of desired therapeutic proteins. Generally, elevated initial concentrations of lactate were found 
to increase final secreted protein titre. This phenomenon was observed in the culture of 
hybridoma cells (Reuveny et al., 1986, Kromenaker and Srienc, 1994), and CHO cell lines (Lao 
and Toth, 1997, Choi et al., 2007). Choi et al. (2007) suggested that an elevated initial lactate 
concentration (at 40 mM) enhanced pyruvate generation (indicated by an observed higher level 
of lactate dehydrogenase (LDH) activity), and ultimately increased production of the EPO 
protein due to pyruvate being more available. This suggestion was later confirmed with 
experimental data showing that the culture of LDH and pyruvate dehydrogenases (PDHs)-
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deficient cells achieved 70% increase in volumetric production of antibody (Zhou et al., 2011). 
However, Cruz et al. (2000) showed that elevated initial lactate concentrations caused a 
decrease in specific productivity (Cruz et al., 2000). Elevated initial ammonia concentrations 
were found to decrease (Reuveny et al., 1986, Cruz et al., 2000) as well as increase (Yang and 
Butler, 2000) production and productivity of secreted bio-proteins. In addition, it was found 
that quality of secreted therapeutic proteins was negatively affected by an elevated initial 
ammonia concentration (at 9 mM) in the culture of CHO cell lines (Borys et al., 1994, Yang 
and Butler, 2000).  It was suggested that elevated levels of ammonia essentially affect the post-
glycosylation process at Golgi apparatus rather than ER and cytosol compartments, as indicated 
by the low expression of sialylation and galactosylation-associated genes and the unchanged 
expression of cytosol and ER localised genes in the ammonia-treated cell culture (Chen and 
Harcum, 2006). 
2.6 Strategies to enhance therapeutic protein production 
 
 High production of heterologous proteins is one of the most desirable characteristics 
of the mammalian cell cultures. Given the key limitations found in mammalian cell cultures 
for production of biopharmaceuticals (sub-section 2.3.4), enhancing the production is however 
not trivial. The control of cell proliferation is believed to be one of strategies to overcome the 
limitations, and thus achieve enhanced production of therapeutic proteins (Kumar et al., 2007). 
In addition, apoptosis has long been identified as the main cause of cell death in the cultures 
(Goswami et al., 1999, DiStefano et al., 1996, Browne and Al-Rubeai, 2011a, Singh et al., 
1994). It is therefore extremely unwanted since it causes reduction in culture viability as well 
as final secreted protein titre. Also, the higher level of dead cells, the poorer product quality 
and the more complicated the downstream processes (Yoon et al., 2003b, Majid et al., 2007, 
Tey et al., 2000a). Therefore, suppression of apoptosis is also believed to be a potential strategy 
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for higher production of secreted proteins. This section reviews cell proliferation control as 
well as apoptosis suppression toward improvements in production of biopharmaceuticals. As 
shown in Figure 2.6.1, the review discusses the effect of those strategies on cellular activities, 
including growth, metabolism and death (apoptosis). In addition, the relationship among cell 
proliferation (cell cycle), apoptosis and metabolism is discussed here.   
 
Figure 2.6.1 Literature review for the effect of cell proliferation control and suppression of 
apoptosis, which are accounted as strategies for enhancement of desired biologics production, 
on cellular activities in the mammalian cell cultures. 
2.6.1 Control of cell proliferation 
 Control of cell cycle progression was found to have effects on secreted protein 
production/productivity. There are a number of cyclin-dependant kinase inhibitors (CdkIs) that 
play a regulatory role in G1/G0 cell cycle arrest, including p21 and p27 (Brugarolas et al., 1999). 
Cell lines metabolically engineered with these cell cycle regulator genes appear to increase 
productivity. The batch culture of a CHO cell line engineered with multi-genes, including p21 
with p27, demonstrated that there was a cell cycle arrest at G1/G0 phase and the culture achieved 
a significant increase in productivity (Fussenegger et al., 1998a). The cell cycle arrest at G1/G0 
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phase was also observed in the batch culture of a GS-NS0 cell line with inducible p21 
transfection, where IgG4 antibody productivity was at least 4 times higher than the control 
(Watanabe et al., 2001). In addition to ceasing cell proliferation at G1/G0 phase, p21 
overexpression appears to enable cells to better adapt themselves to a new environment during 
culture passages or transferring (Astley et al., 2007). The biogenesis of a new mitochondria 
associated with an increase in cell size was suggested as a possible mechanism when cell 
proliferation was inhibited by overexpression of p21. This also suggests that cell growth was 
possibly separated from cell cycle progression, which might underlie the observed increase in 
productivity (Bi et al., 2004). Similar to that of p21, the transfection of inducible p27 in a CHO 
cell line producing a protein for the cold treatment appeared to cease cell cycle progression at 
G1/G0 phase, and thus enhanced productivity (Meents et al., 2002). Overall, the cessation of 
cell proliferation at G1/G0 phase by overexpressing these CdkIs (predominantly p21) appears 
to help boost secreted protein productivity as well as production. This approach becomes a 
fundamental platform for multi-genes engineering where other strategies for improvements in 
secreted protein production can be combined, such as the co-expressing transfection of p21 and 
bcl-2 (Astley and Al-Rubeai, 2008, Ibarra et al., 2003), which combines cell proliferation 
control with anti-apoptotic effects. 
2.6.2 Suppression of apoptosis 
 Attempts have been made to prevent the mammalian cell cultures from apoptosis in 
order to prolong culture viability, and thus increase productivity and/or final titre. The 
metabolic engineering of Bcl-2, an anti-apoptotic protein as described in section 2.2.1, is one 
of predominant strategies for apoptosis suppression given that Bcl-2 molecules can suppress 
apoptosis at a very early stage (Dorai et al., 2010). bcl-2 overexpression appears to rescue CHO 
and BHK cell lines from apoptosis caused by several lethal insults including viral infection, 
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glucose as well as serum deprivation, and ammonia at a high level (50 mM) (Mastrangelo et 
al., 2000b, Mastrangelo et al., 2000a, Figueroa et al., 2001). Furthermore, in addition to Bcl-2, 
Bcl-xL, which can also inhibit apoptosis, is a promising target for metabolic engineering 
toward suppression of apoptosis and improvement of mammalian cells cultures. The batch 
cultures of both BHK and CHO cell lines engineered with bcl-xL achieved inhibition of 
apoptosis, despite the cultures being under exposure to those lethal insults (Mastrangelo et al., 
2000b, Mastrangelo et al., 2000a). The protective effect of bcl-xL transfection was also 
observed in the cultures of CHO and hybridoma cell lines with exposure to various lethal 
culture stresses (Charbonneau and Gauthier, 2000, Figueroa et al., 2004). Figueroa et al. (2004) 
also showed that the transfection of aven, another anti-apoptotic gene, could also limit the onset 
of apoptosis. Moreover, the cultures of mammalian cell lines, which were engineered with 1) 
caspase inhibitors (XIAP and CrmA)  and 2) a heat shock protein (hps70), showed a similar 
result to those with the bcl-2 and bcl-xL transfection (Lasunskaia et al., 2003, Sauerwald et al., 
2003). To enhance the protection for mammalian cell cultures against apoptosis, multi-anti-
apoptotic gene engineering was explored. The co-expressing transfection of bcl-xL and aven in 
the culture of CHO cell line showed prolonged culture viability, suggesting that aven could 
enhance the ability of bcl-xL to limit apoptosis (Figueroa et al., 2004).  
2.6.3 Impact of apoptosis inhibition on productivity and final titre 
Overall, mammalian cell cultures with anti-apoptotic gene(s), such as bcl-2, 
transfection share similar characteristics; inhibition of apoptosis, and consequently enhanced 
viable cell densities and prolonged culture viability. However, to the best of my knowledge, 
cultures with overexpression of anti-apoptotic gene(s) did not always achieve a significant 
increase in productivity as compared to those of wild type cells. The batch culture of GS-NS0 
cells with bcl-2 transfection, despite achieving a 20% and 100% increase in the maximum 
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viable cell density and cultivation time, respectively, did not achieve an increase in final mAb 
titre (Tey et al., 2000a). A similar result were observed in the culture of bcl-2 transfected GS-
CHO cell line. The amount of mAb produced from the transfected cell culture was equal to that 
from the control (wild-type), though a higher viable cell number was achieved (Tey et al., 
2000b), suggesting a decrease in mAb productivity. Having argued that nutrient exhaustion 
during the final phases of the batch culture limits the mAb secretion and thus no increase in 
mAb productivity (Tey et al., 2000a, Simpson et al., 1999b), fed-batch and continuous cultures 
of a variety of cell lines were investigated. Despite achieving final mAb titre around 50% higher 
than that from the control culture, it appeared that productivity did not increase in the fed-batch 
culture of bcl-2 transfected GS-NS0 cells, given a 60% rise in the maximum viable cell number 
(Tey et al., 2000a). The perfusion culture of GS-NS0 cells also showed a similar result; a higher 
cell density but lower mAb productivity as compared to the control culture (Tey and Al-Rubeai, 
2004, Tey and Al-Rubeai, 2005). Similarly, the continuous culture of hybridoma cells with bcl-
2 overexpression achieved a higher viable cell number and longer culture viability than the 
control culture, though there was no increase in final mAb titre (Simpson et al., 1999b). One 
of possible reasons could be that cells utilise fed nutrients for biomass synthesis rather than 
mAb secretion (Tey and Al-Rubeai, 2004, Tey and Al-Rubeai, 2005).    
Other strategies for inhibition of apoptosis attained a similar outcome to that with bcl-
2 overexpression. By adding a caspase activity inhibitor, Z-VAD-fmk, it showed that apoptosis 
induction was reduced, and thus culture viability and viable cell density were enhanced. 
However, there was no improvement in mAb productivity (McKenna and Cotter, 2000). No 
significant increase in recombinant factor VIII protein productivity was witnessed in the culture 
of BHK cells with co-overexpression of aven and EIB-19K, though apoptosis was found to be 
inhibited (Nivitchanyong et al., 2007). Recently, the culture of an EPO-producing CHO cell 
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line with overexpression of bcl-xL at 33ºC and 37ºC also showed no difference in EPO 
productivity compared to the control culture at both temperatures (Kim and Lee, 2009). 
However, there were several studies showing increases in secreted protein/mAb 
productivity. In the bcl-2 transfected hybridoma cell culture, there was a significant increase in 
mAb productivity together with prolonged culture viability and a higher number of viable cells 
(Itoh et al., 1995, Terada et al., 1997). DMSO, which is a reagent that can be toxic to cells, was 
added to the culture of a bcl-xL transfected CHO line cell producing EPO. It was suggested 
that EPO degradation was prevented from DMSO toxicity, and consequently an increase in 
EPO productivity were observed (Kim et al., 2011). Recently, co-transfection of bcl-2 or bcl-
xL and the cytokine IL-2 protein expressing maker in the cultures of CHO and HEK-293 cell 
lines was investigated. This study demonstrated that the culture of 10 wt% of cells with the 
transfection of the anti-apoptotic gene (and 90 wt% of cells with only protein expressing 
marker transfection) achieved in an improvement in specific productivity (Zustiak et al., 2014).  
2.6.4 Apoptosis inhibition and cell cycle arrest 
It was established that overexpression of the anti-apoptotic genes could also cease cell 
proliferation at G1/G0 cell cycle phase (Janumyan et al., 2003, Mazel et al., 1996). The culture 
of a bcl-2 transfected hybridoma cell line showed a high percentage of cells at G1/G0 cell cycle 
phase, indicating G1/G0 cell cycle arrest (Simpson et al. 1999), while cell cycle arrest at G2/M 
phase was seen in the culture of a bcl-2 transfected GS-NS0 cell line (Tey and Al-Rubeai, 
2005). When considering the fact that an improvement in protein/mAb productivity was 
attained in the culture with cell proliferation arrest at G1/G0 cell cycle phase (Ibarra et al., 2003), 
it seems contradictory to unchanged, and sometimes decreased, productivity achieved from the 
cultures of anti-apoptotic gene transfected cell lines, where cell cycle arrest at G1/G0 phase was 
also observed. The possible explanation could be that transfection of the anti-apoptotic genes 
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and cell cycle regulators might affect metabolic activities in a different manner. This can be 
seen in the case of aven and E1B-19K overexpression when compared to the parental cell, 
which there was a difference in metabolic profiles among them (Nivitchanyong et al., 2007). 
Therefore, different shifts in metabolic states could elucidate why cell cycle arrest at G1/G0 
phase due to anti-apoptotic gene overexpression has a different effect on productivity to that 
with overexpression of cell cycle regulators. It was suggested that an optimal level of 
overexpression of anti-apoptotic gene(s) might hold the key to a beneficial compromise 
between apoptosis inhibition and an improvement of productivity (Zustiak et al., 2014).  
2.6.5 Apoptosis inhibition and product quality 
Apoptosis has a detrimental effect on quality of bio-therapeutic products. Generally, 
intracellular contents released from dead cells can degrade quality of bio-therapeutic products 
and complicate downstream processes (Tey et al., 2000a). Inferior product quality as a result 
of low culture viability was observed in the culture of a CHO cell line producing human 
interferon gamma (IFN-γ). The produced IFN-γ was found to have a lower degree of sialylation 
and a shorter glycan length, suggesting degradation being enhanced by several enzymes 
released from dead cells (Chee Furng Wong et al., 2005). The sialylation degree of IFN-γ, 
produced from the culture of a CHO cell line with anti-apoptotic gene (Fadd and Faim) 
overexpression or pro-apoptotic gene (Alg-2 and Requiem) knockdown, was higher than that 
from the control culture, suggesting that apoptosis inhibition helps enhance product quality 
(Wong et al., 2006). Furthermore, it was suggested that lactate consumption, which was seen 
in the culture of a CHO cell line with anti-apoptotic gene transfection, helps reduce osmolality 
and balance culture pH, which is required for better product quality (Dorai et al., 2009). 
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2.6.6 Protein expression and unfolded protein response 
The recombinant protein is synthesised on the ER surface and is processed (folding, 
oligomerisation and post-translational modifications) before leaving the ER (Kober et al., 
2012). Therefore the protein expression could generate extra workload on the ER and 
ultimately lead to apoptosis through the activation of UPR and later the ER-stress associated 
apoptotic pathway (Figure 2.2.3-4). There are conditions that the ER cannot manage the protein 
folding properly, thus generating the ER stress, and eventually triggering the UPR. The UPR 
then activates relevant components in its various pathways, which in turn play regulatory roles 
in many signalling cascades including transcription and translation, metabolism as well as 
apoptosis (Figure 2.2.3), in order to alleviate the ER stress as discussed in Section 2.2.2. 
It was recently shown that the expression of anti-CD20 antibody fragment in 
Arabidopsis seeds generated a certain level of the ER stress (Wang et al., 2015), which was in 
agreement with previous report suggesting that the UPR was found to be activated in response 
to the antibody expression (De Wilde et al., 2013). However, the effect of the UPR activation 
due to the antibody expression on cellular processes was not clearly observed in this system. It 
was also shown that an increase in IgG productivity in a batch culture of CHO cell line was 
associated with an increase in expression levels of majority of chaperones (Prashad and Mehra, 
2015), which was in agreement with previous results (Smales et al., 2004). Following the high 
productivity period, components in the UPR pathways, including PERK, IRE1, ATF4, CHOP 
and XBP1, were up-regulated, suggesting the ER stress possibly due to the high IgG 
productivity (Prashad and Mehra, 2015). Previous results showed that the UPR can be regulated 
by metabolic stresses in addition to the ER stress; CHOP was found to be up-regulated in 
response to both glucose and glutamine limitation (Murphy et al., 2001, Lengwehasatit and 
Dickson, 2002). However, it was suggested that CHOP might not be always necessary for NS0 
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cells to activate apoptosis (Cudna and Dickson, 2006). Furthermore, Prashad and Mehra (2015) 
suggested, based on the expression profile of the UPR-related components, that each pathway 
in the UPR could potentially be activated by different cellular stresses arising from different 
sources, such as from the ER stress and/or the nutrient deprivation (glucose, amino acids, O2), 
since the high productivity and the metabolic stress were interconnected in the batch culture. 
The effect of the UPR on cellular processes was previously studied. As previously 
shown in Figure 2.2.3, the UPR can lead to the activation of ER-associated degradation 
(ERAD), which acts as a misfolded protein remover, allowing cells to avoid accumulation of 
undesirable proteins in the ER (Hussain et al., 2014). The UPR activation can promote lipid 
metabolism and ER membrane biogenesis through activation of XBP1(Sriburi et al., 2004) as 
well as ATF6 (Bommiasamy et al., 2009). Overexpression XBP1 in CHO cells showed an 
increased production of recombinant protein as a result of the expanded ER and golgi capacity 
(Tigges and Fussenegger, 2006) and this was in agreement with later studies showing expanded 
ER size being associated with the increased protein production (Hussain et al., 2014). In 
addition, given that the ER is where proteins are synthesised; believed to be the limiting step 
for the production of exogenous proteins, overexpression of UPR as well as chaperone-related 
components was introduced to mammalian cell cultures. This includes CHOP, ATF4 and 
GRP78 (or BIP). The effect of the overexpression of these components on 
production/productivity was variable depending on cell hosts and overexpressed components 
(Hussain et al., 2014). In addition to apoptosis, the UPR was reported to be associated with 
autophagy. Autophagy can be induced by the ER stress in order to alleviate the stress and 
restore ER functionality. It was reported that the UPR-related mediators (PERK, IRE1 and 
ATF6) can regulate the formation of autophagosome (a component of degradation unit 
structure) (Hussain et al., 2014). 
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2.6.7 Relationships between cell cycle as well as apoptosis, and metabolism 
Apoptosis is subjected to metabolic stresses, including exhaustion of nutrients (glucose 
and amino acids) and toxic metabolite (lactate and ammonia) accumulation. It was revealed 
that apoptosis was triggered by starvation of glucose in the culture of SP2/0 hybridoma and 
wild type NS0 cell lines (Mercille and Massie, 1994a). It was suggested that a decrease in 
glucose metabolism due to glucose exhaustion causes a sudden decrease in intracellular ATP 
levels, and in turn dissipates mitochondria membrane potential and finally triggers the 
cytochrome c release, leading to induction of apoptosis (Moley and Mueckler, 2000). 
Furthermore, Mercille and Massie (1994) also showed that glutamine and cysteine exhaustion 
could result in induction of apoptosis (Mercille and Massie, 1994a). This result was in good 
agreement with the observation in the culture of a hybridoma cell line under exposure to 
deprivation of a single amino acid, where the majority of cells died via apoptosis (Simpson et 
al., 1998). They suggested that a mechanism to trigger apoptosis could be linked to defects in 
transcriptional and translational processes due to a decreased in intracellular ATP levels caused 
by the exhaustion of amino acid (Simpson et al., 1998). The up-regulated expression of 
activating transcription factor 5 (atf5) and transformation related protein 53 binding protein 2 
(trp53bp2) genes could be associated with amino acid deprivation in the batch culture of GS-
NS0 cells (Browne and Al-Rubeai, 2011b). Both atf5 and trp53bp2 were found to have 
regulatory roles in anti-apoptosis and pro-apoptosis pathways, respectively (Dluzen et al., 
2011, Kobayashi et al., 2005). In addition to deprivation of glucose and amino acids, apoptosis 
induction was also observed in the culture of SP2/0 and NS0 cell lines with an oxygen-limited 
condition (Mercille and Massie, 1994b, Zhu et al., 2006). Serum deprivation was also found to 
trigger apoptosis in many studies (Zhu et al., 2006, Tey et al., 2000a, Singh et al., 1994).  
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It is worth discussing that autophagy, a cellular process whereby cells digest themselves 
to remove damage intracellular organelles and balance sources of cellular energy, was found 
to be induced by nutrient-starvation conditions, in addition to apoptosis (Glick et al., 2010). 
Two CHO cell lines producing mAbs underwent autophagy as well as apoptosis during the 
final stages of batch cultures where glutamine and glucose became exhausted (Hwang and Lee, 
2008). In addition to suppressing apoptosis, overexpression of bcl-xL was found to repress 
Beclin-1, one of key mediators in the autophagic pathway, and thus inhibit autophagy (Kim et 
al., 2009). Furthermore, a higher degree of apoptosis was found when autophagy was inhibited 
and vice versa, suggesting that autophagy could be a survival mechanism that prevents cell 
from apoptosis (Han et al., 2011, Jardon et al., 2012). These recent findings suggest a possible 
link between apoptosis and autophagy. However, the role of autophagy remains inclusive 
(Munoz-Pinedo and Martin, 2014) given that autophagy was found not be a survival 
mechanism for cells that undergo glucose starvation-induced apoptosis (Ramírez-Peinado et 
al., 2013). Therefore, autophagy cannot be accounted as one of the main causes of cell death 
in the mammalian cell cultures. 
Extremely elevated levels of lactate and ammonia appears to predominantly trigger 
necrosis, rather than apoptosis. It was found that ammonia at a lower concentration triggered 
both apoptosis and necrosis at a similar degree, while only necrosis was seen in the culture with 
an extreme level of ammonia (>50 mM) (Singh et al., 1994). Similarly, the cultures of SP2/0 
hybridoma and NS0 cell lines with exposure to extreme levels of lactate (30 mM) and ammonia 
(3 mM) demonstrated that necrosis was the main cause of cell death in the cultures (Mercille 
and Massie, 1994a). Growth inhibition was also observed in cultures with the presence of 
ammonia and lactate. It appeared that the specific growth rate of a CHO cell line significantly 
decreased as the ammonia concentration rose (Kurano et al., 1990). Similarly, cell growth of a 
hybridoma cell line in the culture with an initial ammonia concentration at 4 mM exhibited a 
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50% decrease (Ozturk et al., 1992). Similarly, a negative effect of ammonia presence on the 
growth rate was seen in the culture of SP2/0 cells with an initial concentration of ammonia at 
2 mM. In addition to growth inhibition, an increase in death rate was noticed (Newland et al., 
1994), though cell death was not distinguished if it was due to apoptosis or necrosis. In the 
same way to ammonia, 55 mM of lactate accumulated appeared to halve hybridoma cell 
specific growth (Ozturk et al., 1992). 
Given that apoptosis can be triggered by the deprivation of nutrients, the addition of 
key nutrients including glucose, amino acids, and proteins during the batch culture of GS-NS0 
cells demonstrated that apoptosis can be delayed for at least 24 hours (DiStefano et al., 1996). 
The delay might be the result of shifts in metabolic pathways due to the nutrient addition 
(DiStefano et al., 1996). It was later confirmed that the delay of apoptosis due to the nutrient 
addition could be associated with a metabolic shift, which could relieve nutrient deprivation-
induced apoptotic stresses (Zhou et al., 1997a). Zhou et al. (1997) also suggested that a 
transition from production to consumption of lactate and the onset of ammonia production 
might be indicators of the metabolic shift. The transition of lactate-associated metabolic 
activities was seen in the culture of a CHO cell line with transfection of multi-anti-apoptotic 
genes including E1B-19K, XIAP, Aven, and bcl-2. This suggests that overexpression of anti-
apoptotic genes could enable a metabolic shift (Dorai et al., 2010, Dorai et al., 2009). A possible 
mechanism of bcl-2 overexpression enabling a metabolic shift could be that bcl-2 
overexpression down-regulates the lactate dehydrogenase A (LDH-A) gene, and in turn slows 
down the corresponding LDH reaction whereby pyruvate is converted to lactate (Papas et al., 
1999). The recent finding also confirmed that the amount of carbon from pyruvate entering 
TCA cycle during the lactate consumption phase was significantly more than that during the 
lactate production phase, suggesting a reduction in the LDH reaction activity (Templeton et al., 
2014). However, bcl-xL overexpression did not have influence on the transition of lactate 
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production/consumption states (Ha et al., 2013). Furthermore, metabolic activities, including 
specific nutrient consumption/ metabolite production rates, could be influenced by certain 
accumulated levels of ammonia and lactate as regards cell growth inhibition and cell death 
(necrosis and apoptosis) (Newland et al., 1994, Ozturk et al., 1992).   
  The link between metabolism and control of cell cycle progression was also previously 
established. A slower rate of cell proliferation, compared to the control, together with a 
significant increase in cell population in G1/G0 phase was observed in the batch culture of a 
CHO cell line producing IFN-g using glutamine-free medium. This suggests that cell cycle 
arrest might be one of responsive mechanisms to the metabolic stress due to glutamine 
deprivation (Sanfeliu and Stephanopoulos, 1999). Increases in both mRNA and protein 
expressions of p21 and p27 were induced by histidine deprivation in the culture of HepG2 cells, 
suggesting that the exhaustion of histidine may cease cell cycle progression at G1/G0 phase 
(Leung-Pineda et al., 2004). Arrest of cell cycle progression was also seen in serum-starvation 
conditions, in a similar manner to that of essential amino acids (Sherr and Roberts, 1995). 
Arrest of cell cycle was believed to have a tight relation to apoptosis (Al-Rubeai and Singh, 
1998, Kastan et al., 1995). It was established that p21 activation, which facilitates cell cycle 
arrest at G1/G0 phase, was induced by an elevated endogenous p53 expression as a result of 
exposure to apoptotic inducers (El-Deiry et al., 1994). The ultimate cell fate, between apoptosis 
or cell cycle arrest, is decided by the degree of cellular stresses as indicated by changes in 
activation levels of p53 (Mason and Rathmell, 2011). There is a threshold level of cellular 
stresses that enables activated p53 to initiate apoptosis, or otherwise cell cycle arrest 
(Kracikova et al., 2013). This might be a possible mechanism where metabolic stresses are 
linked with control of cell cycle and apoptosis. 
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2.7 Mathematical model development 
 
2.7.1 An overview of mathematical model development 
Table 2.7.1 Existing kinetics describing relations between substrates and rates of reactions. 
 
 
 
 
 
 
 
 
1(Moser, 1958), 2(Megee Iii et al., 1972), 3(Andrews, 1968). 
Where, “X” is the cell concentration (cell/L); “r” and “rx” are the rate of reaction (mol.L-1.s-1) and the cell growth 
rate (cell.L-1.s-1), respectively;  “[A]” and “[S]” are the concentration of species A and the limiting substrate 
concentration (mol.L-1), respectively; “a” and “b” are the order of reaction with regards to A and B (assuming to 
be stoichiometric coefficients), respectively; “k” is the rate constant (mol1-a-b. La+b-1.s-1); “kE[E]0” is the maximum 
reaction rate (sometimes called Vmax, mol.L-1.s-1); “Km” is the Michaelis-menten constant (mol.L-1); “Ks” is the 
limiting substrate concentration (mol.L-1); “Ki,s” is the limiting substrate inhibition constant (mol.L-1); n is the 
cooperative coefficient (depending on which biological context the equation is used). 
There are a number of existing mathematical correlations that were previously 
introduced and became a basis for development of mathematical models for biological systems, 
such as Monod equation (Monod, 1949), Michaelis–Menten kinetics (Chen et al., 2010) and 
Hill equation, as shown in Table 2.7.1. These equations involve two types of variables: state 
and operational variables. The former stands for variables that describe states of the systems, 
Kinetic types Mathematical expressions 
Rate law r = k [A]a[B]b 
Michaelis–Menten kinetics r = kE∙[E]0
[S]
[S] + Km
 
Monod equation  rX= μX,max
[S]
[S] + KS
∙X 
Moser’ formulation (Hill equation)1 rX= μX,max
[S]n
[S]n + KD
n ∙X 
Dual-limiting substrate kinetics2 rX= μX,max
[S1]
[S1] + KS1
∙
[S2]
[S2] + KS21
∙X 
Substrate inhibition  kinetics3 
rX= μX,max
[S]
[S]2
Ki,s
 + [S] + KS
∙X 
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such as viable cell density, nutrient concentration, etc. The latter specifies conditions utilised 
in the systems such as temperature, feeding flowrate, initial nutrient concentration etc. 
According to both state and operational variables, mass balances can be constructed to 
complement kinetic correlations. For example, a mass balance of viable cell density represents 
an accumulation or a depletion rate of viable cell concentration, which depending on the 
specific rate of growth and death, as defined by kinetic equations (Augusto et al., 2008).  
 Given that both kinetic equations as well as mass balances require constants to represent 
physical reactions (i.e. rate constants, Monod and Michaelis constants), constructed 
mathematical models typically consist a number of parameters (Kent et al., 2013). Values of 
parameters can be given from existing models or previous studies, however, some need to be 
determined. Parameter estimation is the process whereby optimal values of parameters can be 
estimated through diminishing the difference between experimental and simulated data. To 
achieve experimental agreement, the constructed mathematical models should be validated 
with an independent set of experimental data under different conditions (Augusto et al., 2008). 
2.7.2 Model classification 
 Given that cellular systems are highly non-linear and their behaviour is subject to a 
dynamic environment, it is therefore not trivial to construct a mathematical model that perfectly 
captures and predicts cellular responses under different circumstances. In addition, 
mathematical models have to be developed in a way that balances how much information must 
be included and model complexity. Several approaches for mathematical model development 
have been introduced in order to help handle complexity of cellular systems. Figure 2.7.1 
illustrates model classification for cell cultures, which divides mathematical models into 
several types according to the approaches for model development.  
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Figure 2.7.1 Model classification. Adapted from (Ramkrishna, 1979, Sidoli et al., 2004). 
Mammalian cell cultures are often found to be non-homogenous; there are various cell 
populations in the cultures, such as cells in different stages of the cell cycle, sizes, metabolic 
conditions etc. There are two main modelling approaches to handle the heterogeneity in 
mammalian cell cultures: unsegregated and segregated. Unsegregated models assume that an 
average property and behaviour of cell populations represent the entire cell population. For 
example, biomass per unit volume is employed to represent the average behaviour of the entire 
system. Segregated models capture the heterogeneity in the cultures, offering opportunities to 
integrate cellular activities/properties specific to each cell population. Population Balance 
Models (PBMs) are examples of segregated models, and can be formulated based on a 
difference in DNA contents of each cell population in different stages of cell cycle (Liu et al., 
2007, Hatzis et al., 1995). For example, production of IgG mAb in a hybridoma cell culture 
was found to be the highest one during G1 and early S phase (Al-Rubeai and Emery, 1990) 
which can be mathematically linked to viable cell densities in G1 and S phases for a higher 
degree of experimental agreement. However, this kind of model typically involves partial 
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differential equations, which are difficult to solve with highly sophisticated computational 
tools.  
 Mathematical models can be further divided into two subgroups: unstructured and 
structured, with regard to biological information included into the models (Figure 2.7.1). 
Unstructured models are frameworks that treat a single cell as “a black box”, where only 
phenomenological changes of cell behaviour/properties in response to environmental 
conditions are considered. Monod kinetics, for example, does not include intracellular 
phenomena that underlie changes in growth of specific cell types. Unstructured models are 
relatively less complicated, and thus not computationally expensive; however, they sometimes 
fail to represent particular behaviour of cellular systems under various culture conditions. 
Structured models take into account intracellular structures and activities, and usually provide 
a better mechanistic representation than unstructured models. Given that more biological 
information is included, structured models often consist of complicated networks of ODEs, and 
may result in mathematical intractability.  
In addition to the unsegregated/segregated and unstructured/structured ones, 
mathematical models can also be classified as deterministic/stochastic in accordance with 
whether likelihood of reactions occurring in the systems is considered. The models can also be 
divided as steady state or dynamic models. State steady models provide system information 
regardless of time, and thus require no mathematical term representing time dependence (time 
derivatives). Flux balance analysis (FBA), for instance, represents the direction and quantity 
of fluxes in biochemical pathways at a steady state (Knoop et al., 2013). Given that cellular 
systems are surrounded by a dynamic environment; FBA might not be able to capture transient 
shifts in cellular behaviour in response to environmental disturbances/signals. In contrast, 
dynamic models can capture behaviour with respect to time. Chemical kinetics or mass action 
law, for example, illustrate changes in reactions over time depending on concentrations of 
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reactants (Waage and Gulberg, 1986). However, compared to FBA, kinetics is more 
computationally intricate. Consequently, experimental validation required for kinetics can be 
relatively complicated.  
As discussed above, each type of mathematical model has its own strong and weak 
points. Hybrid models are ones that combine two or more model types so that each included 
model type can complement the others’ advantages and disadvantages. For example, a hybrid 
mathematical model for GS-NS0 cultures, which was the combination of a structured sub-
model describing a detailed mechanism of antibody synthesis and an unstructured model 
describing cell growth and metabolism, can capture culture dynamics at different osmotic 
conditions with relatively less computational resources required (Ho et al., 2006). Dynamic 
FBA is also an example where the hybrid approach is utilised. Dynamic metabolic profiles 
were achieved through successively executing FBA in accordance with dynamic changes in 
extracellular metabolite concentration and cell density (Nolan and Lee, 2011, Yugi et al., 2005, 
Antoniewicz, 2013). 
2.7.3 Computational tools for model analysis 
 Constructed mathematical models can be highly complicated, and may consist of a large 
number of parameters when considering a large number of biochemical reactions behind 
observed cellular activities as well as responses to environmental factors. Consequently, 
parameter estimation as well as experimental validation can be highly troublesome. Here, 
computational tools for model analysis are required in order to evaluate the constructed model 
characteristics, and thus help guide any further model modifications required prior to parameter 
estimation and experimental validation. In this way, model complexity as well as unnecessary 
experiments can be avoided. 
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Model identifiability 
In addition to being capable of capturing cellular behaviour, the selected mathematical 
models should be identifiable. A model is considered as unidentifiable if they return the same 
simulated output in accordance with a given set of model input, no matter what the values of 
parameter are. On the contrary, the models are identifiable only if a relation between the 
simulated output and the given input can be reproduced from a limited number of values in a 
parameter range (Bellman and Åström, 1970, Walter and Lecourtier, 1981). They can be 
“globally” or “locally” identifiable depending how unique the values of parameter are (Cobelli 
et al., 1979). In addition, “structurally” identifiable models can be distinguished from “at-a-
point” identifiable ones. The only difference is that “at-a-point” identifiability test can be 
performed only for models with given nominal values of parameters, and thus the model 
identifiability holds true only around the given nominal values. Structural ones analyse model 
identifiability regardless of  values of parameters (Quaiser and Monnigmann, 2009).  
Structural identifiability analysis 
Structural identifiability analysis was firstly proposed by Bellman and Åström (1970) 
in an attempt to evaluate structural identifiability of model parameters. The analysis is 
performed based on a given set of model input without taking into account model uncertainty 
and measurement error (Bellman and Åström, 1970). Updated versions of structural 
identifiability analysis have been introduced so that it can study more complicated models, 
especially non-linear ODE systems (Chappell and Godfrey, 1992, Vajda et al., 1989). 
However, applications of structural identifiability analysis are limited to relatively small 
models, consisting less than 10 parameters (Sidoli et al., 2004). In addition, structural 
identification analysis can provide invalid information especially when mathematical models 
for noisy systems such as biological ones are concerned, resulting in a misleading conclusion 
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about the reliability of parameter estimates. Therefore, despite being structurally identifiable, 
models require further evaluation of their parameter reliability and accuracy. It is called 
“practical identifiability analysis”, performed after parameters are estimated. The structural 
identifiability analysis can be considered as “a theoretical suggestion” and practical 
identifiability analysis is the validation of the suggestion (Miao et al., 2011). 
Sensitivity analysis-based identifiability evaluation 
 Sensitivity analysis measures the variation of model output with respect to any change 
in model inputs including model parameters. If model output is found to be highly disturbed 
by small changes in a parameter value, this parameter is considered as a “significant” 
parameter. On the contrary, a large variation in an insignificant parameter value has little 
influence on model output (Kiparissides et al., 2009). Significant parameters are typically 
identifiable given their significant impact on the simulated model output while insignificant 
parameters are most probably unidentifiable. In this way, sensitivity analysis can indicate 
identifiability of model parameters. The sensitivity analysis can be performed prior to actual 
experiments, though it requires pre-estimates of model parameters. Unlike the structural 
identifiability analysis, the sensitivity approach is not concerned with model structure. 
Consequently, it can be applied to highly non-linear models. However, the sensitivity approach 
does not take into account uncertainties and measurement noises while practical identifiability 
analysis does (Miao et al., 2011).   
Evaluation of model identifiability is performed based on sensitivities of parameters 
through several methods. The “correlation method” and the “orthogonal method” search for 
any possible dependent relations among parameters using the matrix of sensitivity coefficients 
representing the influence of each parameter on the simulated trajectories. If a parameter has a 
dependent correlation(s) to another, or other parameters, a change in simulated output caused 
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by a change in this parameter value can be compensated by changing other parameter values, 
and thus this parameter cannot be identifiable (Quaiser and Monnigmann, 2009, Yue et al., 
2006, Rodriguez-Fernandez et al., 2006). Other methods called the “principle component 
analysis” (PCA) and the “eigenvalue method” utilise the sensitivity analysis to rank importance 
of parameters through calculating eigenvalues and their corresponding eigenvectors. The PCA 
employs the order of eigenvalues to justify discarding parameters while keeping any change in 
the simulated or observed output (due to discarding parameters) to a minimum (Degenring et 
al., 2004).  
Global sensitivity analysis (GSA) 
There are two main types of sensitivity analysis; local and global sensitivity analysis. 
Local sensitivity analysis (LSA) investigates each parameter sensitivity through varying a 
parameter estimate at a time while keeping the rest of parameter estimates unchanged. Global 
sensitivity analysis (GSA) provides sensitivity information of each parameter through 
simultaneously and randomly varying all parameter estimates (Kiparissides et al., 2009, Yue 
et al., 2006). Given that LSA does not take into account model uncertainties and depends on 
parameter nominal values, it might provide incomplete information of parameter sensitivities. 
GSA provides parameter sensitivities regardless of given nominal parameter values and 
variation ranges of parameter values. In addition, GSA takes into account model uncertainty 
given that it analyses parameter sensitivities through the simultaneous variation of all model 
parameters. It also provides the information about interactions or correlations between/among 
parameters (Kent et al., 2013, Kiparissides et al., 2009). Therefore, GSA becomes a superior 
choice for model analysis, though it requires relatively more computational resources. 
GSA can be performed through two main approaches: 1) one that employs the model 
approximation to investigate significance of parameters, and 2) the other that measures 
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significance of parameters through estimating the total variance of model output. The variance-
based approach is superior since it can provide information about interactions between/among 
parameters (Cho et al., 2003, Kiparissides et al., 2009). Sobol (2001) introduced variance-based 
GSA, so-called Sobol’ method, which estimates sensitivity indices representing global 
parameter sensitivities. This method represents the output variability as a function of model 
parameters variability, through integrable and orthogonal summands of increasing 
dimensionality, called ANOVA decomposition (Sobol, 2001), as shown in Eq. 2.7.1. The 
output variability is defined as f(X) depending on a parameter vector X. This function is defined 
in the n-dimensional unit cube (In), where n is the number of model parameters of interest. 
Eq. 2.7.1 ANOVA decomposition 
f(X1, …, Xn) = f0  +  ∑ fi(Xi)  + ∑ fij(Xi, Xj) + … + f1,2, …, n(X1, X2, …, Xn)
1≤i<j≤n
n
i=1
 
 
 
Where, f0 is a constant and refers to the mean effect on output variability (the zeroth order term); fi(Xi) is the first 
order term that stands for the fractional contribution of single parameter (Xi) variation to output variability; fij(Xi, 
Xj) is the second order term that accounts for the synergic effect of parameter Xi and parameter Xj on output 
variability; The higher order terms (f1, 2, …, n(X1, X2, …, Xn)) accounts for impact of cooperative interactions 
among two more parameters on output variability f(X).         
As can be seen in Eq. 2.7.1, the first order effects, or so-called “main effects” can be 
distinguished from the higher order ones. It was suggested that the importance of parameters 
should not be ranked using only main effects. In addition, determining the higher order terms 
is essential to understand model parameter interactions and their impact on output variability 
(Chan et al., 1997).Therefore, the main effects and the “total sensitivity indices” (TSIs), which 
are the main effects combined with associated higher order effects, are recommended to be 
calculated in order to sort parameters into the right order of significance (Homma and Saltelli, 
1996) as well as recognise the influence of interactions among model parameters (Kiparissides 
Constant The first 
order 
The higher orders 
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et al., 2009). Sobol (2001) demonstrated a practical approach to estimate the terms in the 
ANOVA decomposition. To estimate terms in the ANOVA decomposition, Monte Carlo (MC) 
algorithm, which employs repeated random sampling in order to estimate the summands, is 
employed. In this way, uncertainties are also introduced to each parameters through (Quasi) 
MC random sequences. This makes it possible to practically estimate both the main effects and 
TSIs (Sobol, 2001). 
In addition to the Sobol’ method, there are other variance-based methods for GSA 
including updated versions of the Sobol’ method. The extended Fourier amplitude sensitivity 
test (FAST) have been found to be on par with Sobol’ method since it gives identical main 
effects and TSIs to those from Sobol’ method (Chan et al., 1997, Kiparissides et al., 2009). 
Recently, the original Sobol’ algorithm has been improved and it became more efficient for 
model evaluation (Sobol et al., 2007). One of the improvements is the method of high 
dimensional model representation (HDMR), which appears to be more computationally 
efficient. This method is fundamentally based on Sobol’ algorithm, and thus the main effects 
and the TSIs can be obtained. Since this method requires much less space for repeated random 
sampling as compared to the original Sobol’ method, the required computational time is 
reduced and the method can be applied to a wider range of applications (Ziehn and Tomlin, 
2009). 
2.7.4 Frameworks for predictive mathematical model development 
A framework for development of mathematical models is a workflow, where steps for 
constructing, analysing and validating mathematical models are systemically organised to 
ensure that the resultant models are capable of capturing behaviour of systems of interest. 
Generally, the framework is comprised of model construction, model analysis (using GSA or 
LSA-based identifiability evaluation) and parameter estimation. Many mathematical models 
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for biological systems were introduced with their own frameworks which were based on such 
similar principles (Fang et al., 2009, Bucher et al., 2011, Nolan and Lee, 2011, Vargas et al., 
2011).  
 
Figure 2.7.2 The framework for predictive mathematical model development proposed by 
(Kontoravdi et al., 2010). 
However, the resulting models often lack predictability, especially when the models are 
applied for simulating situations other than one(s) used in experimental validation. For 
instance, the model developed based on a batch culture can fail to capture fed-batch and 
perfusion modes of cultures. Kontoravdi et al. (2010) introduced a systematic framework, 
where model analysis, design of experiment (DOE) and model validation are incorporated in a 
cooperative manner in order to achieve optimal estimates of sensitive and identifiable 
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parameters, as can be seen in Figure 2.7.2. DOE was performed to generate an optimal 
experimental condition in the fed-batch mode of cell cultures (optimal feeding interval, feeding 
concentration, etc.) in an attempt to validate the mathematical model constructed based on 
batch experiments. The mathematical model was then validated with experimental data from 
the designed experiment(s) and parameter values can be adjusted accordingly. The model with 
amended parameter estimates was tested with sets of experimental data including batch and 
fed-batch experiments. If satisfied, parameters were assumed to be well-fit, otherwise the 
whole process would be repeated until the simulated trajectories satisfactorily matched with 
the experimental data. The predictability of the model with the finalised parameter estimates 
from model validation was tested with data from independent set of experiments (Kontoravdi 
et al., 2010).  
The finalised version of the mathematical model for the culture of a hybridoma cell line 
(CRL-1606), which was developed through the proposed framework, was able to capture an 
independent fed-batch culture profile (Kontoravdi et al., 2010). Ho et al. (2006) proposed the 
similar framework to Kontoravdi et al.’s to develop a mathematical model of mAb synthesis in 
the culture of a GS-NS0 cell line under different hyperosmotic conditions. GSA was performed 
to identify important parameters and to also guide identifiability of parameters. Modifications 
of the model developed based on a normal osmotic condition were performed in accordance 
with the GSA results (Ho et al., 2006). The predictive ability of the finalised version of the 
model was verified with an independent set of hyperosmotic experiments (Ho et al., 2012).  
2.8 Mathematical models for cell growth, metabolism and death 
 
Over the last few decades, mammalian cell cultures for industrial production of bio-
therapeutics have allowed mathematical modelling to emerge as a powerful tool for in silico 
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studies of culture condition effects on culture performance. The models can provide the 
possible outcome of the cultures with regards to the variation of culture conditions, and thus 
help avoid trial-and-error experiments. To date, there are a number of mathematical models for 
bio-therapeutics production platforms, which are exploited as a basis for model development 
herein.  
2.8.1 Unstructured models for cell growth and metabolism  
 Monod equation has been applied in order to represent the specific growth rate of 
mammalian cells under influence of limiting nutrients and metabolic by-products. The generic 
form can be written as shown in Eq. 2.8.1. The maintenance energy model was employed to 
describe utilisation rates of limiting substrates (Pirt, 1965, Pirt, 1982), which was formulated 
based on an assumption that substrates could be consumed for cell growth and cellular 
maintenance (Eq. 2.8.2). The generation rate of metabolic by-products was assumed to be 
proportional to the utilisation rate of substrates. The synthesis of antibodies was mathematically 
expressed by a simple linear correlation, where antibody synthesis can be dependent (αμ) 
and/or independent (β) from cell growth, as can be seen in Eq. 2.8.3. 
Eq. 2.8.1 Monod equation for the specific growth rate 
μ = μ
max
[
S1
S1 + KS1
] [
S2
 S2 + KS2
] [
 KP1
P1 + KP1
] [
KP2
P2+ KP2
] 
 
Where, μ is the specific growth rate (s-1); μmax is the maximum specific growth rate (s-1); S1 and S2 are the 
extracellular concentrations of limiting substrates (mol.L-1); P1 and P2 are the extracellular concentrations of 
metabolic by-products (mol.L-1); K is the substrate limitation or inhibition constant according to the subscripts 
(mol.L-1).  
Note that when substrate availability benefits the specific growth rate, the “limiting” term is used (the more 
available the substrate, the higher the term value), while the “inhibiting” term is used when substrate availability 
is detrimental to the specific growth rate (the more available the substrate, the lower the term value). 
“Limiting” “Inhibiting” 
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Eq. 2.8.2 The constant maintenance energy model 
q
S
= 
μ
YX,S
 + mS 
Where, qS is the specific substrate utilisation rate (mol.cell-1.s-1); YX,S is the maximum yield of cell on substrate S 
(cell. mol-1); mS is the maintenance energy constant, subject to the substrate S (mol.cell-1.s-1). 
Eq. 2.8.3 The correlation between the production rate of mAb and the specific growth rate  
q
mAb
= αμ+𝛽 
Where, qmAb is the specific production rate of mAb (mg.cell-1.s-1); α is the growth-related constant (mg. cell-1) and 
β the growth-independent constant (mg.cell-1.s-1). 
 
 These equations were widely used as a basis for development of cell growth and 
metabolism mathematical models for the mammalian cell cultures, as can be seen in Table 
2.8.1. Model description may vary depending on (1) assumptions based on the observed 
phenomena and (2) characteristics of culture systems, including modes of culture, cell lines, 
and culture conditions. For example, with the culture of a hybridoma cell line, Bree et al. (1988) 
assumed that glutamine is the sole substrate that influenced growth kinetics as well as mAb 
production, while Miller et al. (1988) additionally took into account the impact of glucose on 
the specific growth rate. Models for glutamine consumption often neglect the maintenance 
energy term (mS). de Tremblay et al. (1992) modified the growth-related constant in the mAb 
production equation in order to refine the effect of cell growth on the mAb production rate. 
Dalili, M., et al. (1990) found that both serum and glutamine affected cell growth, consequently 
the mathematical expression for cell growth was derived to take into account the impact of 
initial concentration of serum, and glutamine concentration. Frame, K. K. and Hu, W.-S. (1991) 
mathematically modelled the specific growth rate to be dependant only on glucose, given their 
experimental observation.  
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Table 2.8.1 Equations for the specific growth rate, the specific utilisation rate of substrates, the specific production rate of metabolic by-products, 
and the antibody synthesis rate. Adapted from (Pörtner and Schäfer, 1996). 
Reference Cell growth rate models Substrate utilisation rate  
By-product generation 
rate 
Antibody synthesis 
rate 
(Bree et al., 
1988) 
μ
X
 = μ
X,max
∙ [
Gln
Gln+ KX,Gln
] ∙ 
[
 KX,Amm
Amm + KX,Amm
] ∙ [
 KX,Lac
Lac + KX,Lac
] 
q
Glc
= 
μ
X
YX,Glc
 + ms 
q
Gln
= 
μ
X
YX,Gln
+
q
mAb
YX,Gln
+ 
q
Amm
YAmm,Gln(1)
 
q
Amm
= YAmm,Gln(2)∙qGln 
q
Lac
= YLac,Glc∙qGlc 
q
mAb
= 
αmax
 Kp,Gln
Gln + Kp,Gln
∙ 
XV
XV+ Kp,X
 
(Miller et al., 
1988a) 
μ
X
 = μ
X,max
∙ [
Glc
Glc+ KX,Glc
] ∙ [
Gln
Gln+ KX,Gln
] ∙ 
[
 KX,Amm
Amm + KX,Amm
] ∙ [
 KX,Lac
Lac + KX,Lac
] 
- - - 
(Pörtner and 
Schäfer, 
1996) 
μ
X
 = μ
X,max
∙ [
Gln
Gln + KX,Gln
] q
Gln
 = μ
S,max
∙ [
Gln
Gln + KS,Gln
] qAmm= YAmm,Gln∙qGln 
Constant  
(4x10-10 mg cell-1 hr-1) 
(de Tremblay 
et al., 1992) 
μ
X
 = μ
X,max
∙ [
Glc
Glc+ KX,Glc
] ∙ [
Gln
Gln + KX,Gln
] 
q
Glc
= 
μ
X
YX,Glc
 + ms∙ [
Glc
Glc+ KS,Glc
] 
q
Gln
= 
μ
X
YX,Gln
 
q
Amm
= YAmm,Gln∙qGln 
q
Lac
= YLac,Glc∙qGlc 
q
mAb
= 
α
μ
X
+ KmAb
∙ 
μ
X
+β 
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Table 2.8.1 (continue) Equations for the specific growth rate, the specific utilisation rate of substrates, the specific production rate of metabolic 
by-products, and the antibody synthesis rate. Adapted from (Pörtner and Schäfer, 1996). 
Reference Cell growth rate models 
Substrate utilisation rate 
models 
By-product generation 
rate models 
Antibody synthesis rate 
models 
(Frame and 
Hu, 1991)* 
 μ
X
 = 
μ
X,min
+ [
(μ
X,max
- μ
X,min
) (Glc-Glcthres)
(Glc-Glcthres) + KX,Glc
] 
q
Glc
= 
μ
X
- μ
X,min
 
YX,Glc
 
q
Gln
= 
μ
X
- μ
X,min
 
YX,Gln
 
- - 
(Dalili et al., 
1990) 
μ
X
 = μ
X,max
∙[Serum]
0
[
Gln
Gln + KX,Gln
] qGln= 
μ
X
 
YX,Gln
+Kdeg - 
q
mAb
 = β∙[Serum]
0
 
[
Gln
Gln + KmAb
] 
(Kurokawa 
et al., 1994) 
μ
X
 = 
μ
X,max
∙ [
Glc
Glc+ KX,Glc
] ∙ [
 KX,Lac
Lac + KX,Lac
] 
q
Glc
= 
μ
X
YX,Glc
 + ms qLac= YLac,Glc∙qGlc - 
* The minimum specific growth rate or μmin is the growth rate when the substrate level is at the minimum level, or the threshold substrate concentration (St), that cell can still 
grow. 
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There were attempts to incorporate relatively more detailed biological information into 
the simplified mathematical equations. Suzuki and Ollis (1989) proposed a mathematical 
model that aimed to capture cell growth in association with cell cycle progression, and 
associated production of antibody with culture progression through cell cycle phases. The total 
production of antibody was calculated based on the summation of the production of antibody 
of each cell cycle phase (Suzuki and Ollis, 1989). Unlike the model by Suzuki and Ollis (1989), 
Jang and Barford (2000) proposed an unstructured model that included production of mAb 
from cells arrested at G1 phase. The model was based on Monod-type equation (Eq. 2.8.1) 
accounting for the impact of limiting nutrients and metabolic by-products on the specific 
growth rate (Jang and Barford, 2000). Lam et al. (2008) adopted the same principle as Suzuki 
and Ollis (1989) to develop a mathematical model for the culture of a hybridoma cell line, 
which accounted for the influence of cell cycle progression on cell growth, death and mAb 
production. This model aimed to reproduce batch and fed-batch data toward feeding 
optimisation (Lam et al., 2008). 
Kontoravdi et al. (2007) developed a model library for metabolism of 19 amino acids, 
which was based on the maintenance energy model (Eq. 2.8.3) as well as Monod-like 
expressions (Eq. 2.8.1) (Kontoravdi et al., 2007). Mathematical models for the culture for GS-
NS0 cell line were constructed to capture the impact of intracellular ATP on the specific growth 
rate through Monod-type expressions (Kiparissides et al., 2011b). Recently, a mathematical 
model accounting for effects of culture temperature as well as temperature shifts on cell cycle 
progression and antibody production in the culture of a hybridoma cell line (CRL-1606) was 
proposed. The model was aimed to guide an optimal time point for the temperature shift to 
allow the cultures achieve the maximum antibody production. The model was formulated based 
on previous cell cycle models (where the specific growth rate depends on cell cycle time and 
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the production of mAb is subject to cell cycle phases) and Monod-type expressions (García 
Münzer et al., 2015). 
2.8.2 Detailed cell growth and metabolism models 
Unstructured mathematical models can be capable of reproducing observed 
phenomena. Nevertheless, sometimes they fail to capture particular circumstances where cells 
are dynamically adapting in response to environment changes, such as lag phases in the 
cultures(Fredrickson, 1976). Furthermore, advances in analytical techniques and 
measurements enable us to build up detailed insight into mechanisms of biochemical/cellular 
processes (cell growth, death and metabolism) as well as spatial properties of intracellular 
organelles/structures. Such detailed biological knowledge is essential to be incorporated into 
mathematical models in order to extend model predictive ability. 
Structured models 
 Fredrickson (1976) proposed a formulation of a structured mathematical model, which 
was derived from the law of mass action together with mass balances of metabolic species 
(Fredrickson, 1976). Batt and Kompala (1989) adopted the model formulation by Fredrickson 
(1976) to build a structured mathematical model where metabolism was simplified by lumping 
similar metabolic species together as regards their biological relevance. Interactions among 4 
intracellular and extracellular metabolic species was mathematically expressed by the 
combination of material balances, the law of mass action, and Monod-based expressions (Batt 
and Kompala, 1989). 
Sanderson et al. (1999) developed a model that captured metabolic and transport 
activities throughout the entire cellular system that are applicable to the process of mAb 
synthesis. The reaction rates and specific growth rates were mathematically expressed using 
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Monod-type equations, while the rates of inflow/outflow of nutrients through cell membrane 
as a result of concentration differences (between intracellular and extracellular ones) were 
described using Michaelis-Menten kinetics. The model consists of around 90 ODEs, 109 
algebraic equations (AEs) and around 390 parameters (Sanderson et al., 1999a). By manually 
adjusting parameter values to fit experimental data, 60 of these parameters were found to be 
significant (Sanderson et al., 1999c). Jang et al. (2000) also adopted the same approach to 
identify significant parameters, and then modified the model, which was developed based on 
the batch culture of a hybridoma cell line, to be able to reproduce experimental data from the 
batch culture of an insect cell line (Jang et al., 2000, Sanderson et al., 1999b). Bibila and 
Flickinger (1991) developed a structured, unsegregated mathematical model for the 
intracellular process of antibody synthesis, describing how molecules of antibody are 
synthesised; from transcription of heavy and light chains mRNAs, translation of the 
corresponding mRNAs and the process of antibody molecules being constructed (Bibila and 
Flickinger, 1991). 
Hybrid models 
 Kontoravdi et al. (2005) combined a structured model for mAb synthesis, previously 
proposed by Bibila and Flickinger (1991), to an unstructured model describing cell growth and 
metabolism in the culture of hybridoma and NS0 cell lines. For the unstructured part, Monod-
type mathematical expressions as well as the maintenance energy model were used to capture 
cell growth (subject to nutrient limitation and by-product inhibition), and nutrient utilisation as 
well as metabolic by-product generation, respectively. Like the original model, the mechanism 
of intracellular mAb synthesis was mathematically described using mass action kinetics 
(Kontoravdi et al., 2005). This model was later called a “hybrid model” where its model 
complexity is a compromise between unstructured and structured ones. Later, another hybrid 
model, which is based on the model by Kontoravdi et al., (2005), was constructed to capture 
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the effect of osmotic pressure on production of mAb in the culture of a NS0 cell line, and was 
modified to capture the culture under various osmotic conditions (Ho et al., 2006, Ho et al., 
2012).  
Dynamic metabolic flux analysis (dMFA) 
The hybrid approach was also applied to MFA, so that it can provide changes in 
intracellular metabolic states under influence of a dynamic environment. It was suggested that 
metabolic shifts could be subject to the levels of glucose and glutamine (Zhou et al., 1997b, 
Sanfeliu et al., 1997). Zhou et al. (2006) proposed a dMFA describing intracellular metabolic 
activities (using a quasi-steady state assumption for intracellular metabolic activities), with 
links to Monod-type kinetics describing dynamic changes in extracellular conditions. The 
model can capture two different metabolic states: lactate consumption and production with 
regard to changes in specific glycolysis rates (Zhou et al., 2006). Another dynamic MFA was 
developed for the fed-batch culture of a CHO cell line. Kinetic expressions for dynamic change 
in extracellular conditions (i.e. concentration of glucose, lactate, amino acids, etc.,) were 
combined with quasi-steady state analysis for intracellular metabolic activities. The model was 
validated with various culture conditions, including temperature shifts, inoculum density, and 
concentration of nutrients (Nolan and Lee, 2011). 
Population balance models (PBMs) 
PBMs are mostly formulated based on detailed dynamics of cell cycle. The transition 
rate of cells, from one phase to the subsequent phase, is defined as a probabilistic function. 
This function is typically correlated with specific cellular characteristics that indicate when the 
phase transition could take place, such as cell size and DNA content. Liu et al. (2007) proposed 
a three-phase cell cycle (G1, S, G2/M) PBM to capture dynamics of cell cycle in the culture of 
a myeloma cell line. The probabilities that allow cells to move from G1 to S phase and from 
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G2/M to cell division was defined to depend on cell volume, while the probabilities of cell 
transition from S to G2/M phase was correlated with DNA content. The model was also 
combined with the regulator model, which helps limit cell growth during the lag phase in the 
cultures, and took into account the limiting effect of lysine (Liu et al., 2007). A recent PBM 
describing four cell cycle phases (G0, G1, S, G2/M) also employed the same transition 
probability functions to the model by Liu et al. (2007). However, these function applied more 
constraints such as cell shape factors, cell volume thresholds, etc., (Fadda et al., 2012).     
2.8.3 Unstructured cell death kinetics 
Cell death has a direct influence on culture viability and production as well as quality 
of the secreted bio-proteins. Kinetics of cell death is therefore undoubtedly required to be 
included in the mathematical models for mammalian cell cultures. It can be linked to limiting 
nutrient availability, cell growth as well as accumulation of toxic metabolic by-products, 
depending on assumptions as well as experimental observation. Table 2.8.1 summarises the 
existing mathematical expressions for cell death kinetics, most of which were constructed 
based on Monod-type expressions (Eq. 2.8.1).  
 As can be seen from the table, the specific death rates were correlated with the levels 
of nutrients: glucose (Frame and Hu, 1991) and glutamine (Dalili et al., 1990, Pörtner et al., 
1996), given that these nutrients were assumed to be limiting. In addition, the death rates were 
assumed to be dependent on the concentrations of toxic metabolites, such as lactate and 
ammonia (Batt and Kompala, 1989). The specific death rate can be assumed to depend on the 
limiting substrates and the metabolites (Bree et al., 1988, de Tremblay et al., 1992), given that 
they were found to influence cell death in the cultures (Ozturk et al., 1992). The specific death 
rate may also be assumed to be an inverse function of the specific growth rate. Sanderson et al. 
(1999) employed the inhibition term of the Monod kinetics to describe the correlation between 
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the specific growth and death rates. Glacken et al. (1989) and Linardos et al. (1991) assumed 
the specific death rate to be inversely proportional to the exponential function of the specific 
growth rate, given that potential causes and detailed mechanisms for the onset of cell death was 
not still well-defined (Dodge et al., 1987).  
Table 2.8.2 Models for the specific cell death rate. Adapted from (Pörtner et al., 1996). 
Reference Cell death rate models 
(Frame and 
Hu, 1991) 
μ
d
 = (μ
X,min
- Dmin) - μd,max∙ [
 (Glc-Glcthres)
(Glc-Glcthres) + Kd,Glc
] 
(Dalili et al., 
1990) 
μ
d
 =  kd,min+ (kd,max- kd,min)∙ [
 Kd,Gln
Gln + Kd,Gln
] 
(Pörtner et al., 
1996) 
μ
d
 = b1+ [
b2
Gln + b3
] 
(Batt and 
Kompala, 
1989) 
μ
d
 = μ
d,max
∙ [
Amm
Amm+ Kd,Amm
] ∙ [
Lac
Lac + Kd,Lac
] 
(Bree et al., 
1988)  
μ
d
 = μ
d,max
∙ [
Amm
Amm+ Kd,Amm
] ∙ [
Lac
Lac + Kd,Lac
] ∙ [
 Kd,Gln
Gln + Kd,Gln
] 
(de Tremblay 
et al., 1992) 
μ
d
 = 
μ
d,max
(μ
X,max
- Kd,Lac∙Lac )  (μX,max- Kd,Amm∙Amm )  
∙ [
 Kd,Gln
Gln + Kd,Gln
] 
(Jang and 
Barford, 2000) 
μ
d
 = [
μ
d,max
1+( Kd,Amm AMM⁄ )
n] 
(Linardos et 
al., 1991). 
μ
d
= d0e
d1/μX 
(Glacken et 
al., 1989) 
μ
d
= C1e
C2∙μX  
(Sanderson et 
al., 1999a) 
μ
d
 = μ
d,max
∙ [
 Kd,μX
μ
X
+ Kd,μX
]
2
 
 
Later, Ho et al. (2006) adopted the specific death rate equation, proposed by de 
Tremblay et al. (1992), to account for kinetics of cell death in the culture of GS-NS0 cells. 
Since this culture does not suffer from ammonia accumulation and intracellular glutamine can 
be intracellularly house produced, the ammonia and glutamine terms in the original equation 
were omitted, and thus it was dependent only on lactate accumulation (Ho et al., 2006). Zhou 
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et al., (2006) and Liu et al., (2008) adopted the death rate equation, proposed by Sanderson et 
al. (1999), to describe kinetics of cell death in the myeloma cell cultures (Zhou et al., 2006, Liu 
et al., 2008). Jang and Barford (2000) related the specific cell death rate with ammonia 
concentrations through Hill functions (Table 2.7.1) (Jang and Barford, 2000). This expression 
was later applied to the mathematical models for the cultures of hybridoma and HEK-293 cells 
(Kontoravdi et al., 2005, Kontoravdi et al., 2007). The cell death kinetics in the mathematical 
model for the cultures of CHO cell lines was formulated based on the previously observed 
threshold levels of lactate and ammonia that CHO cells can tolerate. If the levels of lactate and 
ammonia were less than the threshold, the death rate would be reduced and vice versa 
(Kontoravdi et al., 2007). 
2.9 Mathematical model description for apoptosis 
 
Apoptosis becomes in the spotlight since the biochemical reaction network underlying 
apoptotic events as well as the kinetics of apoptosis was established (Vomastek and Franěk, 
1993, Hengartner, 2000, Franěk et al., 1992). Furthermore, the onset of apoptosis is subject to 
various cellular processes, especially cell metabolism (Mason and Rathmell, 2011, Majors et 
al., 2007). Most importantly, apoptosis is found to be the main cause of the viability loss in the 
culture of mammalian cell lines (Goswami et al., 1999, DiStefano et al., 1996, Browne and Al-
Rubeai, 2011a, Singh et al., 1994)). For these reasons, mathematical modelling is required for 
the study of apoptosis as well as its dynamic behaviour in response to various death stimuli in 
the mammalian cell cultures. 
2.9.1 Mathematical models for apoptotic pathways 
 As above discussed, apoptosis is a physiological process that is triggered and executed 
in an organised manner (Saini and Walker, 1998). There are a number mathematical models 
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developed based on mechanistic understanding of biochemical reaction networks underlying 
the apoptotic pathways. These models aim to establish a core apoptotic cascade, whereby cell 
death fate is governed in accordance with death signals. Given that apoptosis induction was 
observed to be a fast process in a single cell level while the speed of apoptosis induction was 
much slower when a cell population level was concerned, Eissing et al. (2004) proposed a 
kinetics-based model describing interactions among apoptotic species in the receptor-induced 
apoptotic pathway: caspase-3, caspase-8, and inhibitors of apoptosis proteins (IAPs), with an 
additional effect of bifunctional apoptosis regulator (BAR). This regulatory cascade displays 
irreversible bistability, where there are two stable states existing in the system, and this 
characteristic might reflect how cell fate is governed and reconciles the fast apoptotic induction 
in the single cell level with the slow induction speed in the cell population level (Eissing et al., 
2004).  
 
                (A)                                                           (B) 
Where, Act is Activator, Ena is Enabler, InBax is Inactive Bax/Bak, acBax is Active Bax/Bak and MAC is 
Mitochondrial Apoptosis Channel. 
Figure 2.9.1 Two models of the Bcl-2 family member interactions. The difference between 
(A) and (B) is the auto-activation of active bax. Adapted from (Cui et al., 2008).  
 Bistability, which can reflect as apoptotic switch-like responses, is often found arising 
from interactions among species forming feedback regulatory networks. Legewie et al. (2006) 
suggested that an implicit feedback loop could arise from the interaction network where active 
caspase-3 molecules enhance itself by neutralising the inhibitory effect of XIAP on caspase-9. 
The simulated results from the proposed kinetics-based model demonstrated that the positive 
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feedback generates bistability, and also irreversibility when considering together with another 
feedback loop where activation of capase-9 is enhanced by the feedback signal from activation 
of caspase-3. This model also suggests that how apoptotic responses to death signals; whether 
switch-like (all-or-none) or gradual; and reversible or irreversible, depends on to what extent 
apoptosis inhibitors (i.e. XIAP) become involved in the feedback loop (Legewie et al., 2006). 
Given that the mechanism of interactions among Bcl-2 family members underlying apoptosis 
induction at the upstream of the mitochondrial pathway was still elusive, Cui et al. (2008) 
proposed possible molecular mechanisms of the interactions, as shown in Figure 2.9.1. The 
simulated results suggested that two proposed positive feedback networks; 1) active Bax 
inhibiting Bcl-2; and 2) auto-activation of Bax, can bring about bistability indicating the 
apoptotic switch-like response. By performing stochastic simulations, this model can reproduce 
the experimental data where bimodal Bax-activation distribution of cell populations was 
observed (Cui et al., 2008). 
Bagci et al. (2006) developed a mathematical model for the mitochondria-mediated 
apoptotic pathway, which cooperative binding (or Hill function) was included to describe the 
formation of apoptosome complex. They pointed out that bistability arose from the 
cooperativity in the apoptosome formation and it was found to be more robust to intrinsic noises 
than other earlier proposed models (Bagci et al., 2006). The concept of cooperative binding 
was applied to Bax-polymerisation, where Bax molecules cooperatively bind to each other to 
form an active, tetrameric compound of bax molecules (active Bax). A mathematical model 
was developed to capture Bax polymerisation in responses to lethal stimuli. It was pointed out 
that a bistable switch with irreversibility (survive or apoptosis) arose from the cooperative 
mechanism for Bax-polymerisation. By analysing the model both deterministically and 
stochastically, the model has high resistance to stochastic noises (Chen et al., 2007).    
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In addition to mathematical models that aim to establish a core module governing 
apoptotic switch-like responses, there are mathematical models that account for the entire 
picture of apoptotic pathways. Fussenegger et al. (2000) developed a mass action kinetics-
based mathematical model where both the intrinsic (mitochondria-dependent) and the extrinsic 
(receptor-mediated) pathways were included (Fussenegger et al., 2000). Although the 
simulated results were comparable to experimental observation, it lacks of experimental 
validation. Furthermore, anti-apoptotic mechanisms were omitted in this model, and 
consequently the model always progresses toward the onset of apoptosis (Bagci et al., 2006). 
Bentele et al. (2004) developed a GSA-associated systematic framework for constructing a 
kinetics-based mathematical model for CD95-induced apoptosis where both apoptotic 
pathways were involved. The use of GSA helps simplify the complexity of resulting model and 
guides to create experimental design for parameter estimation (Bentele et al., 2004).          
Hua et al. (2005) constructed a computational model that describes the death receptor 
mediated apoptosis, where the death signals are transduced from the interactions between Fas 
and Fas ligands to activate caspase-8, and in turn activate caspase-3 as well as the 
mitochondria-induced pathway. Two-third of parameter values were determined by manually 
adjusting the values until the model could reproduce the experimental data. The sensitivity 
study of lethal stimuli suggests that expected symmetric effects on apoptotic responses could 
not always be achieved, given the experimental data showing that Bcl-2 overexpression had 
inhibitory impact on activation of caspase-3 while Bcl-2 knockdown had insignificant impact 
on caspase-3 activation. In addition, the dominant pathway to initiate the caspase-3 activation 
could be both apoptotic pathways depending on expression levels of apoptotic molecules (Hua 
et al., 2005). Okazaki et al. (2008) scrutinised the switch between the two apoptotic pathways, 
as suggested by Hua et al., 2005, via computational simulations. They adopted the 
mathematical model originally developed by Hua et al., (2005), which was then refined by 1) 
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omitting parameters insensitive to activation of caspase-3 via the receptor-mediated apoptotic 
pathway and 2) applying kinetics consideration, including equilibrium and quasi-steady state 
assumptions. It was suggested that the transition from the receptor-dependent pathway to the 
mitochondrial pathway is subject to the activation rate of caspase-8 and the initial expression 
level of caspase-9 (Okazaki et al., 2008). 
Zhang et al. (2009) proposed a kinetics-based mathematical model for the intrinsic 
pathway with a link to the death receptor pathway via activation of caspase-8. What makes this 
model differ from other ones describing both apoptotic pathways is that it generates apoptotic 
switch-like characteristics. The model was applied to study dynamics behaviour of apoptosis 
in various scenarios, including in mutants (overexpression and knockdown of XIAP) and the 
variable levels of p53-associated apoptotic proteins. It was suggested that cell cycle arrest and 
DNA repair are among the very first cellular processes that respond to the cellular stress due 
to DNA damage, and apoptosis is the ultimate destination in case cells could not manage to 
relieve the stress (Zhang et al., 2009). 
Given the involvement of the UPR-associated pathways in apoptosis, mathematical 
models for ER-stress associated apoptosis were introduced. Tyson et al. (2011) developed a 
preliminary mathematical model to account for the oestrogen signalling network in breast 
cancer cells. The model included the UPR pathways in accordance with the ER stress with 
links to cell cycle progression, autophagy and apoptosis. The model, despite not experimentally 
validated, showed decision-making mechanisms where cells decide to survive or die, grow or 
arrest, and repair or bypass (Tyson et al., 2011). A mathematical model accounting for 
mechanistic activation of the three pathways of the UPR was firstly developed. The model was 
constructed using ODEs and consists of interconnected four modules. The module of receptor 
activation accounts IRE1, PERK and ATF6 activities. The module of translation attenuation 
represents translation and apoptosis control by PERK. There are two adaptive response 
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modules accounting for IRE1 and ATF6 branches in the pathways. The model consists of 82 
parameters, most of them were arbitrarily assigned given no experiment conducted for 
parameter estimation. Bifurcation analysis showed that there were three states (low, 
intermediate and high) of behaviour arising from the pathways depending on the level and 
duration of the stress as well as the level of BIP. Oscillation responses, especially in translation, 
were observed in the intermediate state and were thought to be how cells adapt to the ER stress 
(control of apoptosis and translation process) (Erguler et al., 2013).         
2.9.2 Mathematical models for apoptosis in mammalian cell cultures 
 Apoptosis can represent cell death in the mammalian cell cultures, given that the 
majority of dead cells is a result of apoptosis. There are several existing mathematical models 
for the cultures of mammalian cells manufacturing bio-pharmaceuticals that describe apoptosis 
with its link to other cellular processes. Meshram et al. (2012) proposed a population-based 
mathematical model that describes induction of apoptosis via both two pathways in the batch 
culture of a CHO cell line producing Anti-RhD mAb. They assumed that the receptor-mediated 
apoptotic pathway was induced by death signal transduction from cell-cell communication, 
while the mitochondrial pathway was assumed to be triggered by metabolic stresses. Apoptotic 
cell sub-populations were characterised by the difference in activation levels of caspase-8, 9 
and 3. For example, the healthy cell population was defined by a low activation level of all 
caspases while the receptor-mediated apoptotic cell population was the group of cells with a 
higher activation level of caspase-8, but caspase-9 and -3. The transition rates between sub-
populations in the direction that cells eventually underwent apoptosis were presumed to be 
linear (Meshram et al., 2012). MFA was combined with the apoptotic population-based model 
in order to account for interplay between apoptosis and metabolism (i.e. ammonia production, 
and cell growth) (Meshram et al., 2011). However, this apoptosis model was apparently 
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independent from the metabolic model since it was assumed that cell growth and the apoptotic 
triggers were the result of changes in levels of an unidentified substrates which was not 
included in the metabolic sub-model.  
Naderi et al. (2011) studied dynamics of apoptotic cells though a combined 
mathematical modelling and experimental approach. Similar to the model presented by 
Meshram et al. (2012), a logistic model was applied to represent dynamics of cell populations, 
where non-growing cells were separated from growing cells. The logistic model and the MFA-
associated dynamic equations, which describe intracellular metabolic fluxes and their links to 
kinetics of extracellular metabolites, were interlinked through the estimation of cell populations 
(growing and non-growing) and the impact of metabolite levels on the onset of apoptosis 
(glucose and ammonia). Parameter estimation was performed with batch experimental data 
where initial glucose and glutamine were varied and the model with the parameter estimates 
was validated with an independent fed-batch experiment (Naderi et al., 2011). Later, this model 
was modified to account for the inhibitory effect of a pH reducing unidentified compound since 
experimental observation pointed out the impact of reducing pH on cell growth and viability. 
(Naderi et al., 2014). 
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3.1 Research gaps 
 
 As the literature review (Chapter 2) attests, there are several areas that have not been 
explored although they could be the key to better construct understanding of apoptosis in the 
mammalian cell cultures. The following are concluding remarks as well as research gaps 
extracted from the literature review:  
 Apoptosis is the main cause of cell death in the mammalian cell cultures for bio-
therapeutic proteins production. It has strong links to cell proliferation (cell cycle 
progression) and metabolism, nevertheless this links have not been clearly 
demonstrated.  
 The control of cell cycle progression and the apoptosis suppression, despite being 
closely interlinked, show different effects on production and productivity of secreted 
bio-proteins. This could be because they affect metabolic activities in a different 
manner, and how they affect metabolic activities could be the key to establish how to 
balance apoptosis and cell proliferation to achieve higher production and productivity 
of secreted bio-proteins.     
 Apoptosis induction involves significantly transcriptional processes, which are 
activated in accordance with metabolic stresses. In addition, there is a potential link 
between the expression of heterologous proteins and the increased ER stress that can 
induce apoptosis. However, understanding of apoptosis induction at the transcriptional 
and post-translational levels with its association with the metabolic stresses as well as 
the ER stress is still not clearly demonstrated. 
 Culture temperature and medium contents are among those culture conditions that can 
significantly affect cell growth, death and metabolism. However, their effects on 
apoptosis have not been clearly elucidated. 
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 Apoptosis found to be delayed in fed-batch cultures. It is necessary to further study 
apoptosis and its mechanism in response to addition of nutrients, given that fed-batch 
cultures are widely utilised for industrial manufacture of bio-therapeutics and prolong 
culture viability via apoptosis suppression is one of potential strategies used to improve 
productivity and production of the cultures.      
 Cell death has been superficially described in mathematical models for the mammalian 
cell cultures. Given that apoptosis represents cell death in the cultures, mathematical 
models for apoptosis in the mammalian cell cultures are recently presented (Meshram 
et al., 2012, Meshram et al., 2013, Naderi et al., 2011, Naderi et al., 2014). However, 
these models are based on the quasi-steady-state assumption, which dynamic change in 
concentrations of metabolic species is omitted and thus links to metabolism are not well 
described. These models also lack mechanistic representation of apoptosis; they are 
based on logistic equations and include no mechanism for inhibition of apoptosis which 
plays an important role in the control of apoptosis induction.  
 Sensitivity analysis is extensively included in proposed frameworks for model 
development. It helps identify significant parameters, and thus allows managing 
unnecessary information included into mathematical models through discarding 
insignificant parameters. 
 GSA employs simultaneous variations of parameter estimates, and thus provides 
parameter sensitivities regardless of given nominal parameter values and also accounts 
for model uncertainty. In addition, interactions among parameters can be evaluated 
using GSA. Therefore, GSA is a superior tool for model analysis which is essential for 
evaluation of model parameter significance and identifiability.  
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3.2 Thesis goal 
 
 Given the identified research gaps, further investigation of apoptosis is crucial to the 
improvement of mammalian cell cultures toward higher mAb production and productivity. 
Given that mAb production is subject to viability and metabolic states of the cultures, the onset 
of apoptosis and its links with relevant cellular processes, including cell cycle progression and 
metabolism, need to be investigated. The study of the effects of culturing conditions, including 
temperature and extracellular nutrient concentrations, on apoptosis is also essential for the 
improvement of mammalian cell cultures since the culturing conditions directly affect cell 
growth, death and metabolism. In order to construct a mechanistic insight into apoptosis; its 
links with cell growth and metabolism; and the effects of the culturing conditions on apoptosis, 
the study has to be performed in a systemic way where apoptosis is scrutinised as regards 
dynamic change in the culturing conditions, as well as cell proliferation and metabolic 
activities. To the best of my knowledge, such the systematic view of apoptosis has not been 
extensively conducted in any systems of mammalian cell cultures.  
 In this study, the combined experimental and computational approach is adopted to 
study apoptosis in the GS-NS0 cell cultures. The research aim of this thesis is to develop 
understanding of apoptosis, its association with other cellular processes, as well as its dynamic 
behaviour in response to potential apoptotic stimuli in the cultures. The strategy is to firstly 
investigate apoptosis kinetics in batch cultures. The insight into apoptosis gained from the 
batch experiments form the basis for fed-batch experimentation as well as mathematical model 
development. The observed phenomena in the fed-batch cultures can be used to validate 
observed results in the batch cultures as well as assumptions made based on the batch data. The 
model development utilises both batch and fed-batch data in order to enhance model 
reproducibility and practicability toward the fed-batch cultures. Model analysis is employed 
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for further improvements of the developed mathematical model. Overall, the goal is to utilise 
the herein established understating of apoptosis for the construction of a mathematical model 
for apoptosis in the GS-NS0 cell cultures which can reproduce what was observed in the batch 
and fed-batch cultures.  
 
 
 
 
 
 
 
 
 
 
Chapter 4 
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4.1. Mammalian Cell cultures 
 
4.1.1 Cell line 
The NS0 mouse myeloma cell line, kindly provided by Lonza Biologics (Slough, UK), 
was used in this study. The cell line is transfected with the GS selectable marker and DNA 
vectors encoding a chimeric B72.3 IgG4 antibody. Therefore, the cell line can be grown in 
glutamine-free medium and produce the antibody. The antibody is designed to recognise the 
Tag-72 tumour marker in colorectal cancer. 
4.1.2 Medium preparation 
Table 4.1.1 Medium preparation. 
Components 
Final 
concentration 
Amount 
(mL) 
Advance DMEM (Invitrogen, 12491-023) 81% v/v 810 
FBS (Invitrogen, 26400-044); Lot# 1082741 10% v/v 100 
GS-supplement, 50X  (Sigma-Aldrich, 58672C-100mL) 1X 20 
MEM amino acid solution, 50X (Invitrogen, 11130-036) 1X 20 
MEM non-essential amino acid solution, 100X (Sigma-
Aldrich, M7145) 
2X 20 
MEM vitamin solution, 100x (Invitrogen, 11120-037) 1X 10 
Penicillin-Streptomycin Solution, 10,000 I.U./mL 
(ATCC, 30-2300) 
100 I.U./mL 10 
4.5mM MSX (Sigma-Aldrich, M5379) 25µM 10 
 Total 1000 
 
The medium used for maintaining the cell line is based on glutamine-free Advance 
DMEM. The medium was also supplemented by adding dialysed Fetal Bovine Serum (dFBS), 
amino acids and vitamins (the formulation of the added amino acids and vitamins is as the 
DMEM medium). Penicillin-Streptomycin was used as an antibiotic in the medium and L-
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methionine sulfoximine (MSX) was added to the medium so that cells without GS-
overexpression are selectively removed. Table 4.1.1 describes the amount as well as the sources 
of each component required to compose a 1 litre of the medium.  
 The medium pH was measured, using S20 SevenEasy™ pH meter (Mettler-Toledo) 
and adjusted to pH 7.1 – 7.2 by adding drops of 1M NaOH. The adjusted pH medium was then 
filter-sterilised. A sample from the sterile filtered medium was taken and checked for the final 
pH level. Typically, the final pH was around 7.3 to 7.4. The medium was then stored at 4°C for 
up to 2 weeks.           
4.1.3 Cryopreservation and cell expansion 
 The cell line was cryopreserved in a cryovial with the medium containing 10% by 
volume of dimethyl sulfoxide (DMSO). For cell expansion, a cryovial containing 
cryopreserved cells was thawed in a water bath (37°C) for 1 minute. Then, the thawed cells 
were transferred to 10 mL of pre-warmed fresh medium (37°C) in a 15 mL sterile falcon tube. 
The suspension was then centrifuged using Rotina 46R centrifuge (Hettich Zentrifugen) for 5 
minutes at 800 rpm to remove the cryopreservation medium containing DMSO that can be 
toxic to cells (Galvao et al., 2014). The cell pellet was then re-suspended with 25 mL of pre-
warmed medium (37°C) and transferred to a 125 mL Erlenmeyer flask (Corning, 431143). The 
routine subcultures were conducted every 2.8-2.9 days with 2 × 105 cells/mL inoculation cell 
density for 5 to 6 times prior to the experiments.  
4.1.4 Culture conditions  
The cell culture was performed in triplicate (n=3) on NU-5500E (Triple Red) 
humidified incubator under a sterile condition at 37°C and 5% CO2. In the incubator, the cell 
culture was conducted on an orbital shaker (Stuart, SSL1) with the shaking speed at 125 rpm. 
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The conditions were verified and calibrated with independent measurements of temperature 
and CO2 level before starting the culture. A 125 mL flask consisting of 25 mL of the sterile 
medium was treated as a negative control to confirm the sterile condition.  
4.1.5 Experiments 
Batch culture 
The cell line was maintained in the 1 litre Erlenmeyer flask (Corning, 431146) with 250 
mL working volume under the culture condition as previously described. The duration of the 
culture was 7 days without changing any environmental conditions neither adding nutrients 
during the culture period. Samples were regularly harvested for further analysis; it can be once 
a day or twice a day depending on analytical techniques to be performed. This is discussed in 
the following sections. 
Culture temperature and conditioned medium studies 
 These experiments employed the same culturing condition as the batch experiment, 
except that 1) for the culture temperature study, the culture temperature was shifted during the 
culture progression; 2) for the medium shift study, the amount of fresh medium was varied at 
the beginning of the culture. The details of these experiments are discussed in Chapter 6. 
Fed-batch culture  
The fed-batch experiments were conducted under the same culturing conditions as the 
batch experiment. However, there were feeding streams of glucose and amino acids during the 
culture progression. The characteristics of the feeding strategies is discussed in Chapter 6. 
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4.1.6 Sample collection 
 Given that there are analytical techniques that require only cells while others require 
cell-free spent medium, cells have to be separated from the spent medium using centrifugation. 
Separated cells can be divided into two groups: The first group is for the live cells analysis, 
including apoptotic cell quantification. The other group can be stored under appropriate 
conditions for later analysis, such as cell cycle analysis and gene expression measurements. 
More specifically, the separated supernatant samples can be stored at -20°C for later metabolite 
and mAb quantification. Prior to centrifugation, a part of the sample was used for 
measurements of cell density and viability. 
4.2. Cell analysis 
 
4.2.1 Cell density and viability 
Cell density and viability were determined with the use of the haemocytometer. More 
specifically, 25 µL of fresh samples were mixed with 25 µL of 0.1% erythrosine B stain 
(ATCC, 30-2404). Then, the resulting blend was placed on the haemocytometer (Marienfeld-
Superior, 0630030) with a cover glass. The counts of viable and dead cells were performed 
under the light microscope (Leica, DM IL LED), where the dead cells are stained red while the 
viable cells remain unstained (white). The estimation of both viable and dead cell density was 
performed through the following equations. 
Eq. 4.2.1 Cell density estimation 
Cell density (
cell
mL
) =
Average live or dead cells per a square 
volume of a square (0.0001 mL)
× Dilution factor (2)               
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Eq. 4.2.2 Viability estimation 
Viability (%)= 
Viable cells 
Viable cells + Dead cells (Total cells)
× 100 
The following is an example of how cell density and viability are estimated. Assume that 
viable/dead cell counts were obtained under microscope as shown in Figure 4.2.1. 
28/3  32/5 
 21/2  
25/4  24/6 
 
Figure 4.2.1 Cell count example (viable/dead). 
 The total viable cell count; 28 + 32 + 21 + 25 + 24 = 130 cells. 
 The average viable cell count; 130/5 = 26 cells. 
 The total dead cell count; 3 + 2 + 5 + 4 + 6 = 20 cells. 
 The average dead cell count; 20/5 = 4 cells. 
 The total number of cell counts; 130 + 20 = 150 cells. 
 Therefore, the percent of cell viability = 130/150 × 100 = 86.67% (Eq. 4.2.1). 
 The viable cell density = 26 0.0001⁄ × 2=520,000 cells/mL (Eq. 4.2.2). 
 The dead cell density = 4 0.0001⁄ × 2=80,000 cells/mL (Eq. 4.2.2). 
 
4.2.2 Apoptotic cell quantification 
There are morphological and physiological changes that can be accounted as “apoptotic 
characteristics”; namely activation of apoptotic proteins, mitochondrial elements, changes in 
plasma membrane, cell shrinkage, chromatin condensation as well as DNA fragmentation 
(Ormerod, 1999). These distinct apoptotic characteristics generate corresponding analytical 
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techniques that can indicate the occurrence of apoptosis. However, each technique has both 
advantages and disadvantages. The light microscopic technique, for example, identifies 
apoptotic cells by their specific morphological changes, such as cell blebbing, as well as cell 
shrinkage. It has proved to be the most reliable measurement for apoptosis, however, it is not 
suitable for kinetic and statistic studies that request accurate quantitation given its subjective 
nature (Vermes et al., 1995). DNA fragmentation can be observed in both necrosis and 
apoptosis, and therefore techniques measuring DNA fragmentation (such as TUNEL assay as 
well as gel electrophoresis) can provide false-positive apoptotic events. In addition, they are 
more qualitative than quantitative, therefore not suitable for quantitative studies (Milner et al., 
1996, Ormerod, 1999, Vermes et al., 1995).      
In this study, we employ a flow cytometry based technique that measures the 
externalisation of phosphatidyl serine (PS), which is one of key morphological changes 
occurring during the progression of apoptosis. This event was found to be a downstream feature 
of early caspase activation, and occurs as early as chromatin condensation and earlier than 
DNA fragmentation. In addition, it lasts until the final stage of apoptosis (Cotter and Martin, 
1996, van Engeland et al., 1998). This technique provides quantification of apoptotic cells. 
The dual staining assay consists of Annexin-V-FITC (Biolegend, 640906), which is 
specifically binding to PS, and 20 µg/mL Propidium Iodine (PI, Sigma-Aldrich, P4170) in the 
binding buffer. Apoptotic cells can be categorized into 1) early stage apoptotic (ESA) cells and 
2) late stage apoptotic (LSA) cells or secondary necrotic cells. The latter are characterized by 
the rupture of the cell membrane, one of the final morphological changes occurring during final 
stages of apoptosis (Ormerod, 2000). Therefore, LSA cells are PI positive. In contrast, viable 
cells and ESA cells are PI negative, given that their cell membranes are still intact. Annexin V 
binds to PS, which is a phospholipid cell membrane component that normally faces toward 
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cytoplasm. When undergoing apoptosis, PS is externalized. Thus, both ESA and LSA cells are 
Annexin V positive, while viable cells are Annexin V negative (Browne and Al-Rubeai, 
2011a). In this way, ESA cells (Annexin-V positive, PI negative) can be distinguished from 
LSA cells (both positive) and Viable cells (both negative).  
The separated, fresh cell pellets, isolated from each culture replicate as previously 
described, were immediately re-suspended in the binding buffer (Biolegend, 422201). The 
amount of the binding buffer used depended on how many cells (in total) in the pellets in order 
to make 1×106 cell/mL cell suspension; for example, add 0.6 mL for 6 ×105 cells. Then, take 
100 µL from the cell suspension for each microtube as indicated in Table 4.2.1. They were then 
differently stained in order to create controls for the compensation together with the sample.  
Table 4.2.1 ESA cell analysis. 
Microtube Sample Staining 
Control 1 100 µL No staining 
Control 2 100 µL 5 µL of Annexin V-FITC solution 
Control 3 100 µL 3.5 µL of the PI Solution 
Sample 100 µL 5 µL of Annexin V-FITC + 3.5 µL of the PI Solution 
 
The stained samples and controls were incubated for at least 15 minutes but not over 
30 minutes, in the dark and at room temperature. They were then re-suspended with another 
300 µl of the binding buffer, just before the flow cytometry analysis. The data collection was 
performed using LSRFortessa cell analyzer (BD Biosciences). At least 3 × 104 events were 
recorded and all data were then processed and analysed in FlowJo 7.6.5 (Tree Star Inc). The 
gates to discriminate population were created in accordance with the controls and as suggested 
from previous studies (van Engeland et al., 1998, Vermes et al., 1995). Appendix A.1 shows 
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the fluorescent laser configuration set for recording the events and how the gates were created 
to distinguish the apoptotic populations.  
4.2.3 Cell cycle analysis 
Cell cycle analysis is basically the measurement of DNA content by using PI staining. 
PI is a highly fluorescent agent when binding to nucleic acids and it binds to DNA/RNA 
molecules by intercalating between the bases inside these molecules (Suzuki et al., 1997). Thus 
the DNA content in samples can be proportionally measured using a fluorescence 
measurement. To remove any unwanted RNA contamination in samples, the samples were 
treated with Ribonuclease A which was added in the PI staining solution. 
The separated cell pellet from spent medium, as previously described, was re-suspended 
in cold methanol (Sigma-Aldrich, 179337) in order to fix the cells. The suspension was 
maintained at -20°C for 1 week before analysis. By fixing the cells, their cell membranes are 
permeable, and therefore PI can diffuse into cells. The fixed samples were then centrifuged to 
remove the fixing agent. The remaining cell pellets were washed with PBS (Invitrogen, 10010-
015) and then were stained with 1 mL of 50 µg/mL PI (Sigma-Aldrich, P4170) and 100 µg/mL 
of Ribonuclease A (Sigma-Aldrich, R4875) in PBS. The stained samples were incubated at 
room temperature in the dark for 30 minutes prior to flow cytometer analysis. At least 10,000 
events were recorded on LSRFortessa. All data were then processed and analysed in FlowJo 
7.6.5 (Tree Star Inc). The gates to distinguish G1/G0, S, G2/M were applied in accordance with 
the previous study (Watson et al., 1987). Appendix A.2 describes the data acquisition as well 
as the data analysis performed in Flowjo. 
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4.2.4 The profiling of cyclins and Ki-67 proliferation marker 
These analytical techniques were conducted in collaboration with D. G. García Münzer 
(PhD candidate) and A. Gauthier (Master student).  
Fixation and permeabilization 
The following sample preparation procedure was used for both Ki-67 staining and 
cycling profiling. The cell pellets (around 1 × 106 cells) isolated from the harvested samples 
were fixed and permeabilised by drop-wise adding 1 mL of pure and cold methanol for cyclin 
D1 and B1 analysis, or 1 mL of 75% cold ethanol (VWR, 20821) for cyclin E1 analysis. Then, 
the fixed samples were kept at -20°C for up to 48 hours prior to analysis.  
To start analysing the samples, the fixing agent was then removed by centrifugation (at 
the same condition to that for cell culture). The fixed cell pellets were gently washed with 1 
mL of the washing solution. The washing solution is the PBS (Invitrogen, 10010-015) based 
solution containing 1% (w/v) bovine serum albumin (BSA) (Sigma-Aldrich, A9418) and 
0.01% (w/v) sodium azide (Sigma Aldrich, S2002). Then, the washing solution was removed 
by centrifugation at the same condition. The remaining cell pellets were re-suspended with 50 
µL of the saponin based washing solution prior to the staining. The suspension was then stained 
with either Ki-67 marker or anti-cyclins.     
Cyclin profiling 
The measurement of cyclins employs the principle of immunocytochemistry, where a 
primary antibody with a fluorescent tag is used to specifically bind to a protein or an antigen 
of interest. This allows us to track down cyclin activities along with the progression of cell 
cycle. In addition, the threshold expression of cyclins in each phase of the cell cycle can be 
determined. Here, various antibodies were used as specific markers for the corresponding 
Chapter 4 : Materials and Methods 
~ 109 ~ 
cyclins: mouse IgG1 anti-human cyclin B1 FITC-labelled (BD Biosciences, 554108), rabbit 
polyclonal IgG FITC-labelled anti-cyclin E1 (Bioss USA, bs-0573R-FITC) and mouse IgG2a 
anti-human cyclin D1 FITC-labelled (Invitrogen, AHF0088). Given that false positive results 
might arise from non-specific binding or unexpected protein-protein interactions, an isotype 
control antibodies which are corresponding to the cyclin antibody markers were included into 
the assay: mouse IgG1 FITC-labelled isotype control (BD, 554108) for the anti-cyclin B1, 
rabbit polyclonal IgG FITC-labelled anti-mouse isotype control (Bioss USA, bs-0296R-FITC) 
for the anti-cyclin E1 and  mouse IgG2a FITC-labelled isotype control (Invitrogen, MG2a01) 
for the anti-cyclin D1. This was treated as a negative control of the assay, indicating the 
background signal. 
The antibodies as well as the isotope antibodies were mixed with the suspension, 
obtained as above described, as per manufacturer’s instruction. For example, 10 μL of mAb 
anti-cyclin D1 FITC conjugate and 20 μL of mouse IgG2 FITC conjugate (Invitrogen, 
#MG2A01) were added to the samples for cyclin D1 analysis. The incubation was performed 
for 30 minutes at room temperature in the dark.  
Ki-67 proliferation marker 
 Given that Ki-67 protein is present during proliferative states of cycle cell (G1, S, G2 
and M ) and absent in G0 phase where cells are in a quiescent state (Gerdes et al., 1984), the 
expression of Ki-67 can be used to distinguish the resting cells (at G0 phase) from the 
proliferative cells.  
 The suspension, obtained from the sample preparation step, was stained by adding 20 
μL of a PE Mouse Anti-Human Ki-67 or the isotype (BD, 556087). Then, the stained samples 
were incubated for 30 minutes at room temperature in the dark.  
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Cell cycle analysis integration 
DNA can be also stained in both Ki-67 stained samples and anti-cyclin stained samples 
in order to gain the cell cycle prolife together with the Ki-67 expression and the profile of 
cyclins, respectively. The Ki-67 stained samples and anti-cyclin stained samples were washed 
with the washing solution, followed by removing the solution through the centrifugation. Then, 
DNA was stained using the PI solution. The procedure for cell cycle anlysis is described in 
Sub-section 4.2.3. However, FxCycle violet stain (Invitrogen, F10347) could be used for 
staining DNA in case there were more than two staining in a sample (ex. Ki-67, cyclins and 
DNA were all stained). The procedure is the same as the PI, except the flow cytometer set up 
for data acquisition. Appendix A.3 shows the flow cytometer configuration and the 
quantification of cyclins using Flowjo. 
4.2.5 Gene expression measurements 
 The separated cell pellet from supernatant can be stored at -80°C for up to 6 months 
until the analysis can be performed. The frozen cell pellet was thawed at room temperature. 
Total RNA was extracted from the cell pellet using RNeasy® Mini kit (Qiagen, 74104). The 
steps in the RNA extraction were described as per the manufacturer’s instruction. The thawed 
cell pellet was firstly lysed and then was homogenized using a QIAshredder spin column 
(Qiagen, 79654). The flow-through was collected and then mixed with 70% ethanol (VWR, 
10107EP) in nuclease-free water (Invitrogen, AM9937). The mix was transferred to RNeasy 
spin column (provided in the kit) where RNA molecules were retained inside the column. RNA 
molecules were eluted by up to 50 µL of nuclease-free water. The total RNA concentration was 
measured using a biophotometer (Eppendorf AG, Germany). The ratio of 260 nm absorbance 
over 280 nm absorbance being greater than 1.9 confirms the purity of the extracted RNA 
samples. 1 μg of the total RNA was immediately taken for complementary Deoxyribonucleic 
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acid (cDNA) synthesis using Reverse Transcription System (Promega Ltd, A3500). The 
reagents and conditions in the cDNA synthesis were as per the manufacturer’s instruction. The 
1 μg of RNA was mixed with the master mix consisting of 1) Reverse transcriptase enzyme, 2) 
Random primers, 3) Ribonuclease inhibitor, 4) Nucleotides, and 5) the buffer. The reverse 
transcription reaction was carried out using GS1 thermo cycle (G-Storm, UK) with the 
temperature profile as follows; incubate at the room temperature for 10 minutes, then incubate 
at 42°C for 40 minutes and finally incubate at 4°C for 4 minutes. The cDNA can be indefinitely 
stored at -20°C for later real-time polymerase chain reaction (PCR). The real-time PCR was 
carried on using StepOnePlus™ Real-Time PCR machine (Applied Biosystems, USA). cDNA 
samples were mixed with 1) SYBR buffer provided in the SensiFAST™ Hi-ROX SYBR kit 
(Bioline, BIO-92005) and 2) primers specific to genes of interest. All sequences of the primers 
used in this study are shown in Table 4.2.2.  
Table 4.2.2 Primer sequences used in this study. 
Genes Forward Sequences Reverse Sequences 
atf51 GGGTCATTTTAGCTCTGTGAGAGAA ATTTGTGCCCATAACCCCTAGA 
trp53bp2 TTGCTGATAACGAACGGATGTT ACACTTGGATCTTGGGATCTCG 
bcl-2 GGGAGAACAGGGTATGATAACCG TAGCCCCTCTGTGACAGCTTA 
bax TGAAGACAGGGGCCTTTTTG AATTCGCCGGAGACACTCG 
p21 CCTGGTGATGTCCGACCTG CCATGAGCGCATCGCAATC 
casp8 CAACTTCCTAGACTGCAACCG TCCAACTCGCTCACTTCTTCT 
casp32 CCTCAGAGAGACATTCATGGGCC GCTGCTCCTTTTGCTATGATCTTCC 
gapdh AGGTCGGTGTGAACGGATTTG GGGGTCGTTGATGGCAACA 
1from (Sheng et al., 2010), 2from (Francini et al., 2009), The rest are from PrimerBank (Wang et al., 2012). 
 The two-step temperature cycling condition was employed to proceed the real-time 
PCR. The mix was incubated at 95°C for 2 minutes to activate polymerase enzymes. Then, the 
mix was under the two-step thermal cycle: the 1st step is at 95°C for 5 seconds (denaturation), 
and then cooling down to the 2nd step at 60°C for 20 seconds (annealing and elongation). 40 
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cycles of the two-step thermal cycle were performed to amplify the genes of interest. Data were 
recorded at the end of each thermal cycle. The analysis of the collected data was conducted 
using StepOne Software v2.1 (Applied Biosystems, USA). The gene expression was estimated 
using the ∆∆CT approach, where the expression of the genes of interest is normalised to the 
expression of the housekeeping gene, gapdh, and the expression of the same genes of interest 
of the sample at the beginning of the culture (time = 0 hour). Appendix A.4 describes the 
estimation of gene expressions using the ∆∆CT approach.  
Given that this method measures and calculates gene expressions based on the 
housekeeping gene expression, the estimated expression might not represent actual change in 
expression of genes of interest in case the housekeeping gene expression is also affected as 
regards the different conditions or factors in the cultures (i.e. culturing time, temperature, 
growth factors, etc.). In this study, gapdh is selected as a reference expression based on the 
previous study by Browne and Al-Rubeai (2011b) using gapdh as a reference expression. 
However, the estimated expression could take in the change in gapdh expression as regards the 
culturing time as well as experimental conditions (i.e. feeding strategies and medium contents) 
and might not represent actual change in expression of genes of interest. It is recommended 
that at least two housekeeping genes should be included into the measurement and estimation 
of gene expression in order to cross-check between estimates of gene expression obtained from 
different housekeeping genes. 
 It is worth noting that the makers for apoptosis and cell cycle (Table 4.2.2) were 
selected based on previous studies that has established the role of each marker in the apoptotic 
(Hengartner, 2000, Majors et al., 2007) and cell cycle (Gartel and Tyner, 2002b) pathways. In 
addition, previous data reporting the expression of makers related to apoptosis and cell cycle 
in the similar cell culture system to this study were predominantly considered. A significant 
change in trp53bp2 and atf5 expressions was reported during the culture of GS-NS0 cells 
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(Browne and Al-Rubeai, 2011b). In addition, the role of these genes in apoptotic pathways and 
their links to metabolic stresses were established in various cell culture systems. As can be seen 
from Figure 2.2.2, these genes basically sense cellular stresses and involve in regulating 
apoptotic pathways, especially through the p53-mediated pathway. Given these reasons, 
trp53bp2 and atf5 were selected as apoptosis makers in this study. 
 Given that apoptosis can be induced through three different pathways as discussed in 
Section 2.2, there are a number of apoptotic species that can be chosen as apoptotic markers. 
In this study, the number of apoptotic markers that can be applied was limited, therefore, the 
markers were selected based on their relevance to apoptosis pathways, especially the death 
receptor and mitochondrial pathways. bcl-2 (the anti-apoptotic factor) and bax (the pro-
apoptotic factor) were reported to involve both upstream as well as downstream signalling 
apoptosis pathways, as discussed in Section 2.2. These include the apoptosis induction through 
external (receptor) and internal (mitochondria) pathways and also the ER-stress meditate 
pathway. In addition, the activity of them can partly represent the activity of the Bcl-2 family 
proteins, especially in the category of all domain (BH-1 to 4) proteins (anti-apoptotic) and 
without BH4 proteins (pro-apoptotic). Therefore, bax and bcl-2 were among those selected as 
apoptosis markers in this study. The executors of apoptosis were ones of potential choices for 
the apoptosis markers given their roles in apoptotic pathways (Figure 2.2.1). casp3 was chosen 
since caspase-3 is an important final executor of all apoptosis pathways. Given that caspase-8 
is the executor in the external pathway and is the bridge between the external and internal 
pathways (Figure 2.2.1), casp8 was selected as a marker in this study. In addition to apoptosis, 
cell cycle progression was observed. p21 stands out as the excellent marker for cell cycle 
progression given its role and its link with p53-mediated apoptosis pathway.  
 The death receptor and mitochondrial pathways were predominantly investigated in this 
study given the list of selected markers. Although some of them involve the ER-stress mediated 
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pathway; including atf5 (a direct target of eIF2), bcl-2, bax and casp3, but it might be not 
possible to draw any conclusion about the activity of the ER-stress apoptotic pathway. casp-
12, atf6, CHOP, PERK and IRE1 could be excellent markers for the future study of this 
pathway. Another limitation is that only the mRNA level of these selected markers was 
measured and it might not represent the protein level of the markers. In this way, the activities 
of apoptotic protein species might be misestimated. Despite apoptotic gene expression being 
essential in apoptosis induction (as discussed in Section 2.2.1), apoptosis can also be executed 
by the interaction of the pre-existing store of apoptotic proteins in response to lethal signals. 
Given that the signal transduction in apoptotic pathways involves protein-protein interactions; 
such as ligand-receptor interactions in the death receptor pathway, and direct proteolytic 
processing of downstream caspases. The execution of apoptosis could happen only relying on 
the pre-existing store of apoptotic proteins and might not involve the de novo synthesis of 
protein. Therefore, in order to cross-check the observed apoptosis activation based on the 
mRNA level of the markers, the measurement of protein expression needs to be included for 
the future study of apoptosis.   
4.3. Extracellular metabolite quantification 
 
4.3.1 Nutrient and metabolite quantification 
 The spent medium or supernatant collected and stored at -20°C as described earlier, was 
thawed at room temperature. 1.5 mL of the supernatant was taken for the measurement of 
glucose, glutamate, ammonia and lactate. The measurement was performed using a BioProfile 
400 Analyzer (Nova Biomedical Ltd.). The accuracy of the measurement was calibrated with 
five levels of quality controls. 
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4.3.2 Amino acid quantification 
 250 µL of the thawed supernatant was collected for amino acid analysis. 10 kDa filter 
columns (Millipore, MRCPRT010) were used to filter out macromolecules, which were larger 
than 10,000 Da, with at least 95% recovery. All flow-through was collected for the pre-column 
derivatization, whereby amino acids were converted into their derivatives. The derivatization 
reaction conducted in this work involves 2 consecutive steps: 1) o-Phthalaldehyde (OPA) 
derivatization where OPA stably reacts with primary amino acids (18 amino acids) resulting to 
their derivatives; and 2) 9-fluorenylmethyl chloroformate (FMOC) derivatization that converts 
the remaining amino acids (4 amino acids) into their derivatives. Table 4.3.1 shows the 
automated procedure for the pre-column derivatization using an automatic sampler (1329B 
autosampler, Agilent Technologies, UK) as per the manufacturer’s technical notes. 
Table 4.3.1 The procedure for the pre-column derivatization. 
Step No. Action Volume taken 
1 Draw 2.5 µL from 0.4M borate buffer (Agilent, 5061-3339) 
2 Draw 1.5 µL from Sample vials 
3 Mix 4.0 µL in air (washport) default speed 5 times 
4 Wait 0.2 min 
5 Draw 
0.5 µL from 10 mg/mL OPA solution vial (Agilent, 
5061-3335) 
6 Mix 4.5 µL in air (washport) default speed 10 times  
7 Draw 
0.4 µL from 2.5 mg/mL FMOC (Sigma-Aldrich, 
23186) in acetonitrile (ACN, Sigma; 34998) vial 
8 Mix 4.9 µL in air (washport) default speed 10 times  
9 Draw 32 µL from injection diluent vial 
10 Mix 20 µL in air (washport) default speed 8 times (8X) 
* Injection diluent was made from the solution consisting of 1 mL of mobile phase A (which is described later) 
and 4 µL of phosphoric acid solution, H3PO4 (Sigma-Aldrich, 79607-500ML). 
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 These derivatives have different hydrophobicity with each other. Therefore, each 
derivative can be separated using the reversed-phase chromatographic technique, where the 
more hydrophilic the molecules, the faster the molecules are eluted from the column. The 
amino acid derivatives were injected through the 4.6 × 100 mm rapid resolution high 
throughput reversed-phase column with 1.8 µm particle size (Agilent Technologies, 959964-
902). The chromatography was conducted using an HPLC Agilent 1260 Infinity system 
(Agilent Technologies).  
Table 4.3.2 The composition of mobile phases (1 L). 
Mobile phase A 
(ionic solution) 
Mobile phase B 
(organic solvent) 
1.4 g of anhydrous Na2HPO4 
3.8 g of Na2B4O7 •10H2O 
32 mg of NaN 
dH2O making up to 1 liter 
450 mL of acetonitrile (ACN) 
450 mL of methanol 
100 mL of d H2O 
 
Table 4.3.3 The fraction of mobile phase B in the total flowrate of the eluting mobile phase. 
Time (min) %B 
0.0 2 
0.4 2 
13.4 57 
13.5 100 
15.7 100 
15.8 2 
16 end 
   *The total flowrate (mobile phase A+B) was 1.5 mL/min. 
 The eluting mobile phase, which was used to carry the derivatized amino acids through 
the column, consisted of two aqueous solutions. One is relatively “polar” (mobile phase A), 
while the other is relatively “non-polar” (mobile phase B), as shown in Table 4.3.2. Given the 
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difference in hydrophobicity of the derivatives, the gradient flowrate of mobile phase B was 
used to elute each derivative at a different time, as shown in Table 4.3.3.  
 
*Note that 1.560 is aspartate, 2.293 is glutamate, 3.82 is asparagine, 4.07 is serine, 4.732 is histidine, 5.023 is glycine, 5.165 
is threonine, 5.822 is arginine, 6.153 is alanine, 7.145 is tyrosine, 8.182 is cysteine, 8.667 is valine, 8.861 is methionine, 9.558 
is tryptophan, 9.857 is phenylalanine, 10.034 is isoleucine, 10.570 is leucine, 10.920 is lysine and 13.614 is proline.  
Figure 4.3.1 The chromatogram of the standard of 19 amino acids. 
Given that these derivatives are highly fluorescent (Woodward et al., 2007), each eluted 
derivative is detected using a diode array detector (DAD, Agilent Technologies). Signals from 
eluted derivatives were collected using two fluorescence wavelengths: 1) 338nm for OPA 
derivatives and 2) 262 nm for FMOC derivatives. The plot between the fluorescence intensity 
and the eluted time is called “chromatogram”. In the chromatogram, there are a number of 
peaks, each of which specifically represents each derivative, and implicitly each amino acid. 
The identification of each peak and its corresponding amino acid was previously performed as 
per the manufacturer’s technical note (Woodward et al., 2007). Figure 4.3.1 illustrates a 
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chromatogram of known concentration (0.12 mM) of 19 amino acids. Glutamine can also be 
identified by adding the glutamine standard with the standard solution of amino acids. The peak 
indicating glutamine presence is at around 4.580, locating just before the peak of histidine in 
the chromatogram.    
The chromatogram was analysed using OpenLAB Chromatography Data System 
C.01.04 (Agilent Technologies) to estimate the area under each peak. The concentration of 
amino acids was estimated by comparing to the calibration curves, where the concentration of 
each amino acid was plotted against the area under the peak corresponding to the amino acid 
(Henderson Jr and Brooks, 2010). Appendix A.5 shows the calibration curves that were used 
to estimate the concentration of extracellular amino acids in unknown samples. 
4.3.3 cB72.3 mAb quantification 
The thawed supernatant was filtered through a 13 mm syringe filter with 0.22 µm PTFE 
membrane (VWR, 28145-491). The chromatography was carried on using an HPLC Agilent 
1260 Infinity system (Agilent Technologies). 50 µL of the filtered supernatant was injected 
into the affinity column, Bio-Monolith Protein A (Agilent Technologies, 5069-3639). Mobile 
phase A; PBS buffer with pH 7.4, was used to carry the injected sample and to allow mAb 
molecules to attach onto the protein A molecules inside the column. Then, mobile phase B; 0.5 
M acetic acid with pH 2.6, was introduced to the column to elute the mAb. The flowrate of 
both mobile phases used was 1.5 mL/min. The eluted mAb was detected using the fluorescent 
detector (Diode Array Detector, Agilent Technologies) at the collection fluorescence 
wavelength of 280 nm. The chromatogram obtained from the detector was then processed using 
OpenLAB Chromatography Data System C.01.04 (Agilent Technologies). A series of the mAb 
standard dilutions enables us to create the calibration curve, which was used to estimate the 
concentration of mAb in unknown samples, as shown in Appendix A.6.  
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4.3.4 cB72.3 mAb quality assessment  
This section describes two analytical techniques: protein gel electrophoresis and 
enzyme-linked immunosorbent assay (ELISA), used in this study in order to assess to a certain 
extent the quality of the produced mAb as well as cross-check the mAb quantification by the 
HPLC technique.  
Protein gel electrophoresis was conducted in collaboration with D. G. García Münzer 
(PhD candidate) and Sarantos Kyriakopoulos (PhD candidate). Each supernatant sample and 
each dilution of cB72.3 mAb standard (kindly provided by Lonza Biologics (Slough, UK)) 
were mixed with the non-reducing Sample Buffer (Thermo Scientific, BN2003). The mixing 
ratio between the sample buffer and each sample (as well as each dilution of the mAb standard) 
was 1:3. The samples and the standards with the sample buffer, and the 10-180 kDa protein 
ladder (Thermo Scientific, 26616) were then loaded on the native precast protein gel (Thermo 
Scientific, BN1004BOX) in the NativePAGE™ running buffer (Thermo Scientific, BN2007). 
The electrophoresis was performed at 115 V for 50 minutes. 
The sandwich ELISA was performed on a 96-well plate (Greiner Bioone, 655 101). The 
wells in the plate were firstly coated with F(ab')₂ Fragment Goat Anti-Human IgG Fc (Jackson 
Immunoresearch Labs Inc., 109-006-098) in the coating buffer (0.05 M sodium carbonate pH 
9.6). The coating buffer consisted of sodium carbonate (Na2CO3, Sigma-Aldrich, 451614) and 
sodium bicarbonate (NaHCO3, Sigma-Aldrich, S6297) and deionised water. The coated plate 
was incubated overnight at 4°C on a level surface. Then the wells were emptied and washed 6 
times with the washing buffer (comprised of PBS and 0.05% by volume Tween 20 (Sigma-
Aldrich, P2287)). The wells were blocked with the blocking buffer consisting of the coating 
buffer with 0.5% w/v Casein Hammerstein (Sigma-Aldrich, C3400) and the plate was 
incubated at room temperature for 1 hour. The wells were emptied and washed 6 times before 
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plating out a series of dilutions of mAb standard, unknown samples as well as negative controls. 
The plate was incubated at room temperature for 1 hour. The wells were again emptied and 
washed 6 times before plating out anti-human IgG kappa peroxidase conjugate targeting human 
κ light chains (Sigma-Aldrich, A7164) and incubating the plate at room temperature for 1 hour. 
During this incubation, the peroxidase substrate solution, 3,3′,5,5′-Tetramethylbenzidine 
(TMB, Sigma-Aldrich, T3405) in the 0.05 M phosphate citrate buffer pH 5.0 with 2 µL of 
hydrogen peroxide (H2O2, Sigma-Aldrich, H1009) was prepared without light exposure. The 
phosphate citrate buffer consisted of 0.2 M Sodium phosphate dibasic solution (Na2HPO4, 
Sigma-Aldrich, 71640) and 0.1 M citric acid (Sigma-Aldrich, 251275). After the conjugate 
incubation, the wells were again emptied and washed 6 times before plating out the substrate 
solution in the dark. The plate was then incubated in the dark at room temperature on an orbital 
plate shaker for 30 minutes. The peroxidase reaction was stopped by adding 2.5 M sulphuric 
acid (H2SO4, Sigma-Aldrich, 320501) to the wells. The absorbance obtained from the reaction 
was read using the plate reader at 450 nm.  
4.4. Data analysis 
 
4.4.1 The estimation of cell culture descriptive parameters 
Culture parameters were estimated at different phases of the culture: early and 
exponential phases, stationary phase and death phase. The numerical method, the trapezoid 
rule, was employed to estimate the integral of viable cells (IVC), as shown in the following 
equation (Balcarcel and Stephanopoulos, 2001). 
Eq. 4.4.1 The estimation of IVC 
IVC (cell.mL-1.hr) = ∑
1
2
(nv,ti-1  + nv,ti)(ti-1 + ti)
k
i=1
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Where  nv,ti stands for the viable cell density at time t = i. 
The specific cell growth rate was estimated using the net number of viable cells over 
the cultivation time as shown in the following equation (Balcarcel and Stephanopoulos, 2001).  
Eq. 4.4.2 The estimation of specific growth rate 
Specific growth rate (day -1) = 
ln (nv,t2  - nv,t1)
t2 - t1
 
The specific consumption/production rates of extracellular metabolites were estimated 
using the graphical method. The plots between the concentration of each metabolite (y-axis) 
and IVC (x-axis) were performed. Linear correlations between the y axis and the x axis were 
generated, and the slopes obtained from the linear trendlines represent the specific 
consumption/production rates (µmol.10-6cell. day-1). The yield of lactate over glucose 
(mol/mol) was also obtained by the graphical method. Appendix A.7 shows an example of the 
estimation of the specific consumption/production rates and the lactate over glucose yield. 
4.4.2 Statistical Analysis 
The one-way analysis of variance (ANOVA) 
 The one-way analysis of variance (ANOVA) can identify any difference among the 
means of more than two groups under a single factor or treatment. To obtain reliable results 
from the ANOVA, several assumptions are required to be satisfied; 1) the distribution 
population of each group follows the Normal Distribution (with mean and variance), 2) errors 
in each group; defined as deviations of actual observed values from the group mean, are 
independent with each other, and 3) the variance of data in each group should be equal to each 
other. The ANOVA is basically based on the F-test statistic, however it does not specify exactly 
which groups different from one another (Seltman, 2012). To estimate the F-statistic, Mean 
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Squares (MS) are required to be determined. MS can be calculated from Degrees of Freedom 
(DF) and Sum of Squares (SS, the sum of squares between groups and the sum of squares 
between samples within the groups) as shown in Eq. 4.4.3. The F-statistic can be calculated as 
Eq. 4.4.4. Appendix A.8 shows an example of F-statistic calculation. 
 Eq. 4.4.3 Mean Squares 
MSbetween groups= 
SSbetween groups
DFbetween groups
= 
∑ nj(Ŷj- Ŷ)
2k
j=1
k-1
 
MSwithin groups= 
SSwithin  groups
DFwithin  groups
= 
∑ (nj-1)(SDj)
2k
j=1
N-k
 
Where k is the number of groups, n is the number of samples within the groups, N is the number 
of total sample size, Ŷj is the sample mean of the j group and Ŷ is the overall mean. The MSwithin 
groups is also calculated from sample standard deviations (SD) given that it is actually the 
weighted average of sample variances. 
Eq. 4.4.4 F-statistic 
F = 
MSbetween groups
MSwithin groups
 
The null and alternative hypotheses need to be set in the ANOVA. The null hypothesis 
is that there is no difference among the means of the groups of interest while the alternative is 
the opposite; at least two group means are different. p-value is defined as the probability of 
obtaining a value being equal to or more extreme than the actual experimental observation 
under the null hypothesis (the shaded area in Figure 4.4.1). Given that p-value is probability, 
its value is between 0 and 1. It indicates how possible it is that the observed difference arises 
from chance. On one hand, if the value is near 0, the observed difference is less likely to be 
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occur due to chance; on the other hand, if the value is near 1, the observed difference could be 
contributed by chance (Dahiru, 2008). The hypotheses testing (subject to the null hypothesis 
being true) requires us to specify a significant level (or alpha which is normally set at 0.05) and 
the corresponding critical F value (the F-critical value representing where the null hypothesis 
is rejected if the observed F-statistic is larger), and to calculate the observed F-statistic (as 
above shown) and p-value (corresponding to the observed F value). In order to be able to 
compare between the observed F-statistic (calculated as Eq. 4.4.4) and the F-critical, the F-
critical has to be determined using the cumulative F-distribution function as shown in Eq. 4.4.5 
which requires DF (both DFbetween groups and DFwithin groups) and cumulative probability (F(x)). 
The F-distribution with 3 and 10 degrees of freedom (DFbetween groups and DFwithin groups, 
respectively) can be created using the F-distribution function (Eq. 4.4.6) as can be seen from 
Figure 4.4.1. If the significant level is set at 0.05; or 0.95 cumulative probability (F(x) = 0.95), 
F-critical is equal to 3.71 (Eq. 4.4.5). If the observed F-statistic is larger than the critical one 
(thus p-value is less than alpha), the null is rejected, and vice versa (Dahiru, 2008, Seltman, 
2012). 
Eq. 4.4.5 the cumulative F-distribution function 
Fn,m (x) = 2n
(n-2)
2 (
x
m
)
n
2
  
2𝐹1(
1
2
(n+m),
1
2
n; 1+
1
2
n; -n
x
m
)
 B(
1
2
n,
1
2
m)
 
2𝐹1(a, b; c; z) is a hypergeometric function and B(a,b) is the beta function as shown below: 
2F1(a, b; c; z) = ∑
(a)
n
(b)
n
(c)
c
∞
n=0
zn
n!
; |z|<1  
B(a,b) =
(a-1)!(b-1)!
(p+q-1)!
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Eq. 4.4.6 the F-distribution function 
fn,m (x) = 
m
m
2  n
n
2 x
n
2
-1
(m+nx)
(n+m)
2  B(
1
2
n,
1
2
m)
  
Where n is DFbetween groups; m is DFwithin groups; x is the corresponding F-statistic. These 
equations are adapted from (Weisstein, 2016).   
 
Figure 4.4.1 The F-distribution with 3 and 10 degrees of freedom. The vertical line at around 
F=3.71 indicates the F-critical value at α = 0.05. The shaded area is p-value indicating the 
likelihood of getting an F-statistic being equal to or larger than the observed F-statistic. In 
this case, the observed F-statistic is equal to the F-critical, therefore, p-value = 0.05 which is 
equal to α. If the observed F-statistic is larger than the F-critical, then p-value is less than α 
and the null hypothesis is rejected. Adapted from (Seltman, 2012). 
It is worth noting that to identify whether the observed difference is significant could 
not be completely concluded based on the hypothesis testing as well as the obtained p-value. 
Getting p-value < alpha means that it is much more likely to see the difference however there 
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are chances that the indifference could also happen (i.e. 1 in 20 comparisons if p-value = 0.05). 
In addition, using alpha = 0.05, despite common, is not the definite line to judge whether the 
observed difference is significant or not. However, what can be claimed is that there is a 
stronger likelihood against the null hypotheses (no difference observed) as the p-value becomes 
less (Dahiru, 2008).   
Following the ANOVA, if any difference among groups is found, further data analysis 
is performed in order to exactly specify which groups different to one another. This is based 
on multiple pairwise comparison. There are a number of methods that has been introduced for 
this purpose in order to avoid any errors (i.e. type I errors) arising from the multiple 
comparison. Tukey's test and Student–Newman–Keuls (SNK) method are among those that 
has been applied with the ANOVA extensively. It was reported that the SNK method is more 
powerful than the Tukey one (so it is more likely to reveal any difference than the Tukey) since 
it is less conservative. The SNK controls the type I errors among tests of means of all groups 
while the Tukey controls the errors for all comparison simultaneously. Given its nature, The 
SNK might suffer from the errors and could generate unreliable results. However, the results 
from both methods are comparable (Seltman, 2012, Abdi and Williams, 2010, SigmaStat, 
2006a).   
In this study, the one-way ANOVA was applied for analysis of experimental data. It 
was conducted using SigmaStat 3.5 (Systat Software, Inc, Germany). The alpha value of 0.05 
was assigned as the significant level. The SNK method was employed for any multiple pairwise 
comparison following the ANOVA. All data shown represent their mean values with the 
standard deviation from the triplicate experiments (n = 3). 
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Determination of the correlation coefficient (CC)  
 There are a number of methods of determining correlation coefficient (CC) providing 
information about to what extent two variables are associated or correlated. In this study, 
Pearson product-moment CC (rp) and Spearman's rank CC (rs) were applied to indicate the 
strength of the potential correlation between two variables. The former is the parametric test 
based on an assumption that errors (differences between the observed data and the 
corresponding data on the regression line) are normally distributed with constant variance, 
while the latter is the non-parametric one that does not require the normality of the errors and 
provides the correlation measure based on data ranking (SigmaStat, 2006b). In other words, 
the former is a measure of correlation based on determining the linear regression (linear 
relationship) while the latter rather seeks for a monotonic relationship that is not necessary to 
be linearly correlated. 
 Both methods provide 1) the CC and 2) p-value. The CC is mathematically calculated 
based on how a pair of variables are linearly associated (normalised covariance). The value can 
be varied from -1 to 1. If the CC is close to -1, an inversely proportional correlation could be 
concluded. In contrast, if the CC is close to 1, a proportional correlation could be claimed. 
However, if the CC is close to 0, there might be no relationship between the two variables. As 
above discussed, the p-value here stands for the probability of being wrong in rejecting the null 
hypothesis; there is no correlation between the two variables (SigmaStat, 2006b). Therefore, to 
interpret the CC needs to consider the p-value. In this study, alpha=0.05 was used as the 
significant level where the two variables are more like to be correlated. The determination of 
the CC was performed in SigmaStat 3.5 (Systat Software, Inc, Germany). 
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5.1 Background 
 
Metabolic stresses, including nutrient deprivation and toxic metabolite accumulation, 
can hinder mammalian cell cultures in their viability and productivity. They essentially 
influence cell cycle progression as well as facilitate apoptosis induction, causing a deterioration 
in the final titre as well as quality of manufactured therapeutic proteins. Therefore, 
understanding of relationships between control of cell cycle and apoptosis, and the metabolic 
stresses is critical for the improvement of the mammalian cell culture toward higher bio-
therapeutic production. 
Chapter 5 presents an experiment that aims to establish the effect of metabolic stresses, 
especially nutrient deprivation, on the induction of apoptosis and cell cycle progression in the 
GS-NS0 cell culture. Flow cytometry as well as real-time PCR were exploited to measure shifts 
in cell cycle profiles as well as apoptotic gene expressions in response to metabolic stresses. A 
complete map of the induction of apoptosis as well as the cell cycle progression as regards 
culture phases can be achieved from the results.   
5.1.1 Introduction 
 Mammalian cell cultures are widely utilised for industrial production of biologics of 
importance, such as mAbs. The total sale of mAbs was valued at 18.5 billion dollars in 2010 
and it was speculated that the global demand for mAbs would be continuously increasing 
within the next future years (Buss et al., 2012, Elvin et al., 2013). This draws attention to 
improvement in mammalian cell culture systems toward a higher quantity as well as a better 
quality of mAbs produced. However, given limitations of mammalian cell cultures as listed in 
the sub-section 2.3.4; including relatively slow growth and production rate of desired products 
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as well as being sensitive to environmental conditions, increasing mAb production is one of 
greatest challenges facing the biotechnology and bioprocess community nowadays. 
  There are a number of strategies for the improvement of mammalian cell cultures 
toward mAb production enhancement. One of them is the suppression of apoptosis. Apoptosis, 
or programmed cell death, was previously identified as the main cause of cell death occurring 
in the mammalian cell cultures (Goswami et al., 1999, DiStefano et al., 1996, Browne and Al-
Rubeai, 2011a, Singh et al., 1994). The onset of apoptosis can be delayed through 
overexpression of anti-apoptotic genes, including bcl-2 and bcl-xL. The effect of apoptosis 
suppression on mAb production as well as productivity was reported to be variable, depending 
on cell line and culturing systems. The hybridoma cell cultures with bcl-2 overexpression 
showed an increase in mAb productivity (Itoh et al., 1995, Terada et al., 1997) while the GS-
NS0 cell cultures with bcl-2 overexpression showed no improvement in mAb productivity (Tey 
et al., 2000a, Tey et al., 2004, Tey et al., 2005). However, a higher viable cell number and 
longer culture viability were typically obtained in the cultures with the overexpression of anti-
apoptotic genes (Simpson et al., 1999b). The control of cell proliferation was also established 
as a strategy to increase mAb production and productivity. Cell proliferation can be regulated 
through overexpression of cyclin-dependant kinase inhibitors, including p21 and p27, which 
facilitate cell cycle arrest resulting in a slowdown in cell cycle progression or cell proliferation 
(Brugarolas et al., 1999). This strategy generally enables cultures to achieve higher production 
and productivity (Fussenegger et al., 1998b, Watanabe et al., 2002), suggesting a positive effect 
of cell cycle arrest on cellular mAb synthesis.   
  As earlier reviewed in Chapter 2, the established findings/data are, however, 
contradictory and variable among cell lines. As above mentioned, the control of cell 
proliferation in the mammalian cell cultures often results in an increase in productivity 
(Fussenegger et al., 1998b, Watanabe et al., 2002); however, this is not always the case when 
Chapter 5 : A Map of the Dynamic Interplay between Cell Cycle  
and Apoptosis, and Metabolism 
~ 130 ~ 
cell proliferation arrest is a result of apoptosis suppression (Ibarra et al., 2003, Tey et al., 2000a, 
Tey and Al-Rubeai, 2004). It was found that overexpression of anti-apoptotic genes, especially 
bcl-2 resulted in cell proliferation arrest (Simpson et al., 1999b) as similar to that of cell cycle 
regulator overexpression. Despite the similar effect on cell proliferation, the different effects 
on productivity were achieved (Ibarra et al., 2003, Tey et al., 2000a, Tey and Al-Rubeai, 2004). 
This could be because the apoptosis suppression and the cell proliferation control might affect 
differently metabolic activities underlying the difference in productivity (Nivitchanyong et al., 
2007). Thus, a balanced degree of apoptosis suppression (Zustiak et al., 2014) and cell 
proliferation arrest is potentially the key to allow the cultures to achieve higher 
production/productivity. In order to establish the key, it is necessary to construct systematic 
understanding of interplay between apoptosis and cell cycle and its relations to metabolism 
including production/productivity in the mammalian cell cultures. 
  A relationship between metabolic stresses, and induction of apoptosis as well as control 
of cell proliferation was previously investigated (Mercille and Massie, 1994a, Simpson et al., 
1998, Dorai et al., 2009, Newland et al., 1994). The onset of apoptosis was found to be subject 
to availability of nutrients, including glucose and amino acids (DiStefano et al., 1996, Zhou et 
al., 1997a). The apoptotic responses to metabolic stresses were reported to be at the 
transcriptional level (Browne and Al-Rubeai, 2011b). In addition to apoptotic responses, 
metabolic shifts, which can be considered as a survival mechanism in response to metabolic 
stresses, was found to be subject to availability of nutrients (Dorai et al., 2009, Dorai et al., 
2010). Apoptosis and cell cycle progression were also found to be intimately correlated through 
interactions between p53 and p21, key transcription factors that play regulatory roles in 
apoptosis and cell cycle arrest, respectively (El-Deiry et al., 1994, Mason and Rathmell, 2011). 
 To the best of my knowledge, a complete picture of the relationship between apoptosis, 
and metabolism as well as cell cycle; where kinetics of apoptosis and its association with cell 
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cycle progression with respect to dynamic metabolic changes, has not been constructed. The 
backbone of the relationship is at the transcriptional level, where changes in apoptosis and cell 
cycle associated gene expressions take place in response to the metabolic stresses and underlie 
the control of cell proliferation and apoptosis. Therefore, the effect of metabolic stresses on 
apoptosis and cell cycle needs to be investigated at a transcriptional level, so that understanding 
of the relationship can be elucidated.   
5.1.2 Objectives 
 This chapter aims to establish cell cycle and apoptosis associated cellular responses, at 
the transcriptional level, to the metabolic stresses as a result of extracellular nutrient 
deprivation as well as toxic metabolic by-product accumulation. The scientific objectives were 
set as the following: 
o Design and conduct an experiment of GS-NS0 cell culture with analytical techniques 
that would enable to elucidate cellular dynamic responses at the transcriptional level, 
especially apoptosis and cell cycle, to metabolic stresses. 
o Identify relevant metabolic stresses occurring in the culture of GS-NS0, and establish 
relevant links between the metabolic stresses, and the induction of apoptosis and cell 
cycle arrest for future model development. 
5.2 Methodology 
 
 A batch culture of GS-NS0 cell line was conducted in triplicate, with the medium 
composition, and on the incubator under the culturing condition as previously discussed in 
Chapter 4. The culture lasted for 6 days (139 hours) without nutritional additions and culturing 
condition shifts. Sample were collected twice a day and were prepared for immediate or later 
analysis, as previously discussed in Chapter 4.  
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 The analytical techniques that were performed are as follows – cell density and viability 
estimation (haemocytometer), apoptotic cell quantification and cell cycle analysis (flow 
cytometer), gene expression quantification (real-time PCR), measurements of nutrients and 
metabolite levels (BioProfile 400 and HPLC), and mAb quantification (HPLC). The procedure 
was as per manufacturer’s instruction if not described in Chapter 4.  
5.3 Results 
 
5.3.1 Cell growth and metabolic profiles 
The batch culture of GS-NS0 cells was carried out to study the impact of nutrient 
deprivation and toxic by-products accumulation on cell proliferation (Figure 5.3.1-A&B). 
Figure 5.3.1-A.2 shows the plot of viable cell concentration on the base 10 logarithmic scale 
Y-axis, allowing to identify culture phases. The boundary between early-exponential and 
exponential phases was located at around 24 hours of the culture while the boundary between 
exponential and stationary phases was defined at around 50 hours of the culture. The death 
phase starting at around 80 hours was identified by the late stage apoptotic cell fraction and 
viability as can be seen from Figure 5.3.1-B. This was in agreement with the significant 
difference in specific growth rate among the phases (Table 5.3.1).  
During the first 24 hours of culture, a significantly lower cell growth rate was observed 
compared to the exponential growth phase (p=0.003). Cell viability remained constant and high 
(approx. 90%) during the early exponential phase (Figure 5.3.1-B). During this phase, no 
significant change in the glucose and glutamate concentrations was observed, while lactate 
concentration significantly increased (Figure 5.3.1-C & D). The lactate to glucose yield in both 
early and exponential phases proved to be statistically significant (p=0.007) different to the 
stationary phase (Table 5.3.1). Following the early exponential phase, cell concentration started 
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to increase rapidly at the exponential phase. Simultaneously, lactate concentration constantly 
increased with a non-statistically significant different yield on glucose when compared to the 
early exponential phase (p=0.739). The cell density peaked soon after glutamate was 
completely exhausted (approximately 50 hours of the culture).  
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Figure 5.3.1 Cell growth, dead and 
extracellular nutrient level profiles 
of the batch culture of GS-NS0: (A) 
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significant highest specific glucose consumption rate (p<0.001, Table 5.3.1) – was observed 
with a simultaneous increase in the mAb titre (Figure 5.3.1-E). In addition, ammonia was 
detected and started to increase at the end of this phase (80 hours of the culture). The LSA cell 
fraction (Figure 5.3.1-B) started to increase soon after the end of the stationary phase (after 80 
hours of the culture), which corresponds with the drop in viability. In the death phase (between 
80 and 140 hours of the culture), the LSA fraction constantly increased, as well as the mAb 
titre – statistically significant highest antibody specific production rate (p=0.0019, Table 5.3.1). 
Glucose concentration appeared to remain constant until the end of the culture, whereas lactate 
and ammonia showed a statistically significant increase between 80 hours to 120 hours 
(p<0.05), both concentrations remain statistically constant thereafter (from 120 hours of the 
culture). 
 
 
 
 
 
  
                     (A)                    (B) 
Figure 5.3.2 The assessment of produced mAb quality: (A) protein gel electrophoresis and 
(B) the comparison between mAb quantified by the HPLC technique and the ELISA 
technique. rp represents the Pearson correlation coefficient. 
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showed two bands different in size. One was around 170 kDa while the other was around 80 
kDa, reflecting two different forms of the mAb; the 170 kDa form represented a complete IgG 
molecules (Y-shape) while the 80 kDa accounted for molecules containing both heavy and 
light chains but failing to assembly to the complete form of mAb as previously reported 
(Colcher et al., 1989, Mead et al., 2012). The supernatant sample, which was harvested from 
the culture at 144 hours, showed the 170 kDa band (Figure 5.3.2-A, column 6 and 8) indicating 
that the produced mAb had the same size and form as the mAb standard. However, the 80 kDa 
was not clearly visualised in the both raw and diluted samples. The amount of produced mAb 
was measured and cross-checked using the HPLC and ELISA techniques. Figure 5.3.2-B shows 
the comparison between two measurements obtained from the HPLC (Y-axis) and the ELISA 
(X-axis) techniques. The measurements were in the same order of magnitude and showed a 
positive linear correlation (rp = 0.988). However, the ELISA measurement appeared to be lower 
than that of HPLC. This could be due to ELISA involving errors arising from 1) high dilutions 
given its relatively higher sensitivity and 2) human error. The difference in binding specificity 
between the two methods cannot be completely excluded given that the protein A in the HPLC 
technique can also bind to other classes of antibodies while the capture antibody in the ELISA 
can only bind to the IgG class of antibodies.   
5.3.2 Amino acid profiles 
Extracellular amino acids were measured over the duration of the culture. Alanine, an 
amino acid that can be converted into intermediates in the Citric Acid cycle (TCA, Figure 
5.3.3), showed a different trend compared to other key amino acids such as glutamate, 
aspartate, asparagine and arginine (Figure 5.3.4-A, B&C). Alanine concentration increased 
60% from the beginning up to 50 hours of culture (Figure 5.3.4-C), whereas other amino acids 
concentrations showed a statistical significant decrease (p<0.001, Figure 5.3.4-A&B). The 
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glutamate and aspartate levels (Figure 5.3.4-A) rapidly decreased from the beginning of the 
culture and became limited at around 50 hours of the culture – when the culture entered the 
stationary phase. After these two amino acids were exhausted, a switch in the alanine 
concentration profile (started to decrease) was observed. Arginine showed a similar trend to 
asparagine (Figure 5.3.4-B), both decreased over the entire culture and were exhausted at the 
end of the culture. After glutamate and aspartate were exhausted, the asparagine consumption 
showed a statistical significant increase during the stationary phase and decreased again in the 
death phase (p<0.001, Table 5.3.1). However, the arginine consumption showed a statistical 
significant decrease after the exponential phase (p=0.05). 
 Leucine, lysine, isoleucine, and valine concentrations (Figure 5.3.4-D&E) decreased 
gradually over the culture, but were not exhausted. Serine (Figure 5.3.4-C) and proline (Figure 
5.3.4-F) showed a similar trend, both concentrations decreased steadily before levelling off at 
around 80 hours of the culture. Other amino acids such as histidine (p=0.695), threonine 
(p=0.757), phenylalanine (p=0.158), and glycine (p=0.111) showed no significant change 
during the culture (Figure 5.3.4-F, I&J). A summary of the relevant amino acid reactions 
involved in the TCA is presented (Figure 5.3.3). At the early and exponential phases, the 
observed yield of lactate over glucose was greater than 2.00 mol/mol. Aerobic glycolysis 
occurs in most cancer cells with a high glucose-lactate yield (Filipp et al., 2012), though lactate 
can also be converted back to pyruvate via the lactate dehydrogenase reaction (EC 1.1.1.27 & 
EC1.1.1.28). This inefficient pathway to generate ATP is known as the Warburg effect (Vander 
Heiden et al., 2009, Warburg et al., 1927) and could be a remaining signature as the GS-NS0 
cell line, which is derived from myeloma cells (Barnes et al., 2000a).  
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Figure 5.3.3 A metabolic network of relevant amino acids and reactions involved in the 
TCA. Modified from (Nelson and Cox 2004; Sellick et al. 2011). 
The decrease in both aspartate and asparagine levels implies the activation of the 
asparaginase reaction (EC 3.5.1.1) and the aspartate transaminase reaction (EC 2.6.1.1). In 
addition, at both early and exponential phases the alanine transaminase reaction (EC 2.6.1.2) 
appeared to be favouring the backward reaction as supported by the increasing alanine levels 
(Figure 5.3.4-C). The backward reaction (EC 2.6.1.2) is also supported by the glutamate 
consumption. However, glutamate consumption during the early and exponential phases could 
Reaction Name Number (EC) Reaction 
Asparaginase 3.5.1.1 L-asparagine + H2O ↔ L-aspartate + NH3 
Aspartate transaminase 2.6.1.1 L-aspartate + α-ketoglutarate ↔ oxaloacetate + L-glutamate 
Alanine transaminase 2.6.1.2 L-alanine + α-ketoglutarate ↔ pyruvate + L-glutamate 
Glutamate dehydrogenase 1.4.1.2 L-glutamate + H2O + NAD
+ ↔ α-ketoglutarate + NH3 + NADH + H+ 
Glutamine synthetase (GS) 6.3.1.2 ATP + L-glutamate + NH3 ↔ ADP + phosphate + L-glutamine 
Pyruvate carboxylase 6.4.1.1 ATP + pyruvate + HCO3
- ↔ ADP + phosphate + oxaloacetate 
L-lactate dehydrogenase 1.1.1.27 L-lactate + NAD+ ↔ pyruvate + NADH + H+ 
D-lactate dehydrogenase 1.1.1.28 D-lactate + NAD+ ↔ pyruvate + NADH + H+ 
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also be attributed to the glutamate dehydrogenase (EC 1.4.1.2) and the glutamine synthetase 
(GS) (EC 6.3.1.2). The later reaction is supported by the absence of ammonium (below 
detection), indicating that the ammonia produced is being consumed. In addition, glutamine - 
which is absent in the initial media composition - appears to be produced as indicated by the 
relative specific glutamine rate in the early and exponential phases (Table 5.3.1). An 
extracellular mass balance around the glutamate consumption rate and the alanine/glutamine 
production rates (Table 5.3.1) for the early and exponential was performed. The mass balance 
revealed that approximately 67% for the early-exponential and 50% for exponential phase of 
the glutamate was consumed towards these reactions (EC 2.6.1.2, EC 6.3.1.2). Presumably the 
rest of the glutamate was used for the production of the intermediate α-ketoglutarate (EC 
1.4.1.2) as it is a key reaction of the TCA (Altamirano et al., 2013). A reaction network for the 
early and exponential phases is proposed (Figure 5.3.5-A) summarizing the key reactions and 
their possible directions.
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Figure 5.3.4 (Continued) Extracellular amino acid concentrations in the batch culture of GS-
NS0: A) aspartate and glutamate; B) asparagine and arginine; C) serine and alanine; D) 
leucine and lysine E) valine and isoleucine; F) cysteine and proline; G) tryptophan and 
histidine; H) methionine and tyrosine; I) threonine and phenylalanine; and J) glycine. (n=3, 
error bar = SD). 
During the stationary phase, the significant decrease of asparagine indicates that the 
asparaginase reaction (EC 3.5.1.1) remains in the forward direction in order to provide 
aspartate (which was extracellularly depleted). However, the reaction direction of the aspartate 
transaminase (EC 2.6.1.1) is not clear as it was not detected extracellularly. Plausibly the 
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due to sudden glutamine consumption (Altamirano et al., 2013). The relative specific glutamine 
rate (Table 5.3.1) in this phase suggests that glutamine is uptaken (and potentially consumed 
in the GS reaction). In addition, the decrease in the alanine level suggests that the forward 
reaction of alanine transaminase (EC 2.6.1.2) is taking place producing glutamate. Despite a 
net glutamate production balance from glutamine and alanine (Table 5.3.1), glutamate was not 
detected extracellularly. This suggests that glutamate was consumed and converted to either 
aspartate (EC 2.6.1.1) or α-ketoglutarate (EC 1.4.1.2). Furthermore, the yield of lactate over 
glucose decreased (Table 5.3.1) suggesting that there is a change in the net lactate 
dehydrogenase rate. A reaction network for the stationary phase is proposed (Figure 5.3.5-B). 
 
 
 
 
 
 
 
 
  (A) Early- and Exponential phase              (B) Stationary phase 
 
Figure 5.3.5 Cell culture dependent metabolic networks: A) early and exponential phases; 
and B) stationary phase. Notation: solid arrows show the supported direction by the results, 
dashed arrows show the proposed direction. 
At the death phase, mAb productivity increased and it appeared to be the highest 
statistically significant productive phase of the culture (Table 5.3.1). However, this could be a 
result of a high lysis rate. Although most of the amino acid profiles appeared to level off at the 
death phase, the consumption of asparagine was still significant. In addition, ammonium was 
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detected at the beginning of the death phase and increased thereafter. In contrast, the change in 
glutamine concentration was not significant. The yield of lactate on glucose, increased during 
this phase although the glucose consumption rate was at its minimum. Overall, the metabolic 
reaction network appeared to remain unchanged compared to the stationary phase. 
Table 5.3.1 Calculated specific consumption/production rates and yields. 
Analysis 
Culture Phase 
Early-
exponential phase 
(0 - 24 h) 
Exponential 
phase 
(24 - 50 h) 
Stationary 
phase 
(50 - 80 h) 
Death  
phase 
(80 - 140 h) 
Specific Growth rate  
(day -1) 
0.34 ± 0.32 0.96 ± 0.14 -0.05 ± 0.05 -0.24 ± 0.09 
Metabolites, Amino acids (µmol.10-6 cell. day -1) 
Glucose -2.64 ± 0.31 -2.73 ± 0.22 -5.41 ± 0.13 -1.21 ± 0.33 
Lactate 11.47 ± 0.26 5.95 ± 0.38  6.36 ± 1.56 4.39 ± 2.22 
Ammonium -- -- 0.20 ± 0.03 0.27 ± 0.07 
Glutamate -0.58 ± 0.02 -0.49 ± 0.02 -0.01 ± 2E-3 -- 
Aspartate -0.42 ± 0.05 -0.22 ± 0.01 0.01 ± 2E-3 -- 
Asparagine -0.12 ± 0.12 -0.12 ± 0.04 -0.17 ± 0.01 -0.11 ± 0.01 
Alanine 0.25 ± 0.11 0.18 ± 0.01 -0.12 ± 0.01 -0.02 ± 0.01 
Arginine -0.26 ± 0.06 -0.19 ± 0.04  -0.12 ± 0.02 -0.03 ± 0.01 
Valine -0.21 ± 0.07 -0.12 ± 0.04 -0.12 ± 0.03 -0.03 ± 0.02 
Isoleucine -0.17 ± 0.10 -0.20 ± 0.05 -0.13 ± 0.05 -0.07± 0.02 
Leucine -0.33 ± 0.09 -0.21 ± 0.03 -0.17 ± 0.02 -0.08 ± 0.01 
Lysine -0.07 ± 0.18 -0.06 ± 0.10 -0.11 ± 0.01 0.03 ± 0.04 
Glutamine 0.05 ± 0.01 0.05 ± 0.01 -0.02 ±1E-3 -- 
cB72.3 mAb  
(µg.10-6 cell. day -1) 
11.95 ± 2.78 8.72 ± 1.02 10.61 ± 1.00 23.36 ± 1.89 
Yield (mol/mol) 
Lactate over Glucose 
2.68 ± 0.12 2.00 ± 0.78 0.72 ± 0.25 1.98 ± 1.55 
 
5.3.3 Cell cycle and apoptosis  
Cell cycle distribution was tracked over the culture (Figure 5.3.6-A). The culture started 
with a high fraction of cells in the G1/G0 phase (approximately 60%), which rapidly exited this 
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state to join the proliferating population. Concomitantly, an increase in G2/M phase cell fraction 
– from 20% to 35% – was observed during the first 24 hours of the culture. This was followed 
by a decrease in the G2/M fraction (back to ~20%) with the corresponding increase in G1/G0 
fraction (above 50%); both in agreement with the growth phases (early and exponential). Next, 
a decrease (to around 43%) in the G1/G0 population during the stationary phase of the culture 
(starting at around 60 hours) with a minor increase in the S and G2/M populations (to 
approximately 28%) was observed. These changes took place simultaneously with the sudden 
increase in the ESA cell fraction (Figure 5.3.6-B). After 24 hours of increase in the ESA 
fraction (at 80 hours of the culture) a continuous decrease in viable cell numbers and viability 
was observed (Figure 5.3.1-A&B). In the death phase of the culture, there was an accumulation 
of the G1/G0 population (back to ~60%), which remained constant after 120 hours. The 
observed G1/G0 population increase was accompanied by a decrease in the S and G2/M 
populations. During this period, the fraction of ESA cells was about 3 times higher than at the 
beginning of the culture and stayed at this level until the end of culture.  
5.3.4 Pro-apoptotic and anti-apoptotic gene expressions 
Pro-apoptotic and anti-apoptotic genes showed different expression levels between the 
growth phases (early and exponential) and the death phase. Three of the pro-apoptotic gene 
expressions casp3, casp8 and trp53bp2 showed a similar trend (Figure 5.3.7-A&B). casp8 and 
trp53bp2 were suppressed during the early and exponential phases showing a statistically 
significant decrease between 0 and 50 hours of the culture (p<0.001 and p=0.007, respectively). 
Although there was no significant decrease in casp3 expression between 0 and 50 hours 
(p=0.376), both casp8 and casp3 (Figure 5.3.7-B), reached a two-fold increase (compared to at 
50 hours) in their expressions by the end of the culture, which was triggered after extracellular 
glutamate and/or aspartate were exhausted. Similarly, trp53bp2 also doubled its expression 
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(Figure 5.3.7-A), but the triggering effect appeared to be delayed 24 hours after the up-
regulation of casp8 and casp3. Additionally, the up-regulation of casp8 and casp3 took place 
simultaneously with the increase in the ESA and LSA cell fractions (i.e. in the stationary 
phase). Conversely, bax (Figure 5.3.7-A), one of the pro-apoptotic genes in the mitochondrial 
pathway, showed a different trend as compared to the others. Its expressions significantly 
increased (p<0.001) between 0 and 50 hours and significantly decreased between 50 and 96 
hours (p<0.001). 
 
 
 
 
 
 
Figure 5.3.6 Cell cycle distribution and early stage apoptotic cell fraction in the batch culture 
of GS-NS0 cells: A) cell cycle distribution; and B) early stage apoptotic cells. (n=3, error bar 
= SD). 
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Figure 5.3.7 Relative expressions of key apoptotic and cell cycle-related genes: A) trp53bp2 and bax; B) casp3 and casp8; C) atf5; D) bcl-2 
and p21. Notation: relative gene expression quantification normalized to gapdh (housekeeping gene) and with respect to the time at 0 hour. 
(n=3, error bar = SD). 
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Figure 5.3.8 Map of events occurring in each phase of the GS-NS0 culture. 
The atf5 anti-apoptotic gene (Figure 5.3.7-C) showed a different expression compared 
to the other genes. The atf5 expression levels decreased during the growth phases (early and 
1Serine, Arginine, Asparagine, Leucine, Proline, Cystine, Isoleucine, Valine, Methionine, Tryptophan. 
2Asparagine, Leucine, Cystine, Isoleucine, Valine. 
3Proline, Arginine, Serine, Tryptophan, Methionine.  
Other amino acids remained roughly constant; Histidine, Threonine, Tyrosine, Phenylalanine, Glycine.  
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exponential) to its minimum (24 hours), and soon after it started rising during the exponential 
phase (p<0.001). The rise resulted in the atf5 peak expression (80 hours), back to the starting 
level (at time 0 hour), being 3 times higher when compared to the early and exponential phases. 
After peaking, the atf5 gene expression decreased (halved) and remain fairly constant until the 
end of the culture. 
The cell cycle regulatory gene p21 and anti-apoptotic gene bcl-2 (Figure 5.3.7-D), 
showed similar expression patterns to the pro-apoptotic genes. There was an increase in p21 
expression at the end of the stationary phase (80 hours), concurrently with the rise of the ESA 
and LSA cell populations. The significant increase and peak of p21 expression (p<0.001) was 
followed by a significant rise in the percentage of cells at the G1/G0 phase. The bcl-2 expression 
also increased at the end of the culture. However, the bcl-2 expression showed an insignificant 
decrease (p=0.322) during the exponential phase as compared to at 0 hour, and began to rise 
during the stationary phase (p=0.025, after 80 hours). A map of events summarizing the main 
findings on the gene expression, metabolic profiling, cell cycle and apoptosis level is shown in 
Figure 5.3.8. 
5.4 Discussion 
 
5.4.1 Extracellular metabolite levels and its effect on cellular activities  
Glutamate and aspartate were identified as key limiting nutrients, as cell proliferation 
ceased immediately after these amino acids were exhausted. Consequently, the drop in cell 
viability and concomitant increase in ESA and LSA cell fractions were identified to be 
associated with the glutamate and aspartate levels rather than with glucose. After the depletion 
of glutamate and aspartate a constant increase in the LSA cell fraction (and concurrent viability 
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drop) was observed with a high and constant ESA fraction. The observed profiles for the ESA 
and LSA appeared to support that ESA is a fast dynamic process (Riccardi and Nicoletti, 2006).  
The extracellular dynamic profiles of amino acids provide an indication of the 
intracellular amino acid levels (Sellick et al., 2011). Therefore, it is possible to make inferences 
on the metabolism based on the extracellular measurements. The shifts in the extracellular 
amino acid levels during the early and exponential phases indicate the activation of TCA cycle, 
thus providing intermediates, some of which are required for biosynthesis (Nelson and Cox, 
2004). The proposed reaction networks summarise the key observations for each phase. During 
the early and exponential phases the extracellular glutamate appeared to be preferentially 
diverted towards alanine and glutamine. Alanine production can be seen as a path to produce 
key TCA intermediates such as α-ketoglutarate (Nelson and Cox, 2004). In addition, the GS 
reaction pathway produces glutamine necessary for biological function of the GS-NS0 cells 
(Barnes et al., 2000a), which is supported by the detection of extracellular glutamine. Other 
consumption patterns, such as the elevated consumption of asparagine in the early exponential 
phase, appeared to be linked to the passage history. Given that the cells are passed every 3 days 
prior to starting the batch culture, the cells experience a short period of glutamate and aspartate 
exhaustion (between 50 hours and 72 hours), which appeared to trigger an increase asparagine 
uptake (as observed in the stationary phase). The asparagine increased uptake suggests the 
conversion first to aspartate and further to glutamate. Glutamate metabolism includes the 
glutamate dehydrogenase (as observed in the early and exponential phases) or via 
transaminases (aspartate transaminase or alanine transaminase), which have a closed loop 
structure and is used by cells as an internal mechanism to adjust to culture conditions 
(Altamirano et al., 2013).  
It is worth discussing about possible involvement of leucine in cell growth, metabolism 
and protein synthesis given its observed monotonically-decreasing profile and previous studies 
Chapter 5 : A Map of the Dynamic Interplay between Cell Cycle  
and Apoptosis, and Metabolism 
~ 151 ~ 
suggesting its effects. The mammalian target of rapamycin (mTOR)-associated signalling 
pathway was found to be subject to hormones (i.e. insulin) as well as amino acids, especially 
leucine. This pathway is involved mainly in protein synthesis (translation) which is linked to 
cell growth, apoptosis, metabolism (Proud, 2004, Edros et al., 2014). Leucine availability was 
found to promote mitochondrial metabolism through; in addition to its oxidative 
decarboxylation, binding to glutamate dehydrogenase, and thus facilitating the reaction where 
glutamate is converted to α-ketoglutarate (EC 1.4.1.2 ) (Xu et al., 2001, Proud, 2004, Yang et 
al., 2010). This is in agreement with our observed data and suggested directions of metabolic 
reactions (Figure 5.3.5). In addition, leucine availability was reported to have a positive effect 
on growth-related protein synthesis through the activity of the mTOR Complex 1 (mTORC1) 
(Proud, 2004, Dodd and Tee, 2012), which was found to be a nutrient-sensitive factor in the 
mTOR pathway (Kim et al., 2002). This effect of leucine was observed in insulin-secreting β 
cells (Proud, 2004, Yang et al., 2010) as well as muscle cells (Lynch, 2001). In the mammalian 
cell culture systems, it was found that the activity of the mTORC1 pathway was promoted by 
nutritional feeding (glucose and amino acids). Given the involvement of the mTORC1 
signalling pathways in growth, metabolism and protein synthesis, its activation could underlie 
the observed increased growth and recombinant protein productivity in the fed-batch cultures 
(Edros et al., 2014, Dadehbeigi and Dickson, 2015). 
At the stationary phase, it could be hypothesized that the exhaustion of glutamate and 
aspartate triggers certain metabolic changes. Previous reports support metabolic changes in 
order to provide alternative sources for intracellular energy and biosynthetic precursors 
(Young, 2013, Sellick et al., 2011), as well as the adaptation to the nutrient availability (Vander 
Heiden et al., 2009). The change in the alanine reaction direction is most likely due to the use 
of glutamate as main source for intermediate generation in the TCA cycle, as well as the 
biological relevance of glutamine. Alanine biosynthesis is reported to provide a bridge between 
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the glycolytic and glutaminolytic metabolism (Filipp et al., 2012). In addition, glutamate can 
also be generated from several amino acids (Nelson and Cox, 2004). Arginine is a plausible 
candidate for the glutamate’s supply as its level constantly decreased during the culture, 
particularly after glutamate is depleted (Dempsey et al., 2003, Nelson and Cox, 2004). The 
continuous consumption of asparagine in the stationary phase suggests its conversion to 
provide aspartate intracellularly, as aspartate is exhausted extracellularly. It can be inferred that 
glucose was converted into pyruvate and not diverted to lactate due to the decreased calculated 
yield, compared to the early and exponential phases. However, in order to validate the decrease 
in the lactate dehydrogenase activity a specific assay is required. As a result of the changes 
both in the glucose metabolism and the alanine transaminase reaction, there is possibly an 
increase in the pyruvate level. Herein, we hypothesized that the increased pyruvate levels are 
partially diverted towards the production of oxaloacetate via pyruvate carboxylase reaction, 
which serves as an intermediate for both biosynthesis and energy production. In order to fully 
quantify and validate the metabolic fluxes and active pathways both intracellular metabolic 
measurements, as well as carbon-labelled experiments are required.       
At the death phase, the highest mAb productivity was observed despite key substrates 
having been depleted. Although a possible reason for the increased mAb productivity would 
be the conversion of other available amino acids for biosynthesis; it is also possible that this is 
an effect of cell lysis, as viability decreased sharply. The sharp viability decrease could be 
enhanced by the lactate inhibitory levels reached in the late stages of culture (Hassell et al., 
1991, Lao and Toth, 1997, Ozturk et al., 1992). It can be inferred that glutamate is still being 
produced by 1) aspartate transaminase and possibly from 2) GS reaction given the steep and 
significant ammonia increase.  
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5.4.2 The genetic control of cell cycle and apoptosis linked to metabolic 
stresses 
During the early and exponential phases, cell proliferation is supported by the observed 
viable cell density, changes in the cell cycle, and gene expression. Constant changes in the cell 
cycle together with the down-regulated cell cycle regulatory gene p21, and anti-apoptotic gene 
bcl-2, allow us to infer a highly proliferative state (Simpson et al., 1999a, Watanabe et al., 
2002). In addition, during this period the effects of metabolic stresses (toxic byproduct and 
nutrient deficiency) are negligible. This is reflected in the invariant levels of ESA/LSA cell 
fractions and the significant decrease in the pro-apoptotic genes (casp8, trp53bp2 and casp3) 
expression levels. Similarly, the anti-apoptotic gene atf5, responsible for sensing an 
endoplasmic reticulum (ER) metabolic stress induced by amino acid deprivation (Watatani et 
al., 2007, Zhou et al., 2008), was down-regulated during the early exponential phase and started 
increasing during the exponential phase. Consequently, the bcl-2 anti-apoptotic mechanism 
was not activated and the expression level of bcl-2 significantly decreased in this period. At 
the end of the exponential phase (when glutamate and aspartate were exhausted) the cell density 
peaked while the cells accumulated at the G1/G0 phase. However, given the unchanged p21 
expression it can be concluded that the cells were not arrested.  
The expression of casp3, casp8 and trp53bp2, whose target proteins are caspase3, 
caspase8 and 53BP2, respectively, plays a role in facilitating apoptosis (Hengartner, 2000, 
Kobayashi et al., 2005). After glutamate and aspartate were exhausted, there was a significant 
increase in the ESA cell fraction and pro-apoptotic gene expression, mainly casp8 and casp3. 
Thus, glutamate/aspartate deprivation is linked with the onset of apoptosis at the genetic level. 
This is in agreement with previous studies that showed that apoptosis can be triggered by single 
amino acid deprivation (Simpson et al., 1998, Tintó et al., 2002). Similarly, ASPP2 encoded 
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by trp53bp2 is believed to stimulate the transactivation of p53, which ultimately triggers 
apoptosis via the mitochondrial pathway (Kobayashi et al., 2005, Patel et al., 2008, Samuels-
Lev et al., 2001). In contrast, p53 activation also can regulate metabolic defensive adaptations 
to lethal signals (Hu et al., 2010, Maddocks et al., 2013). The increase in trp53bp2 expression, 
24 hours later than the surge in casp8 and casp3 expression and the ESA cell fraction increase, 
suggests that apoptosis initiated via the death receptor pathway followed by activation of the 
mitochondrial pathway at a later time. Caspase-8 is an upstream protein in the death receptor 
pathway that activates caspase-3, which is the final executor of both apoptosis pathways 
(Stennicke et al., 1998). The observed delay to up-regulate trp53bp2 can be attributed to two 
possible causes: 1) there is a lag from the moment that the extracellular glutamate is exhausted 
until it is internally exhausted, and/or 2) the cell was able to synthesize glutamate from other 
sources delaying the trp53bp2 up-regulation. The latter is supported from the availability of 
extracellular glutamine synthesized in the early and exponential phases and depleted at the 
stationary phase. The peak of atf5 expression was observed at the end of the stationary phase, 
after glutamine became exhausted, and it transactivates the anti-apoptotic gene bcl-2 as 
previously reported (Dluzen et al., 2011). These changes took place simultaneously with the 
increase both in the G1/G0 cell fraction and the ESA fraction. The observed increase in the 
G1/G0 cell fraction appeared to be a defensive mechanism to apoptosis (Moore et al., 1997, 
Sanfeliu and Stephanopoulos, 1999) driven by the simultaneous increase of the cell cycle 
regulator p21. It has been reported that p21 expression leads to cell cycle arrest in the G1/G0 
cell fraction (Bissonnette and Hunting, 1998). The bcl-2 gene is known to play a role in the 
control of cell cycle progression, while the p21 has a suppressive effect on the onset of 
apoptosis (Gartel and Tyner, 2002a, Hockenbery et al., 1990, Niculescu et al., 1998). At the 
start of the death phase, both ESA and LSA cell fractions remained high, suggesting that cell 
death (apoptosis) is dominant. 
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It is worth discussing about the expression profile of bax. The role of bax has been 
found to be associated with pro-apoptotic and anti-apoptotic molecules. There was an inversely 
proportional correlation between bax and bcl-2 (Paul-Samojedny et al., 2005), suggesting that 
the Bcl-2 associated survival mechanism involves supressing bax expression. In contrast, bax 
was found to be one of transcriptional targets of p53 (Toshiyuki and Reed, 1995), suggesting 
its pro-apoptotic effect. Given these facts, the observed bax expression profile could be 
therefore influenced by both pro-apoptotic and anti-apoptotic molecules. The increase in its 
expression could be the result of pro-apoptotic signals being dominant, while the decrease in 
its expression could be driven by anti-apoptotic signals. 
 The observed batch culture profiles at the gene transcription, cell cycle distribution and 
apoptosis extent are summarized in a map. The map can serve as a tool for developing feeding 
strategies of key amino acids in the fed-batch systems maintaining a balance between cell 
proliferation, arrest at G1/G0 phase and the induction of apoptosis. Such feeding strategies will 
allow the culture to achieve longer culture times, while keeping a high viability and mAb 
production. For instance, the addition of key amino acids can prolong the cultivation duration 
(Kiparissides et al., 2014). Further, the selected feeding profile could be constraint or bounded 
to partially achieve a control between cell proliferation arrest at G1/G0 phase and the induction 
of apoptosis as herein observed. 
5.5 Conclusions 
 
This chapter aims to identify metabolic stresses in the batch culture of GS-NS0 cells 
and investigate cell cycle and apoptosis-related dynamic responses to the identified metabolic 
stresses. Metabolism, cell cycle and apoptosis were extensively investigated. In addition, 
relationships among them were previously reported. However, kinetics of apoptosis and its 
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association with cell cycle as respect to dynamic metabolic changes have not been clearly 
elucidated. Our work shows that apoptosis and cell cycle are intimately related at the genetic 
level and also linked to the extracellular conditions. A map of events occurring in each phase 
of the GS-NS0 culture based on the experimental observation was presented. The atf5 gene 
showed a prompt response to extracellular glutamate/aspartate deprivation, while casp8 and 
casp3 genes up-regulation indicates cell death via apoptosis in response to the metabolic 
stresses. Furthermore, the up-regulation of p21 during the end of stationary phase and death 
phase and a high G1/G0 cell fraction implies that cell cycle arrest is the mechanism to delay 
apoptosis when cells are lethally insulted. The gene markers provide relevant information to 
detect unfavourable conditions that reduce cell viability. Furthermore, the metabolic shift 
occurring in the culture as regards the glutamate/aspartate deprivation was proposed. This 
involves redirecting metabolic fluxes in relevant metabolic reactions in an attempt to relieve 
the metabolic stresses. All this information can be potentially use to formulate feeding 
strategies beyond improving product quality and productivity, which could partially control 
key cell cycle events such a cell proliferation and apoptosis. 
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6.1 Background 
 
 
Temperature levels, medium composition as well as additional nutrients are culturing 
conditions that can directly influence a cell culture performance. They are preferentially 
optimised so as to enable the cultures to achieve higher production of therapeutic proteins. 
However, this task is challenging given that detailed understanding of their effects on cell 
growth, viability as well as productivity have not been well established.  
In this chapter, a set of experiments aiming to investigate the impact of these culturing 
conditions is presented. The effects of 1) temperature shifts, 2) the variation of medium contents 
(using conditioned medium), and 3) different nutrient feeding strategies predominantly on 
induction of apoptosis in the culture of GS-NS0 cells, were studied. The expression of apoptotic 
genes under the influence of these parameters was monitored using real-time PCR techniques. 
Based on the observed results, optimal culturing conditions for the GS-NS0 cell culture can be 
elucidated. 
6.1.1 Introduction 
As previously discussed, high-yielding mammalian cell culture systems are greatly 
desirable for production of bio-therapeutics. There are a number of culturing conditions that 
can directly affect culture performances including cell growth, death and metabolism (product 
synthesis). It is, therefore, essential to understand the effect of the culturing conditions on 
cellular processes so that an optimal culturing condition where synthesis of bio-therapeutics is 
highly facilitated can be identified.  
Culturing temperature stands out from other culturing conditions given that it can be 
measurable and manipulated during the cultivation. 37ºC, which is the physiological 
temperature level where cellular systems can perform their normal activities, is believed to be 
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an optimal level for the mammalian cell cultures. Given that temperature does not only affect 
yield of desired products but also other cellular processes such as cell growth and death, 
culturing at 37ºC might not be the optimal one that enables the cultures to achieve the highest 
yield of desired products. Medium composition, which specifies initial supply of nutrients; 
including glucose and amino acids, and metabolites; including lactate and ammonium, is also 
one of important culturing conditions that can designate the fate of the culture. The addition of 
nutrients during the cultivation, including glucose and amino acids, is also considered as an 
important culturing condition given that fed-batch cultures are widely utilised in large-scale 
production of biologics. Given the relationship between extracellular nutrient concentrations 
and the cellular processes, to identify an optimal supply of nutrients and metabolites as well as 
nutrient feeding strategy requires mechanistic understanding of cellular responses with respect 
to medium composition and nutrient addition.  
The impact of temperature shifts, medium composition as well as addition of nutrients, 
including glucose and amino acids, on cellular activities: cell growth, metabolism and death, 
has been extensively studied. However, variable effects of these culturing parameters were 
observed from various cultures. For example, the shift to hypothermic temperature, which is 
the condition where culturing temperature is lower than the physiological one, during the 
exponential phase of cell cultures enhanced final antibody or protein of interest titre and/or 
productivity (Furukawa and Ohsuye, 1999, Kaufmann et al., 1999, Fox et al., 2004, Hendrick 
et al., 2001, Rodriguez et al., 2005, Oguchi et al., 2006, Bollati-Fogolín et al., 2005), while 
other cultures with the similar temperature shift did not (Barnabé and Butler, 1994, Weidemann 
et al., 1994, Marchant et al., 2008). A high initial glutamine concentration was found to enhance 
the productivity in the culture of a cell line (Dalili et al., 1990, Schneider and Lavoix, 1990), 
while the culture of another cell line with the high glutamine concentration did not achieve the 
productivity improvement (Takagi et al., 2001).   
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Adding complexity to the problem, relevant cellular activities affected by the culturing 
conditions are essentially interlinked, making the determination of an optimal state of these 
conditions highly difficult. On the one hand, the presence of growth factors as well as an 
elevated level of nutrients and metabolic by-products, for example, can promote cell 
proliferation and metabolic activities (Miller et al., 1988a, Reuveny et al., 1986). On the other 
hand, the absence of these factors can cause growth arrest as well as induction of apoptosis 
(Fussenegger and Bailey, 1998, Mercille and Massie, 1994a, Simpson et al., 1998, Singh et al., 
1994). Hypothermia generally causes growth arrest and thus prolonged culture viability, 
nevertheless, the effect of hypothermia on the final titre and productivity appears to be variable 
(Swiderek and Al-Rubeai, 2007, Barnabé and Butler, 1994, Yoon et al., 2006). Feeding 
nutrients during the culture progression was found to delay the onset of apoptosis (DiStefano 
et al., 1996, Xu et al., 2014) and improve the production of therapeutic proteins. However, 
excessive amount of added nutrients can cause an excessive level of toxic metabolite 
accumulation (Xie and Wang, 1994), thereby causing induction of cell death and deterioration 
in both production and quality of secreted proteins.  
As the discussion above attests, a systematic view of the culturing condition effects, 
which takes into account their cell line-specific characteristics as well as the interrelation among 
affected cellular processes, is the key to establish optimal conditions. To the best of my 
knowledge, apoptosis-associated responses to these culturing conditions as well as links to cell 
proliferation and metabolic activities have not been clearly elucidated for the GS-NS0 cell 
cultures. These stresses the necessity of expanding the understanding of the effect of these 
culturing conditions predominantly on apoptosis induction. In this way, strategies to control the 
degree of apoptosis while enhancing protein production/productivity in the GS-NS0 cell 
cultures can be ultimately devised.    
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6.1.2 Objectives 
 This chapter aims to investigate the effect of temperature shifts, medium contents and 
nutrient additions on apoptosis in the culture of GS-NS0. The following are the scientific 
objectives proposed for the study: 
o Design and conduct GS-NS0 culture experiments that would enable to assess the effect 
of temperature shifts on apoptosis. 
o Design and conduct GS-NS0 culture experiments that would enable to elucidate 
apoptosis responses at a transcriptional level to the variation in medium contents. 
o Design and conduct GS-NS0 culture experiments that would enable to elucidate 
apoptosis responses at a transcriptional level to the different nutrient additions. 
o Identify key relations between these culturing conditions and apoptosis induction for 
further model development. 
6.2 Methodology 
 
6.2.1 Temperature fluctuations 
 The impact of temperature fluctuations was studied in the batch cultures of GS-NS0 cell 
line. The cultures were performed in triplicate using the same medium composition and 
incubation condition as described in Chapter 4. In this experiment, cells were inoculated at 2.5 
× 105 cells/mL and the temperature shifts were implemented to the cultures. The cultures were 
maintained at 37ºC for the first 30 hours of the culture, then the temperature was shifted to either 
35ºC or 39ºC. The level of temperature shifts (±2ºC from 37ºC) was adopted based on the fact 
that cell could experience excessive stresses (due to extreme temperature difference) to the 
extent that cells could not manage to adapt themselves for the new temperature condition 
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(Sureshkumar and Mutharasan, 1991). The cultures were maintained for 5 days (120 hours). 
The batch culture at 37ºC, as described previously in Chapter 4 and discussed in Chapter 5, was 
used as a control culture, to which the cultures exposed to temperature fluctuations were 
compared.   
 The analysis performed in this experiment includes cell density and viability 
determination (haemocytometer), apoptotic cell and cell cycle analysis (flow cytometer), cyclin 
D1 profiling (flow cytometer), measurements of nutrient and metabolite levels (BioProfile 400), 
and mAb quantification (HPLC). The procedure of the performed analysis is described in 
Chapter 4, otherwise it is as per manufacturer’s instruction. Samples were harvested twice a 
day for the analysis, except for apoptotic cell quantification and cyclin D1 profiling that samples 
were collected daily. 
 This experiment was conducted in collaboration with D. G. García Münzer (PhD 
candidate) and A. Gauthier (MSc student).  
6.2.2 Medium composition 
 The effect of the medium composition was investigated in the batch cultures of GS-NS0 
cell line. The cultures were performed in triplicate, and under the same incubation condition as 
described in Chapter 4; though the inoculation cell density, the medium contents, the size of 
cultivation flask as well as the sampling time point were different. In this experiment, cells, 
isolated from the mid-exponential phase of the sub-culture (using the centrifugation with the 
condition as described in Chapter 4), were seeded at 5 × 105 cells/mL in 250 mL Erlenmeyer 
flask (Corning, 431144) with 50 mL working volume. The different medium blends used for 
growing cells include 1) 100% fresh medium + 0% spent medium (100%FM), 2) 50% fresh 
medium + 50% spent medium (50%FM), and 3) 0% fresh medium + 100% spent medium 
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(0%FM). The spent medium was isolated from the culture at the late stationary phase (day 4 
and 5 of the sub-cultures). 
 Samples were collected every 6 hours until 24 hours of culture in order to reveal short-
term responses induced by the medium content change. The analysis involved measuring cell 
density and viability (haemocytometer), apoptotic cell and cell cycle fractions (flow cytometer), 
the expression of cyclins (flow cytometer), gene expression (Real-time PCR), nutrient and 
metabolite levels (BioProfile 400), and mAb titre (HPLC). The procedure for the analysis is 
described in Chapter 4. 
 This experiment was conducted in collaboration with D. G. García Münzer (PhD 
candidate). 
6.2.3 Nutrient additions 
 This experiment includes fed-batch cultures of GS-NS0 cell line, aiming to evaluate the 
effect of nutrient additions during the culture progression. The cultures employed the same 
incubation condition as well as medium composition, as described in Chapter 4. There were 
two feeding strategies implemented in this experiment: F1 and F2, as shown in Figure 6.2.1. 
They were devised based on the understanding established in Chapter 5, suggesting limiting 
substrates in the culture of GS-NS0 cell line as well as and the time point that these substrates 
should be fed. The difference between F1 and F2 is the number of substrates that were fed into 
the culture. F2 assumes that glutamate and glucose are only limiting substrates (Figure 6.2.1-
B) while F1 takes into account the limiting effect of aspartate, asparagine and arginine in 
addition to glucose and glutamate (Figure 6.2.1-A). 
 The feeding volume was determined based on the facts that 1) the net culture volume 
change due to the nutrient additions and sampling should not be larger than ± 30% of the culture 
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volume (Trummer et al., 2006) in order to avoid the dilution effect (Kyparissidis, 2012), 2) any 
increases in nutrient concentration in the culture should not be over the concentration of these 
nutrients in the fresh medium in order to avoid possible cytotoxicity caused by excessive 
amount of nutrients (Sellick et al., 2011). The concentration of feeding nutrient stock solutions 
(Figure 6.2.1) were made up by dissolving glucose (Sigma-Aldrich, G7021-1KG), glutamate 
(Sigma-Aldrich, G8415-100G), aspartate (Sigma-Aldrich, A7219-100G), asparagine (Sigma-
Aldrich, A4159-25G) and arginine (Sigma-Aldrich, A8094-25G) in sterile de-ionised water (< 
18.2 mΩ cm).  
 
 
 
 
 
 
   (A)             (B) 
Figure 6.2.1 Two different schemes of nutrient additions in the fed-batch cultures: (A) F1 
(glucose, glutamate, aspartate, asparagine and arginine); and (B) F2 (glucose and glutamate). 
The concentration of each feeding nutrient stock solution is as follows: 200 g/L (1.1 M) of 
glucose; 7.5 g/L (50mM) of glutamate; 5 g/L (37.5 mM) of aspartate; 10 g/L of (76 mM) 
asparagine; and 10 g/L (57.5 mM) arginine. 
 Samples were harvested twice a day after the nutrient feeding. The analytical assays 
performed in this experiment is as follows: cell density and viability determination 
(haemocytometer), apoptotic cell and cell cycle analysis (flow cytometer), gene expression 
(real-time PCR), measurements of nutrient and metabolite levels (BioProfile 400 and HPLC), 
and mAb quantification (HPLC). The procedure for these assays is described in Chapter 4.  
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6.3 Results & Discussion 
 
6.3.1 Temperature fluctuations 
Cell proliferation and apoptosis 
In this study, the culture temperature was shifted to either 35ºC or 39ºC, though the 
temperature could be shifted to higher than 39ºC or lower than 35ºC as can be seen from 
previous studies (Masterton and Smales, 2014). The reason why these temperature shift levels 
were selected specifically for this study is that our cultures with the temperature shift to less 
than 35ºC or higher than 39ºC experienced no growth and a sudden drop in cell viability, and 
thus the cultures could not be maintained. Therefore, ±2ºC from 37ºC could be the working 
temperature range for our culture system. It is worth noting that the difference in how lower (or 
higher) the culture temperature is shifted to in a cell culture might induce different responses. 
In addition, despite applying the same level of hypothermic (and also hyperthermic) 
temperature, different effects might also be observed from different cell culture systems (i.e. 
different cell lines, different medium used, etc.) (Masterton and Smales, 2014, Marchant et al., 
2008). 
The maximum cell concentration was affected by the temperature shifts in the culture 
of GS-NS0 cells. As can be seen from Figure 6.3.1-A, the culture with the temperature shift to 
35ºC achieved a lower maximum cell concentration while the culture with the temperature shift 
to 39ºC demonstrated a comparable cell density profile, compared to the control culture or the 
culture at 37ºC. More specifically, cell growth became slower after 30 hours of the culture 
(where the temperature shift to 35ºC was introduced), given that cell density did not changes 
significantly. In addition, compared to the control culture, the culture with temperature shift to 
39ºC demonstrated a faster cell density drop after 96 hours of the culture.  
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Figure 6.3.1 The profiles of A) cell density and viability; B) % ESA; and C) % LSA VS. % dead 
cells, in the temperature shift experiment. The vertical dot line represents the temperature shift. 
The arrows indicate the corresponding axes to the data (n=3, error bar = SD). rp represents the 
Pearson correlation coefficient.  
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  Generally, the cultures exposed to the temperature fluctuations showed a similar pattern 
of culture viability to the control culture. However, a sudden culture viability drop in the 
cultures exposed to temperature fluctuations was observed at around 60 hours, earlier than the 
control culture (Figure 6.3.1-A). ESA cells appeared to be affected by the temperature shifts in 
a similar manner to cell density. After 30 hours until 72 hours of the culture, there was no 
significant change in % ESA cells in the culture with the temperature shift to 35ºC, while the 
culture with temperature shift to 39ºC as well as the control culture demonstrated a sudden rise 
in % ESA cells (Figure 6.3.1-B) as a result of glutamate became exhausted (Figure 6.3.2-A). 
The unchanged level of ESA cells in the culture with temperature shift to 35ºC suggests the 
effect of hypothermic condition that helped delay the onset of apoptosis. After 72 hours, % ESA 
cells in the culture with the temperature shift to 35ºC, however, was suddenly increased and 
became comparable to % ESA cells in the control culture. In the meantime, the culture with the 
temperature shift to 39ºC did not change until the end of culture, despite the observed viability 
drop. Figure 6.3.1-C confirms that there was no significant error in the cell viability 
determination technique or the cell count given the strong linear correlation between % LSA 
cells obtained from flow cytometry and % dead cells (rp = 0.940) obtained from the cell viability 
determination technique.  
 The observed effects of the temperature shift to 35ºC are in good agreement with 
previous data. A lower maximum cell density (Kaufmann et al., 1999, Hendrick et al., 2001, 
Fox et al., 2004, Bollati-Fogolín et al., 2005, Oguchi et al., 2006) as well as the delay in 
apoptosis induction (Furukawa and Ohsuye, 1998, Shi et al., 2005, Moore et al., 1997, Marchant 
et al., 2008) have been reported from the culture of various cell lines with the temperature shifts 
to hypothermic conditions. In addition, the observed result showing no prolongation of culture 
viability is also in agreement with previous data (Furukawa and Ohsuye, 1999, Rodriguez et 
al., 2005). Nevertheless, it is contrary to other previous studies reporting that culture viability 
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is prolonged in the culture under mild hypothermic conditions (Swiderek and Al-Rubeai, 2007, 
Yoon et al., 2006). The observed phenomena in the culture with the temperature shift to 39ºC 
are in agreement to the previous data (Sureshkumar and Mutharasan, 1991) showing a 
comparable level of the maximum cell density between the temperature shifted culture and the 
control culture. However, Barnabé and Butler (1994) showed that the temperature shift to a 
hyperthermic condition decreased the maximum cell density. The sudden viability drop despite 
lowering %ESA cells, observed in the culture with the temperature shift to 39ºC, could be 
because apoptosis is a highly dynamic process (Riccardi and Nicoletti, 2006),  and the increase 
in temperature could increase the transition rate between ESA and LSA. This observed viability 
drop is confirmed by previous data showing fast cell death in hyperthermic cultures (Barnabé 
and Butler, 1994, Furukawa and Ohsuye, 1998). Another explanation is that ESA could be 
inhibited by activation of heat shock proteins (HSPs) in response to the hyperthermic condition 
while the observed drop in viability could be contributed by other types of cell death.  Many of 
HSPs, including HSP70, HSP90 and HSP27, were found to have anti-apoptotic roles, where 
apoptosis can be blocked at either upstream, mitochondrial or downstream pathways of 
apoptosis (Lanneau et al., 2008), as previously discussed in Chapter 2. The activity of cold 
shock proteins (CSPs) in response to hypothermia might underlie the observed lower viable cell 
concentration as well as delay in apoptosis in the hypothermic culture. As discussed in Chapter 
2, CIRP and RBM3, ones of CSPs, can inhibit apoptosis in response to hypothermia (Kita et 
al., 2002, Sakurai et al., 2006). In addition, CIRP was found to partly contribute to cell cycle 
arrest (Kumar et al., 2007).These CHPs could partly contribute to the observed effect of 
hypothermia in the culture.  
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Metabolic activities and mAb production 
 As shown in Figure 6.3.2-A, the profile of glutamate level was similar among the 
cultures. Glutamate was completely consumed at around 48 hours of the cultures. Despite the 
lowest maximum cell density in the biphasic and hypothermic culture, the culture showed the 
lowest rate of specific lactate generation as well as the comparable specific glucose 
consumption rate to that of the control culture (Figure 6.3.2-B&C). The yield of lactate over 
glucose in the culture with the temperature shift to 35ºC appeared to be the lowest one (~1.2 
mol/mol) as compared to that of the other cultures (Appendix B1). These results are in 
agreement with the previous report, showing reduction in lactate production (Weidemann et al., 
1994, Barnabé and Butler, 1994, Moore et al., 1997) as well as reduction in the yield of lactate 
on glucose (Sureshkumar and Mutharasan, 1991). However, several studied demonstrated that 
hypothermia in general reduced metabolic activities, including glutamine and glucose 
consumption (Reuveny et al., 1986, Barnabé and Butler, 1994, Weidemann et al., 1994, 
Swiderek and Al-Rubeai, 2007, Marchant et al., 2008), which is contrary to our observation. 
The specific glucose rate in the culture with the temperature shift to 39 ºC appeared to be the 
highest one among the cultures, as shown in Figure 6.3.2-B. The observed result is in good 
agreement with previous data (Barnabé and Butler, 1994, Trummer et al., 2006). However, 
these previous studies showed that there was an increase in lactate production rates under 
hyperthermic conditions, which is contrary to our observed result where the specific lactate 
generation rate did not change significantly, compared to the control culture (Figure 6.3.2-C).   
For the first 48 hours, the trend of mAb titre among the cultures did not significantly 
vary with each other (Figure 6.3.2-A). However, after 72 hours, it appeared that the mAb titre 
in the culture with the temperature shift to 39ºC was significantly higher than those of the other 
cultures. Figure 6.3.2-D illustrates the specific mAb productivity among the cultures. It 
appeared that the cultures with the temperature shift to 35ºC and 39ºC achieved around 1.5 times 
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and 2.2 times, respectively, higher mAb productivity than that of the culture at 37ºC. The 
observed increase in mAb productivity in the biphasic hypothermic culture could be because 
the reduced activity in global mRNA translation and metabolism, and the enhanced mRNA 
stability (could be due to the CSP activation (Kumar et al., 2007), as a result of the reduced 
temperature, occurred simultaneously. This provided more chance, as compared to the normal 
cultures, for the recombinant mRNAs to undergo translation and post-translational protein 
processing, leading to enhanced productivity (Masterton and Smales, 2014, Marchant et al., 
2008). The observed increased mAb productivity in the hyperthermic culture could be linked 
to the activation of HSPs due to the increased temperature given that they act as chaperones 
helping facilitate the process of the recombinant protein folding and prevent possible 
aggregation as well as misfolding arising from denatured proteins (Sonna et al., 2002). 
 Cell cycle progression and links to apoptosis 
 Cell cycle profiles were similar among the observed cultures (Figure 6.3.3). There was 
no clear evidence of immediate cell cycle responses to the temperature shifts, given that most 
changes were observed long after the temperature shifts. There was a temporary and sudden 
increase in G2/M cell fraction during 48 to 60 hours (Figure 6.3.3-B), before the temporary 
increase in G1/G0 cell fraction after 72 hours in the culture with the temperature shift to 35
ºC 
(Figure 6.3.3-A). This might indicate cell cycle arrest at G2/M lumped phase due to the effect 
of hypothermic temperature shift. This suggestion is supported by the previous studies 
demonstrating that there were an increase in cell fraction in G2/M lumped phase (Shi et al., 
2005) and an increase in Cdc2 (G2/M regulator) expression (Swiderek and Al-Rubeai, 2007) 
under hypothermic conditions. It appeared that the increase in G1/G0 cell fraction in the cultures 
exposed to temperature fluctuations and the control culture was followed by the increases in 
ESA cell fraction. In the culture with temperature shift to 39ºC and the control culture, the 
increases in G1/G0 cell fraction were seen during 24 to 48 hours (Figure 6.3.3-A), followed by 
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the increases in ESA cell fraction with the drop in G1/G0 cell fraction after 48 hours of the 
cultures (Figure 6.3.1-B). In the culture with temperature shift to 35 ºC, the increase in ESA cell 
fraction was observed at 72 hours, after the increase in G1/G0 cell fraction (Figure 6.3.3-A). 
These observed results agree with the previous data showing that cells progress to apoptosis via 
the late G1 cell cycle phase (Fussenegger and Bailey, 1998), suggesting the link between G1/G0 
cell cycle arrest and the induction of apoptosis (El-Deiry et al., 1994).  
 The observed cyclin D1 expression for the G1/G0 lumped phase in the cultures exposed 
to temperature fluctuations did not significantly vary with each other (Figure 6.3.3-C). This 
observed result is not in agreement with the previous study demonstrating that hyperthermia 
caused an increase in cyclin D1 expression (Han et al., 2002). However, it supports the 
correlation between substrate availability and the cyclin D1 expression as previously suggested 
(García Münzer, 2014), given that the similar correlation between cyclin D1 expression and 
glutamate level was observed. At the beginning of the culture, the cycling D1 expression was 
at a low level due to the nutrient exhausted condition cells experienced in the sub-culture prior 
to the temperature shift experiment. As can be seen in Figure 6.3.3-C, the cyclin D1 increased 
with the abundant glutamate availability and decreased with the glutamate exhaustion. This 
suggests that the cyclin D1 expression in the cultures exposed to temperature fluctuations is 
predominantly affected by the nutrient availability, though there is no clear evidence of no 
impact of hyperthermia and hypothermia on the cyclin D1 expression.  
6.3.2 Medium composition 
Cell proliferation and apoptosis 
 There was a difference in the cell growth profile among the cultures. At the end of the 
cultures (24 hours), the culture with medium blends containing fractions of fresh medium (i.e. 
50%FM and 100%FM) achieved significantly higher viable cell concentrations than the culture 
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using only conditioned medium (Figure 6.3.4-A). The highest viable cell density was achieved 
in the culture with 50%FM blend, however, it was not statistically significant different to the 
culture with 100%FM blend. There was also a difference in culture viability between the culture 
with 0%FM blend and the other cultures at 24 hours. All cultures started at the high cell viability 
(>94%) as shown in Figure 6.3.4-A. The culture with 0%FM blend showed around 10% drop 
in viability, while the other cultures maintained the initial viability. There was a significant 
increase in ESA cell fraction in the culture with 0%FM blend after 24 hours as compared to the 
ESA cell fraction at the time 0 hour (Figure 6.3.4-B). This was corresponding to the drop in 
viability. In addition, the culture with 0%FM blend demonstrated a significantly higher ESA 
cell fraction than those of the other two cultures (50%FM and 100%FM). There was no 
significant difference in ESA cell fraction between these two cultures. There was also no 
significant difference in Ki-67 positive cell fraction among all the cultures, although, after 6 
hours, a slight drop in Ki-67 positive cell fraction was observed in the culture with 0%FM 
blend. 
 Metabolic activities and mAb production 
 Differences in glucose and lactate concentration profiles were observed among the 
cultures with different medium blends. More specifically, after 24 hours, there was a significant 
decrease in glucose concentration as well as a corresponding increase in lactate concentration 
in the cultures with medium blends containing fractions of fresh medium, compared to the 
beginning of the cultures (Figure 6.3.5-A). The increase in lactate concentration in the culture 
with 100%FM blend was found to be steeper than that in the 50%FM blend. This could be 
because the presence of lactate at the beginning of the culture inhibits the production of lactate, 
as previously reported (Cruz et al., 2000, Choi et al., 2007). There was no clear evidence of 
glucose consumption in the culture with 0%FM blend, given that there was no significant 
decrease in glucose concentration after 24 hours. In contrast, lactate concentration was found 
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to decrease after 24 hours of the 0%FM blend culture. It was previously reported that the 
metabolic shift to lactate consumption is subject to the level of limiting substrates, especially 
glucose and glutamine (Zhou et al., 1997b, Sanfeliu et al., 1997, Zhou et al., 2006) as well as 
conditions of slow cell growth and low glycolysis flux (Zagari et al., 2013, Li et al., 2012). Our 
result suggests that the observed lactate consumption could be induced by the absence of 
limiting substrate(s), most likely glutamate, as well as the high initial concentration of lactate 
resulting in the reduction in lactate production as well as cell growth (Cruz et al., 2000, Choi et 
al., 2007, Chen et al., 2009). 
There was a sudden decrease in glutamate concentration in the cultures with medium 
blends containing fractions of fresh medium where glutamate was present, as can be seen in 
Figure 6.3.5-B. After 24 hours, the produced mAb concentration in the cultures with 100%FM 
was the lowest one as compared to the other cultures (Figure 6.3.5-C&D), despite achieving a 
high level of viable cell density. In addition, there was no significant difference in the profile 
of mAb titre between the culture with 50%FM and 0%FM blends. It could be inferred from 
these results that the increase in the mAb production is associated with spent medium, given 
that medium used in these two cultures contained a fraction of conditioned medium containing 
metabolites released from cells such as lactate and ammonia. Previous studies showed that 
elevated levels of lactate at the beginning of the culture enhanced the final secreted protein titre 
(Reuveny et al., 1986, Kromenaker and Srienc, 1994, Lao and Toth, 1997) through the 
metabolic shift that favours the process of the protein synthesis (Choi et al., 2007, Zhou et al., 
2011). However, it cannot be firmly concluded that the observed increase in the mAb 
production was due to the presence of lactate, given that condition medium also consists of 
other known and unknown factors. In addition, cell lysis might partly contribute to the increase 
in the mAb titre, especially in the culture with 0%FM blend. Therefore, further experimentation 
is required to identify factors in conditioned medium that enhance the mAb production.       
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Figure 6.3.4 Cell proliferation profiles in the medium blend experiment: A) viable cell density 
and viability; and B) apoptotic & Ki-67 positive (proliferative) cell fraction. FM is fresh medium 
and the arrows indicate the corresponding axes to the data (n=3, error bar = SD). 
Apoptosis-related gene expressions  
 The expression profiles of apoptosis-related genes varied among the cultures with 
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significant decrease in the expression of atf5 (Figure 6.3.6-A). However, the 100%FM culture 
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culture, before decreasing to its minimum at 24 hours. In the meantime, it appeared that there 
was a significant increase in the expression of atf5 in the culture with 0%FM medium blend. 
The observed changes in atf5 expression are in agreement with previous reports. The immediate 
increase in atf5 expression (i.e. in the culture with only conditioned medium) could be a result 
of the limitation of amino acids (Watatani et al., 2007) as well as endoplasmic reticulum (ER) 
stress (Izumi et al., 2012). Nevertheless, the temporary rise (and later decrease) in the atf5 
expression in the culture with 100%FM medium blend might be due to the absence of 
unidentified factors present in spent medium, causing the culture to experience adaptation.  
 After 24 hours, the culture with 100%FM blend demonstrated a significant decrease in 
the bcl-2 expression (Figure 6.3.6-B). A similar trend of bcl-2 expression was also observed in 
the 50%FM culture, though the bcl-2 expression started to decrease after 12 hours of the culture. 
The culture with 0%FM medium blend did not show a significant change in the bcl-2 
expression, though the bcl-2 expression became the highest one among the cultures after 24 
hours. Given that bcl-2 is one of transcriptional targets of atf5 (Dluzen et al., 2011), the 
observed high and maintained level of bcl-2 expression could be induced by the increase in atf5 
expression level. However, the possibility that the bcl-2 expression can be governed by the 
activation of other apoptosis-related factors, such as p53 (Miyashita et al., 1994) and nuclear 
factor kappa B (Catz and Johnson, 2001), cannot be completely excluded. The expression 
profile of cyclin-dependent kinase inhibitor gene p21, however, did not show a significant 
difference among the time points in all cultures (Figure 6.3.6-C), suggesting that immediate 
responses to the variation in medium contents is not growth arrest-associated. Nevertheless, 
there was a drop and an increase in p21 expression at 12 hours and 6 hours in the culture with 
100%FM and 0%FM medium blends, respectively. 
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6.3.3 Fed-batch strategies 
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Figure 6.3.6 The expressions of genes related to apoptosis and cell cycle in in the medium blend 
experiment: A) atf5; B) bcl-2; C) p21; D) trp53bp2; E) casp8; and F) casp3. The relative fold 
change represents the gene expression normalised to 0 hr and the housekeeping gene, gapdh (see 
Appendix A). “*” indicates p<0.05 and the corresponding p-values are showed in Appendix B.3, 
(n=3, error bar = SD). 
Chapter 6 : The Impact of Temperature, Medium Composition  
and Nutreint Addition, on Apoptosis 
~ 180 ~ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0.4
1.0
1.6
2.2
0.4 0.8 1.2 1.6
C
y
cl
in
 D
1
 r
e
la
ti
v
e 
ex
p
re
ss
io
n
bcl-2 relative expression
0% FM 50% FM 100% FM
0.4
1.0
1.6
2.2
0.4 0.8 1.2 1.6
C
y
cl
in
 E
1
 r
el
a
ti
v
e 
ex
p
re
ss
io
n
bcl-2 relative expression
0% FM 50% FM 100% FM
0.8
1.0
1.2
1.4
0.4 0.8 1.2 1.6
C
y
cl
in
 B
1
 r
el
a
ti
v
e 
ex
p
re
ss
io
n
bcl-2 relative expression
0% FM 50% FM 100% FM
Figure 6.3.7 Scatter plots between bcl-2 and cyclins in the medium shift experiment: A) bcl-
2 and cyclin D1 expressions; B) bcl-2 and cyclin E1 expressions; and C) bcl-2 and cyclin B1 
expressions. FM is fresh medium and the dash dot lines represent the basal expressions. All 
relative expressions were normalised to time 0 hour (n=3, error bar = SD). rp and rs represent 
the Pearson and Spearman, respectively, correlation coefficients.   
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 The expression profiles of trp53bp2, casp8 and casp3 showed a similar pattern among 
the cultures as can be seen in Figure 6.3.6-D, E & F, respectively. After 24 hours, there was a 
significant decrease in the expression of these genes in the culture with fractions of fresh 
medium. In contrast, in the 0%FM culture, there was a significant increase in the expression of 
these genes from the beginning to 6 hours of the culture. From 6 hours to 12 hours, the 
expression of these genes decreased, before rising and becoming the highest ones at 24 hours 
as compared to those in the other cultures. Given that these genes are apoptosis markers, these 
results agree with the observed profile of ESA cell fraction and viability. The results also 
suggest that the limitation of nutrients as well as the presence of metabolites introduce stresses 
to cells, given the observed increase in the expression of these apoptotic makers. The temporal 
drop in the expression of these apoptotic makers could be affected by a survival mechanism in 
response to the stresses as indicated by the elevated expression level of atf5 and bcl-2 (Dluzen 
et al., 2011, Izumi et al., 2012, Persengiev et al., 2002). However, given the increase in these 
apoptotic maker expressions after 12 hours, it can be inferred that the culture progresses toward 
apoptosis. 
 The link between cell cycle and apoptosis 
 The link between cell cycle progression and the onset of apoptosis could be established, 
given the previously reported roles of the apoptosis-related genes. p21 has been reported to 
regulate cell cycle progression (Gartel and Tyner, 2002b) through the suppression of cyclin-
dependent kinases (CDKs) as well as cyclin-CDK complexes, which are required for the cell 
cycle transition from G1 to S phase (Fussenegger and Bailey, 1998, Cazzalini et al., 2010) as 
well as from G2 to M phase (Niculescu et al., 1998). The pro-apoptotic gene, trp53bp2 encodes 
53BP2 (p53-binding protein 2), which specifically interacts with p53 to trigger apoptosis via 
the intrinsic pathway (Samuels-Lev et al., 2001, Kobayashi et al., 2005). It has been reported 
that p53 controls the G2/M cell cycle checkpoint through p21 activation-associated mechanisms 
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(Bunz et al., 1998, Agarwal et al., 1995), one of  which involves the deactivation of cyclin B 
complexes (Innocente et al., 1999). Furthermore, a correlation between the expression of Bcl-
2 (protein) and cyclin D1 has been reported (Lin et al., 2001a, Hong et al., 2008), given that 
Bcl-2 was found to arrest cell proliferation in response to apoptotic stimuli (Simpson et al., 
1999b, Janumyan et al., 2003). The overexpression of bcl-2 was also found to cause G2/M cell 
cycle arrest. It was suggested that its role involves the deactivation of cyclin-CDK complexes 
for the G2/M checkpoint (Crescenzi et al., 2002).  
 The prolife of cyclins (D1, E1 and B1) was measured as a part of the collaboration work 
with D.G. García Münzer (PhD candidate). Cyclin D1 and E1 have regulatory roles in the cell 
cycle progression through G1-phase (Coqueret, 2002, Mazumder et al., 2004), while cyclin B1 
facilitates the cell cycle progression though G2-phase (Kawamoto et al., 1997). Therefore, the 
plots between the relative expression of apoptosis-related genes and cyclins can reveal any 
possible correlations among them. As previously suggested, a moderate positive correlation can 
be indicated by the correlation coefficient being between 0.4 to 0.59 (hence, -0.4 to -0.59 for a 
moderate negative correlation) while the correlation coefficient being between 0.0 to 0.19 
indicates a very week positive correlation (and between 0 to -0.19 for a negative one) (Evans, 
1996). As shown in Figure 6.3.7-C, a moderate negative correlation between the bcl-2 
expression and the cyclin B1 expression could be drawn given the rp and rs. However, the 
suggested correlation might be only a monotonic negative relationship rather than a linear one 
given the p-value equal to 0.096 obtained by the Pearson method while the p-value equal to 
0.031 obtained by the Spearman method. The correlation found here is in agreement with the 
previous studies (Crescenzi et al., 2002, Furukawa et al., 2000). Although Bcl-2 were found to 
cause the inhibition of G1 to S phase transition (Mazel et al., 1996), there were very week 
correlations observed from the plots between the expression of bcl-2 and cyclin D1, and 
between  the expression of bcl-2 and E1 as can be seen from the rp and rs (Figure 6.3.7-A&B).  
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The plots between the relative expression of p21 and all cyclins demonstrates a 
correlation where the expression of p21 is inversely proportional to the expression of cyclins 
(Appendix B1). However, the cyclin D1 and E1 expressions in the culture with 0%FM blend at 
6 hours do not follow this correlation. Given that there was the corresponding drop in %Ki-67 
cell fraction (and thus cell proliferation arrest), it can be inferred that the p21 expression partly 
underlie the cell proliferation arrest (Bi et al., 2004) and the observed imbalances of cyclin D1 
and E1 expression. The relationship between the relative expression of trp53bp2 and all cyclins 
could not be clearly drown from the plots (Appendix B1). This might be because trp53bp2 is 
the factor that is predominantly responsible for the induction of apoptosis as a result of p53 
activation (Samuels-Lev et al., 2001). In addition, the association of p53 with the control of cell 
cycle progresses through intricate pathways; for example, through the transactivation of p21 
(Li et al., 1994) and the interaction with Bcl-2 (Naumovski and Cleary, 1996), making it 
difficult to draw any direct relations between them.   
 The herein proposed relations between the expression of relevant genes and cyclins are 
subject to the experimental conditions presented in this study. In order to validate the proposed 
relations, further experimentation is needed. In addition, the cultures in this study employed 
medium containing a fraction of serum which consists of a number of unknown factors, 
therefore complicating the analysis. However, the observed results point out the importance of 
the link between cell cycle and apoptosis. 
6.3.3 Nutrient additions 
Cell proliferation and apoptosis 
 There was a significant difference in the profiles of viable cell density in the cultures 
with different nutrient feeding schemes as can be seen in Figure 6.3.8-A. The maximum viable 
cell concentrations in the fed-batch cultures were higher than that in the batch culture. The F1 
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fed-batch culture achieved the maximum viable cell density of 16 × 105 cells/mL at 96 hours, 
while the F2 fed-batch culture achieved the maximum viable cell density of around 14 × 105 
cells/mL at around 72 hours. After 24 hours, it appeared that the F2 fed-batch culture showed 
a faster growth rate (0.72 day-1), as compared to the other cultures (around 0.35 day-1 for the 
other cultures). The decrease in viable cell concentration in the F1 fed-batch culture occurred 
after 96 hours, while the F2 fed-batch and the batch cultures experienced the decrease in viable 
cell concentration at earlier time points: 72 hours and 54 hours, respectively. All the cultures 
showed a similar pattern of culture viability, though that in the F2 fed-batch culture started to 
decrease before the other cultures (Figure 6.3.8-B). In contrast, the F1 fed-batch culture 
demonstrated the highest viability as compared to the other cultures at the same time point. The 
observed profile of ESA cell fraction was corresponding to the viability profile (Figure 6.3.8-
C). The %ESA cells in the F2 fed-batch culture started to increase after 36 hours, earlier than 
the increase in %ESA cells observed in the other cultures. The %ESA cells in the F1 fed-batch 
culture and the batch culture started to rise at around 70 hours; however, the %ESA cells in the 
F1 fed-batch culture remained the lowest one due to the gradual increase in %ESA cells. The 
observed results suggest that the induction of apoptosis might be delayed in the F1 fed-batch 
culture, which is in agreement with the previous study (DiStefano et al., 1996, Zhou et al., 
1997a). However, the F2 fed-batch culture did not follow the reported data, given the higher 
%ESA and the earlier drop in culture viability.  
Metabolic activities and mAb production 
 There was a difference in the concentration profiles of glucose and lactate among the 
cultures. For the first 60 hours, all cultures showed a similar decrease in glucose concentration 
(Figure 6.3.9-A). During this period, the specific glucose utilisation rates were comparable 
among the fed-batch cultures (2.2 and 2.3 µmol.10-6cell.day-1 in the F1 and F2 cultures, 
respectively); however, they were lower than the batch culture (3.2 µmol.10-6cell.day-1). It 
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appeared that during 72 and 84 hours (after the 1st glucose feeding) the F2 fed-batch culture 
showed a higher glucose consumption (2.2 µmol.10-6cell.day-1) than the F1 culture (0.5 
µmol.10-6cell.day-1), resulting in the lower glucose concentration observed at 84 hours. After 
84 hours, the glucose concentration profiles of the fed-batch cultures were comparable. The 
batch culture after 72 hours showed the lowest concentration of glucose as a result of no glucose 
addition. An increase in lactate concentration was observed in all cultures, which was 
corresponding to the decrease in glucose concentration (Figure 6.3.9-B). However, the observed 
specific lactate production rates in the fed-batch cultures were significantly lower than that in 
the batch culture (1.3, 1.9, and 5.7 µmol.10-6cell.day-1 for the F1, F2 and batch cultures, 
respectively). While the lactate production continued until the final stages of the batch culture, 
the F1 and F2 fed-batch cultures showed decreases in lactate concentration after 60 hours and 
84 hours, respectively. In addition, a similarity between the concentration profile of produced 
lactate and consumed serine was observed in all cultures (Figure 6.3.9-C).  
After 36 hours, glutamate and aspartate were exhausted in the F2 culture, earlier than 
the other cultures, as shown in Figure 6.3.9-D&E. The observed specific glutamate 
consumption rate during the first 36 hours in the F2 culture was the highest one among the 
cultures (0.45, 0.75, and 0.6 µmol.10-6cell.day-1 for the F1, F2 and batch cultures, respectively), 
nevertheless the observed specific aspartate consumption rate was comparable to that in the 
batch culture. Up to 72 hours, It appeared that there was no significant difference in the specific 
consumption rates of asparagine (0.16 and 0.17 µmol.10-6cell.day-1) as well as arginine (0.25 
and 0.25 µmol.10-6cell.day-1) among the fed-batch cultures (F1 and F2, respectively), though 
they were higher than those in the batch culture (0.13 and 0.18 µmol.10-6cell.day-1 for 
asparagine and arginine specific consumption rates, respectively). This indicates that nutrient 
additions (glucose and glutamate) could enhance the consumption rates of limiting amino acids. 
There was a difference in the profile of alanine concentration among the cultures, as can be 
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seen in Figure 6.3.9-F. The F1 fed-batch culture demonstrated a continuous increase in alanine 
concentration until the end of the culture. The level of alanine in the F2 culture also 
continuously increased, though it stayed unchanged between 60 and 84 hours of the culture. 
The concentration profile of glutamine, however, did not vary among the cultures (Appendix 
B1).  
The concentration profiles of other amino acids, mostly essential ones, showed a similar 
pattern among the cultures. These amino acids include lysine, valine, isoleucine, tryptophan, 
leucine, cystine, phenylalanine, threonine, and methionine. Their profiles shared a common 
pattern as similar to the concentration profile of leucine shown in Figure 6.3.9-G. The fed-batch 
cultures showed steeper decreases in these amino acid levels than the batch, causing these 
amino acid levels becoming lower than those in the batch culture during final stages of the 
cultures. In addition, some of these amino acids, such as leucine and methionine, became 
exhausted especially in the F1 culture after 120 hours (Figure 6.3.9-G). The fed-batch cultures 
showed higher production of mAb, as compared to the batch culture (Figure 6.3.9-H). The F1 
and F2 cultures seemed to achieve the similar final mAb titre at 120 hour. However, given the 
viable cell concentration profiles, the specific productivity of the F2 culture (13.8 µg.10-
6cell.day-1) was higher than that of the F1 culture (11.6 µg.10-6cell.day-1), despite similar to that 
of the batch culture (13.7 µg.10-6cell.day-1). In addition, the mAb titre during the exponential 
and stationary phases in the F2 culture was the highest compared to the other cultures. 
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Figure 6.3.8 Cell growth and ESA cell profiles in the batch & fed-batch cultures: A) viable 
cell concentration; B) viability; and C) %ESA cells. F1 and F2 represent the feeding 
strategies as described in section 6.2.3. (n=3, error bar = SD). 
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cultures. F1 and F2 represent the feeding strategies as described in section 6.2.3. (n=3, 
error bar = SD). 
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As previously discussed in Chapter 5, the mTOR-associated pathway plays regulatory 
roles in cell growth, metabolism as well as protein synthesis and it is subject to nutrient levels, 
especially amino acids (i.e. leucine) (Dodd and Tee, 2012). The observed higher viable cell 
concentrations, enhanced amino acid metabolism as well as increased mAb production in the 
fed-batch cultures (compared to the batch culture) could be partly contributed by the activation 
of the mTOR pathway. This is in agreement with the previous report suggesting that the 
activation of mTORC1 due to feeding of nutrients (glucose and amino acids) to the culture of 
CHO cells might underlie the observed increased growth, metabolism and recombinant protein 
synthesis (Dadehbeigi and Dickson, 2015). 
The observed decreases in glucose concentration and the corresponding increases in 
lactate concentration suggests lactate production phase in the cultures (Zagari et al., 2013, 
Young, 2013). In addition, the observed decreases in lactate concentration in the fed-batch 
cultures support previous studies showing lactate consumption phase in the fed-batch cultures 
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(Zhou et al., 1997a, Ma et al., 2009). It was suggested that the metabolic shift to lactate 
consumption was triggered by nutrient depletion (Zhou et al., 1997a), cessation of exponential 
growth as well as conditions of low glycolysis flux (Zagari et al., 2013, Li et al., 2012). 
However, this does not always hold true, given that there was no evidence of lactate 
consumption in the batch culture which experienced nutrient deprivation and cessation of cell 
growth. The observed lactate consumption at a different time point between the F1 and F2 fed-
batch cultures suggests that lactate consumption might be subject to the level of metabolites as 
well as nutrients, which is in agreement with the previous report demonstrating that the 
metabolic shift to lactate consumption depends on medium composition (Zagari et al., 2013). 
This could provide the condition that favours lactate consumption, such as a low glycolysis flux 
as indicated by the observed lower specific glucose consumption in the fed-batch cultures. The 
observed similarity between the concentration profiles of consumed serine and lactate suggests 
the association of serine in lactate metabolism. Given that serine can be converted to pyruvate 
(Duarte et al., 2014), as well as intermediates in TCA cycle (Hoshino, 1987), it may play a 
critical role in supporting the metabolic shift to lactate consumption.  
 The observed higher specific glutamate utilisation rate, higher growth rate, higher ESA 
cell fraction as well as earlier drop in culture viability in the F2 culture follow the previous 
study suggesting that the higher substrate utilisation rate can cause the culture to earlier reach 
the point of commitment to apoptosis as a result of substrate exhaustion (Pavlostathis et al., 
2006). Given that the metabolic shift to alanine consumption is subject to glutamate exhaustion 
as discussed in Chapter 5, the difference in alanine concentration profile between the F1 and 
the F2 cultures confirms that the F2 culture experienced glutamate deprivation as a result of its 
fast growth rate nature, though glutamate was supplied during the culture. The similar final 
mAb titre between the fed-batch cultures could link to the limitation of amino acids required 
for the mAb synthesis, given a number of amino acids became exhausted at final stages of the 
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cultures (Carrillo-Cocom et al., 2014). However, the possibility that the increase in mAb titre 
from the lysed or broken cells due to cell death cannot be completely excluded. 
Cell cycle profile 
 The cell cycle profile varied among the cultures, as shown in Figure 6.3.10. There was 
a steeper increase in relative change in G1/G0 phase cell fraction in the F2 fed-batch culture 
during 36 to 48 hours as compared to the other cultures (Figure 6.3.10-A). The relative change 
in G1/G0 phase cell fraction in the F2 culture remained the highest one between 48 to 120 hours, 
while the F1 and batch cultures demonstrated a similar level of relative change in G1/G0 phase 
cell fraction until 96 hours. After 96 hours, there was an increase in cell fraction in G1/G0 phase 
in the F2 and batch cultures. In the meantime, the cell fraction in G1/G0 phase in the F1 culture 
did not significantly change. The relative change in S phase cell fraction in the F1 culture was 
significantly higher than the other cultures after 24 hours (Figure 6.3.10-B). Between 54 and 
108 hours, there were increases in relative change in G2/M phase cell fraction in all cultures 
(Figure 6.3.10-C). The steepest increase was in the batch culture, while the increase in the F1 
culture started after 72 hours and the F2 fed-batch culture showed a gradual one. 
Given the relation between cyclin D expression and substrate availability in the 
temperature shift study, the observed high relative change in G1/G0 phase cell fraction in the F2 
culture could be linked to the glutamate limitation. The observed highest level of relative 
change in G1/G0 phase cell fraction in the F2 culture also suggests that the F2 culture 
experienced stronger metabolic stresses related to nutrient availability than other cultures. The 
gene expression results (see later) support this suggestion. It appeared that the feeding scheme 
F1 enables more cells to stay in S phase of cell cycle. However, given the observed lowest mAb 
productivity in the F1 culture, it can be inferred that the mAb synthesis is not S phase dependent 
(Banik et al., 1996), which are not in agreement with previous reports (Chong et al., 2008, Al-
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Rubeai and Emery, 1990). On the other hand, the mAb synthesis might be dependent on other 
cell cycle phases (Robinson and Memmert, 1991, Kubbies and Stockinger, 1990, Turner et al., 
1985, Buell and Fahey, 1969), given the highest mAb titre along the culture progression and 
the highest mAb productivity in the F2 and batch cultures, respectively.   
Apoptosis-related gene expressions 
The F2 fed-batch culture showed the steepest increase in the expression of atf5 since 
the 24 hours of the culture (Figure 6.3.11-A). Unlike that of the F2 culture, the atf5 expression 
significantly dropped between 0 and 24 hours before starting to rise to its peak at 72 hours in 
the batch culture. The atf5 expression in the F1 culture, however, showed a significant change 
after 72 hours of the culture and reached its peak at 120 hours. The observed up-regulated level 
of atf5 expression indicates amino acid deprivation as well as ER associated metabolic stresses 
(Watatani et al., 2007, Izumi et al., 2012) as previously discussed. It can be inferred that the 
batch and F2 cultures experienced the metabolic stresses earlier than the other culture (F1) given 
the significant increase in atf5 expression from 24 hours. The F1 culture might suffer from the 
stresses from 72 hours as indicated by the increase in atf5 expression. All cultures demonstrated 
a similar trend of bcl-2 and p21 expression as can be seen in Figure 6.3.11-B&C. The bcl-2 
expression significantly decreased from the beginning of the fed-batch cultures, before rising 
after 72 hours and 96 hours of the F1 and the F2 cultures, respectively. The steepest one was 
observed in the F2 culture reaching the bcl-2 expression peak at 96 hours, while the F1 culture 
showed a gradual increase in bcl-2 expression until the final stages of the culture. The batch 
culture, however, showed a significant increase in bcl-2 expression after 72 hours without a 
significant decrease in bcl-2 expression during the first 72 hours of the culture. After 96 hours, 
there was a significant drop in bcl-2 expression in the F2 culture. The F2 and batch cultures 
showed a significant increase in the p21 expression after 72 hours of the cultures, while the 
increase in the p21 expression took place in the F1 culture after 96 hours (Figure 6.3.11-C). 
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Figure 6.3.11 The expression profiles of apoptosis-associated genes in the batch & fed-batch cultures: A) atf5; B) bcl-2; C) p21; D) bax; E) trp53bp2; 
F) casp8; and G) casp3. The gene expressions were normalised to time 0 hour and a housekeeping gene (gapdh). F1 and F2 represent the feeding 
strategies as described in section 6.2.3. “*” indicates p<0.05 and the corresponding p-values are showed in Appendix B.3, (n=3, error bar = SD). 
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Figure 6.3.11 (continued) The expression profiles of apoptosis-associated genes in the batch 
& fed-batch cultures: A) atf5; B) bcl-2; C) p21; D) bax; E) trp53bp2; F) casp8; and G) casp3. 
The gene expressions were normalised to time 0 hour and a housekeeping gene (gapdh). F1 
and F2 represent the feeding strategies as described in section 6.2.3. “*” indicates p<0.05 and 
the corresponding p-values are showed in Appendix B.3, (n=3, error bar = SD). 
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  The expression profiles of pro-apoptotic genes, including bax, trp53bp2, casp8 and 
casp3, in the F1 culture did vary from the other cultures (Figure 6.3.11-D, E, F&G). While the 
batch culture showed both increase and decrease in the expression of bax as discussed in 
Chapter 5, the fed-batch cultures showed no significant change in the bax expression during 
the first 72 hours (Figure 6.3.11-D). After 96 hours, there was a significant increase in the bax 
expression in the F2 culture. Contrary to the F2 and batch cultures, the F1 culture maintained 
insignificant change in bax expression until the end of the culture. Generally, the expression of 
trp53bp2, casp8 and casp3 did significantly decrease by the 48 hours of the batch and fed-
batch cultures, except that there was no significant change in the expression of casp3 between 
0 and 48 hours in the batch culture. The expression of trp53bp2 started to rise after 48 hours in 
the batch and F2 cultures (Figure 6.3.11-E). Like that of trp53bp2, the increase in casp8 (Figure 
6.3.11-F) and casp3 (Figure 6.3.11-G) expressions in the batch and F2 cultures also occurred 
after 48 hours of the cultures. The F2 culture showed a steeper increase in trp53bp2 and casp8 
expressions, while the batch culture showed a steeper increase in casp3 expression. Contrary 
to the F2 and batch cultures, a significant increase in trp53bp2 and casp8 expressions in the F1 
culture occurred after 96 hours of the culture (Figure 6.3.11-E&F). In addition, unlike that of 
the batch and F2 cultures, there was no significant change in caps3 expression after 24 hours 
of the F1 culture (Figure 6.3.11-G). 
 The observed expression profiles of bcl-2 and p21 during the exponential phase could 
indicate a proliferative state, as discussed in Chapter 5. The impact of metabolic stresses, as 
indicated by the increase in atf5 expression, became dominant after the proliferative state. As 
discussed in Chapter 5, the elevated levels of bcl-2 and p21 as well as the increase in relative 
change in G1/G0 phase cell fraction during the death phase suggest the occurrence of cell cycle 
arrest at G1/G0 phase as an anti-apoptotic mechanism in response to the metabolic stresses 
(Moore et al., 1997, Sanfeliu and Stephanopoulos, 1999). The ultimate cell fates, between 
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apoptosis and cell cycle arrest, are governed by the level of metabolic stresses (Mason and 
Rathmell, 2011, Kracikova et al., 2013). However, it can be inferred from the observed results 
of cell cycle analysis and gene expressions that cell cycle arrest at G1/G0 phase might not occur 
in the F1 culture.  
 Both batch and F2 cultures appeared to undergo apoptosis via both intrinsic and 
extrinsic pathways given the elevated expression of caps8, trp53bp2 and casp3 as well as the 
profiles of %ESA cells and culture viability (Stennicke et al., 1998, Kobayashi et al., 2005). 
Nevertheless, cell death in the F1 culture appeared to involve apoptosis in a different manner. 
The observed delay in the increase in %ESA, the drop in culture viability and the elevated pro-
apoptotic gene expressions levels in the F1 culture indicate that the F1 feeding strategy helps 
delay the onset of apoptosis, though the degree of ESA at the final stages of the F1 culture is 
comparable to that in the other cultures. Contrary to the high level of %ESA cells and the drop 
in viability, the casp3 expression, believed to be the final executor of apoptosis pathways 
(Hengartner, 2000, Majors et al., 2007), was down-regulated until the final stages of the F1 
culture. This suggests the possibility that, in addition to apoptosis, there was apoptosis-like cell 
death occurring in the culture. This type of apoptosis is independent of caspase-3 activation 
while it can induce morphological (especially, PS externalisation) as well as physiological 
(DNA fragmentation) apoptotic characteristic-like changes (Cummings et al., 2004, Meng et 
al., 2000). Therefore, it can be inferred that the F1 feeding scheme might enable the culture to 
experience other cellular stresses that favour caspase-3 independent apoptosis over the caspase-
mediated apoptosis (Carmody and Cotter, 2000).    
 It is worth mentioning that the effect of the feeding schemes (F1 and F2) on cell growth, 
metabolism and apoptosis cannot be directly compared, given that there was a difference in the 
profile of growth rates as well as glutamate consumption. The variation from a culture to 
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another culture can contribute to the nature of biological heterogeneity and errors. For example, 
serum, one of medium composition, has a number of known and unknown growth factors as 
well as proteins. Its content can be varied from batch to batch, and the slight variation in a 
growth factor level can result in a different profile of cell growth as well as metabolism (Vander 
Heiden et al., 2001). Further experimentation is required in order to confirm those hypotheses 
and to be able to make a fair comparison between the nutrient feeding strategies.  
6.4 Conclusions 
 
 This chapter aims to investigate the effect of culturing conditions, including 
temperature, medium composition and addition of nutrients including glucose and amino acids, 
on apoptosis in the culture of GS-NS0 cells. The novelty of this chapter is the systematic 
investigation of apoptosis in order to establish apoptosis-related responses to the variation in 
culturing conditions. The temperature shift experiment demonstrated that the shift to 
hypothermia caused a slower growth, a reduction in metabolic activities, a delay in the 
induction of apoptosis, as well as no significant change in mAb productivity as compared to 
the control culture. The opposite effect was observed in the culture with the shift to 
hyperthermia, except that there was no significant increase in cell growth.  
 The medium shift experiment revealed the effect of medium composition on the 
induction of apoptosis. The culture with 0% FM showed a decrease in cell growth as well as 
viability in a period of 24 hours. A higher degree of apoptosis was also seen at the 
transcriptional level as well as morphological changes (% ESA). In addition, the metabolic 
shift to lactate consumption was observed, which could be attributed by glutamate deprivation 
as well as the elevated initial lactate concentration. The cultures with medium containing 
fractions of FM showed a similar cell growth, viability as well as apoptosis-related gene 
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expression. The expression of apoptosis-related genes was correlated with the cyclin 
expressions, supporting the previous established link between apoptosis and cell cycle arrest.  
         The fed-batch experiment suggests the effect of nutrient addition on apoptosis. Compared 
to the batch culture, the fed-batch cultures achieved a higher cell density as well as final mAb 
titre. However, there was no significant improvement in mAb productivity. The metabolic shift 
to lactate consumption was observed in the fed-batch cultures, though glutamate was 
sufficiently available, suggesting that there might be other causes of the metabolic shift than 
what was hypothesised based on the medium shift experiment. Given the observed %ESA cells 
as well as pro-apoptotic gene expressions, the F1 feeding scheme appeared to delay apoptosis 
while the F2 culture showed no delay in the apoptosis onset. The apparent apoptosis in the F1 
culture might be associated with the apoptosis pathway dependently from the activation of 
caspase-3. The observed high cell growth as well as fast glutamate consumption could be the 
reason why apoptosis in the F2 culture was not delayed.    
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7.1 Background 
 
 Chapter 7 presents an experimentally-validated mathematical model capturing the 
induction of apoptosis in the culture of GS-NS0 cells. This includes mathematical expressions 
of cell growth and metabolism with their links to the transcriptional regulation of apoptosis. 
GSA was applied to the constructed mathematical model to reveal relationships between model 
output and parameters, and evaluate the significance of model parameters. Based on the 
mathematical model, an optimal culture condition where higher final titre mAb is achieved can 
be computationally simulated, and thus trial-and-error experiments can be avoided.  
7.1.1 Introduction 
 Given that cellular processes are essentially interlinked, it is not trivial to construct 
understanding of their dynamic behaviour in response to environmental changes. Mathematical 
modelling has been utilised to cope with such the complexity in biological systems. This 
approach involves formulating a system of mathematical equations that relates culture 
conditions, such as temperature and nutrient levels, with cellular responses, including cell 
growth, nutrient utilisation, protein synthesis and cell death. Thus, dynamic behaviour of 
cellular systems as respect to culture conditions can be quantitatively predicted, providing 
valuable information for process control, development and optimisation. Furthermore, the 
number of possible trial and error experiments can be reduced.  
 Mathematical models can be classified according to biological information included 
into the mathematical models. Segregated models take into account heterogeneity occurring in 
the cell cultures while unsegregated ones assume properties in the cultures to be homogenous. 
In addition, mathematical models can be structured or unstructured depending on how much 
mechanistic understanding, both extracellularly and intracellularly, is included into the 
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constructed models. Given that cellular activities are highly non-linear, segregated and 
structured models tend to be mathematically complicated. Thus, it might not be possible to 
experimentally validate these models, and to achieve an insight into the model dynamic 
behaviour. Unsegregated and unstructured models are mathematically friendly and can be 
experimentally validated, however they lack mechanistic representation of cellular activities, 
making it difficult to gain detailed insight into cellular responses. Hybrid models are ones that 
combine detailed models (such as structured models) with simple models (such as unstructured 
models) so that a good balance between the mathematical complexity of resulting model and 
mechanistic biological information included into the model can be achieved. The hybrid 
approach, therefore, enables to mathematically model complex systems, like cellular ones, 
while the resulting models remain computationally inexpensive. 
 A large number of mathematical models has been proposed with an attempt to capture 
dynamic behaviour of the mammalian cell cultures for production of bio-pharmaceuticals. 
Monod kinetics and its variants, which are classified as unstructured models, are widely used 
to describe cell growth (Eq. 2.8.1). These equations link cell growth (viable cell concentrations) 
with nutrient availability (extracellular nutrient levels), including glucose and amino acids 
(Pörtner and Schäfer, 1996). Cell metabolism; including nutrient utilisation, metabolite 
production and desired protein synthesis, is usually mathematically described using a linear 
equation, such as the constant maintenance energy model (Eq. 2.8.2), which assumes that the 
metabolic activities depends on both growth and non-growth associated activities. In addition, 
there are structured models for cell growth and metabolism, where mechanistic understating of 
cell growth and metabolism is incorporated into the models. Population balance models, for 
example, were constructed to describe cell growth in association with cell cycle progression 
(Liu et al., 2007, Fadda et al., 2012). In addition, the mechanistic assembly of mAbs was 
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mathematically modelled to capture kinetics of synthesis of mAbs (Bibila and Flickinger, 
1991).          
 Although there are a large number of mathematical models constructed for mammalian 
cell cultures; cell death, which is also one of the most important cellular events in the cultures, 
has been superficially described in these proposed models (Pörtner and Schäfer, 1996). The 
mathematical equations describing cell death were based on empirical correlations which lack 
mechanistic representation as well as links between cell death and other cellular processes. 
Given that production and quality of bio-therapeutic proteins depend greatly on the occurrence 
of cell death (Yoon et al., 2003b, Majid et al., 2007, Tey et al., 2000a) representing the 
significance of it in the cultures, it is necessary to include detailed mechanism of cell death into 
mathematical models. 
 Over the last two decades, apoptosis has emerged as the major cause of viability loss in 
the mammalian cell cultures for production of bio-pharmaceuticals (Goswami et al., 1999, 
DiStefano et al., 1996, Browne and Al-Rubeai, 2011a, Singh et al., 1994). Given that apoptosis 
is an orderly physiological process (Hengartner, 2000), its established mechanistic 
understanding can be expressed as mathematical equations and can be linked to other relevant 
cellular processes including cell growth and metabolism. There are a couple of existing 
mathematical models for the cultures of mammalian cells that capture apoptosis. However, 
these models did not fully take into account dynamic behaviour in response to changes in 
culture conditions, links to other cellular activities as well as mechanistic regulation of 
apoptosis (Naderi et al., 2014, Meshram et al., 2012). In addition, mathematical models for 
apoptosis should incorporate the transcriptional regulation of apoptosis, which is a crucial part 
in apoptosis pathways and provides links to other cellular processes (Dudgeon et al., 2009, Yu 
and Zhang, 2005).  
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 As the discussion above attests, mathematical description of apoptosis in the 
mammalian cell culture models needs to be further improved. Apoptosis has to be 
mathematically expressed in a way that represents its kinetics, relevant mechanisms as well as 
dynamic behaviour as respect to apoptotic stimuli. However, the increased degree of model 
complexity as a result of detailed mechanisms of apoptosis being extensively included has to 
be taken into consideration. Model analysis is therefore required for the mathematical model 
development framework to assure model identifiability as well as avoid unnecessary model 
complexity (Kent et al., 2013, Kiparissides et al., 2009, Ho et al., 2006, Saltelli et al., 2000). 
7.1.2 Objectives 
 The aim of this chapter is to develop a first-principles mathematical model for the GS-
NS0 cell culture that captures apoptosis as well as its links to metabolic stresses as suggested 
in Chapter 5 and Chapter 6. The following are herein scientific objectives:  
o Propose a framework that would allow formulating mathematical model description 
and evaluating the resultant model structure. 
o Construct mathematical expressions that would allow capturing kinetics of cellular 
activities, including cell growth, metabolism as well as apoptosis, and their 
interrelationships with each other, based on the previously observed experimental data. 
o Perform model analysis that would allow evaluating the validation of the constructed 
mathematical model, and identifying any further model modifications. 
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7.2 Methodology 
 
7.2.1 The proposed model development framework 
 
 
Figure 7.2.1 The proposed framework for the development of a mathematical model for 
the culture of GS-NS0 cells in this study. 
 A framework for the mathematical model development in this study was proposed as 
shown in Figure 7.2.1. The framework aims to integrate the observed phenomena in the GS-
NS0 cell cultures, as previously discussed in Chapter 5 and Chapter 6, as well as the 
computational tool for model analysis into the process of mathematical model development. 
The model was initially constructed based on the observed results from the batch culture. In 
the meantime, the validation of the constructed model was evaluated using the experimental 
data from batch and fed-batch cultures. This step involved modifying and refining the model 
structure, as well as fitting parameter values so that the model could reproduce the experimental 
data. The constructed model with a set of preliminary parameter values (not optimised), that 
showed a reasonable fit for the experimental data, was analysed using global sensitivity 
analysis (GSA). The result from GSA determined whether the constructed model was required 
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to be further refined in order to remove unnecessary model complexity as well as to improve 
model identifiability. The refined model can be further validated with independent sets of 
experimental data to increase model predictability. The ultimate goal of the constructed model 
is to be applied with a model-based optimisation algorithm which can generate optimal 
culturing conditions where mAb titre can be maximised.           
 Previous mathematical models for the mammalian cell cultures were adopted as a basis 
for developing mathematical description in this study. However, given the observed 
phenomena which are specific to the cultures of GS-NS0 cells, they need to be improved, 
refined, and modified in order to be able to capture the observed experimental data. Parameter 
values in the constructed model were initially set as given from literature and then manually 
changed if needed. For example, literature parameters might be adjusted in case the structure 
of mathematical expressions was changed or modified. If there is no published parameter value; 
especially in mathematical expressions that has not been introduced before, these parameter 
values were preliminarily assigned based on the values of other parameters that are biologically 
relevant and their estimates can be assigned from literature. 
7.2.2 Model construction 
 The mathematical model was herein formulated along the line of the hybrid approach 
(Ho et al., 2006, Kontoravdi et al., 2010) in order to be able to incorporate the observed 
phenomena in the GS-NS0 cultures (batch and fed-batch) while keeping the resulting model 
computationally traceable. The constructed model was the combination of three sub-models 
with different model types. The first sub-model was an unstructured model capturing cell 
proliferation with links to cell death and metabolism. The second one was also an unstructured 
model capturing cellular metabolism, including glucose and amino acid utilisation, metabolite 
production and mAb synthesis. The final one is a structured model represents transcriptional 
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and translational regulation of apoptosis with its links to growth and death kinetics as well as 
metabolic activities. All sub-models were constructed based on the general assumption that the 
cultures are homogenous, and thus there is no temporal and spatial variation in, for example, 
metabolite concentration and temperature throughout the culture systems. 
Cell growth sub-model 
 The overall material balance over the cultures (both batch and fed-batch) provides a 
simple correlation among the volume of the culture, inlet and outlet streams shown as follows: 
Eq. 7.2.1 Overall mass balance 
dV
dt
 =  Fin-  Fout 
Where, V is the total volume of the system (Litre, L), Fin is the total flowrate of feeding streams 
(L/hr) and Fout is the total flowrate of outlet streams (L/hr). 
 Given that there were up to 5 substrates added into the cultures (the fed-batch cultures), 
the following equation describes the summation of all feeding streams.  
 Eq. 7.2.2 The total flowrate of feeding streams 
 Fin  =  Fin, glc +  Fin, glu +   Fin, asp +   Fin, asn +   Fin, arg 
Where, Fin, glc, Fin, glu, Fin, asp, Fin, asn and Fin, arg are the flowrates of fed glucose, glutamate, 
aspartate, asparagine and arginine, respectively (L/hr).   
The following equations involve mass balances on cell populations. As can be seen in 
Figure 7.2.2, the flow of cell population started at the viable cell population where they were 
either proliferating, or dying via two major routes: apoptosis (Hengartner, 2000, Browne and 
Al-Rubeai, 2011a), and other cell death pathways such as necrosis and autophagy (Hwang and 
Lee, 2008, Singh et al., 1994). Apoptotic cells entered early stage apoptosis (ESA) before 
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eventually becoming late stage apoptotic (LSA) cells or dead cells. Cell death via other 
pathways than apoptosis, however, are characterised as a sub-set of the dead cells, given that 
they shared the same morphological markers, such as loss of plasma membrane integrity 
(Ormerod, 2000). Therefore, there is no net outflow or inflow between them (Figure 7.2.2).  
 
Eq. 7.2.3 Viable cell balance 
d(VXv)
dt
 = μVXv - μadVX v- μndVX v 
Eq. 7.2.4 Early stage apoptotic cell balance 
d(VXad)
dt
 =  μ
ad
VX v - μdVX ad 
Eq. 7.2.5 Cell death via other pathways than apoptosis 
d(VXnd)
dt
 =  μ
nd
VX v 
Eq. 7.2.6 Dead cell balance 
d(VXd)
dt
 =  μ
nd
VX v +  μdVX ad - kdVX d 
Figure 7.2.2 The flowchart of cell 
population kinetics in the culture 
of GS-NS0 cells. It was herein 
postulated based on the 
experimental observation and 
used as a basis for the 
construction of cell growth 
mathematical sub-model. 
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Where, Xv is the viable cell concentration (cells/mL), Xad is the ESA cell concentration 
(cells/mL), Xnd is the concentration of dead cells from other pathways than apoptosis 
(cells/mL), Xd represents dead cell concentration (cells/mL), μad is the specific rate of early 
stage apoptotic death (hr-1) and μnd is the specific rate of cell death via other pathways than 
apoptosis (hr-1), and kd is the degradation rate (hr
-1). 
 The total number of cells can be formulated as follows. 
Eq. 7.2.7 The total number of cells 
X t  =  X v +  X ad +  X d 
Where, Xt is the total cell concentration (cells/mL). 
 Herein, based on the experimental data in Chapter 5&6, the specific growth rate was 
assumed to be dependent on the extracellular levels of limiting nutrients: glucose and 
glutamate. Given the observed viable cell concentration with respect to glutamate deprivation 
as well as the glucose uptake rate (Chapter 5), the specific growth rate was formulated to be 
the summation of the glucose-associated and the glutamate-associated cell growth rates. The 
mathematical expression for the glucose-associated specific growth rate was constructed based 
on the adapted version of Monod kinetics, which took into account the limiting effect of viable 
cell concentration (Contois, 1959). Hill equation was adopted for the glutamate-associated 
specific growth rate (Moser, 1958, Hill, 1913).  
Eq. 7.2.8 The specific growth rate 
μ  =  μ
 max, glc
Glc
Glc + Kglc∙10
-6∙XV
 + μ
 max, glu
Glu
2
Glu
2
 + Kglu
2
 
Where, Glc and Glu are the extracellular concentration of glucose and glutamate, respectively 
(mM); μmax, glc and μmax, glu are the glucose and glutamate-associated maximum specific growth 
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rates, respectively (hr-1); Kglc and Kglu are glucose and glutamate limiting constants for the cell 
growth, respectively (mM).  
 As described in Chapter 4, phosphatidyl serine (PS) externalisation, one of 
morphological changes during apoptosis, was used to determine ESA cell fractions. This ESA 
marker was found to be one of the downstream targets of caspase activation and occurs as early 
as the caspase activation (van Engeland et al., 1998, Riccardi and Nicoletti, 2006). Given that 
caspase-3 is the final executor of the apoptotic pathways (Hengartner, 2000, Majors et al., 
2007) and the onset of apoptosis is subject to its activation, the death rate of ESA was assumed 
to be dependent on the concentration of caspase-3 molecule. The following equation describes 
the ESA death rate using Monod-like kinetics, which is herein developed along the line of 
Monod-like kinetics. 
Eq. 7.2.9 The specific death rate of ESA 
μ
 ad
 =  μ
 max, ad
Casp3
Casp3 + Kcasp3
 
Where, μmax, ad is the maximum specific rate of early stage apoptotic death rate (hr-1), Casp3 
stands for the concentration of active caspase-3 molecule (mM), and Kcasp3 is the Monod 
constant for ESA (mM). 
It was previously reported that the activation of caspases triggered both apoptotic 
physiological as well as morphological events, such as the lysis of plasma membrane and DNA 
degradation, during LSA (Widlak, 2000, Collins et al., 1997). The specific rate of LSA was, 
therefore, assumed to be proportional to that of ESA. It was also assumed to be dependent on 
ESA and LSA cell fractions given that apoptotic signals could be transmitted from apoptotic 
cells to surrounding cells (Jäger and Fearnhead, 2012, Pérez-Garijo et al., 2013). The 
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mathematical expression for the LSA specific death rate was herein constructed based on 
Monod-type expression.   
Eq. 7.2.10 The specific death rate of LSA 
μ
 d
 =  μ
 max, d
μ
 ad
Xad
Xad + Xd
 
Where, μmax, d is the maximum specific rate of LSA or dead cells (hr-1). 
Cell death via other pathways than apoptosis was not well investigated in this study. It 
can potentially be necrosis (Singh et al., 1994, Mercille and Massie, 1994a) or autophagy 
(Hwang and Lee, 2008, Glick et al., 2010, Jardon et al., 2012) as previously reported. Herein, 
the specific rate of cell death via other pathways than apoptosis was therefore assumed to be 
dependent on the concentration of lactate since it is only a factor that can be linked to the cause 
of cell death via other pathways than apoptosis (Mercille and Massie, 1994a). This rate was 
herein constructed based on Monod-like kinetics as described in the following equation.  
Eq. 7.2.11 The specific death rate for cell death via other pathways than apoptosis 
μ
 nd
 =  μ
 max, nd
Lac
Lac + KLac
 
Where, μmax, nd is the maximum specific rate of cell death via other pathways than apoptosis 
(hr-1), Lac is the extracellular lactate concentration (mM), and Klac is the Monod constant for 
lactate limitation effect (mM). 
 The cell growth sub-model consists of 14 variables in total (7 of which are differential 
variables) and 10 parameters.  
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The cell metabolism sub-model 
 Dynamic changes in extracellular concentrations of nutrients (glucose and amino acids) 
as well as metabolites (lactate) were mathematically expressed based on mass balances as well 
as metabolic reactions among these molecules. The consumption/production rates were 
represented using the constant maintenance energy equation (Eq. 2.8.2), despite being modified 
to take into account the proposed interrelationships among substrates and metabolites, as shown 
in Figure 7.2.3. The interrelationships were described using Monod-like terms (limiting and 
inhibiting as shown in Eq. 2.8.1) which were adapted along the lines of models that were 
demonstrated in previous studies (Jang and Barford, 2000, Ho et al., 2006, Kontoravdi et al., 
2007, Kiparissides et al., 2010).  
 
Figure 7.2.3 The network of enzymatic reactions among nutrients, metabolites and amino 
acids. This network was herein postulated based on the experimental observation and used as 
a basis for the construction of the unstructured sub-model for glucose and amino acid 
metabolism in the GS-NS0 cultures. 
 The following equations describe dynamic changes in extracellular glucose and lactate 
concentrations. The equations were constructed based on the proposed network of glucose and 
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lactate metabolism (Figure 7.2.3), where the production of lactate was assumed to be dependent 
of the flux of glucose utilisation, and to simultaneously coincide with lactate consumption. The 
lactate metabolism was also assumed to be governed by the aspartate concentration given the 
observed phenomena as shown in Chapter 5&6 (a rapid increase in glucose consumption in the 
batch culture and the lactate consumption in the fed-batch cultures). The highlighted 
term/equation is the modification herein developed using Monod-type expression in order to 
take into account the effect of the concentration of a substrate on another substrate 
utilisation/production rate(s) as well as reaction(s) as proposed in Figure 7.2.3 where the model 
was constructed based on. 
Eq. 7.2.11 Glucose balance 
d(VGlc)
dt
 = Fin, glcGlcin - FoutGlc - QglcVXv 
Eq. 7.2.12 Glucose kinetics 
Q
glc
= 
μ
Yx, glc
 +  mglc
Kmglc, asp
2
 Asp2 + Kmglc, asp
2
 
Eq. 7.2.13 Lactate balance 
d(VLac)
dt
 = (Q
lac, pro
- Q
lac, con
)VXv - FoutLac 
Eq. 7.2.14 Lactate kinetics  
Q
lac, pro
 = Q
glc
Ylac, glc 
 Q
lac, con
 = klac, con
Asp
Asp + Kmlac, asp
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Where, Glcin is the concentration of fed glucose (mM); Qglc is the specific glucose utilisation 
rate (mmol cells-1 hr-1); Yx, glc is the yield of cells over glucose (cells/mmol); mglc is the glucose 
associated maintenance energy constant (mmol.cells-1.hr-1); Kmglc, asp and Kmlac, asp are the 
Monod constants for aspartate-associated glucose and lactate limiting effects, respectively 
(mM); Qlac, pro and Qlac, con are the specific lactate production and consumption rates, 
respectively (mmol cells-1 hr-1); Ylac, glc  is the yield of lactate over glucose (mmol/mmol); and 
klac, con is the specific lactate consumption constant (mmol.cells
-1.hr-1). 
 The mass balance of glutamate involves enzymatic reactions that produce glutamate 
from the conversion of other amino acids, and that convert glutamate into other amino acids, 
as proposed in Figure 7.2.3. The consumption rate of amino acids was mathematically 
expressed using the constant maintenance energy equation with similar modifications to that 
for glucose metabolism. The production rates of alanine as well as glutamine, and the 
consumption rate of alanine were assumed to be governed by the availability of glutamate, as 
suggested in Chapter 5. The consumption rate of asparagine was assumed to be dependent on 
aspartate concentration, given the enzymatic relation between them. In addition, the availability 
of glutamate was assumed to positively affect its consumption rate, given previous reports 
(Takagi et al., 2001). This was also applied to aspartate, arginine and glutamine consumption 
rates (Figure 7.2.3).  
Eq. 7.2.15 Glutamate balance 
d(VGlu)
dt
 = Fin, gluGluin - FoutGlu - QgluVXv + (fglu, alaQala, con - Qala, pro +  fglu, glnQgln, con - Qgln, pro +  
fglu, aspQasp +  fglu, argQarg)VXv  
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Eq. 7.2.16 Glutamate kinetics 
Q
glu
= (
μ
Yx, glu
 +  mglu)
Glu
0.5
 Glu
0.5
 + Kmglu, glu
0.5
 
Where, Gluin is the concentration of fed glutamate (mM); Qglu, Qasp, Qarg, Qala, con, and Qgln, con 
are the specific glutamate, aspartate, arginine, alanine and glutamine utilisation rates, 
respectively (mmol cells-1 hr-1); Qala, pro and Qgln, pro are the specific alanine and glutamine 
production rates, respectively (mmol cells-1 hr-1); fglu, asp, fglu, arg, fglu, ala, and fglu, gln are the yield 
of glutamate over aspartate, arginine, alanine and glutamine, respectively (mmol/mmol); Yx, glu 
is the yield of cells over glutamate (cells/mmol); mglu is the glutamate-associated maintenance 
energy constant (mmol.cells-1.hr-1); Kmglu, glu is the Monod constant for glutamate-associated 
glutamate limiting effect (mM). 
Eq. 7.2.17 Aspartate balance 
d(VAsp)
dt
 = Fin, aspAspin - FoutAsp + (fasp, asnQasn- Qasp)VXv 
 Eq. 7.2.18 Aspartate kinetics 
Q
asp
= (
μ
Yx, asp
 +  masp)
Asp
 Asp  + Kmasp, asp
 
Where, Asp is the extracellular concentration of aspartate (mM); Aspin is the concentration of 
fed aspartate (mM); Qasn is the specific asparagine utilisation rates (mmol cells
-1 hr-1); fasp, asn 
are the yield of aspartate over asparagine (mmol/mmol); Yx, asp is the yield of cells over 
aspartate (cells/mmol); masp is the aspartate-associated maintenance energy constant 
(mmol.cells-1.hr-1); Kmasp, asp is the Monod constant for aspartate-associated aspartate limiting 
effect (mM). 
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Eq. 7.2.19 Asparagine balance 
d(VAsn)
dt
 = Fin, asnAsnin - FoutAsn - QasnVXv 
 Eq. 7.2.20 Asparagine kinetics 
Q
asn
= (
μ
Yx, asn
 +  masn)
 Kmasn, asp
 Asp  + Kmasn, asp
 
Where, Asn is the extracellular concentration of asparagine (mM); Asnin is the concentration 
of fed asparagine (mM); Yx, asn is the yield of cells over asparagine (cells/mmol); masn is the 
asparagine-associated maintenance energy constant (mmol.cells-1.hr-1); Kmasn, asp is the Monod 
constant for asparagine-associated aspartate limiting effect (mM). 
Eq. 7.2.21 Arginine balance 
d(VArg)
dt
 = Fin, argArgin - FoutArg - QargVXv 
 Eq. 7.2.22 Arginine kinetics 
 Q
arg
 = 
μ
Yx, arg
∙
Arg
Arg + Kmarg, arg
 +  marg 
Where, Arg is the extracellular concentration of arginine (mM); Argin is the concentration of 
fed arginine (mM); Qarg is the specific arginine utilisation rates (mmol cells
-1 hr-1); Yx, arg is the 
yield of cells over arginine (cells/mmol); marg is the arginine-associated maintenance energy 
constant (mmol.cells-1.hr-1); Kmarg, arg is the Monod constant for arginine-associated arginine 
limiting effect (mM). 
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Eq. 7.2.23 Alanine balance 
d(VAla)
dt
 = (Q
ala, pro
 - Q
ala, con
)VXv - FoutAla  
Eq. 7.2.24 Alanine kinetics 
Q
ala, pro
 =  Q
gluYala, glu 
 Q
ala, con
 = 
μ
Yx, ala
∙
Kmala, glu
Glu + Kmala, glu
 +  mala 
Where, Ala is the extracellular concentration of alanine (mM); Yala, glu is the yield of alanine 
over glutamate (mmol/mmol); Yx, ala is the yield of cells over alanine (cells/mmol); mala is the 
alanine-associated maintenance energy constant (mmol.cells-1.hr-1); Kmala, glu is the Monod 
constant for alanine-associated glutamate limiting effect (mM). 
Eq. 7.2.25 Glutamine balance 
d(VGln)
dt
 = (Q
gln, pro
 - Q
gln, con
)VXv - FoutGln 
Eq. 7.2.26 Glutamine kinetics 
Q
gln, pro
 =  Q
glu
Ygln, glu 
 Q
gln, con
 = 
μ
Yx, gln
∙
Gln
2
Gln
2
 + Kmgln, glu
 +  mgln 
Where, Gln is the extracellular concentration of glutamine (mM); Ygln, glu is the yield of 
glutamine over glutamate (mmol/mmol); Yx, gln is the yield of cells over alanine (cells/mmol); 
mala is the alanine associated maintenance energy constant (mmol.cells
-1.hr-1); Kmala, glu is the 
Monod constant for alanine-associated glutamate limiting effect (mM). 
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Leucine plays an important role in the translation initiation of protein synthesis (Norton 
and Layman, 2006) through the mTOR signalling pathway (as previously discussed in Chapter 
5). The activation of this pathway due to nutrient addition was suggested to underlie the 
observed increased productivity in a fed-batch culture of CHO cells (Dadehbeigi and Dickson, 
2015). In addition, it was reported that the produced mAb contained a high content of leucine 
(González-Leal et al., 2011). Therefore, leucine must be included in the mAb synthesis kinetics 
in order to represent its effect on mAb production. However, our results showed that the 
production of mAb continued though leucine became exhausted in the fed-batch cultures, 
suggesting the mAb synthesis could be subject to other amino acids in addition to leucine. 
Asparagine was found to have a positive effect on the production of mAb in the GS-CHO cell 
culture (Xu et al., 2014). In addition, our data showed that there was a linear correlation 
between asparagine level and mAb produced in the batch culture. The following equations 
describe leucine utilisation and the synthesis of mAb which was assumed to be dependent on 
leucine and asparagine concentrations. 
Eq. 7.2.26 Leucine balance 
d(VLeu)
dt
 =  - FoutLeu - QleuVXv 
Eq. 7.2.27 Leucine kinetics 
 Q
leu
 = 
μ
Yx, leu
∙
Leu
Leu + Kmleu, leu
 +  mleu 
Where, Leu is the extracellular concentration of leucine (mM); Qleu is the specific leucine 
utilisation rates (mmol cells-1 hr-1); Yx, leu is the yield of cells over leucine (cells/mmol); mleu is 
the leucine associated maintenance energy constant (mmol.cells-1.hr-1); Kmarg, arg is the Monod 
constant for leucine -associated leucine limiting effect (mM). 
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Eq. 7.2.28 mAb balance 
d(VAb)
dt
 =  - FoutAb + QabVXv 
Eq. 7.2.29 mAb kinetics 
 Q
ab
 = αab (
Leu
Leu + Kmab, aa
+
Asn
Asn + Kmab, aa
) 
Where, Ab is the extracellular concentration of mAb (mg/L); Qab is the specific mAb prediction 
rate (mg.cells-1.hr-1); αab is the constant for the mAb synthesis rate (mg cells-1 hr-1); Kmab, aa is 
the Monod constant for amino acid limiting effect on mAb synthesis (mM). 
 The cell metabolism sub-model consists of 19 variables in total (10 of which are 
differential variables) and 36 parameters (not including parameters for fed nutrient 
concentrations, i.e Gluin, Glcin, etc.). 
The apoptosis sub-model 
 The apoptosis sub-model was aimed to describe dynamics of apoptotic events at the 
transcriptional level, with their links to metabolic stresses. The model also included the 
apoptosis regulatory network of protein-protein interactions given the relation between 
transcription and translation processes. These events were mathematically expressed using the 
combination of mass action kinetics, Monod-type as well as Hill equations, along the line of 
the previous mathematical models describing the genetic control of biodegradation with the 
links to kinetics of growth and metabolism in a microbial system (Koutinas et al., 2010, 
Koutinas et al., 2011). The highlighted term is the modification herein developed using Monod-
type expression in order to take into account the effect of the mRNA level of an apoptotic 
species on the transcription rate of relevant apoptotic species as the proposed interactions 
among them (Figure 7.2.4) where this sub-model was constructed based on. 
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Figure 7.2.4 The transcriptional and translational regulatory network of apoptosis with links 
to metabolic stresses in the cultures of GS-NS0. This was herein proposed in accordance with 
previous reports as well as the herein experimental observation. This was used as a basis for 
the construction of the apoptosis structured sub-model. 
 The regulatory network of apoptosis as well as links to metabolic stresses were 
proposed based on previous studies and our experimental results, as can be seen in Figure 7.2.4. 
The expression of atf5 was assumed to be dependent on the aspartate deprivation as well as the 
ER stress as a result of the synthesis of mAb, given its reported role in the survival mechanism 
in response to these metabolic stresses (Watatani et al., 2007, Zhou et al., 2008, Browne and 
Al-Rubeai, 2011b). The expression of trp53bp2 and casp8 was assumed to be subject to 
glutamate deprivation as well as lactate accumulation given the observed data in Chapter 5&6 
and the previous study (Browne and Al-Rubeai, 2011b). The following equations represent the 
expression of atf5, trp53bp2 and casp8, which was correlated with the concentrations of 
aspartate, glutamate and mAb. 
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Eq. 7.2.30 The transcription of atf5  
d(mRNAatf5)
dt
 = β
mRNAatf5
(
Kmasp, atf5
Asp + Kmasp, atf5
) (
Kmab, atf5
2
Ab2 + Kmab, atf5
2
) - αmRNAatf5mRNAatf5
0.5 
Where, mRNAatf5 is the relative fold change of atf5 expression (-); βmRNAatf5 is the maximal fold 
change of atf5 expression (hr-1); Kmasp, atf5 and Kmab, atf5 are the Monod constants for atf5 
associated aspartate (mM) and mAb (mg/L) limiting effect, respectively; αmRNAatf5 is the mRNA 
degradation rate of atf5 (hr-1).   
Eq. 7.2.31 The transcription of trp53bp2  
d(mRNAtrp53bp2)
dt
 = β
mRNAtrp53bp2
(
Kmglu, trp53bp2
Glu + Kmglu, trp53bp2
) (
Lac2
Lac2 + Kmlac, trp53bp2
2
) - αmRNAtrp53bp2mRNAtrp53bp2 
Where, mRNA trp53bp2 is the relative fold change of trp53bp2 expression (-); βmRNAtrp53bp2 is the 
maximal fold change of trp53bp2 expression (hr-1); Kmglu, trp53bp2 and Kmlac, trp53bp2 are the 
Monod constants for trp53bp2 associated glutamate and lactate limiting effect, respectively 
(mM); αmRNAtrp53bp2 is the mRNA degradation rate of trp53bp2 (hr
-1). 
Eq. 7.2.32 The transcription of casp8 
d(mRNAcasp8)
dt
 = β
mRNAcasp8
(
Kmglu, casp8
0.5
Glu0.5 + Kmglu, casp8
0.5
) - αmRNAcasp8mRNAcasp8 
Where, mRNAcasp8 is the relative fold change of casp8 expression (-); βmRNAcasp8 is the maximal 
fold change of casp8 expression (hr-1); Kmglu, casp8 is the Monod constants for casp8 associated 
glutamate limiting effect, respectively; αmRNAcasp8 is the mRNA degradation rate of casp8 (hr
-1). 
 The transcription of bcl-2 was assumed to be dependent on the expression of atf5 as 
well as trp53bp2 since it was previously demonstrated that the expression of bcl-2 was linked 
to the expression level of atf5 (Dluzen et al., 2011), and p53 (Haldar et al., 1994, Miyashita et 
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al., 1994) that was associated with the expression of trp53bp2 (Naumovski and Cleary, 1996, 
Samuels-Lev et al., 2001, Kobayashi et al., 2005), respectively. The mathematical equation for 
the expression of bax was constructed based on previous studies showed that there was an 
inversely proportional correlation between bax and bcl-2 (Paul-Samojedny et al., 2005). In 
addition, the equation includes the effect of trp53bp2 expression on the bax expression given 
that bax is one of transcriptional targets of p53 (Toshiyuki and Reed, 1995).   
Eq. 7.2.33 The transcription of bcl-2 
d(mRNAbcl2)
dt
 = β
mRNAbcl2
(
mRNAtrp53bp2
2
mRNAtrp53bp2
2 + Kmtrp53bp2, bcl2 + 
mRNAatf5
Kmatf5, bcl2
⁄
) - αmRNAbcl2mRNAbcl2 
Where, mRNAbcl2 is the relative fold change of bcl-2 expression (-); βmRNAbcl2 is the maximal 
fold change of bcl-2 expression (hr-1); Kmtrp53bp2, bcl-2 and Kmatf5, bcl-2 are the Monod constants 
for trp53bp2 and atf5 limiting effects, respectively, on bcl-2 expression (-); αmRNAbcl2 is the 
mRNA degradation rate of bcl-2 (hr-1). 
Eq. 7.2.34 The transcription of bax 
d(mRNAbax)
dt
 = β
mRNAbax
(
Kmbcl2, bax
mRNAbcl2 + Kmbcl2, bax
) (
mRNAtrp53bp2
2
mRNAtrp53bp2
2 + Kmtrp53bp2, bax
2
) - αmRNAbaxmRNAbax 
Where, mRNAbax is the relative fold change of bax expression (-); βmRNAbax is the maximal fold 
change of bax expression (hr-1); Kmbcl-2, bax and Kmtrp53bp2, bax are the Monod constants for bcl-
2 and trp53bp2 limiting effects, respectively, on bax expression (-); αmRNAbax is the mRNA 
degradation rate of bax (hr-1). 
 Procaspase-3 is the catalytically inactive form of caspase-3 (Duan et al., 1996). 
However, once activated, the activation of caspase 3 was found to be auto-processing (Colussi 
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et al., 1998). Therefore, the expression of casp3 was assumed to be proportional to the 
concentration of caspase 3 as shown in the following equation.  
Eq. 7.2.35 The transcription of casp3 
d(mRNAcasp3)
dt
 = β
mRNAcasp3
(
Casp32
Casp32 + Kmcasp3, iC3
2
) - αmRNAcasp3mRNAcasp3
2 
Where, mRNAcasp3 is the relative fold change of casp3 expression (-); βmRNAcasp3 is the maximal 
fold change of casp3 expression (hr-1); Kmcasp3, iC3 is the Monod constant for caspase 3 limiting 
effect, respectively, on casp3 expression (mM) ; αmRNAcasp3 is the mRNA degradation rate of 
casp3 (hr-1). 
In addition to the transcription of apoptotic genes, cells require interactions among 
proteins involved in the apoptotic pathways to initiate or govern apoptosis (Sax and El-Deiry, 
2003), and thus this should be also included in the apoptosis sub-model. The model should be 
constructed based on the reactions among apoptotic proteins and the connection between the 
mRNA levels of the apoptotic species of interest and the corresponding protein levels. As 
shown in Figure 7.2.4, the translation rates of procaspases-3, caspase-8, inactive Bax and Bcl-
2, given the initial concentration of these proteins found in cells, were assumed to be dependent 
on the mRNA levels of casp3, casp8, bax and bcl2, respectively. The mathematical expression 
for the balances of these proteins accounts for the translation and protein-protein interactions 
among apoptotic proteins. The translation was mathematically expressed using Monod-type 
kinetics along the line of the mathematical models for microbial biodegradation by Koutinas et 
al. (2010), while the equations for protein-protein interactions were based on mass-action 
kinetics. 
There are previous reports showing a positive correlation between the mRNA and the 
corresponding protein levels (Ghazalpour et al., 2011, Schwanhausser et al., 2011). However, 
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this is not always the case given that no/a very weak correlation between the mRNA and its 
corresponding protein levels was found in many cases, suggesting that the positive correlation 
is protein and pathways specific. For example, the mAb productivity did not increase as its 
mRNA levels were found increased due to hypothermia in GS-NS0 and GS-CHO cell cultures 
(Marchant et al., 2008). In a study of apoptosis in breast cancer brain metastases, Bcl-2 protein 
and bcl-2 mRNA levels were found to have a positive correlation while there was no correlation 
found between Bax protein and bax mRNA expressions (Stark et al., 2006). It was also 
suggested, based on the observed result showing a weak correlation between the mRNA and 
its protein levels in human monocytes, that mRNAs can provide lots of information but may 
not be able to predict their corresponding protein expressions (Guo et al., 2008). This could be 
because mRNAs are not directly converted into proteins. During the process of protein 
synthesis, there are places where several factors can affect the process. This includes translation 
initiation (ribosomic binding site, presence of internal ribosome entry site, IRES), regulatory 
proteins as well as small RNAs (repressing its own translation), translational efficiency (as 
regards ribosomal density and ribosome occupancy), and protein half-life affecting post-
translational protein levels (Maier et al., 2009). Given the above discussion indicating the 
inconsistent correlation between the mRNA and the corresponding protein levels, the 
assumption made for the apoptosis sub-model construction could not be truly valid, which is 
one of weakest points in the apoptosis sub-model. The proteins included in the model will need 
to be quantified to validate the assumption as well as confirm model estimation capability. 
 The activation of caspase-3 was assumed to be dependent on the concentration of 
caspase-8 and the active form of Bax (tetrameric complex); while the translation was assumed 
to be proportional to the expression of mRNAcasp3. 
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Eq. 7.2.36 Procaspase-3 balance 
d(ViCasp3)
dt
= (  β
iC3
(
mRNAcasp3
KbiC3+mRNAcasp3
 ) - kC3Bax4iCasp3 - kC8Casp8iCasp3) V- FoutiCasp3 
Eq. 7.2.37 Caspase-3 activation 
d(VCasp3)
dt
 = ( kC3Bax4iCasp3 + kC8Casp8iCasp3)V- FoutCasp3 
Where, iCasp3, Casp3, bax4 and Casp8 are the concentration of procaspases-3, Caspase-3, 
active bax and caspase-8, respectively (mM); βiC3 is the maximal procaspase-3 translation rate 
based on the expression of casp3 (mmol.hr-1); kC3 and kC8 are the rate constants for active bax 
and caspase-8, respectively, associated caspase-3 activation (L.mmol-1.hr-1); KbiC3 is the 
Monod constant for mRNAcasp3 limiting effect on the translation of procaspase-3 (-). 
 Like that of procaspases-3, the mass balance of inactive Bax accounts for the translation 
and the relevant protein-protein interactions in apoptotic pathways (Eq. 7.2.38). It was 
previously proposed that the tetrameric form of Bax molecules is the active form that is 
required to activate the apoptosis pathway (Chen et al., 2007). The herein mathematical 
expression of Bax activation, therefore, was constructed using mass-action kinetics considering 
Bax-polymerisation, as shown in Eq. 7.2.39.   
Eq. 7.2.38 Inactive Bax balance 
d(ViBax)
dt
 =  ( β
ibax
(
mRNAbax
Kbibax+mRNAbax
 ) - kbaxiBax
4) V- FoutiBax 
Eq. 7.2.39 Bax activation 
d(VBax4)
dt
 = ( kbaxiBax
4 - k_baxBax4Bcl2 )V- FoutBax4 
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Where, iBax and Bcl2 are the concentration of inactive Bax and Bcl-2, respectively (mM); βibax 
is the maximal inactive Bax translation rate based on the expression of bax (mmol.hr-1); kbax 
and k_bax are the rate constants for the Bax tetramerization (L
3.mmol-3.hr-1) and the inhibitive 
binding of Bcl-2 to active Bax (L.mmol-1.hr-1), respectively; Kbibax is the Monod constant for 
mRNAbax limiting effect on the translation of inactive Bax (-). 
 Mass balances of Bcl-2 and caspase-8 were proposed as the following equations (Eq. 
7.2.40-41), which were constructed to account for the translation and apoptotic protein-protein 
interactions.  
Eq. 7.2.40 Bcl-2 balance 
d(Vbcl2)
dt
= (  β
bcl2
(
mRNAbcl2
Kbbcl2+mRNAbcl2
 ) - k_baxbax4bcl2 ) V- Foutbcl2 
Where, βbcl2 is the maximal Bcl-2 translation rate based on the expression of bcl2 (mmol.hr
-1); 
Kbbcl2 is the Monod constant for mRNAbcl2 limiting effect on the translation of Bcl-2 (-). 
Eq. 7.2.41 Caspase-8 balance 
d(VCasp8)
dt
 = β
C8
(
mRNAcasp8
KbC8+mRNAcasp8
 ) V- FoutCasp8 
Where, βcasp8 is the maximal caspase-8 translation rate based on the expression of casp8 
expression (mmol.hr-1); KbC8 is the Monod constant for mRNAcasp8 limiting effect on the 
translation of caspase-8 (-). 
 The apoptosis sub-model is basically the system of ODEs, which consists of 12 
variables and all of which are differential variables. There are 34 parameters in this sub-model. 
 It is worth discussing about the validity of the presented model as well as its potential 
applications in the mammalian cell culture systems. The herein constructed mathematical 
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model was based on the batch and fed-batch cultures of GS-NS0 cells. In addition, the proposed 
mathematical equations were constructed preliminarily based upon existing biological 
knowledge; including cell growth kinetics, metabolism and apoptotic pathways, and were 
further modified along the line of what was experimentally observed in the cultures. Therefore, 
the validity of this model is most likely limited to the GS-NS0 cell cultures in either batch or 
fed-batch modes. However, given that the model was structured to a certain extent based on 
the generalised biological knowledge, it can be further modified either structurally or with 
regards to change in parameter values in order to be able to capture the behaviour of other 
mammalian cell culture systems, such as GS-CHO cells.  
However, the presented model is still in the beginning steps toward the predictive 
mathematical model development. Its applications are therefore limited to only the system 
behaviour that the model was developed based on. The model can be potentially used for the 
study of effects of apoptosis induction/suppression on growth, metabolism, death and 
recombinant/exogenous protein synthesis in the GS-NS0 cell cultures given the model 
description. With the aid of the mathematical model simulations, the effect of 
overexpression/knockdown apoptotic genes (only ones included in the model) on cell viability 
and mAb synthesis, for example, could be evaluated. Thus, this helps us to narrow down the 
choice of apoptotic gene engineering toward higher mAb synthesis and longer culture viability, 
and plan the screening procedure and corresponding experiments before the experiments are 
actually conducted. This would ultimately help shorten the timeline for the process 
development stage for the improvement of the mammalian cell culture systems (Ho et al., 
2013), given possible trial and error could be avoided. 
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7.2.3 Parameter values 
 The values of model parameters assigned herein were aimed to 1) provide a reasonable 
reproduction of the experimental data from batch and fed-batch cultures, 2) be preliminarily 
used for the model analysis to evaluate model characteristics as well as parameters significance 
(and thus model identifiability). Therefore, the parameter estimates shown here are not the 
finalised ones which are not yet be globally optimised. 
 Parameters in the proposed mathematical models can be roughly divided into two 
groups. The first one is the group of parameters that their values can be preliminarily estimated 
from literature. These values were treated as initial guesses, providing the information about 
the order of magnitude of these parameters. They were further manually adjusted in order to 
reproduce the experimental data. The second group is ones that their values could not be 
estimated from literature since they have not been introduced in any studies before. The values 
of these parameters were left at dummy values (such as 1, 0.1, 0.01 etc.) with a similar order 
of magnitude to the values of biological relevant variables or parameters. These values were 
then further adjusted manually and computationally (parameter estimator in the model builder 
software). The following tables shows the values and the sources of parameters used herein.  
Table 7.2.1 The preliminary values of model parameters and their references. 
 No Parameters (unit) 
Values 
used 
herein 
Reference values 
C
el
l 
g
ro
w
th
 s
u
b
-m
o
d
el
 
1 μmax, glc (hr-1) 2.80E-02 [5.80E-03, 1.25E-01]; μmax [1-5] 
2 Kglc (mM) 3.90E+01 [7.50E-01, 4.61E+01]; Kglc [1-5] 
3 μmax, glu (hr-1) 1.70E-02 [5.80E-03, 1.25E-01]; μmax [1-5] 
4 Kglu (mM) 1.00E-01 [3.00E-03, 4.27E-00]; Kgln [1-5] 
5 μmax, ad (hr-1) 3.83E-02 [1.00E-02, 6.00E-02]; μmax, d or kd, max [1-5] 
6 Kcasp3 (mM) 1.01E+00 1.76E+00; Kd, amm [1,3] 
7 μmax, nd (hr-1) 1.13E-02 [1.00E-02, 6.00E-02]; μmax, d or kd, max [1-5] 
8 Klac (mM) 1.03E+02 [4.50E+01, 1.77E+02]; KI, lac  [1,3,5] 
9 μmax, d (hr-1) 1.57E+01 [1.00E-02, 6.00E-02]; μmax, d or kd, max [1-5] 
10 kd (hr-1) 6.26E-05 [1.89E-05, 2.60E-03]; Kd, 1 or klysis [2, 3, 5] 
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M
et
a
b
o
li
sm
 s
u
b
-m
o
d
e
l 
11 Yx, glc (cells/mmol) 4.00E+05 
[4.91E+4 to 1.21E+6]; 1/ Kglc,max  or Yx, glc 
[2,3] 
12 mglc (mmol.cells-1.hr-1) 5.14E-07 [3.16E-08, 4.1E-08]; mglc  [2] 
13 Kmglc, asp(mM) 1.00E-02 [1.00E-02, 1.00E-01]; Kamino acid  [5]  
14 Ylac, glc (mmol/mmol) 2.50E+00 [0.97E+00, 2.00E+00]; Ylac, glc  [2-5] 
15 klac, con (mmol.cells-1.hr-1) 1.50E-07 Assumed to be similar to mglc 
16 Kmlac, asp(mM) 1.00E-02 [1.00E-02, 1.00E-01]; Kamino acid  [5] 
17 Yx, glu (cells/mmol) 6.05E+06 [5.5E+05, 1.21E+6]; Yx, glu [3] 
18 mglu(mmol.cells-1.hr-1) 8.87E-09 [-4.5E-08, 5.91E-08]; mlac [2] 
19 Kmglu, glu(mM) 1.00E-01 [1.00E-02, 1.00E-01]; Kamino acid  [5] 
20 fglu, ala (mmol/mmol) 5.00E-01 
[1.00E-04, 1.00E-00]; Yamino acid, amino acid  [5], 
but adjusted to 0.5 for all yields   
21 fglu, gln (mmol/mmol) 5.00E-01 
22 fglu, asp (mmol/mmol) 5.00E-01 
23 fglu, arg (mmol/mmol) 5.00E-01 
24 Yx, asp (cells/mmol) 1.40E+06 Assumed to be similar to Yx, glu 
25 masp(mmol.cells-1.hr-1) 8.00E-10 Assumed to be similar to mglu 
26 Kmasp, asp (mM) 2.00E-02 [1.00E-02, 1.00E-01]; Kamino acid  [5] 
27 fasp, asn (mmol/mmol) 5.00E-01 
[1.00E-04, 1.00E-00]; Yamino acid, amino acid  [5], 
but adjusted to 0.5 for all yields   
28 Yx, asn (cells/mmol) 1.50E+06 Assumed to be similar to Yx, glu 
29 masn(mmol.cells-1.hr-1) 1.00E-09 Assumed to be similar to mglu 
30 Kmasn, asp (mM) 9.00E-02 [1.00E-02, 1.00E-01]; Kamino acid  [5] 
31 Yx, arg (cells/mmol) 2.50E+06 Assumed to be similar to Yx, glu 
32 marg(mmol.cells-1.hr-1) 1.00E-09 Assumed to be similar to mglu 
33 Kmarg, arg(mM) 5.00E-02 [1.00E-02, 1.00E-01]; Kamino acid  [5] 
34 Yx, ala (cells/mmol) 3.00E+06 Assumed to be similar to Yx, glu 
35 mala(mmol.cells-1.hr-1) 3.50E-09 Assumed to be similar to mglu 
36 Kmala, glu (mM) 9.00E-02 [1.00E-02, 1.00E-01]; Kamino acid  [5] 
37 Yala, glu (mmol/mmol) 1.60E+00 [1.43E+00, 1.00 E+01]; Ygln, glu [5]  
38 Yx, gln (cells/mmol) 7.00E+05 Assumed to be similar to Yx, glu 
39 mgln(mmol.cells-1.hr-1) 2.00E-09 Assumed to be similar to mglu 
40 Kmgln, gln(mM) 7.00E-02 [1.00E-02, 1.00E-01]; Kamino acid  [5] 
41 Ygln, glu (mmol/mmol) 2.50E+00 1.43E+00 to 1.00 E+01; Ygln, glu [5] 
42 Yx, leu (cells/mmol) 2.00E+06 Assumed to be similar to Yx, glu 
43 mleu(mmol.cells-1.hr-1) 1.00E-09 Assumed to be similar to mglu 
44 Kmleu, leu(mM) 5.00E-02 [1.00E-02, 1.00E-01]; Kamino acid  [5] 
45 αab (mg cells-1 hr-1) 3.96E-07 [4.02E-11, 8.10E-11];  [3,4] 
46 Kmmab, aa (mM) 1.00E-01 [1.00E-02, 1.00E-01]; Kamino acid  [5] 
A
p
o
p
to
si
s 
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b
-m
o
d
el
 
47 βiC3 (mmol.hr-1) 9.08E-03 n/a: adjusted from a dummy value of 1.0E-03  
48 KbiC3 (-) 2.00E-03 
Assumed to be within the order of magnitude 
of casp3 expression; [0, 1.0E+01] 
49 kC3 (L.mmol-1.hr-1) 3.58E+00 n/a: adjusted from a dummy value of 1.0E-02 
50 βiC8 (mmol.hr-1) 1.02E-03 n/a: adjusted from a dummy value of 1.0E-03 
51 KbiC8 (-) 1.45E-01 
Assumed to be within the order of magnitude 
of casp8 expression; [0, 1.0E+01] 
52 kC8 (L.mmol-1.hr-1) 1.12E-02 n/a: adjusted from a dummy value of 1.0E-02 
53 βibax (mmol.hr-1) 2.97E-03 n/a: adjusted from a dummy value of 1.0E-03 
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54 k_bax (L.mmol-1.hr-1) 2.96E+00 0.00E+00 [6]  
55 kbax (L3.mmol-3.hr-1) 1.82E+00 2.00E+00 [6] 
56 Kbibax (-) 8.47E-01 
Assumed to be within the order of magnitude 
of bax expression; [0, 1.0E+01] 
57 βbcl2 (mmol.hr-1) 2.38E-04 n/a: adjusted from a dummy value of 1.0E-03 
58 Kbbcl2 (-) 1.30E+01 
Assumed to be within the order of magnitude 
of bcl2 expression; [0, 1.0E+01] 
59 βmRNAcasp3 (hr
-1) 6.36E-02 n/a: adjusted from a dummy value of 1.0E-02 
60 Kmcasp3, iC3 (mM) 1.41E-01 
Assumed to be within the order of magnitude 
of caspase-3 concentration; 0.2 mM initial 
concentration [6] 
61 αmRNAcasp3 (hr
-1) 1.25E-02 n/a: adjusted from a dummy value of 1.0E-02 
62 βmRNAbax (hr
-1) 1.11E-01 n/a: adjusted from a dummy value of 1.0E-02 
63 Kmtrp53bp2, bax (-) 6.27E-01 Assumed to be within the order of magnitude 
of gene expressions; [0, 1.0E+01] 64 Kmbcl-2, bax (-) 7.00E-01 
65 αmRNAbax (hr
-1) 1.81E-02 n/a: adjusted from a dummy value of 1.0E-02 
66 βmRNAbcl2 (hr
-1) 6.83E-01 n/a: adjusted from a dummy value of 1.0E-02 
67 Kmtrp53bp2, bcl-2 (-) 2.10E+00 Assumed to be within the order of magnitude 
of gene expressions; [0, 1.0E+01] 68 Kmatf5, bcl-2 (-) 6.98E+00 
69 αmRNAbcl2 (hr
-1) 1.97E-01 n/a: adjusted from a dummy value of 1.0E-02 
70 βmRNAtrp53bp2 (hr
-1) 4.68E-02 n/a: adjusted from a dummy value of 1.0E-02 
71 Kmlac, trp53bp2 (mM) 1.73E+00 Assumed to be within the order of magnitude 
of lactate [0, 3.0E+01]  and glutamate levels 
[0, 1.0E+00] 72 Kmglu, trp53bp2 (mM) 1.00E-01 
73 αmRNAtrp53bp2 (hr
-1) 2.01E-02 n/a: adjusted from a dummy value of 1.0E-02 
74 βmRNAatf5 (hr
-1) 3.82E-01 n/a: adjusted from a dummy value of 1.0E-02 
75 Kmasp, atf5 (mM) 2.29E-02 Assumed to be within the order of magnitude 
of aspartate [0, 1.0E+00] and mAb levels [0, 
1.0E+02] 76 Kmab, atf5 (mg/L) 2.77E+01 
77 αmRNAatf5 (hr
-1) 5.42E-02 n/a: adjusted from a dummy value of 1.0E-02 
78 βmRNAcasp8 (hr
-1) 9.46E-02 n/a: adjusted from a dummy value of 1.0E-02 
79 Kmglu, casp8 (mM) 1.21E-01 
Assumed to be within the order of magnitude 
of casp8 expression; [0, 1.0E+01] 
80 αmRNAcasp8 (hr
-1) 5.13E-02 n/a: adjusted from a dummy value of 1.0E-02 
[1](Kontoravdi et al., 2010)&(Kiparissides et al., 2011a), [2](Ho et al., 2006), [3](Kiparissides et al., 2015), 
[4](Teixeira et al., 2005), [5](Kontoravdi et al., 2007), [6](Chen et al., 2007)& (Hua et al., 2005). 
 
 The initial conditions for differential variables (such as concentrations of viable cells, 
glucose, amino acids, etc.) were defined according to the experimental data obtained from 
Chapter 5&6. However, the initial conditions for apoptotic proteins, including procaspases-3, 
caspase-8, inactive Bax and Bcl-2 were assigned using the previously reported values (Chen et 
al., 2007, Hua et al., 2005). 
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7.2.4 Model analysis  
 All simulations and parameter fitting were performed on an Intel® CoreTM i7 870 (2.93-
3.07 GHz) personal computer with 8.00 GB of RAM memory. The proposed mathematical 
model was implemented in the advanced process model builder gPROMS version 4.0.0 (64bit)  
(gPROMS, 2014). - 
 As discussed earlier, the validity of model parameters could not be fully claimed since 
the parameter values were non-optimised. Global sensitivity analysis (GSA) can provide 
sensitivity of each parameter through simultaneously and randomly varying all parameter 
values within a limited and pre-specified range using the Quasi-Monte Carlo method-based 
Sobol random number sequences. The randomness inherent in GSA enables to explore the 
sensitivity of values around the parameter nominal values (through randomly sampling values 
around the parameter nominal values within the range); in other words, to take into account 
uncertainty surrounding the parameter values (Kent et al., 2013, Kiparissides et al., 2009). 
Therefore, given the preliminary set of parameters used in the presented model, GSA was 
herein adopted as a computational tool for model analysis to identify sensitive or significant 
parameters.  
The global parameter sensitivities were quantified using Sobol’ method. This method 
allows acquiring the first order sensitivity indices as well as the total sensitivity indices (TSIs). 
Herein, the parameter significance was evaluated using the TSIs (Homma and Saltelli, 1996), 
while the interactions among model parameters were pinpointed by comparing the TSIs with 
the main effects of model parameters (Kiparissides et al., 2009). 
 The Sobol’ sensitivity indices were estimated using GUI-HDMR software (Ziehn and 
Tomlin, 2009). The inputs for the software were 1) the Sobol’ quasi-random sequences and 2) 
the variation of model variables with respect to the Sobol’ quasi-random sequences. These 
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inputs were generated through the cooperation between Matlab (MATLAB, 2014) and 
gPROMS. A Sobol’ sequence, which is a sequence of random numbers in the unit hypercube 
(0-1), was firstly generated in Matlab. Each random number in the sequence was treated as a 
percentage change of a model parameter. The parameter values were then varied from their 
nominal values in accordance with the random numbers in the sequence; nevertheless, they 
could only be changed within the pre-specified range/space that parameter values could be 
deviated from their nominal values. Matlab then sent the varied parameter values to gPROMS 
in order to acquire the effects of the parameter variation on model variables. Finally, gPROMS 
simulated the mathematical model with the variation of parameter values and sent the output 
back to Matlab, where all information was stored. This process was repeated with a newly 
generated Sobol’s sequence. The iteration continued as the number of Sobol’s sequences were 
pre-specified.  
 In this study, ±25% deviation from the nominal values of parameters was set for the 
range/space of parameter variation. 100,000 Sobol’s sequences were employed in order to 1) 
allow exploring any possible scenarios of simultaneous variation of all model parameters, and 
2) assure the convergence of the sensitivity results, as suggested previously (Benedetti et al., 
2011). The sensitivity indices were collected at 0, 24, 48, 60, 72, 96 and 120 hours of the culture 
time (or model simulation time). Viable cell (Xv), ESA cell (Xad), dead cell (Xd) and mAb (Ab) 
concentrations were primary model variables that the sensitivity indices were estimated based 
on.  
 ±25% deviation of parameter values in the cell growth sub-model (Table 7.2.1) often 
caused the simulations to be terminated before the time points that the sensitivity indices were 
collected, especially during the stationary and death phases. Consequently, the effect of 
parameters in the other sub-models on the model variables could not be truly investigated 
during these periods of the culture. In addition, values of the parameters in metabolism and 
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apoptosis sub-models were relatively uncertain as compared to the cell growth sub-model since 
some of them were herein estimated with very limited clues from previous studies. Further 
evaluation of parameter sensitivities, therefore, were conducted specifically to pinpoint the 
effect of parameters in these sub-models on the model variables of interest.  
 GSA was further performed with the range/space of parameter variation in the 
metabolism and apoptosis sub-models being relatively larger than those in other sub-models. 
±25% and ±50% deviation from the nominal values of parameters in the metabolism and 
apoptosis sub-models, respectively, were implemented while the range/space of parameter 
variation of the remaining parameters was set at ±5%. The GSA was performed with 60,000 
Sobol’s sequences and the sensitivity indices were collected at 0, 24, 48, 60, 72, 96 and 120 
hours of the culture time. Apart from viable cells (Xv), ESA cells (Xad), dead cells (Xd) and 
the concentration of mAb (Ab), the effect of these parameter variation on other variables were 
also explored. 
 It is worth noting that the global sensitivities obtained from this study, however, were 
based on the preliminary set of parameter values, which is most likely to be later amended 
according to the GSA result. Despite taking into account the uncertainty of parameter values 
used in the model (the preliminary ones), the GSA with the amended parameter values could 
provide a different result to the one achieved from the preliminary values. This could be 
because the analysis range of the preliminary parameter values was limited (±25%) and the 
later amended ones can be outside this range.  
Given that parameter values are randomly and simultaneously sampled within the pre-
specified range of the parameter values in the GSA, it is possible to determine a set of optimal 
parameter values that provides the best reproduction of experimental data based on the GSA 
algorithm. This was performed using the same algorithm as the GSA (Matlab-gPROMS 
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simulations) as above described. All 80 parameters were randomly and simultaneously sampled 
in the ±60% deviation from their default values. 100,000 Sobol’s sequences were generated to 
represent the random sampling within the ±60% pre-specified range of parameter values (a 
random sequence is a set of 80 parameter values that their values were randomly selected within 
the range). Viable cells (Xv), ESA cells (Xad), viability (Via) and the concentration of mAb 
(Ab) were used as primary model variables of interest and were simulated in accordance with 
the sampled sets of parameter values at 0, 24, 48, 60, 72, 96 and 120 hours of the culture time. 
Simulations using the 100,000 randomly sampled sets of parameter values provided 100,000 
different trajectories of the model output. In order to determine the trajectory that showed the 
best reproduction of the corresponding experimental data, the percentage error for each 
simulated output trajectory was calculated using Eq. 7.2.42, which represents the percent 
difference between the simulated output trajectory and the experimental data for a model 
variable at a culture time point.  
Eq. 7.2.42 The percentage error (PE) 
PE i, j= 
|Simulated datai, j -Experimental datai, j|
Experimental data
i, j
;i=model variable, j=time 
Eq. 7.2.43 The total percentage error (TPE) 
TPE = ∑  ∑ PE i, j
N
i=1
M
  j=1
 ;N=No. of model variables of interest, j=No. of time points 
The percentage error was estimated for each model variable (Xv, Xad, Via and Ab) and 
at the different observed culture time (0, 24, 48, 60, 72, 96 and 120 hours). Therefore, there 
were 7 percentage errors for each model variable and 28 percentage errors for each simulated 
output trajectory. The total percentage error is the summation of all 28 percentage errors (Eq. 
7.2.43) in order to take into account the errors for all the model variables of interest at all the 
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observed time points. The simulated output trajectory that provided the minimum total 
percentage error was selected as the best reproduction of experimental data. Therefore, the 
sampled set of parameter values that generated the selected output trajectory was treated as the 
set of optimal parameter values.  
7.3 Results & Discussion 
 
7.3.1 Batch and Fed-batch simulations  
The data obtained from simulations in gPROMS were compared to the experimental data. 
The Pearson correlation coefficient (rp) was determined to indicate whether the simulations 
could capture the trend of experimental data. If the simulation results can perfectly capture the 
trend of experimental data, there should be a linear correlation between those types of data, 
indicated by the rp being close to 1 with the p-value (indicating the likelihood of being wrong 
in concluding that there is a linear correlation between in the two variables) being less than the 
significant level (alpha=0.05). In addition, to represent the goodness of fit of, the adjusted R2 
value was calculated through the sum-of-squares of errors generated from 1) deviation between 
simulated data and observed data and 2) deviation between observed data and the mean of the 
observed data (based on the assumption of two degrees of freedom can be adjusted to obtain 
the simulation data of a variable). It represents how well the model simulation reproduces the 
experimental data. The closer to 1 the adjusted R2 value is, the better the model can potentially 
fit the experimental data.  
In this study, both the adjusted R2 value and the rp were together considered to compare 
between the simulation and experimental data because 1) in several occasions the adjusted R2 
value being close to 1 is not necessary to ensure the goodness of fit of the model simulation 
and 2) the rp can only indicate whether the simulation data and the experimental data are 
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correlated, in the other words, whether the model simulations can capture the trend of the 
experimental data, but not exactly how well the model can reproduce the experimental data. 
The criterion of rp being larger than 0.8 indicates a very strong correlation (Evans, 1996), which 
can imply that the model simulation can reasonably capture the trend of experimental data. 
There is no critical value for the adjusted R2; however, in this context, if the model can 
reasonably reproduce the experimental data, the high adjusted R2 value (close to 1) is expected; 
otherwise the model might not well represent the experimental data.  
Figure 7.3.1 illustrates the agreement of simulation results with the experimental data 
of cell growth and death-related variables from the batch and fed-batch cultures. Overall, the 
model provided a reasonably good reproduction of the experimental data especially for the 
batch culture as can be seen from the rp and adjusted R
2 values being close to 1, though there 
were several situations that the experimental data were quantitatively misestimated. The model 
appeared to overpredict the viable cell concentration during the early-exponential phase (0 to 
24 hours) in both batch and fed-batch cultures (Figure 7.3.1-A). The model could also not well 
capture the viable cell concentration during the death phase of the both cultures (from 96 
hours). For the batch data, the underestimation of viable cell concentration during the death 
phase could be as a consequence of the overprediction of dead cell concentration as can be seen 
from Figure 7.3.1-B&C. Although the concentration of ESA cells was overestimated during 
the death phase in the fed-batch culture (Figure 7.3.1-B&C), the model simulation showed the 
overprediction of viable cell concentration during the same period. The value of R2 being equal 
to -0.863 might reflect this overestimation though the model could capture the trend of the ESA 
cell concentration. This could be because the net growth rate during the death phase in the fed-
batch culture was overpredicted as a result of the feeding of glutamate and other amino acids. 
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rp = 0.896 
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Adjusted R2 = 0.711 
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Adjusted R2 = -0.863 
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Figure 7.3.1 Model simulation results for (A) viable cell concentration; (B) ESA cell concentration; 
and (C) viability. The left column represents the batch data and the right column represents the fed-
batch data. rp stands for the Pearson correlation coefficient, p-value indicates the probability that the 
identified correlation might not be existing, and Adjusted R2 indicates goodness of fit. 
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Figure 7.3.2 Model simulation results (A) glucose; (B) lactate; and (C) glutamate concentrations. 
The left column represents the batch data and the right column represents the fed-batch data. rp 
stands for the Pearson correlation coefficient, p-value indicates the probability that the identified 
correlation might not be existing, and Adjusted R2 indicates goodness of fit. 
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Figure 7.3.3 Model simulation results for (A) aspartate; (B) asparagine; and (C) arginine 
concentrations. The left column represents the batch data and the right column represents the fed-
batch data. rp stands for the Pearson correlation coefficient, p-value indicates the probability that 
the identified correlation might not be existing, and Adjusted R2 indicates goodness of fit. 
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Figure 7.3.4 Model simulation results (A) alanine; (B) leucine; and (C) mAb concentrations. The 
left column represents the batch data and the right column represents the fed-batch data. rp stands for 
the Pearson correlation coefficient, p-value indicates the probability that the identified correlation 
might not be existing, and Adjusted R2 indicates goodness of fit. 
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Figure 7.3.5 Model simulation results for (A) atf5; (B) bcl-2; (C) trp53bp2; (D) casp8; and (E) 
casp3 expressions. The left column represents the batch data and the right column represents the 
fed-batch data. rp stands for the Pearson correlation coefficient, p-value indicates the probability 
that the identified correlation might not be existing, and Adjusted R2 indicates goodness of fit. 
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The metabolic profiles in the batch and fed-batch cultures were well reproduced by the 
model simulations as indicated by the rp and the adjusted R
2 values being close to 1 as shown 
in Figure 7.3.2 to 7.3.4. There was a good agreement between the model simulations and the 
experimental data of glucose and lactate concentrations. It appeared that the concentration 
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Figure 7.3.5 (continued) Model simulation results for (A) atf5; (B) bcl-2; (C) trp53bp2; (D) 
casp8; and (E) casp3 expressions. The left column represents the batch data and the right column 
represents the fed-batch data. rp stands for the Pearson correlation coefficient, p-value indicates the 
probability that the identified correlation might not be existing, and Adjusted R2 indicates 
goodness of fit. 
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7.3.2-A). In addition, the lactate consumption phase in the fed-batch culture was also 
reproduced by the model simulation (rp>0.9, Figure 7.3.2-B). The models’ reproduction of 
glucose and lactate concentrations in the cultures supports the hypothesis that the glucose and 
lactate consumption were subject to aspartate availability. The simulated profiles of glutamate 
as well as aspartate concentrations in the fed-batch culture, however, were not quantitatively 
accurate as reflected by the adjusted R2 values being relatively lower than those for other 
metabolites (Figure 7.3.2-C & 7.3.3-A). Compared to the experimental data, they were 
qualitatively precise (rp=0.80 for glutamate and rp=0.865 for aspartate with p<0.05). The 
underestimation of the net glutamate and aspartate consumption during the fed-batch culture 
could be further corrected by adjusting the simulated glutamate as well as aspartate fluxes in 
accordance with the parameter sensitivity data.    
 As indicated by the rp and the adjusted R
2 values, the model showed a reasonably good 
fit for the concentration profiles of asparagine (Figure 7.3.3-B), arginine (Figure 7.3.3-C), 
alanine (Figure 7.3.4-A) and leucine (Figure 7.3.4-B) in both batch and fed-batch cultures. 
However, in some circumstance, the simulated data of these amino acid concentration profiles 
were slightly quantitatively incorrect during the death phase of the fed-batch culture, despite 
being qualitatively accurate and showing reasonably high values of the adjusted R2 values. This 
could be because glutamate consumption was misestimated during the death phase. The 
simulated concentration profiles of asparagine and leucine appeared to be not quantitatively 
accurate during the stationary phase of the cultures as a result of the proposed assumptions that 
1) the asparagine and leucine consumption rates are enhanced by aspartate exhaustion and 
leucine availability, respectively. The model provides a good estimation of the cB72.3 mAb 
concentration profiles in both cultures, indicated by both the rp and the adjusted R
2 values being 
very close to 1 (Figure 7.3.4-C). 
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 The profiles of apoptotic gene expression in the batch culture were well captured by the 
model simulations. However, it appeared that the model relatively failed to reproduce the gene 
expression profiles in the fed-batch culture. The simulated profile of atf5 expression (Figure 
7.3.4-A) showed a good fit for the batch experimental data (rp = 0.88, the adjusted R
2 = 0.49), 
while it failed to capture the elevated level of the gene expression after the stationary phase of 
the fed-batch culture. The misestimation in the fed-batch culture was also reflected by the 
negative values of the rp and the adjusted R
2 in Figure 7.3.4-A. Given that mathematical 
expression of the atf5 expression was assumed to be subject to aspartate deprivation and ER 
stresses due to mAb synthesis, the simulated atf5 expression profile was, therefore, down-
regulated throughout the culture time as a result of aspartate being excessively fed into the 
culture.  
 The simulated expression profiles of bcl-2, trp53bp2 and casp8 were in good agreement 
(rp>0.9) with the experimental data of the batch culture (Figure 7.3.4-B, Figure 7.3.4-C and 
Figure 7.3.5-A, respectively). bcl-2 and trp53bp2 might possibly follow the trend of the fed-
batch experimental data given their rp values being between 0.4 and 0.6 (Evans, 1996) as well 
as the larger than 0.05 p-values. In addition, they were not quantitatively accurate as reflected 
by their adjusted R2 values being negative. This could be because of the oversimplification of 
bcl-2 and trp53bp2 related interactions/activities for the model construction since these two 
factors can be also influenced by other cellular signalling pathways. The simulated expression 
profile of casp3 showed a relatively good fit for the batch experimental data (rp>0.8 and a high 
adjusted R2). However, it did not follow the trend of the experimental data of the fed-batch 
culture (rp=0.163 and negative adjusted R
2, Figure 7.3.5-B). As discussed in Chapter 6, 
apoptosis cell death could be triggered independently from the caspase-3 activation under a 
particular condition probably occurring in the fed-batch culture. Given that apoptosis cell death 
in this model was assumed to be proportionally correlated with the activation of caspase-3, the 
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model was therefore not able to represent the circumstance where there was a steady increase 
in apoptotic cells while there was no caspase-3 activation. 
 Overall, the simulation results were reasonably acceptable. However, the simulated 
profiles of apoptotic gene expression were relatively poorer compared to the others, and 
required to be further refined. GSA was performed in order to provide an insight into model 
parameter sensitivities, and to allow improving the proposed mathematical model. 
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Figure 7.3.6 Model simulation results based on the set of optimal parameter values providing the 
minimum percentage error for (A) viable cell concentration; (B) ESA cell concentration; (C) 
viability; and (D) mAb concentration in the batch culture. rp stands for the Pearson correlation 
coefficient, p-value indicates the probability that the identified correlation might not be existing, 
and Adjusted R2 indicates goodness of fit. 
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Figure 7.3.6 illustrates simulation results from the set of parameter values providing the 
minimum percent error, which was identified through randomly and simultaneously sampling 
from the parameter space as described in Section 7.2.4. The values are shown in Table B.4.1 
in Appendix B.4 which are within ±60% from the default parameter values. The simulation 
results for the variables of interest, including viable cells, ESA cells, viability and mAb 
concentration, capture the trend of the experimental data, as indicated by the correlation 
coefficient being larger than 0.8. However, it seems that the simulation results show a relatively 
poorer reproduction of the experimental data given the adjusted R2. The process of determining 
the sampled parameter values with the minimum percentage error to the experimental data 
conducted here was based on only 4 variables and only 7 discrete time points (given the 
computational expensive and model complexity). This could contribute to the observed 
misestimation of the experimental data from the simulation with the samples parameter values.  
7.3.2 Parameter sensitivities  
In order to select significant parameters, a cut-off threshold of total sensitivity (Stot) was 
pre-specified. The threshold was typically set from 0.01 to 0.1 of Stot (Tang et al., 2007, van 
Werkhoven et al., 2008, Vanrolleghem et al., 2015). Significant parameters were herein defined 
as “the ones that contribute to ≥ 10% of total model variability”. The following tables show the 
TSIs of potential parameters with respect to model variables of interest (Table 7.3.1-4), 
including viable, ESA, and dead cell concentrations, and mAb titre. In addition, the percentage 
contribution of higher order effects to the Stot of the potential parameters was also included 
(shown in brackets).      
 During the exponential phase, it appeared that μmax, glc and μmax, glu are the most 
significant parameters to the viable cell concentration given these parameter total sensitivities 
being the highest ones as shown in Table 7.3.1. This was in good agreement with the model 
Chapter 7 : An Experimentally-Validated Mathematical Model of Apoptosis 
~ 247 ~ 
assumption that the cell growth was assumed to be associated with glucose and glutamate. 
These parameters became less significant over time given the decrease in their Stot while mglu 
and Yx, asp became more significant, suggesting the simulated viable cell density after the 
exponential phase was also subject to glutamate and aspartate metabolism. 
Table 7.3.1 The total sensitivity indices (TSIs) with respect to the viable cell concentration 
(XV). The GSA was performed with ±25% simultaneous variation of all parameter values and 
100,000 Sobol’s sequences. Coloured cells are the parameter sensitivities being over the 
threshold (≥ 0.1). 
Stot  
(% interaction) 
with respect to viable cell concentration (XV) 
 Potential  
significant parameters 
Culture time (hours) 
Exponential phase 
Stationary 
phase 
Death phase 
24 48 60 72 96 120 
C
el
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w
th
 
S
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b
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o
d
el
 μmax, glc 
0.42 
(0.00) 
0.29 
(0.00) 
0.17 
(0.00) 
0.10 
(0.00) 
  
Kglc 
0.09 
(3.13) 
0.09 
(2.15) 
0.06 
(1.22) 
   
μmax, glu 
0.48 
(0.17) 
0.42 
(0.02) 
0.22 
(0.45) 
0.08 
(3.89) 
  
M
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a
b
o
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sm
 S
u
b
-m
o
d
el
 mglu  
0.06 
(12.74) 
0.18 
(4.26) 
0.13 
(2.37) 
  
Yx, asp     
0.15 
(27.42) 
0.17 
(8.50) 
fasp, asn     
0.06 
(31.19) 
0.09 
(18.79) 
Yx, asn      
0.05 
(69.72) 
Yala, glu   
0.06 
(6.30) 
   
A
p
o
p
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s 
S
u
b
- 
m
o
d
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βmRNAtrp53bp2 
0.06 
(100.0) 
     
 
ESA-associated parameters: μmax, ad and Kcasp3, were found to be sensitive parameters 
with respect to the ESA cell concentration, as can be seen in Table 7.3.2. These parameters 
were found significant from the exponential phase until the end of stationary phase, though 
their sensitivities decreased over time. Parameters that were associated with the activation of 
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caspase-3: kC3 and kbax, were also found significant during the same period. Later, βibax became 
significant during the 48 to 72 hours of the culture. At the death phase, the aspartate 
metabolism-associated parameters, including Yx, asp and fasp, asn, became significant. These 
results were in agreement with the mathematical model expression for the ESA cell 
concentration, where the generation rate of ESA cells was assumed to be dependent on caspase-
3 activation (Eq. 7.2.9). However, the results suggest that the dependence of ESA cell 
concentration on the activation of caspase-3 could be at the translational level, rather than the 
transcriptional level. The significant sensitivities of Yx, asp and fasp, asn indicate the effect of the 
aspartate balance on the ESA cell concentration during the death phase, though this effect was 
greatly contributed by the higher order effects. 
The parameters relating to the cell death by other pathways than apoptosis: μmax, nd and 
Klac, were found significant to the dead cell concentration at 24 hours of the culture (Table 
7.3.3). In addition, the lactate production-related parameter, Ylac, glc, was also a significant 
parameter. These results were in line with the mathematical expression of the generation of 
dead cells via other pathways than apoptosis (Eq. 7.2.11), which was assumed to be dependent 
on lactate concentration. These results also suggest that the generation of dead cells during the 
beginning of the culture was most likely subject to the cell death via other pathways than 
apoptosis. However, apoptosis-related parameters, including μmax, ad, Kcasp3 and βibax, became 
significant after the exponential phase (60 and 72 hours), suggesting the dead cell concentration 
was later dependent on apoptosis after the exponential phase. μmax, glu was also found significant 
at the 48 hours of the culture, reflecting that the connection between the dead cell concentration 
and cell growth. 
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Table 7.3.2 The total sensitivity indices (TSIs) with respect to the ESA cell concentration (Xad). 
The GSA was performed with ±25% simultaneous variation of all parameter values and 
100,000 Sobol’s sequences. Coloured cells are the parameter sensitivities being over the 
threshold (≥ 0.1). 
Stot  
(% interaction) 
with respect to ESA cell concentration (Xad) 
Potential  
significant parameters 
Culture time (hours) 
Exponential phase 
Stationary 
phase 
Death phase 
24 48 60 72 96 120 
C
el
l 
g
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w
th
 S
u
b
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o
d
el
 
μmax, glc  
0.05 
(0.00) 
0.07 
(0.00) 
0.07 
(0.00) 
  
μmax, glu  
0.07 
(0.14) 
0.09 
(0.01) 
0.08 
(1.66) 
  
μmax, ad 
0.25 
(0.42) 
0.17 
(1.11) 
0.14 
(1.14) 
0.10 
(0.74) 
  
Kcasp3 
0.27 
(2.40) 
0.16 
(1.85) 
0.11 
(1.38) 
0.07 
(0.94) 
  
μmax, d    
0.07 
(2.75) 
0.06 
(0.34) 
 
M
et
a
b
o
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sm
 
S
u
b
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o
d
el
 Yx, asp      
0.16 
(22.32) 
fasp, asn      
0.10 
(39.46) 
Yx, asn      
0.09 
(83.24) 
A
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o
p
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s 
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b
-
m
o
d
el
 
kC3 
0.12 
(5.06) 
0.09 
(3.52) 
0.07 
(3.10) 
   
βibax 
0.08 
(15.58) 
0.20 
(7.08) 
0.20 
(5.64) 
0.14 
(5.73) 
  
k_bax 
0.05 
(14.13) 
0.06 
(9.57) 
    
kbax 
0.11 
(8.59) 
0.08 
(6.45) 
0.05 
(5.20) 
   
 
 The most significant parameter with respect to the mAb concentration was αab, which 
represents the specific rate of mAb synthesis. As can be seen from Table 7.3.4, its sensitivity 
was the highest since the beginning of the culture until the death phase, though it gradually 
decreased. In addition, the sensitivities of the growth-related parameters, μmax, glu and μmax, glc, 
also contributed to the total variation of mAb concentration during the exponential and 
stationary phases. Yx, asp was found significant to the mAb titre during the death phase with a 
Chapter 7 : An Experimentally-Validated Mathematical Model of Apoptosis 
~ 250 ~ 
high level of the higher order effects. It is worth noting that the significant sensitivity of Yx, asp 
showed a similar pattern of the TSIs among the observed variables as above shown. This could 
be inferred that the aspartate balance had a significant effect on these variables as a result of 
aspartate levels being mathematically linked with the induction of apoptosis as well as glucose 
and amino acid metabolism.     
Table 7.3.3 The total sensitivity indices (TSIs) with respect to the dead cell concentration (Xd). 
The GSA was performed with ±25% simultaneous variation of all parameter values and 
100,000 Sobol’s sequences. Coloured cells are the parameter sensitivities being over the 
threshold (≥ 0.1). 
Stot  
(% interaction) 
with respect to dead cell concentration (Xd) 
 Potential  
significant parameters 
Culture time (hours) 
Exponential phase 
Stationary 
phase 
Death phase 
24 48 60 72 96 120 
C
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l 
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w
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 S
u
b
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o
d
el
 
μmax, glc 
0.06 
(0.00) 
0.09 
(0.00) 
0.06 
(0.00) 
   
μmax, glu 
0.07 
(0.55) 
0.13 
(3.46) 
0.09 
(0.96) 
0.06 
(0.32) 
  
μmax, ad  
0.08 
(0.68) 
0.12 
(0.82) 
0.14 
(0.65) 
0.11 
(0.26) 
 
Kcasp3  
0.08 
(6.23) 
0.11 
(4.72) 
0.11 
(3.30) 
0.06 
(1.46) 
 
μmax, nd 
0.31 
(0.93) 
     
Klac 
0.32 
(3.39) 
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Yx, glc 
0.09 
(7.38) 
     
Ylac, glc 
0.16 
(7.88) 
     
Yx, asp  
0.06 
(22.32) 
0.05 
(22.32) 
  
0.11 
(36.46) 
fasp, asn      
0.08 
(54.29) 
Yx, asn      
0.09 
(84.72) 
A
p
o
p
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s 
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b
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o
d
el
 kC3  
0.05 
(14.59) 
0.06 
(10.66) 
0.06 
(7.13) 
  
βibax  
0.11 
(18.57) 
0.18 
(13.62) 
0.20 
(9.64) 
0.11 
(7.43) 
 
kbax  
0.05 
(27.70) 
0.05 
(17.75) 
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Table 7.3.4 The total sensitivity indices (TSIs) with respect to the mAb titre (Ab). The GSA 
was performed with ±25% simultaneous variation of all parameter values and 100,000 Sobol’s 
sequences. Coloured cells are the parameter sensitivities being over the threshold (≥ 0.1). 
Stot  
(% interaction) 
with respect to mAb concentration (Ab) 
 Potential  
significant parameters 
Culture time (hours) 
Exponential phase 
Stationary 
phase 
Death phase 
24 48 60 72 96 120 
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w
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d
e
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μmax, glc  
0.07 
(0.00) 
0.06 
(0.00) 
   
μmax, glu  
0.10 
(0.01) 
0.08 
(0.86) 
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b
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u
b
-
m
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d
el
 
Yx, asp      
0.12 
(21.17) 
fasp, asn      
0.07 
(45.44) 
Yx, asn      
0.08 
(82.64) 
αab 
0.91 
(0.17) 
0.79 
(0.52) 
0.75 
(0.56) 
0.56 
(0.49) 
0.18 
(0.13) 
0.07 
(13.13) 
       
 The further evaluation of parameter sensitivities was performed to take into account the 
possibilities that the nominal parameter estimates in metabolism and apoptosis sub-models 
could be containing a relatively higher degree of uncertainty. While keeping the variation 
degree of the rest of parameters at ±5%, parameters in the metabolism and apoptosis sub-model 
were varied within ±25% and ±50%, respectively, of their nominal values.    
The further analysis showed that fasp, asn, Yala, glu and Ygln, glu were found significant to 
the viable cell concentration (Table 7.3.5-A), in addition to above discussed ones. The results 
confirmed that the simulated viable cell concentration was dependent on aspartate and 
glutamate metabolism in a time-dependent manner, given that these significant parameters 
were aspartate and glutamate metabolism-associated and they became significant at a different 
phase of the culture. A number of parameters in apoptosis sub-model were found significant in 
the further analysis, though their significance was not previously found. It appeared that βibax 
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was the most significant parameter with respect to the viable cell concentration given its highest 
sensitivity over all phases of the culture (Table 7.3.5-B). In addition, βiC3, kC3 and kbax were also 
found significant, suggesting that the simulated viable cell concentration during the stationary 
and death phase was subject to the control of apoptosis at the translational level.  
 Glutamate metabolism-associated parameters: mglu and Yala, glu, were among significant 
parameters with respect to the ESA cell concentration (Table 7.3.6-A), though they were not 
previously found significant. This result also indicates the dependence of the ESA cells on the 
glutamate balance in addition to the aspartate one. Additional significant parameters were 
found in the apoptosis sub-model, such as βiC3 and k_bax. Furthermore, their significant 
sensitivities were observed from the exponential phase until the end of stationary phase or the 
beginning of dead phase (Table 7.3.6-B), which was different from what was previously 
showed (Table 7.3.2). These results also confirmed the assumption that the ESA is dependent 
on the caspase-3 balance. However, it appeared that the Bax-activation was the major route 
whereby caspase-3 was activated, given the high contribution of Bax activation-related 
parameters to the model total sensitivities. This might not truly represent the induction of 
apoptosis in the culture as previously discussed in Chapter 5 and Chapter 6. 
The further analysis also showed that Yx, glc, Ylac, glc and Ylac, con were among significant 
parameters to the dead cell concentration during the exponential phase of the culture (Table 
7.3.7-A). This complements the above discussed results, suggesting that dead cells were subject 
to cell death via other pathways than apoptosis (which was assumed to be governed by lactate 
concentration). In addition, aspartate and glutamate metabolism-related parameters: mglu and 
Yx, asp, were also found significant, suggesting the dependence of the dead cell concentration 
on aspartate and glutamate levels. In addition to βibax, additional apoptosis-related parameters: 
βiC3, kC3, k_bax, kbax and kbibax, were found significant (Table 7.3.7-B). 
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The results from the further evaluation of Stot with respect to the mAb titre was similar 
to the previous shown result, where αab was the most significant parameter to the mAb 
concentration (Table 7.3.8-A). This analysis also showed that βiC3, kC3, kbax and βibax were 
significant to the mAb titre (Table 7.3.8-B).  
  It is worth discussing about the contribution of higher order effects on the Stot. As can 
be seen from the above shown results, the sensitivities of several significant parameters, such 
as  Yx, asp, Yx, asn, fasp, asn, k_bax, kbax and kbibax contained a large portion of sensitivities contributed 
by the higher order effects. The parameters with the high percentage parameter interactions 
(higher order effects) tend to be unidentifiable since the effect of these parameters on a 
particular model variable can be compensated by the effects of other parameters that these 
parameters interact with. However, the effect of the parameter interactions must be evaluated 
based on how significant it is to the model variables. It was suggested that the higher order 
effects were counted as “significant” if its sensitivities is larger than 0.1 (Vanrolleghem et al., 
2015). Therefore, if the higher order effects are found significant, the corresponding parameters 
will be considered as unidentifiable. In this study, the presented significant parameters, 
however, contained less than 0.1 total sensitivities of the higher order effects.          
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Table 7.3.5 The total sensitivity indices (TSIs) with respect to the viable cell concentration: A) ±25% simultaneous variation of metabolism sub-
model parameter values while 5% simultaneous variation of the reaming parameter values; and B) ±50% simultaneous variation of apoptosis 
sub-model parameter values while 5% simultaneous variation of the reaming parameter values. The analysis was performed with 60,000 
simulations. Coloured cells are the parameter sensitivities being over the Stot threshold (≥ 0.1).    
 
      
 
Stot  
(% interaction) 
with respect to viable cell concentration (XV) 
 Potential  
significant 
parameters 
Culture time (hours) 
Exponential 
phase 
Stationary 
phase 
Death phase 
24 48 60 72 96 120 
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d
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Yx, glu  
0.08 
(0.62) 
0.09 
(0.38) 
0.07 
(0.23) 
  
mglu  
0.30 
(2.56) 
0.41 
(0.61) 
0.35 
(1.45) 
  
fglu, gln  
0.06 
(14.96) 
0.07 
(3.49) 
0.06 
(9.65) 
  
Yx, asp     
0.20 
(19.20) 
0.24 
(6.76) 
Kmasp, asp      
0.05 
(18.18) 
fasp, asn     
0.10 
(28.21) 
0.13 
(18.13) 
Yx, asn      
0.07 
(54.13) 
Yala, glu  
0.12 
(17.83) 
0.13 
(2.94) 
0.12 
(7.67) 
  
Ygln, glu  
0.11 
(19.55) 
0.11 
(2.12) 
0.09 
(6.22) 
  
Stot  
(% interaction) 
with respect to viable cell concentration (XV) 
 Potential  
significant 
parameters 
Culture time (hours) 
Exponential 
phase 
Stationary 
phase 
Death phase 
24 48 60 72 96 120 
A
p
o
p
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si
s 
S
u
b
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o
d
el
 
βiC3   
0.07 
(3.77) 
0.10 
(2.63) 
0.14 
(1.68) 
0.19 
(1.17) 
kC3  
0.08 
(4.61) 
0.11 
(4.38) 
0.13 
(4.15) 
0.11 
(1.90) 
0.09 
(2.14) 
βibax  
0.15 
(7.09) 
0.29 
(4.87) 
0.40 
(2.85) 
0.46 
(1.03) 
0.46 
(1.97) 
k_bax   
0.07 
(13.74) 
0.08 
(10.73) 
0.07 
(10.96) 
0.06 
(21.40) 
kbax  
0.07 
(17.45) 
0.09 
(13.07) 
0.10 
(9.86) 
0.08 
(6.04) 
0.06 
(11.89) 
kbibax   
0.07 
(25.24) 
0.07 
(16.86) 
0.08 
(6.78) 
0.07 
(13.54) 
βmRNAtrp53
bp2 
0.08 
(100.0) 
     
A) B) 
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Table 7.3.6 The total sensitivity indices (TSIs) with respect to the ESA cell concentration: A) ±25% simultaneous variation of metabolism sub-
model parameter values while 5% simultaneous variation of the reaming parameter values; and B) ±50% simultaneous variation of apoptosis 
sub-model parameter values while 5% simultaneous variation of the reaming parameter values. The analysis was performed with 60,000 
simulations. Coloured cells are the parameter sensitivities being over the Stot threshold (≥ 0.1).    
 
      
 
 
 
 
 
 
Stot  
(% interaction) 
with respect to ESA cell concentration (Xad) 
 Potential  
significant 
parameters 
Culture time (hours) 
Exponential 
phase 
Stationary 
phase 
Death phase 
24 48 60 72 96 120 
A
p
o
p
to
si
s 
S
u
b
-m
o
d
el
 
βiC3 
0.06 
(2.21) 
0.09 
(2.43) 
0.10 
(2.10) 
0.11 
(2.10) 
0.11 
(2.18) 
 
kC3 
0.26 
(2.45) 
0.18 
(3.14) 
0.16 
(2.04) 
0.14 
(1.84) 
0.10 
(6.11) 
 
kC8 
0.07 
(20.31) 
     
βibax 
0.17 
(8.79) 
0.36 
(3.41) 
0.41 
(1.15) 
0.44 
(1.00) 
0.45 
(7.54) 
0.24 
(71.64) 
k_bax 
0.13 
(21.02) 
0.11 
(12.29) 
0.10 
(9.21) 
0.09 
(10.88) 
0.08 
(32.68) 
0.05 
(100.0) 
kbax 
0.29 
(18.95) 
0.16 
(10.21) 
0.13 
(5.44) 
0.11 
(5.87) 
0.09 
(26.02) 
0.07 
(100.0) 
kbibax 
0.06 
(40.70) 
0.09 
(21.21) 
0.08 
(10.40) 
0.07 
(7.15) 
0.07 
(29.33) 
0.07 
(100.0) 
βmRNAtrp53
bp2 
     
0.06 
(100.0) 
Kmatf5, 
bcl2 
0.06 
(99.90) 
     
Stot  
(% interaction) 
with respect to ESA cell concentration (Xad) 
 Potential  
significant 
parameters 
Culture time (hours) 
Exponential 
phase 
Stationary 
phase 
Death phase 
24 48 60 72 96 120 
M
et
a
b
o
li
sm
 S
u
b
-m
o
d
el
 
Yx, glu   
0.06 
(0.87) 
0.07 
(0.36) 
  
mglu  
0.05 
(14.64) 
0.25 
(1.80) 
0.32 
(0.77) 
  
fglu, ala    
0.05 
(2.03) 
  
Yx, asp      
0.20 
(18.86) 
Kmasp, asp      
0.06 
(37.98) 
fasp, asn      
0.13 
(18.13) 
Yx, asn      
0.09 
(39.09) 
Yala, glu   
0.09 
(8.34) 
0.11 
(2.48) 
  
Ygln, glu   
0.08 
(7.99) 
0.09 
(2.35) 
  
A) B) 
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Table 7.3.7 The total sensitivity indices (TSIs) with respect to the dead cell concentration: A) ±25% simultaneous variation of metabolism sub-
model parameter values while 5% simultaneous variation of the reaming parameter values; and B) ±50% simultaneous variation of apoptosis 
sub-model parameter values while 5% simultaneous variation of the reaming parameter values. The analysis was performed with 60,000 
simulations. Coloured cells are the parameter sensitivities being over the Stot threshold (≥ 0.1). 
   
Stot  
(% interaction) 
with respect to dead cell concentration (Xd) 
 Potential  
significant 
parameters 
Culture time (hours) 
Exponential 
phase 
Stationary 
phase 
Death phase 
24 48 60 72 96 120 
M
et
a
b
o
li
sm
 S
u
b
-m
o
d
el
 
Yx, glc 
0.35 
(0.20) 
0.17 
(0.58) 
    
Ylac, glc 
0.35 
(1.91) 
0.23 
(1.86) 
0.10 
(2.14) 
   
Ylac, con 
0.17 
(0.29) 
0.10 
(0.37) 
    
mglu   
0.07 
(5.47) 
0.15 
(2.57) 
  
Yx, asp    
0.22 
(6.47) 
0.32 
(4.64) 
0.20 
(3.15) 
 
0.15 
(31.27) 
Kmasp, asp      
0.05 
(51.13) 
fasp, asn      
0.12 
(53.22) 
Yx, asn      
0.10 
(85.76) 
Yala, glu    
0.05 
(7.16) 
  
Stot  
(% interaction) 
with respect to dead cell concentration (Xd) 
 Potential  
significant 
parameters 
Culture time (hours) 
Exponential 
phase 
Stationary 
phase 
Death phase 
24 48 60 72 96 120 
A
p
o
p
to
si
s 
S
u
b
-m
o
d
el
 
βiC3  
0.07 
(4.13) 
0.09 
(3.51) 
0.11 
(2.50) 
0.14 
(1.47) 
0.19 
(1.08) 
kC3 
0.13 
(1.18) 
0.16 
(11.05) 
0.15 
(8.80) 
0.14 
(6.26) 
0.11 
(2.88) 
0.09 
(2.42) 
βibax 
0.07 
(7.06) 
0.33 
(15.52) 
0.39 
(10.05) 
0.43 
(5.32) 
0.47 
(1.38) 
0.46 
(1.60) 
k_bax 
0.05 
(10.59) 
0.13 
(31.88) 
0.11 
(23.20) 
0.09 
(15.50) 
0.07 
(11.39) 
0.06 
(19.32) 
kbax 
0.13 
(16.99) 
0.17 
(33.47) 
0.14 
(24.09) 
0.11 
(14.58) 
0.08 
(6.20) 
0.07 
(10.54) 
kbibax  
0.12 
(48.49) 
0.11 
(36.14) 
0.10 
(22.93) 
0.08 
(7.51) 
0.07 
(10.73) 
A) B) 
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Table 7.3.8 The total sensitivity indices (TSIs) with respect to the mAb concentration: A) ±25% simultaneous variation of metabolism sub-
model parameter values while 5% simultaneous variation of the reaming parameter values; and B) ±50% simultaneous variation of apoptosis 
sub-model parameter values while 5% simultaneous variation of the reaming parameter values. The analysis was performed with 60,000 
simulations. Coloured cells are the parameter sensitivities being over the Stot threshold (≥ 0.1).  
  
      
 
 
 
 
 
Stot  
(% interaction) 
with respect to mAb concentration (mAb) 
 Potential  
significant 
parameters 
Culture time (hours) 
Exponential 
phase 
Stationary 
phase 
Death phase 
24 48 60 72 96 120 
M
et
a
b
o
li
sm
 S
u
b
-
m
o
d
el
 
Yx, asp        
0.16 
(20.11) 
fasp, asn      
0.10 
(46.95) 
Yx, asn      
0.08 
(86.91) 
αab 
0.98 
(0.01) 
0.96 
(0.03) 
0.94 
(0.08) 
0.87 
(0.13) 
0.27 
(0.34) 
0.09 
(16.47) 
Stot  
(% interaction) 
with respect to  mAb concentration (mAb) 
 Potential  
significant 
parameters 
Culture time (hours) 
Exponential 
phase 
Stationary 
phase 
Death phase 
24 48 60 72 96 120 
A
p
o
p
to
si
s 
S
u
b
-m
o
d
el
 
βiC3     
0.08 
(2.91) 
0.12 
(1.42) 
kC3    
0.05 
(5.86) 
0.10 
(3.69) 
0.10 
(2.51) 
βibax   
0.05 
(15.17) 
0.14 
(7.52) 
0.31 
(2.73) 
0.38 
(1.29) 
k_bax     
0.06 
(9.47) 
0.06 
(8.82) 
kbax 
0.10 
(99.93) 
0.09 
(94.06) 
0.10 
(80.69) 
0.10 
(61.17) 
0.10 
(33.39) 
0.09 
(22.48) 
kbibax     
0.06 
(13.40) 
0.06 
(7.79) 
A) B) 
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 The relation between the other model variables and their corresponding parameters was 
also revealed. Table 7.3.9 summarises significant and insignificant parameters with respect to 
corresponding model variables. Generally, most of parameters that were mathematically 
related to the corresponding variables were found significant as respect to these variables. For 
example, the yield of cells over glucose (Yx, glc) and the yield of lactate over glucose (Ylac, glc) 
were found significant with respect to glucose and lactate concentrations, respectively. 
However, there were also parameters that were not found significant to model variables, though 
they were mathematically associated. For examples, the aspartate and asparagine associated 
maintenance energy constants (masp and masn) were not significant parameters with respect to 
aspartate and asparagine concentrations, respectively. 
 The results from GSA pave the way for the further model modification. The 
identification of significant and insignificant parameters indicate model identifiability. Given 
that insignificant parameters have minor effect on the model total variation, these parameters 
tend to be unidentifiable since their estimates can be any values without severely affecting the 
model output (Ho et al., 2006). Significant parameters are most likely identifiable, nevertheless, 
some of them could be unidentifiable if they were found to have interactions with other 
parameters. Further model modifications will be performed in a direction that avoids having 
unidentifiable parameters in the model. For example, according to the results, the maintenance 
energy constants (i.e. masp and masn) could be considered to be removed or refined. However, 
this action will have to be justified with the negligible overall effects on the model 
reproducibility. The GSA will be re-performed for the refined mathematical model.   
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Table 7.3.9 Significant and insignificant 
parameters with respect to the 
corresponding model variables. The 
parameter significance was judged based 
on Stot values being larger than 0.1. The 
Stot was achieved from the further 
evaluation of parameter sensitivities as 
discussed earlier.  
 
 
Model variables Significant parameters Insignificant parameters  
M
et
a
b
o
li
sm
 S
u
b
-m
o
d
el
 
Glc Yx, glc,  Yx, asp,  Yx, asn,  fasp, asn Kmglc, asp 
Glu Yx, glu,   mglu, Yala, glu,  Ygln, glu fglu, ala,  fglu, gln,  fglu, asp,  fglu, arg,  Kmglu, glu 
Gln mglu,  Yala, glu,  Yx, gln,  Kmgln, gln,  Ygln, glu  fglu, gln,  mgln   
Lac Yx, glc,  Ylac, glc,  Ylac, con,  Yx, asp,  Yx, asn,  fasp, asn       klac, con 
Asp Yx, asp,  Yx, asn,  fasp, asn fglu, asp,  masp,  Kmasp, asp 
Asn mglu,  fglu, gln,  Yx, asp,  Yx, asn,  Kmasn, asp masn   
Arg mglu,  Yx, arg    fglu, arg,  marg,  Kmarg, arg 
Ala mglu,  fglu, gln,  Yala, glu,  Ygln, glu     Yx, ala,  mala,  Kmala, glu,  fglu, ala   
Leu Yx, leu,  mglu    mleu,  Kmleu, leu 
A
p
o
p
to
si
s 
S
u
b
-m
o
d
el
 
iCasp3 βiC3,  βibax,  βmRNAcasp3,  Kmtrp53bp2, bcl-2 KbiC3,  kC3 
Casp3 βiC3,  kC3,  βibax,  k_bax,  kbax,  Kbibax,  βmRNAcasp3 KbiC3   
Casp8 βiC8,  Kbbcl2 KbiC8,  kC8 
Bax4 βibax,  k_bax,  kbax,  Kbibax - 
iBax βibax,  kbax,  Kbibax k_bax,   
Bcl2 βibax,  kbax,  Kbibax βbcl2,  Kbbcl2 
mRNA casp3 βiC3,  βibax,  βmRNAcasp3,  Kmcasp3, iC3,  αmRNAcasp3     - 
mRNAcasp8 βmRNAcasp8,  αmRNAcasp8,  Kmlac, trp53bp2 Kmglu, casp8 
mRNAbax 
βmRNAbax, Kmtrp53bp2, bax,  Kmbcl-2, bax,  αmRNAbax,  
βmRNAbcl2 
- 
mRNAtrp53bp2 βmRNAtrp53bp2,  Kmglu, trp53bp2  αmRNAtrp53bp2 Kmlac, trp53bp2 
mRNAbcl2 
βmRNAbcl2, Kmtrp53bp2, bcl-2, αmRNAbcl2, βmRNAtrp53bp2, 
αmRNAtrp53bp2 
Kmbcl-2, bax 
mRNAatf5 βmRNAatf5,  Kmasp, atf5,  Kmab, atf5,  αmRNAatf5 - 
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7.4 Conclusions 
 
 This chapter aims to construct a first-principles and experimentally validated 
mathematical model for apoptosis in the GS-NS0 cell culture. Apoptosis was, previously and 
extensively, mathematically modelled; however, its dynamic and mechanistic behaviour as 
regards relevant cellular processes was not fully described. Our constructed mathematical 
model demonstrates that the mechanistic understanding of apoptosis and its links to cell growth 
and metabolism is well incorporated.  
 The constructed mathematical model consists of three sub-models describing cell 
growth, metabolism and apoptosis. The cell growth sub-model describes viable, apoptotic, and 
dead cell balances. Cell growth was assumed to be proportional to glutamate and glucose 
concentrations while apoptosis cell death was subject to the caspase-3 activation. The cell 
metabolism sub-model captures glucose and amino acid metabolism. Glucose consumption and 
the net lactate consumption/production were linked to the amino acid availability. Glutamate 
was assumed to be converted to glutamine as well as alanine. In the meantime, its production 
rate was subject to aspartate, alanine, arginine, and glutamine consumption. The synthesis of 
mAb was assumed to be dependent on asparagine and leucine concentrations. The 
transcriptional regulation of apoptosis was mathematically described in apoptosis sub-model. 
The activation of caspase-3 was assumed to be subject to active Bax as well as caspase-8 
activation which were also assumed to be governed by their transcriptional activities. The 
transcription of casp8, trp53bp2 as well as atf5 with its links to metabolic stresses due to 
changes in amino acid availability and the mAb synthesis was also included in this sub-model.  
 The proposed model showed a reasonably good fit for the experimental data from the 
batch and fed-batch cultures. It reproduced the observed cell growth and death, including viable 
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cell, ESA cell and dead cell concentrations, as well as glucose and amino acids metabolism 
over the cultivation period. However, the model provides a relatively pooper reproduction of 
the transcriptional control of apoptosis in the fed-batch culture given that the fed-batch culture 
experienced apoptosis in a difference manner to that in the batch culture where the apoptosis 
mathematical expression was constructed based on. The GSA was performed to reveal 
relationships between model variables and parameters. Significant parameters were mostly 
among those corresponding to model variables; μmax, glc and μmax, glu are significant parameters 
with respect to the viable cell concentration while the ESA and dead cell concentrations are 
highly dependent on μmax, ad, Kcasp3 and μmax. The results from the parameter sensitivity 
evaluation provide a crucial guide to refine the proposed model structure. Insignificant 
parameters could be considered to be removed from the mathematical model, though the model 
reproducibility has to be accordingly evaluated to justify the removal of unnecessary 
parameters.        
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8.1 Overall conclusions 
 
8.1.1 Summary of results 
 In this thesis, a combined computational and experimental approach was adopted to 
study apoptosis in the culture of GS-NS0 cell line producing cB72.3 mAb. A batch culture 
experiment was performed in order to pinpoint relationships between the metabolic stresses - 
which inherently occur in this mode of culture - and apoptosis. Interplay between cell cycle 
and apoptosis, and its effects on cell growth and metabolism was also explored. In addition, 
culturing condition studies; temperature shifts and medium content shifts, were conducted in 
order to investigate effects of these culturing conditions on the induction of apoptosis as well 
as its association with cell cycle and metabolism. A fed-batch culture experiment was later 
carried out in accordance with what was observed in the batch cultures. The feeding strategies 
employed were devised based on the identified limiting nutrients. The fed-batch cultures were 
aimed to validate experimental phenomena observed in the batch cultures. The fed-batch 
together with the batch experimental data were then utilised for the development of a 
mathematical model for apoptosis in mammalian cell cultures. The aim of the mathematical 
model was to describe the kinetics of growth and metabolism, and its association with the 
induction of apoptosis at the transcriptional level. Global sensitivity analysis (GSA) was then 
performed to evaluate model characteristics, and to thus allow further refining the structure of 
the model.  
 The observed results from the experiments conducted and the proposed mathematical 
model are summarised as follows: 
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 The batch culture experiment showed that there was a strong relationship among 
cell growth (cell cycle), metabolism, and the induction of apoptosis. Aspartate and 
glutamate were among first nutrients that became exhausted during the culture. It 
appeared that deprivation of these amino acids triggered metabolic shifts as well as 
apoptosis, as indicated by the transition from the alanine production phase to the 
consumption phase, and the simultaneously elevated level of apoptotic gene 
expressions, respectively. In addition, a relationship between the control of cell cycle 
and apoptosis was suggested, given that the increase in percentage of G1/G0 cells with 
the elevated p21 expression level was coincident with the increase in the early stage 
apoptotic (ESA) cell density. This experiment provides a map of cell proliferation, 
metabolism and apoptosis for the culture of GS-NS0 cells, indicating metabolic shifts 
as well as apoptosis and cell cycle-associated events occurring as regards culture 
phases. 
 The temperature shift experiment showed that mAb productivity was enhanced in 
the cultures with the temperature shifts (to both 35ºC and 39ºC), although there was 
no significant difference in final mAb titre in the biphasic hypothermic (35ºC) culture 
as compared to the monophasic batch culture at 37ºC. It appeared that apoptosis 
induction and cell growth were delayed by the hypothermic condition, while they 
were not significantly affected in the biphasic hyperthermic (39ºC) culture. In 
addition, the accumulation of cells at G2/M cell cycle phase was observed after the 
temperature shift to the hypothermic condition. Given the delayed apoptosis 
induction, this supports the hypothesis that cell growth arrest at this phase could be a 
survival mechanism against apoptosis.  
 The medium content experiment revealed the effect of medium content variation 
on the apoptosis induction. It appeared that pro-apoptotic genes, including trp53bp2, 
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casp8 and casp3, were up-regulated in the culture using 100% spent medium. The 
other cultures, which grew cells in the medium containing fractions of fresh medium, 
showed a higher cell growth and a lower ESA cell fraction, as compared to the 100% 
conditioned medium culture. The net lactate production was reduced in the culture 
with the medium containing fractions of conditioned medium, suggesting the 
presence of possible factors in the conditioned medium that could trigger the 
metabolic transition from lactate production to consumption. In addition, the 
observed apoptotic gene expressions and cyclin expression profiles elucidated the 
relationship between the induction of apoptosis and the control of cell cycle 
progression in response to the variation in the medium contents.  
 The fed-batch culture experiments demonstrated that the onset of apoptosis was 
delayed by the addition of nutrients, including glucose and amino acids. The down-
regulated expression of casp3 was observed in the culture with feeding 4 amino acids: 
glutamate, aspartate, asparagine and arginine. In addition, atf5, casp8 and trp53bp2 
expressions were also lower than those in the batch culture especially during the 
stationary phase of the cultures. Nevertheless, the fed-batch culture eventually 
underwent apoptosis as indicated by the increase in ESA and drop in viability during 
the death phase of the culture. This suggests that the addition of these nutrients could 
help reduce metabolic stresses arising from nutrient deprivation, however it could not 
completely prevent cells from apoptosis. In addition, the observed apoptosis in the 
fed-batch culture might progress without caspase-3 activation (as indicated by the 
down-regulated level of casp3 expression). It also appeared that the addition of these 
nutrients triggered lactate consumption, suggesting that changes in the concentration 
of these nutrients influence the metabolic activities in the TCA cycle.   
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 The mathematical model for apoptosis in the GS-NS0 cell culture captured 
apoptosis at the transcriptional level with its links to cell growth, death and 
metabolism. The model was the combination of unstructured and structured sub-
models, each of which described 1) cell growth and death, 2) glucose and amino acid 
metabolism, and 3) the transcriptional control of apoptosis. The model demonstrated 
a reasonably good reproducibility of the batch and fed-batch experimental data with 
a preliminary and unoptimised set of parameter estimates. Significant and in 
significant parameters to model output were identified through GSA. The parameter 
sensitivity analyses guide further model refinement required for improving model 
identifiability as well as reproducibility.  
8.1.2 Main conclusions 
 According the results obtained in this study, a number of conclusions can be drawn as 
follows: 
1) The metabolic shifts in the cultures of GS-NS0 cell line are subject to levels of amino 
acids, especially glutamate and aspartate. The shifts in alanine, lactate and ammonium 
concentration profiles can be treated as indicators of the change in directions of relevant 
metabolic fluxes in TCA cycle pathways. 
2) The expression level of atf5 can be treated as an indicator of the presence of metabolic 
stresses arising from the deprivation of amino acids and cell adaptation. The expression 
level of casp3, in contrast, can partially indicate the activation of apoptosis, given that 
apoptosis could be observed without the up-regulated level of caps3.          
3) The delay in apoptosis might not result in enhancing mAb productivity given the 
observed results in the batch and fed-batch cultures. Nevertheless, the final mAb titre 
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can be improved because the cultures can achieve a greater number of viable cells and 
a longer culture period due to the delayed cell death.   
4) The temperature shift to a hyperthermic condition can be applied to the culture of GS-
NS0 cell line to achieve a higher mAb productivity and final titre. However, the 
induction of apoptosis can be accelerated as a result of hyperthermia, causing shorter 
cultivation lifetime and lower viability. Therefore, the multiphasic culture which 
combines the hyperthermic temperature shift(s) with the hypothermic one(s)-which can 
prolong culture viability- could help further enhance the final mAb titre as well as mAb 
productivity. 
5) Cells experience adaptation to a lesser degree when they are seeded in the medium that 
contains a fraction (up to 50% based on the observation) of conditioned medium from 
previous sub-cultures. 
6) Given the observed results in all experiments, a balanced level between apoptosis cell 
death and cell cycle arrest could be the key to improve mAb productivity. The 
combination of optimised culture conditions, including culture temperature, medium as 
well as addition of limiting nutrients, could pave the way for the control of apoptosis in 
the mammalian cell cultures. 
7) The use of GSA can provide model behaviour as well as significance of parameters 
with respect to model output. Model parameters in the constructed mathematical model 
are most likely sensitive to their corresponding variables. However, this is not the case 
for some parameters. These insignificant parameters contribute to unidentifiability of 
the model and need to be refined.  
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8.2 Recommendations for future work 
 
 Based on the results and conclusions of this thesis, the following suggestions can be 
made for future research directions. 
8.2.1 Experimental investigations  
 Dynamic profiling of intercellular metabolites involves the quantification of 
intracellular metabolites of interest over the culture time. The observed results in the batch and 
fed-batch cultures demonstrated changes in extracellular concentration of glucose and amino 
acids, and also suggested possible metabolic reactions that could take place intracellularly. 
Therefore, the dynamic profiles of intracellular nutrient concentrations, such as glucose, 
lactate, and amino acids, can complement what was experimentally observed in this study, and 
can also validate the proposed reaction networks, the direction of the reactions, as well as 
metabolic shifts, as suggested in Chapter 5 & 6. The dynamic profiling of intercellular 
metabolites can be performed using high-performance liquid chromatography (HPLC) 
according to the previous studies (Dietmair et al., 2010, Kyriakopoulos et al., 2013).   
 Quantification of apoptotic proteins is certainly essential for the study of apoptosis 
given their roles in apoptotic pathways. In this study, transcriptional regulation of apoptosis in 
response to metabolic stresses was predominantly investigated. Additionally, in the constructed 
mathematical model, the levels of apoptotic proteins were assumed to be directly dependent on 
their corresponding gene expressions. Therefore, the quantification of apoptotic proteins can 
help confirm the effect of metabolic stresses on the induction of apoptosis, and validate the 
proposed reaction networks among apoptotic genes and proteins as well as the assumptions 
made for the apoptosis model construction. Apoptotic proteins can be quantified with several 
analytical techniques, including Flow cytometer, ELISA and Western blotting.   
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 Identification and evaluation of cells death via other pathways than apoptosis can 
be a major breakthrough in the mammalian cell cultures. This study focused on cell death via 
apoptosis, however, cells can die via other pathways than apoptosis depending on the culture 
and physiological conditions. Necrosis is another mode of cell death, which can be recognised 
by specific morphological and physiological characteristics, such as cell swelling, dilution of 
cytosols, and loss of cell membrane integrity (Cobb et al., 1996, Lecoeur et al., 2001). It can 
be induced by non-physiological severe injuries, such as high concentration of toxic 
metabolites (Singh et al., 1994, Mercille and Massie, 1994a), heat shock, and oxidative stresses 
(Lecoeur et al., 2001). However, some of its makers are similar to those of late stage apoptosis 
(LSA), making it difficult to distinguish between them (Darzynkiewicz, 1998, Riccardi and 
Nicoletti, 2006). In addition, autophagy, which is also considered as a stress-response 
mechanism, was reported to be induced by glucose and amino acid deprivation (Hwang and 
Lee, 2008, Glick et al., 2010, Jardon et al., 2012). The role of autophagy still remains inclusive 
(Ramírez-Peinado et al., 2013, Munoz-Pinedo and Martin, 2014), although it was reported to 
actually protect cells from apoptosis (Han et al., 2011, Jardon et al., 2012). Previous studies 
also suggested that there is a strong relationship between cell death (necrosis and apoptosis) 
and autophagy, and they are actually occurring simultaneously in the culture in order to 
maintaining systems’ homeostasis (Thorburn, 2008). These facts attest the necessity to study, 
in addition to apoptosis, necrosis and autophagy in the mammalian cell cultures. Given the 
production of the recombination was enhanced by suppressing autophagy (Jardon et al., 2012), 
it is interesting to investigate its effect on cell growth and metabolism as well as its association 
with necrosis and apoptosis.     
 
 
Chapter 8 : Overall Conclusions and Future Research Directions 
~ 270 ~ 
8.2.2 Mathematical modelling and its applications 
 Further model refinement is certainly essential for the model development. It will be 
performed in accordance with the analyses obtained from GSA. The extension of global 
sensitivity analysis (i.e. identifying higher order terms in details, further exploring parameter 
sensitivity with respect to all model variables) might be also conducted in order to gain more 
details of parameter sensitivities and interactions among parameters. The first-principle 
mathematical model will be refined in a way that 1) unnecessary parameters could be removed, 
and 2) model identifiability could be improved, while maintaining reasonable model 
reproducibility.  
 Model enhancement involves including further relevant cellular processes into the 
existing mathematical model. In this study, the model focuses on apoptosis and its links to cell 
growth and metabolism. Cell cycle progression is a basic biological mechanism that underlies 
cell proliferation. It also has a strong relation to apoptosis, and its regulation has effects on 
mAb production and mAb quality. The combined cell cycle and apoptosis model can be used 
for the study of dynamics of interrelation between them, and the investigation of their combined 
effects on culture viability and productivity.  
 Parameter estimation and model validation involve iterative steps that are required 
to assure model validity and predictability. The steps consist of 1) optimal experimental design, 
2) experimentation, 3) parameter estimation, and 4) model validity evaluation (Kontoravdi et 
al., 2010, Kiparissides et al., 2011a). Significant parameters are identified by performing GSA 
with the refined mathematical model. Based on identified significant parameters and possible 
variables that can be treated as degrees of freedom (such as feeding volume, feeding time, 
temperature shift time etc.), an optimally-designed experiment can be computationally 
generated. The experimentation is conducted in accordance with the designed experiment. The 
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values of significant parameters are then estimated based on the experimental data obtained 
from the designed experimentation. The 95% confidence intervals falling within ±10% of the 
parameter estimates suggest the validity of the model, otherwise the parameter estimates are 
not considered valid and the whole process will be repeated. The predictability of the validated 
model can be further checked with independent sets of experiments. 
 Model-based applications employ the predictive and experimentally-validated 
mathematical model, which is achieved from the parameter estimation and model validation, 
to simulate/predict various scenarios in the corresponding biological systems. Process control 
and optimisation is one of examples of model-based applications. An optimal feeding strategy 
can be computationally postulated using the model. The model can be also useful for the scale-
up of mammalian cell cultures. The information of the difference between lab-scale (250 mL 
working volume) and large-scale (>10 L working volume) cultures can be achieved through 
simulations. Finally, automated mammalian cell cultures indeed require optimisation software 
with a predictive mathematical model in order to real-time generate an optimal strategy to 
control of culture conditions, such as temperature and feeding schemes, in response to online 
measurement data. 
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A.1 Apoptotic cell population quantification 
For the data acquisition in LSRFortessa cell analyser, the fluorescent laser 
configuration was set as follows: an excitation wavelength of 488 nm for Annexin-V-FITC and 
of 561 nm for PI and with a 530/30 nm and a 610/20 nm collection filters, respectively. In this 
study, the fluorescence compensation is required since there are more than two staining colours 
in the assay. It helps cancel out the “spillover”, caused by that one colour has the fluorescence 
emission range overlapping with the fluorescent detection range of another staining colour 
(Roederer, 2000). Therefore, the single colour stained cells together with unstained cells were 
treated as controls and used for the compensation.   
 
Figure A.1.1 Side scatter (SSC) VS. Forward scatter (FSC) diagram of an unstained sample 
with a gate to include viable and dead cell populations. 
Forward scatter (FSC) and side scatter (SSC) were exploited to generally distinguish 
(viable and dead) cells from tiny debris, as shown in Figure A.1.1. The signal level of FSC is 
Possible viable 
cell population 
Possible tiny 
debris 
Possible dead 
cell population 
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proportional to the size of cell, while the SSC refers to the intracellular structure (Milner et al., 
1996). This gate was applied to all samples and controls.   
 
(A)             (B) 
Figure A.1.2 The histograms of the single stained samples, (A) Annexin V FITC and (B) PI. 
The single stained samples; Annexin-V-FITC and PI, were analysed through their 
histograms, where the frequency of counts (cells) was plotted against the intensity of the 
specific fluorescence according to the staining colour. As can be seen in Figure A.1.2, there is 
a clear separation between the two populations; Annexin-V-FITC (A) and PI (B) positive, and 
Annexin-V-FITC negative and PI negative populations, respectively. The intensity value of the 
florescence, where the two populations were separated, was used to locate the gate to separate 
viable cells, apoptotic cells, and damaged cells in the next step. The compensation was 
computationally created using Flowjo with the data obtained from unstrained and single stained 
samples. The compensation was then applied to all unknown samples to avoid the possible 
false-positive/negative results caused by the “spillover” of the emission and collection 
fluorescence wavelengths. 
It is worth mentioning here that flow cytometry records pulse signals when particles 
pass through the laser light. This signals can be collected by three options: height (the peak), 
~1.5 to 2 × 103 ~0.9 to 1 × 103 
Annexin-
V-FITC 
Positive 
PI 
Positive 
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area (the integral of the pulse signal) and width (the duration). It is believed that the dot plot of 
FSC width versus FSC area helps discriminate among cell populations by the difference in their 
size, such as doublets from singlets (Wersto et al., 2001), because the width signal can be 
directly proportional to the particle diameter (Tzur et al., 2011). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A.1.3 The workflow of the quantification of apoptotic population fractions; (A) the 
first gate applied to the double stained sample; (B) the dot pot of FSC width versus FSC area 
to differentiate between populations by the diameter size; (C) and (D) quad gates used to 
separate the four populations.  
C 
D 
A 
B 
Cell death via 
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Cell death via 
Apoptosis 
Early stage 
apoptotic cells 
Damaged cells 
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In this analysis, the dot plot of FSC width versus FSC area was applied to separate 
potential swollen cells from normal and shrunk cells (Figure A.1.3-B). Then, both separated 
sub-populations were gated into four populations (Figure A.1.3-B&C); 1) Annexin-V-FITC 
and PI negative, or viable cells; 2) Annexin-V-FITC positive and PI negative, or ESA cells; 3) 
Annexin-V-FITC and PI positive, or dead cells; 4) Annexin-V-FITC negative and PI positive, 
or damaged cells. The quad gate was placed at the intensity values obtained from the single 
stained samples as previously shown; around 1.5 × 103 of 488 nm wavelength for Annexin-V-
FITC and 0.9 × 103 561 nm wavelength for PI. The difference between the two sub-populations 
is that the swollen cells with both Annexin-V-FITC and PI positive (Figure A.1.3-C) was 
treated as “cell death by other pathways than apoptosis”, since, for example, cell swelling is 
one of key morphological changes of necrotic cells (Cobb et al., 1996, Meshram et al., 2012). 
The normal size and shrunk cells with both staining positive were treated as cell death via 
apoptosis. 
A.2 Cell cycle analysis 
Figure A.2.1 DNA analysis with gates: (A) the dot plot of SSC versus FSC; and (B) the 
histogram showing the events against 561 nm fluorescence intensity. 
DNA in viable 
cells 
(A) (B) 
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The wavelength used for the data acquisition in the LSRFortessa cell analyser was at 
561nm for excitation with a 582/15 nm collection filter, when PI solution was used to stained 
DNA. The data obtained were then analysed in Flowjo. The first gate introduced to the dot plot 
of SSC versus FSC, aims to include mostly DNA in viable cells as cell cycle is a proliferation 
process, as shown in Figure A.2.1-A. Figure A.2.1-B shows a histogram of the sup-population 
obtained from the first gate. Another gate was allocated to the histogram in order to crop-out 
possible debris and dead cell populations, as can be seen in Figure A.2.1-B.   
 
Figure A.2.2 Watson Algorithm (Watson et al., 1987) used to quantify the fraction of each 
sub-populations; G1/G0, S and G2/M. 
To identify each cell cycle phase sub-population, the gated DNA histogram was 
analysed using a well-established algorithm provided by Flowjo. There are two choices of the 
algorithms: 1) Watson and 2) Dean-Jett-Fox. The latter comes with a mathematical model to 
estimate the S phase population while the former has no assumption, but replicate the histogram 
curve. In this study, Watson algorithms was selected as it realistically capture the s phase 
population (Figure A.2.2). The G1/G0 phase population was identified as the first peak of the 
histogram. Given that cells at G2/M have theoretically double amount of DNA to the G1/G0, 
the G2/M population in the histogram can be also estimated when the G1/G0 one is identified. 
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In this analysis, a constraint of G2 = approx.1.9 times of G1 was used estimate the G2/M 
population. 
A.3 Cyclin quantification 
The stained samples were analysed using the LSRFortessa flow cytometer (BD 
Biosciences). Data acquisition was performed using an excitation wavelength and emission 
filters for data collection as shown in Table A.3.1. 
Table A.3.1 Flow cytometers configurations. 
 
 Once cell cycle was analysed, the bivariate plot between DNA content and cyclin 
fluorescence was then generated, as shown in Figure A.3.1. There are two gates: one is around 
the isotype-stained area indicating non-specific binding; the other is above the isotype area 
indicating the positive expression of cyclins (Figure A.3.1). These gates were then applied to 
the DNA content of each phase of cell cycle. The expression of both isotype and cyclin-positive 
in each phase of cell cycle was compared. The cyclin that has the lowest expression at a 
corresponding phase was used as a reference expression; cyclin D1, E1 and B1 expressions 
were assumed to be minimal in the S, G2/M and G1/G0, respectively. The expression of cyclins 
at a specific phase was normalised to the reference, enabling the cyclin quantification by 
comparison.   
 
Stains Excitation wavelength (nm) Emission filters (nm/nm) 
PI (DNA) 
FITC (cyclins) 
561 
488 
582/15 
530/30 
FxCycle (DNA) 
FITC (cyclins) 
PE (Ki-67) 
405 
488 
561 
450/50 
530/30 
582/15 
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Figure A.3.1 Data analysis for cyclin 
quantification. Adapted from (García 
Münzer, 2014). 
 
 
 
A.4 The estimation of gene expression using ∆∆CT approach  
As described earlier, the data were collected at the end of each thermal or PCR reaction 
cycle. The highly fluorescent marker (SYBR®), which is attached to the PCR product during 
the reactions, enables us to “real-time” monitor the quantity of the PCR product (in the form 
of fluorescence intensity) as respect to the increasing number of cycles. The plot between the 
cycle number and the net fluorescence intensity (∆Rn) is called “amplification plot”, as shown 
in Figure A.4.1-A&B. There are three main phases of the plots: 1) linear-ground or lag phase 
(I), 2) exponential phase (II), and 3) linear or plateau phase (III). A threshold value of the 
fluorescence intensity was manually set in the region of the exponential phase (II), as 
previously reported (Karlen et al., 2007). Setting the threshold value enables us to obtain the 
threshold cycle (CT), which is the number of cycle required to achieve the threshold value of 
the PCR product quantity. The logarithm plot of the amplification curve is preferable since the 
exponential phase is easier to be identified (Figure A.4.1-B). The CT value is used for the 
estimation of gene expressions using the ∆∆CT comparative method.       
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 The ∆∆CT comparative approach presents the gene expression in the form of relative 
fold change, which takes into account 1) the internal control expression (i.e. a housekeeping 
gene such as gapdh) and the reference sample expression (i.e. the sample at the beginning of 
the culture). After CT values were obtained, the following equations were employed to estimate 
the relative fold change of unknown samples (Livak and Schmittgen, 2001).  
Eq. A.4.1 The estimation of ∆CT 
∆CT, g=i, t=j = CT, g=i, t=j - CT, gapdh, t=j 
Where, “g” is gene and “t” is time point (CT,i,j is CT value of gene “i” at time “j”). 
Eq. A.4.2 The estimation of ∆∆CT 
∆∆CT, g=i, t=j  = ∆CT, g=i, t=j - ∆CT, g=i, t=0 
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Figure A.4.1 The amplification 
plot and the threshold cycle 
(CT) value; (A) the linear scale, 
and (B) the logarithm scale of 
the net fluorescence intensity. 
For example, The CT value is 
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Eq. A.4.3 The estimation of relative fold change 
Relative fold change* = 2-∆∆CT  
*The calculation assumed that all PCR reactions exhibited equally efficient DNA amplification. 
 
The estimation of standard deviation (SD) of the expression was also performed along 
with the relative fold change of gene expression calculation. Since the real-time PCR was 
carried out in duplicate for each replicate, two CT values were averaged for a CT value of a 
gene at a time point of each culture replicate (Table A.4.1). The calculation of ∆CT and ∆∆CT 
involves the number with SD. Therefore, the SD of the outputs was estimated using Equation 
A.4.4. Table A.4.1 shows an example of the calculation of ∆∆CT of atf5 expression at 23 hour 
with its deviation. 
Eq. A.4.4 The summation of number with standard deviation  
(C ± dC) = (A ± dA) ± (B ± dB)  C = A ± B,  dC ≈ √dA2 + dB2 
Table A.4.1 The estimation of ∆∆CT value of atf5 gene at time = 23 hours of a culture replicate.  
Time 
(hr) 
Gene dupli 
cate 
CT Mean 
CT 
SD 
CT 
Mean 
∆CT  
SD 
∆CT 
Mean 
∆∆CT  
SD 
∆∆CT 
0 
atf5 
1 26.95 26.93 0.025 7.939 0.0432 0.00 0.0611 
2 26.91  0.018     
gapdh 
1 19.02 18.99 0.035 - - - - 
2 18.97       
23 
atf5 
1 27.99 27.97 0.020 9.423 0.0693 1.485 0.0816 
2 27.96       
gapdh 
1 18.60 18.55 0.066 - - - - 
2 18.50       
 
The ∆∆CT values from each culture replicate were averaged (Table A.4.2). The SDs of 
the ∆∆CT replicate averages were determined in the same way as Eq. A.4.4. Then, the relative 
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fold change of a gene expression at a time point was estimated using Equation A.4.3 with the 
∆∆CT replicate means. The deviation of the resulting relative fold change arises from the value 
of 2-∆∆CT+SD∆∆CT  and 2-∆∆CT-SD∆∆CT . Table A.4.2 shows an example of the calculation of the 
relative fold change of atf5 expression at 23 hour with its deviation.  
Table A.4.2 The estimation of average atf5 expression relative fold changes for all culture 
replicates at time = 23 hours. 
Time 
(hr) 
Flask 
Mean 
∆∆CT 
SD 
∆∆CT 
Mean 
of 
Mean 
∆∆CT 
SD of 
SD 
∆∆CT 
Mean 
2-∆∆CT 
Max. 
2-∆∆CT−𝑺𝑫 
Min. 
2-∆∆CT+𝑺𝑫 
0 
A 0.000 0.0446 
0.000 0.121 1.00 1.087 0.920 B 0.000 0.0943 
C 0.000 0.0611 
23 
A 1.706 0.1368 
1.624 0.198 0.33 0.372 0.283 B 1.680 0.1179 
C 1.485 0.0816 
 
A.5 Calibration curve construction for amino acid quantification 
Free amino acids in samples from the cultures were analysed using the HPLC system 
with the pre-column derivatization as described earlier in Chapter 4. To quantify the amino 
acids in the samples, a series of amino acid standard dilutions was constructed. It was analysed 
using the same procedure as that for the unknown samples. Table A.5.1 shows a series of amino 
acid standard dilutions where the concentrations of amino acid standards were consecutively 
diluted (by 50% from the 3rd dilution). The amino acid standard (Sigma-Aldrich, AAS18-
10X1ML) do not include several amino acids: L-asparagine (Sigma-Aldrich, 51363), L-
tryptophan (Sigma-Aldrich, 51145) and L-glutamine (Sigma-Aldrich, 76523). The solution 
form of these amino acids is not relatively stable at room temperature. They were, therefore, 
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prepared in a high concentration (22.5 mM in dH2O) and then mixed with the standard, as 
shown in Table A.5.1. Then, the dilution was conducted by adding 0.1 N HCl as indicated in 
Table A.5.1.  
Given that the concentration of amino acids in fresh medium is not greater than 1.0 
mM, calibration curves were constructed based on the data of up to the 3rd dilution. The 
injection of the standard dilutions was performed at least two times; before and after the 
analysis, to confirm the reproducibility. The absorbance data was recorded as the form of 
multiple-peak curves or chromatograms. Each peak represents each derivative, or implicitly 
each amino acid corresponding to its derivative. Areas under each peak were determined using 
OpenLAB Chromatography Data System C.01.04 (Agilent Technologies). Then, the plot 
between the area and concentration was created. Figure A.5.1 shows a plot between four key 
amino acid standards, glutamate, aspartate, asparagine and arginine, at different dilutions, and 
the area under corresponding peaks. Linear regression was applied to the data to relate the 
concentration of amino acid standards with the areas. Table A.5.2 summarises the linear 
correlations between the areas under the peaks and the concentrations of all the amino acids of 
interest. 
 
Figure A.5.1 The plot of the amino acid concentrations versus the corresponding areas under 
peaks. The linear lines represent the correlations between the concentrations and the areas.  
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Table A.5.1 A series of amino acid standard dilutions. 
Dilutions 
ta
ke
 
(µ
L
) 
1st  
Dil. 
ta
ke
 
(µ
L
) 
2nd   
Dil. 
ta
ke
 
(µ
L
) 
3rd   
Dil. 
ta
ke
 
(µ
L
) 
4th   
Dil. 
ta
ke
 
(µ
L
) 
5th   
Dil. 
ta
ke
 
(µ
L
) 
6th   
Dil. 
ta
ke
 
(µ
L
) 
7th   
Dil. 
ta
ke
 
(µ
L
) 
8th 
Dil. 
Amino acids 
Concentration  
(mM) (mM) (mM) (mM) (mM) (mM) (mM) (mM) (mM) 
L-Alanine 2.5  
 
 
 
 
 
 
 
 
 
 
 
900 
  
  
  
  
  
  
  
  
  
   
1.875  
 
 
 
 
 
 
 
 
 
 
 
 
 
800 
  
  
  
  
  
  
  
  
  
  
  
  
1.5  
 
 
 
 
 
 
 
 
 
 
 
 
 
600 
  
  
  
  
  
  
  
  
  
  
  
   
0.9  
 
 
 
 
 
 
 
 
 
 
 
 
 
500 
  
  
  
  
  
  
  
  
  
  
  
  
0.45  
 
 
 
 
 
 
 
 
 
 
 
 
 
500 
  
  
  
  
  
  
  
  
  
  
  
   
0.225  
 
 
 
 
 
 
 
 
 
 
 
 
 
500 
  
  
  
  
  
  
  
  
  
  
  
  
0.113  
 
 
 
 
 
 
 
 
 
 
 
 
 
500 
  
  
  
  
  
  
  
  
  
  
  
  
0.0563  
 
 
 
 
 
 
 
 
 
 
 
 
 
500 
  
  
  
  
  
  
  
  
  
  
  
  
0.028 
NH4Cl 2.5 1.875 1.5 0.9 0.45 0.225 0.113 0.0563 0.028 
L-Arginine 2.5 1.875 1.5 0.9 0.45 0.225 0.113 0.0563 0.028 
L-Aspartic Acid 2.5 1.875 1.5 0.9 0.45 0.225 0.113 0.0563 0.028 
L-Cystine 1.25 0.9375 0.75 0.45 0.225 0.113 0.056 0.0281 0.014 
L-Glutamic Acid 2.5 1.875 1.5 0.9 0.45 0.225 0.113 0.0563 0.028 
Glycine 2.5 1.875 1.5 0.9 0.45 0.225 0.113 0.0563 0.028 
L-Histidine 2.5 1.875 1.5 0.9 0.45 0.225 0.113 0.0563 0.028 
L-Isoleucine 2.5 1.875 1.5 0.9 0.45 0.225 0.113 0.0563 0.028 
L-Leucine 2.5 1.875 1.5 0.9 0.45 0.225 0.113 0.0563 0.028 
L-Lysine 2.5 1.875 1.5 0.9 0.45 0.225 0.113 0.0563 0.028 
L-Methionine 2.5 1.875 1.5 0.9 0.45 0.225 0.113 0.0563 0.028 
L-Phenylalanine 2.5 1.875 1.5 0.9 0.45 0.225 0.113 0.0563 0.028 
L-Proline 2.5 1.875 1.5 0.9 0.45 0.225 0.113 0.0563 0.028 
L-Serine 2.5 1.875 1.5 0.9 0.45 0.225 0.113 0.0563 0.028 
L-Threonine 2.5 1.875 1.5 0.9 0.45 0.225 0.113 0.0563 0.028 
L-Tyrosine 2.5 1.875 1.5 0.9 0.45 0.225 0.113 0.0563 0.028 
L-Valine 2.5 1.875 1.5 0.9 0.45 0.225 0.113 0.0563 0.028 
(add) L-asparagine 22.5 100 1.875 1.5 0.9 0.45 0.225 0.113 0.0563 0.028 
(add) L-tryptophan 22.5 100 1.875 1.5 0.9 0.45 0.225 0.113 0.0563 0.028 
(add) L-glutamine 22.5 100 1.875 1.5 0.9 0.45 0.225 0.113 0.0563 0.028 
Adding 0.1 N HCl  0 add 200 add 400   500   500   500   500   500   
total  1200  1000  1000  1000  1000  1000  1000  1000  
remaining 
 400  400  500  500  500  500  500  1000  
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Table A.5.2 The linear correlations between the areas under the peaks and the concentrations 
of corresponding amino acids, where [Amino acid Conc.] = A × [Peak area] + B. 
Amino 
acid 
A B R2 
Amino 
acid 
A B R2 
Aspartate 0.0038 -0.0093 0.9947 Tyrosine 0.0033 -0.0041 0.9999 
Glutamate 0.0034 -0.0037 0.9993 Cystine 0.0019 -0.0033 0.9998 
Asparagine 0.0033 -0.0040 0.9997 Valine 0.0032 -0.0095 0.9996 
Serine 0.0032 -0.0003 1.0000 Methionine 0.0031 -0.0045 0.9999 
glutamine 0.0032 -0.0023 0.9999 Tryptophan 0.0032 -0.0027 0.9999 
Histidine 0.0038 0.0037 0.9999 Phenylalanine 0.0032 -0.0040 0.9998 
Glycine 0.0031 0.0057 0.9999 Isoleucine 0.0031 -0.0059 0.9997 
Threonine 0.0033 -0.0046 0.9999 Leucine 0.0031 -0.0061 0.9997 
Arginine 0.0030 0.0018 0.9999 Lysine 0.0017 0.0118 0.9982 
Alanine 0.0031 -0.0048 0.9997     
 
A.6 Calibration curve construction for mAb quantification 
A series of mAb standard dilutions is required to construct a calibration curve for the 
mAb quantification. The mAb standard (8.76 mg/mL) was kindly provided by Lonza Biologics 
(Slough, UK). It was consecutively diluted by a factor of 2 as shown in Table A.6.1; from 8.76 
mg/mL or 8760 mg/L to 8.554688 mg/L. PBS was used to dilute the standard. Since the 
concentration of mAb in samples ranges from around 15 mg/L possibly up to 300 mg/L, the 
dilutions used to construct the calibration curve were from the 4th (D4) to the 10th dilution 
(D10). The dilutions were injected, detected and analysed using the same procedure/method to 
that of samples, as described earlier in Chapter 4. The injection of the dilutions was performed 
twice to confirm its reproducibility. The area under peak was estimated using OpenLAB 
Chromatography Data System C.01.04 (Agilent Technologies). Figure A.6.1 shows the linear 
correlation between the area under the peak and the concentration of mAb. The linear 
regression shows an excellent fit for the measure data (R2 > 0.99). The linear correlation was 
used to estimate the concentration of mAb in samples.  
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Table A.6.1 A series of mAb standard dilutions. 
 
 
 
 
 
 
 
 
Figure A.6.1 The calibration curve for mAb quantification. 
A.7 Examples of cell culture descriptive parameter estimation  
The integral of viable cells (IVC) and the specific cell growth rate were determined 
according to Eq. 4.4.1 as previously described in Chapter 4. IVC was used to estimate other 
cell culture parameters, including specific consumption/production rates of extracellular 
y = 0.282129306x + 9.381895662
R² = 0.999528048
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Dilutions mg/mL mg/L  
D0 8.76 8760  
D1 4.38 4380  
D2 2.19 2190  
D3 1.095 1095  
D4 0.5475 547.5  
D5 0.27375 273.75  
D6 0.136875 136.875  
D7 0.068438 68.4375  
D8 0.034219 34.21875  
D9 0.017109 17.10938  
D10 0.008555 8.554688  
Working dilutions 
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nutrients, metabolites and mAb. To determine these parameters, plots between IVC (x-axis) 
and the extracellular concentration of nutrients, mAb and metabolites (y-axis) were created. As 
can be seen in Figure A.7.1, the specific consumption rate of aspartate were obtained from the 
linear regression line for the data. The slope of the line represents the specific consumption 
rate, where the unit of the slope is the unit of Y-axis; µmole.mL-1, over the unit of x-axis; 
106 cell.mL-1.hr = µmole.10-6 cell.hr-1.  
 
 
Figure A.7.1 The estimation of specific consumption rates (slope) of aspartate in each phase 
of a culture replicate: (I) early exponential, (II) exponential, (III) stationary and (IV) death 
phases. 
The data were divided into culture phases: early exponential (I), exponential (II), 
stationary (III) and death phases (IV). The slope of the linear regression line in each phase, 
therefore, represents the specific consumption/production rate in each culture phase, as can be 
seen in Figure A.7.1. The mean value of the culture parameters and their SD were estimated 
from the culture parameter of each culture replicate. Table A.7.1 shows an example of the 
estimation of the mean specific consumption rate of aspartate and the SD from all culture 
replicates.  
Culture 
phase 
Slope 
Early 
exponential 
(I) 
-0.0174 
Exponential 
(II) 
-0.0093 
Stationary 
(III) 
0.0004 
Death  
(IV) 
-8.00E-5 
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
0 10 20 30 40 50 60 70 80 90
m
M
IVC (106 cell. mL-1.hr)
Specific consumption rate of aspartate
(flask A)
I II IV III 
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Table A.7.1 The average value of the specific consumption rate of aspartate (µmol.10-6 cell. 
day-1) from all culture replicates and its standard deviation. 
    
The yield of lactate over glucose was also determined using the graphical method. 
Instead plotting against IVC, the concentration of lactate produced (y-axis) was plotted against 
the glucose consumed (x-axis). The slope of the linear regression line in the plot stands for the 
yield of lactate over glucose. This was performed for all culture replicate (flask A, B and C) to 
determine the mean yield and its SD, as similar to the one for the specific 
consumption/production rates. 
A.8 F-statistic calculation 
Degrees of freedom can be simply estimated from the data size. Table A.8.1 shows the 
data of p21 expression in the batch culture.  
Table A.8.1 p21 expression in the batch culture. 
 
 
 
 
 
Culture phase 
Specific consumption rate  
( µmol.10-6 cell. day-1) 
Flask A Flask B Flask C Average SD 
Early exponential (I) -0.6505 -0.6969 -0.8219 -0.4165 0.0511 
Exponential (II) -0.4070 -0.3641 -0.3953 -0.2239 0.0128 
Stationary (III) 0.0142 0.0147 0.0209 0.0095 0.0022 
Death (IV) 0.0013 -0.0058 -0.0052 -0.0019 0.0022 
Time 
(hr) 
Group Mean SD Size 
0 1 1.00 0.03 3.00 
23 2 1.03 0.06 3.00 
45 3 1.18 0.03 3.00 
69 4 0.93 0.26 3.00 
93 5 3.17 0.27 3.00 
116 6 3.74 0.28 3.00 
139 7 2.40 0.17 3.00 
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As you can see from Table A.8.1, there are 7 groups (k) and the total sample size is 
equal to 7×3 = 21.  
Therefore, the degrees of freedom between groups = k-1 = 7-1 = 6, while the degrees of 
freedom within groups = N-k = 21-7 = 14. (Note that the total degrees of freedom = N-1 = 20). 
The mean squares (MS) are calculated from the degrees of freedom (DF) and the sum of 
squares (SS) of both one between groups and one within the groups. The overall mean is 
calculated from the sum of the group means divided by the number of groups, which is equal 
to 1.92 as can be seen from Table A.8.2. The SS within the groups is estimated from the sum 
of sample variances, or the square of the samples SDs multiplied by the DF of the 
corresponding groups. The MS within the groups is the SS within the groups divided by the 
DF within the groups, as can be seen at the column 3 in Table A.8.2. The MS between groups 
is estimated according to Eq. 4.4.3 which is based on the variance among sample means from 
the overall mean, as you can see from the column 4. The F-statistic is shown in the column 5 
which is the MS between groups over MS within groups.  
Table A.8.2 F-statistic calculation. 
Group Mean SS within SS between F 
1 1.00 0.00 2.54 116.07 
2 1.03 0.01 2.40  
3 1.18 0.00 1.63  
4 0.93 0.14 2.93  
5 3.17 0.14 4.65  
6 3.74 0.15 9.89  
7 2.40 0.06 0.69  
Total  0.50 24.73  
 Overall mean MS within     MS between 
 1.92 0.04 4.12  
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B.1 Raw data of batch and fed-batch mAb quantification 
Table B.1.1 Batch culture raw data of mAb quantification. 
N/A indicates that samples were not available due to missing during storage. 
Table B.1.2 F1 Fed-Batch culture raw data of mAb quantification. 
 
 
Time 
(hours) 
Flask A 
(mg/L) 
Flask B 
(mg/L) 
Flask C 
(mg/L) 
Mean 
(mg/L) 
SD 
(mg/L) 
0 N/A 14.03 13.05 13.54 0.69 
8 16.77 19.10 17.43 17.77 1.20 
23 18.68 19.15 19.22 19.02 0.29 
31 20.10 21.14 21.07 20.77 0.59 
45 20.71 N/A 22.26 21.49 1.10 
54 27.07 N/A 28.07 27.57 0.70 
69 37.10 N/A 38.93 38.01 1.29 
79 33.24 N/A 34.01 33.63 0.54 
93 42.66 N/A 47.36 45.01 3.32 
101 56.91 60.92 58.20 58.68 2.05 
116 58.95 N/A 61.60 60.27 1.87 
126 67.73 N/A 74.33 71.03 4.67 
139 73.87 84.25 83.66 80.59 5.83 
148 75.21 84.13 90.39 83.24 7.63 
Time 
(hours) 
Flask A 
(mg/L) 
Flask B 
(mg/L) 
Flask C 
(mg/L) 
Mean 
(mg/L) 
SD 
(mg/L) 
0 19.04 19.42 18.74 19.07 0.34 
23.5 24.08 23.64 23.69 23.80 0.24 
34.5 26.15 27.91 27.44 27.17 0.91 
47.5 33.41 33.19 33.22 33.27 0.12 
58 40.13 39.88 39.06 39.69 0.56 
71.5 48.62 47.47 48.29 48.13 0.59 
82 56.68 56.43 56.82 56.64 0.20 
95.5 67.57 65.49 67.77 66.94 1.26 
106 76.45 75.83 75.10 75.79 0.68 
119.5 83.62 83.20 86.58 84.47 1.84 
131 95.61 88.88 96.48 93.66 4.16 
144.5 100.83 100.70 101.26 100.93 0.30 
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Table B.1.3 F2 Fed-Batch culture raw data of mAb quantification. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Time 
(hours) 
Flask A 
(mg/L) 
Flask B 
(mg/L) 
Flask C 
(mg/L) 
Mean 
(mg/L) 
SD 
(mg/L) 
0 18.84 18.55 18.55 18.64 0.17 
23 23.79 23.25 24.20 23.75 0.48 
35.5 30.90 29.93 29.54 30.13 0.70 
47 37.31 36.55 36.38 36.75 0.49 
58.5 48.38 48.57 47.99 48.32 0.30 
71 56.91 59.02 59.37 58.43 1.33 
83.5 69.93 75.50 70.30 71.91 3.11 
95 76.99 77.28 77.18 77.15 0.15 
108 80.91 81.87 82.92 81.90 1.01 
119 77.31 85.35 86.10 82.92 4.87 
131.5 85.10 86.41 85.29 85.60 0.71 
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B.2 Supplementary figures 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure B.2.1 Lactate and glucose metabolism in the temperature shift experiment: A) lactate 
and glucose concentration profiles; and B) lactate yields over glucose. The vertical dot line 
represents the temperature shifts, the arrows indicate the corresponding axes to the data (n=3, 
error bar = SD). 
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Figure B.2.2 Scatter plots between p21 and cyclins in the medium shift experiment: A) p21 
and cyclin D1 expressions; B) p21 and cyclin E1 expressions; and C) p21 and cyclin B1 
expressions. FM is fresh medium and the dash dot lines represent the basal expressions. All 
relative expressions were normalised to time 0 hour (n=3, error bar = SD).  
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Figure B.2.3 Scatter plots between trp53bp2 and cyclins in the medium shift experiment: A) 
trp53bp2 and cyclin D1 expressions; B) trp53bp2 and cyclin E1 expressions; and C) trp53bp2 
and cyclin B1 expressions. FM is fresh medium and the dash dot lines represent the basal 
expressions. All relative expressions were normalised to time 0 hour (n=3, error bar = SD).  
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Figure B.2.4 The concentration profiles of glutamine in the batch & fed-batch cultures. F1 
and F2 represent the feeding strategies as described in section 6.2.3. (n=3, error bar = SD). 
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B.3 The statistical analysis results  
Table B.3.1 p-values from the statistical analysis in Figure 6.3.6. 
Figure  p-values 
6.3.6-A 
*1 0.047 
*2 <0.001 
*3 0.003 
*4 0.023 
6.3.6-B 
*1 0.014 
*2 0.005 
*3 - 
*4 0.001 
6.3.6-C  
0.440(0%) 
0.993(50%) 
0.226(100%) 
6.3.6-D 
*1 0.013 
*2 0.05 
*3 0.023 
*4 0.009 
 
Table B.3.2 p-values from the statistical analysis in Figure 6.3.11. 
 
 
 
 
 
 
 
 
Figure  p-values 
6.3.6-E 
*1 0.031 
*2 0.001 
*3 0.007 
*4 0.001 
6.3.6-F 
*1 0.018 
*2 0.003 
*3 <0.001 
*4 <0.001 
Figure  p-values 
6.3.11-E 
*1 0.007 
*2 0.028 
*3 0.018 
*4 0.004 
*5 0.022 
*6 <0.001 
6.3.11-F 
*1 0.034 
*2 0.003 
*3 <0.001 
*4 <0.001 
*5 0.03 
*6 <0.001 
6.3.11-G 
*1 <0.001 
*2 <0.001 
*3 0.018 
*4 <0.001 
Figure  p-values 
6.3.11-A 
*1 <0.001 
*2 0.001 
*3 <0.001 
*4 <0.001 
6.3.11-B 
*1 0.025 
*2 0.01 
*3 0.011 
*4 <0.001 
*5 0.023 
6.3.11-C 
*1 <0.001 
*2 <0.001 
*3 <0.001 
6.3.11-D 
*1 <0.001 
*2 0.004 
*3 <0.001 
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B.4 The optimal set of parameter values 
Table B.4.1 An optimal values of model parameters determined using the quasi-Monte Carlo 
algorithm with the minimisation of the total percentage error. 
    No Parameters (unit) Old values  Optimised values  
C
el
l 
g
ro
w
th
 s
u
b
-m
o
d
el
 
1 μmax, glc (hr-1) 2.80E-02 4.77E-02 
2 Kglc (mM) 3.90E+01 2.25E+01 
3 μmax, glu (hr-1) 1.70E-02 1.85E-02 
4 Kglu (mM) 1.00E-01 1.61E-01 
5 μmax, ad (hr-1) 3.83E-02 4.26E-02 
6 Kcasp3 (mM) 1.01E+00 1.86E+00 
7 μmax, nd (hr-1) 1.13E-02 2.31E-02 
8 Klac (mM) 1.03E+02 1.48E+02 
9 μmax, d (hr-1) 1.57E+01 3.14E+01 
10 kd (hr-1) 6.26E-05 1.31E-04 
M
et
a
b
o
li
sm
 s
u
b
-m
o
d
e
l 
11 Yx, glc (cells/mmol) 4.00E+05 5.47E+05 
12 mglc (mmol.cells-1.hr-1) 5.14E-07 8.01E-07 
13 Kmglc, asp(mM) 1.00E-02 1.64E-02 
14 Ylac, glc (mmol/mmol) 2.50E+00 4.50E+00 
15 klac, con (mmol.cells-1.hr-1) 1.50E-07 1.77E-07 
16 Kmlac, asp(mM) 1.00E-02 2.15E-02 
17 Yx, glu (cells/mmol) 6.05E+06 8.58E+06 
18 mglu(mmol.cells-1.hr-1) 8.87E-09 1.32E-08 
19 Kmglu, glu(mM) 1.00E-01 2.11E-01 
20 fglu, ala (mmol/mmol) 5.00E-01 7.36E-01 
21 fglu, gln (mmol/mmol) 5.00E-01 8.91E-01 
22 fglu, asp (mmol/mmol) 5.00E-01 1.00E+00 
23 fglu, arg (mmol/mmol) 5.00E-01 7.69E-01 
24 Yx, asp (cells/mmol) 1.40E+06 2.60E+06 
25 masp(mmol.cells-1.hr-1) 8.00E-10 1.64E-09 
26 Kmasp, asp (mM) 2.00E-02 2.23E-02 
27 fasp, asn (mmol/mmol) 5.00E-01 9.21E-01 
28 Yx, asn (cells/mmol) 1.50E+06 2.20E+06 
29 masn(mmol.cells-1.hr-1) 1.00E-09 1.36E-09 
30 Kmasn, asp (mM) 9.00E-02 1.21E-01 
31 Yx, arg (cells/mmol) 2.50E+06 2.89E+06 
32 marg(mmol.cells-1.hr-1) 1.00E-09 1.49E-09 
33 Kmarg, arg(mM) 5.00E-02 8.30E-02 
34 Yx, ala (cells/mmol) 3.00E+06 6.43E+06 
35 mala(mmol.cells-1.hr-1) 3.50E-09 6.50E-09 
36 Kmala, glu (mM) 9.00E-02 1.46E-01 
37 Yala, glu (mmol/mmol) 1.60E+00 2.10E+00 
38 Yx, gln (cells/mmol) 7.00E+05 1.45E+06 
39 mgln(mmol.cells-1.hr-1) 2.00E-09 4.06E-09 
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40 Kmgln, gln(mM) 7.00E-02 1.19E-01 
41 Ygln, glu (mmol/mmol) 2.50E+00 4.17E+00 
42 Yx, leu (cells/mmol) 2.00E+06 2.21E+06 
43 mleu(mmol.cells-1.hr-1) 1.00E-09 1.55E-09 
44 Kmleu, leu(mM) 5.00E-02 7.49E-02 
45 αab (mg cells-1 hr-1) 3.96E-07 4.20E-07 
46 Kmmab, aa (mM) 1.00E-01 1.87E-01 
A
p
o
p
to
si
s 
su
b
-m
o
d
el
 
47 βiC3 (mmol.hr-1) 9.08E-03 1.67E-02 
48 KbiC3 (-) 2.00E-03 3.86E-03 
49 kC3 (L.mmol-1.hr-1) 3.58E+00 4.30E+00 
50 βiC8 (mmol.hr-1) 1.02E-03 1.53E-03 
51 KbiC8 (-) 1.45E-01 2.28E-01 
52 kC8 (L.mmol-1.hr-1) 1.12E-02 1.22E-02 
53 βibax (mmol.hr-1) 2.97E-03 3.82E-03 
54 k_bax (L.mmol-1.hr-1) 2.96E+00 5.55E+00 
55 kbax (L3.mmol-3.hr-1) 1.82E+00 2.89E+00 
56 Kbibax (-) 8.47E-01 1.26E+00 
57 βbcl2 (mmol.hr-1) 2.38E-04 4.98E-04 
58 Kbbcl2 (-) 1.30E+01 2.18E+01 
59 βmRNAcasp3 (hr
-1) 6.36E-02 8.54E-02 
60 Kmcasp3, iC3 (mM) 1.41E-01 2.37E-01 
61 αmRNAcasp3 (hr
-1) 1.25E-02 2.23E-02 
62 βmRNAbax (hr
-1) 1.11E-01 1.39E-01 
63 Kmtrp53bp2, bax (-) 6.27E-01 8.95E-01 
64 Kmbcl-2, bax (-) 7.00E-01 9.15E-01 
65 αmRNAbax (hr
-1) 1.81E-02 3.82E-02 
66 βmRNAbcl2 (hr
-1) 6.83E-01 1.31E+00 
67 Kmtrp53bp2, bcl-2 (-) 2.10E+00 2.65E+00 
68 Kmatf5, bcl-2 (-) 6.98E+00 9.78E+00 
69 αmRNAbcl2 (hr
-1) 1.97E-01 4.14E-01 
70 βmRNAtrp53bp2 (hr
-1) 4.68E-02 8.49E-02 
71 Kmlac, trp53bp2 (mM) 1.73E+00 2.93E+00 
72 Kmglu, trp53bp2 (mM) 1.00E-01 1.48E-01 
73 αmRNAtrp53bp2 (hr
-1) 2.01E-02 2.55E-02 
74 βmRNAatf5 (hr
-1) 3.82E-01 4.15E-01 
75 Kmasp, atf5 (mM) 2.29E-02 2.50E-02 
76 Kmab, atf5 (mg/L) 2.77E+01 5.26E+01 
77 αmRNAatf5 (hr
-1) 5.42E-02 9.43E-02 
78 βmRNAcasp8 (hr
-1) 9.46E-02 1.18E-01 
79 Kmglu, casp8 (mM) 1.21E-01 1.90E-01 
80 αmRNAcasp8 (hr
-1) 5.13E-02 8.20E-02 
 
